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Introduction 
 
 
1.1  Part one: Introduction 
 
1.1.1   Definition and classification of lignans 
 
Lignans are a class of secondary metabolites widely encountered in the plant kingdom. The term 
lignan was originally introduced by Harworth1 to describe a group of plant phenols whose 
structure was determined by union of two cinnamic acids residues or their biogenetic 
equivalents, linked ß,ß’ (fig. 1). 
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Fig. 1. General structure of lignans. 
Several hundred lignans have been discovered in different parts of various plants, including 
wooden parts, roots, leaves, flowers, fruits and seeds. The range of natural structures 
encountered is very diverse and can be exemplified with a proposed classification according to 
their skeleton2 (fig. 2). In spite of recognizing the distribution of lignans in plants their biological 
purpose in nature is still unclear in most cases. It is however known, that the accumulation of 
lignans in the core of trees is important for the durability and longevity of the species. Lignans 
are also assumed to function as phytoalexins, which provide protection for the plants against 
diseases and pests. In addition, they may participate in controlling the growth of the plants. From 
a pharmacological point of view, these compounds display a wide array of interesting biological 
activities and have a long and fascinating history beginning with their use as folk remedies by 
many different cultures. No longer only a matter of interest for botanists, the lignans have thus 
attracted the attention of various branches of medicine as well as the pharmaceutical industry and 
have been the target of intensive synthetic studies. During the last twenty years, a plethora of 
publications have appeared on the subject, including books 3 and numerous reviews.4 Continued 
research is currently focused on structure optimization of the active natural lignans to generate 
derivatives with superior pharmacological profiles as well as broader therapeutic scope.  
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Fig. 2. Classification of lignans.  
 
1.1.2   Biological and clinical properties 
 
A broad range of biological activities has been associated with lignans, including antitumor, 
antimiotic, antimicrobial and antiviral activities. The aryltetralin lactone, (–)-podophyllotoxin 
(1), has been under continued investigation due to its significant pharmacological activity (fig. 
3).  
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Fig. 3. Structure of (–)-podophyllotoxin. 
 
Podophyllin (an alcoholic extract from the roots and rhizome of may apple which contains as the 
main active ingredient podophyllotoxin) was considered such a popular cathartic and 
choalagogue in America that it was included in the U.S. pharmacopea. However, in 1942 it was 
removed from U. S. pharmacopea because of its severe gastrointestinal toxicity. Currently, it still 
remains an effective therapy for treatment of venereal warts.5 Furthermore, podophyllotoxin and 
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its derivatives have been extensively studied in the last 60 years for their powerful antitumor 
effects. Podophyllotoxin itself is a powerful microtubule inhibitor. Microtubules, which are the 
dynamic constituents of the cytoskeleton, could be defined as tubular polymers whose 
protomeric unit, consisting of α- and β-tubulins, forms a heterodimer. The cytoplasm of 
eukaryotic cells contains a soluble pool of unpolymerised tubulin protomers as well as an 
organised array of microtubules. Microtubules can be rapidly assembled or disassembled in 
response to various stimuli with little or no change in the total amount of tubulin.  
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Fig. 4. Structures of etoposide, teniposide and GL-331. 
 
Cytoplasmatic microtubules are implicated in an array of different processes as cellular mobility, 
intracellular transport, secretion, organization of cytoplasm and proteins growth factor 
signalling. The action of podophyllotoxin basically consists in disrupting the dynamic 
equilibrium of assembled and disassembled microtubules in vitro and in vivo. The net result is 
the destruction of the cytoskeletal framework in the cytoplasm and in the spindle fibres causing 
inhibition of cell division in the metaphase. As the result, the cell duplication at the miotic stage 
is impeded. However, since podophyllotoxin attacks both normal and cancerous cells, the toxic 
side effect has limited its application as a drug in cancer therapy. Therefore, analogs of 1 have 
been prepared in order to reduce its toxic properties and to enhance its pharmacological profile. 
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Particularly successful have been tenoposide (2) and etoposide (3), two semi-synthetic 
derivatives currently used in treatment of small cell lung cancer, testicular carcinoma, lymphoma 
and Kaposi´s sarcoma.6 Another podophyllotoxin derivative, GL-331 (4), was undergoing phase 
II clinical trials for treatment of various cancers7 (fig. 4). Antitumor activity has been observed 
in several other classes of lignans, including butyrolactones, for example burseran (5)8 and 
dibenzocyclooctadienes such as steganacin (6) or steganone (7)9 (fig. 5). Other dibenzo-
cyclooctadiene lignans, such as schinzandrin B,10 are responsible for the antihepatotoxic effects 
of some of chinese herbal remedies. Tetrahydrofuran lignans magnone A (8) and B (9)11 have 
been found active against the bioactive phospholipid PAF linked to various haematological 
responses, including aggregation and degranulation of platelets and neutrophils, which is also an 
important mediator of inflammation and asthma.  
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Fig. 5. Examples of biological active lignans. 
 
Finally, some lignans have also showed antimicrobial properties12 as well as synergic effects on 
a range of insecticides.13 
 
1.1.3   Biogenesis 
 
The biogenesis of lignans strictly relates to the production of the plant polymer lignin. Lignin is 
a constituent of the plant cell wall, which together with hemicellulose cements the cellulose 
microfibrils, thus connecting cells to one another and strengthening them. The chemical structure 
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of lignin challenged scientists for decades. Unlike what was initially thought it does not possess 
an easily hydrolysable linear array of repeating units but instead is a three-dimensional polymer 
incorporating many different stable carbon-carbon bonds and ether linkages between monomeric 
phenylpropane units. Lignans are presumed to be related to lignins due to the similarities of the 
precursors and processes involved in the biogenesis of both classes of compounds. However, 
differences undoubtedly exist between the two biosynthetic pathways because lignans are almost 
entirely optically active whereas no optical activity has been observed in lignins. Indeed, the first 
steps in the biosynthesis are common. A sequence of five reactions - deamination, aromatic 
hydroxylation, O-methylation, CoA-mediated ligation and NADPH mediated reduction converts 
phenylalanine to monolignols such as coniferyl alcohol.14 After this point the two-biogentic 
pathways diverge. Lignins are probably formed by random radical polymerization whereas 
enzyme catalysis is assumed to control the dimerization step of monolignols as well as the 
oxidation step in the biogenesis of lignans.  
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Scheme 1. Biosynthesis of lignans in Forsithya intermedia. 
 
The biosynthesis of lignans in plants has been established at least in the following cases: 
Forsythia intermedia Podophyllum peltatum, Thuja plicata and Linum Flavum.15 The pathway 
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involves a stereoselective coupling of two coniferyl alcohols (10) to afford (+)-pinoresinol (11) 
(Scheme 1). The protein responsible for defining the stereoselectivity of this process is not itself 
capable of performing the oxidation and therefore an additional oxidase is required. Sequential 
stereoselective reductions of (+)-pinoresinol give (+)-lariciresinol (12) and (−)-
secoisolariciresinol (13). Two isofunctional forms of reductase, which are responsible for this 
process, have been isolated. Both enzymes catalyse the sequential NADPH dependent 
stereospecific reduction of (+)-pinoresinol and (+)-lariciresinol and have similar kinetic 
parameters as well as molecular weights. Stereoselective dehydrogenation of (−)-
secoisolariciresinol yields (−)-matairesinol (14), which is considered to be the branch point 
leading to other important classes of lignans such as the podophyllotoxin series. 
 
1.1.4   Synthesis of lignans 
 
Lignans have long been recognised as challenging targets for organic synthesis due to their 
complex and diverse architectures as well as their important pharmacological properties. To date, 
much effort has been concentrated on the synthesis of naturally occurring and biologically active 
compounds in their enantio-enriched form as in most cases the biological properties vary 
between the enantiomers. The majority of approaches used in the synthesis of lignans can be 
divided in four general groups: 
 • Diastereoselective alkylation of chiral butyrolactones 
 • Diastereoselective conjugate addition to chiral 2-(5H)-furanones 
 • Routes involving cycloaddition reactions 
 • Routes involving the use of chiral oxazolidines 
 
1.1.4.1 Diastereoselective alkylation of chiral butyrolactones 
 
This is one of the earliest and most commonly utilized approaches, which focuses on the use of 
the chiral monobutyrolactone (15) as a springboard to different classes of lignans (scheme 2). 
Deprotonation of the monobutyrolactone 15 followed by diastereoselective alkylation or aldol 
reaction, permitted an efficient entry into the skeleton of functionalized dibenzobutyrolactones, 
which could be in a straightforward manner converted in other types of lignans. In the pioneering 
work of Koga and co-workers,16 the key building block 15 was originally synthesized by a 
multistep sequence starting from L-glutamic acid in modest enantiomeric excesses. Achiwa et 
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al.17 furnished a great improvement of this methodology by developing a very efficient catalytic 
asymmetric method to access the monobutyrolactone skeleton. 
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Scheme 2. Transformations of monobutyrolactone. 
 
Arylidenesuccinic acid mono-methyl esters (17), obtained by Stobbe condensation of dimethyl 
succinate and the corresponding substituted aldehydes, were enantioselectively hydrogenated 
using a neutral rhodium (I) complex of (4S,5S)-MOD-DIOP (16) (scheme 3). The corresponding 
(R)-arylmethylsuccinic acid monomethyl esters (18) were obtained in quantitative yields and in 
excellent optical purity (ee ≥ 93%). Moreover, virtually optically pure products could be 
obtained by a single recrystallization from isopropylether. Esters 18 were converted in (R)-
arylmethyl-γ-butyrolactones 19 according to the procedure developed by Brown.18 Doyle et al. 
investigated another very interesting catalytic approach,19 in which chiral dirhodium(II) 
carboxamidate catalysts controlled a highly enantioselective carbene insertion into the 
unactivated C-H bond of 3-aryl-1-propyl diazoacetate (21) (scheme 4). The diazoacetate species 
were obtained in high chemical yields from the corresponding cinnamic acids (20) by standard 
methods. Among the different Rh catalysts tested, particularly efficient results were obtained  
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Scheme 3. Asymmetric synthesis of monobutyrolactones by Achiwa et al. 
 
with Rh2(4S-MPPIM) and the corresponding enantiomer Rh2(4R-MPPIM) providing 
enantiomeric excesses ranging from 91-96%. 
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Scheme 4. Asymmetric synthesis of monobutyrolactones by Doyle et al. 
 
A very original strategy based on enantioselective deprotonation was used by Honda et al.20 The 
starting cyclobutanone 24 was prepared in two steps from safrole (23) by adopting a literature 
procedure (scheme 5). Enantioselective deprotonation of 24 was carried out using a chiral base, 
lithium (S,S´)-α,α´-dimethyldibenzylamide (25), at –100°C and the resulting enolate was trapped 
with triethylsilyl chloride to provide the silyl enol ether 26 in 77% yield. Compound 26 was 
further converted into γ-butyrolactone 27 by ozonolysis followed by sodium borohydride 
reduction of the ozonide. The optical purity of 27 was found to be as 80%. Costa et al. reported 
an efficient pathway utilizing a chiral auxiliary to enter the monobutyrolactone skeleton (scheme 
6).21 Carboxylic acid 28 was transformed into the corresponding acyl chloride and then esterified 
using a homochiral enantiomeric alcohol 29. The resulting ester 30 was deprotonated with LDA  
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Scheme 5. Asymmetric synthesis of monobutyroloactone by Honda and co-workers. 
 
and alkylated with piperonyl iodide providing the alkylated ester 31 in 62% yield and high 
diastereomeric excess (94% de). Ester 51 was reduced to the homoallylic alcohol 52 and finally 
converted into the desired lactone 29, in a one-pot oxidation step in the presence of sodium 
periodate and catalytic amount of potassium permanganate. Finally, Charlton and coworkers22 
demonstrated the use of oxazolidinones23 as an effective chiral auxiliary.  
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Scheme 6. Asymmetric synthesis of (R)-piperonyl-γ-butyrolactone by Costa and co-workers. 
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The commercially available (4R)-benzyl and (4S)-isopropyl-2-oxazolidinones were N-acylated 
with dihydrocinnamic acid to give N-acyloxazolidinones (33 and 34) in yields greater than 80% 
(scheme 7). Diastereoselective alkylation with tert-butylbromoacetate gave in each case 
principally only one diastereomer (35 and 36, respectively) (de ≥ 95%). The oxazolidinone 
moiety could be removed by means of LiOH-H2O2 without affecting the tert-butyl ester. The 
crude acid was reduced to the corresponding primary alcohol with BH3·THF, then turned into a 
lactone using TFA to afford the desired benzylbutyrolactones (37 and 27). 
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 Scheme 7. Asymmetric synthesis of monobutyrolactone by Charlton and co-workers. 
 
1.1.4.2   Diastereoselective conjugate addition to 2-(5H)-Furanones 
 
Koga et al. developed an alternative ex-chiral pool approach to access lignans, based on 
diastereoselective Michael addition to chiral butenolide 39 (scheme 8).24 Butenolide 39 was 
easily accessible starting form the chiral butanolide 38 via a two steps procedure consisting in 
phenylselenization of 38 and subsequent thermal elimination. Michael addition of 39 by a 
sulphur stabilized carbanion 40 followed by desulfurization and alkylation gave the disubstituted 
hydroxymethylbutanolide 41. Finally, successive reduction of 41 with LiAlH4, cleveage of the 
obtained 1,2-diol by NaIO4 and oxidation with Collins reagent provided dibenzylbutyrolactone 
42, the key intermediate in the first synthesis of (+)-steganacin25 (44). Feringa and coworkers26 
presented an efficient variant of the diastereoselective 1,4-addition utilizing 5-(menthyloxy)-
2(5H)-furanone (45) as chiral Michael acceptor (scheme 9). 
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Scheme 8. Asymmetric synthesis of (+)-steganacin by Koga. 
 
The enantiomerically pure 45 and its enantiomer, could be prepared in several gram scale from 
furfural and L- or D-menthol. The Michael addition of lithiated dithianes 46 with butenolide 45 
and subsequent quench of the resulting lactone enolate anions with different benzylbromides 
afforded, in tandem fashion, dibenzobutyrolactones 47 in good yields. Moreover, in every case 
only the single trans diastereomers was observed indicating complete stereocontrol in both steps. 
The synthesis was completed by desulfuration, removal of the chiral auxiliary via acetal 
hydrolysis, reduction of an aldehyde group and ring closure of the resulting alcohol to give γ-
lactones 48. The natural dibenzobutyrolactones were obtained in excellent overall yields and 
optical purity. Moreover this approach was extended to other groups for the synthesis of 
different types of lignans such as aryltetralines and dibenzocyclooctadienes.27 Bhat and co-
workers28 applied an asymmetric tandem Michel addition-aldol reaction using a novel chiral 
nucleophile, to achieve a very short synthesis of (–)-podophyllotoxin (1) (scheme 10).  
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Scheme 9. Asymmetric synthesis of dibenzobutyrrolactones by Feringa and coworkers. 
 
The S-(–)-piperonyl phenyl sulfoxide (49) was obtained from piperonal in four steps, which 
included chiral sulfoxidation via a modified Sharpless method reported by Kagan and 
coworkers.29 The tandem conjugate addition-aldol reaction was performed following Feringa´s 
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Scheme 10. Asymmetric synthesis of (–)-podophyllotoxin by Bath. 
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procedure providing adduct 50 in 60% yield. The cyclization step was accomplished by treating 
50 with trifluoroacetic acid and subsequent treatment with HgO and BF3·Et2O giving directly  
(–)-podophyllotoxin (1), albeit in low yield. 
 
1.1.4.3   Routes involving cycloaddition reactions 
 
Asymmetric Diels-Alder reactions have found widespread use in the total synthesis of complex 
natural products. However, only few examples have been reported as regard to their application 
towards the asymmetric synthesis of lignans. Charlton et al. used an asymmetric Diels-Alder 
reaction as a key step in the total synthesis of (–)-α-dimethylretrodendrin (58)30 (scheme 11).  
 
MeO
MeO
OMe
OMe
O
MeO
MeO
SO2
OH
OMe
OMe
OH
CO2R*
CO2R*
OMe
OMe
MeO
MeO
CO2Me
CO2H
OMe
OMe
MeO
MeO
OMe
OMe
MeO
MeO
O
O
OMe
OMe
MeO
MeO
O
O
R* =
Ph
H
CO2Me
1) pyridine,
    SO2, hν
2) 54, ZnO, 
     toluene,
     reflux
58
57 56
OH
MeO
MeO
OMe
MeO
7) t-BuONa,
t-BuOH,
51 52 53
55
54
44%
overall
94%
72% 97%
*RO2C
CO2R*
3) NaOMe,
    MeOH
4) H2, Pd/C
5) LiEt3BH,
6) p-TsOH, ∆
 
Scheme 11. Asymmetric synthesis of (–)-α-dimethylretrodendrin by Charlton 
13 
Introduction 
 
 
The aldehyde 51 was prepared in a three step sequence and in good overall yield starting from 
3,4-dimethoxybenzaldehyde. Irradiation of 51 in a benzene solution containing dissolved SO2 in 
excess, afforded the key intermediate 52. Thermolysis of 52 produced the diene 53 which could 
be trapped with chiral fumarate 54 yielding a mixture of diastereomers in a ratio of 9:1. Upon 
purification, the cycloadduct 55 was isolated in 44% yield. Lactonization of the secondary 
hydroxy group with γ-ester followed by transesterification and opening of the lactone were 
achieved in a one-pot reaction utilizing sodium methoxide in methanol to give acid ester 56 in 
excellent yield. Catalytic hydrogenation followed by reduction of the ester group and refluxing 
of the crude product in a benzene/p-toluenesulfonic acid mixture afforded the lactone 57 as sole 
product in 72% yield. Finally, epimerization of the C-2 carbon gave optically pure (–)-α-
dimethylretrodendrin (58). In addition, a modified version of this methodology was applied some 
years later to the synthesis of (–)-deoxypodophyllotoxin31 as well as other aryltetralines.32 Jones 
and co-workers33 achieved a very efficient synthesis of (–)-podophyllotoxin (1) based on an 
asymmetric Diels-Alder addition to 1-aryl-2-benzopyran-3-one.34  
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Scheme 12. Asymmetric synthesis of (–)-podophyllotoxin by Jones and co-workers 
 
The o-quinonoid pyrone 59 reacted smoothly when (5R)-menthyloxy-2(5H)-furanone (45) was 
used as dienophile (scheme 12). The cycloaddition proceeded with high facial selectivity as well 
as very high regioselectivity affording 60 as single isomer in 79% chemical yield. The 
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cycloadduct 60 underwent ring opening by treatment with acetic acid affording the acid 61 in 
87% yield. Hydrogenation followed by oxidation with lead tetraacetate converted 61 into the 
acetate 62. Finally a sequence of five steps completed the total synthesis of (–)-podophyllotoxin 
(1) in 15% overall yield starting from 59 and with 98% de. Pelter and coworkers employed a 
similar pathway in an asymmetric synthesis of (−)-isopodophyllotoxin.35 However the Diels–
Alder reaction performed using 45 as dienophile and an arylisobenzofuran specie as diene, 
resulted in a very complex mixture of products reducing drastically the synthetic utility of the 
reaction. 
 
1.1.4.4   Routes involving the use of chiral oxazolidines 
 
Meyers et al. pioneered the use of chiral oxazolidines to synthesize enantiomerically enriched 
lignans belonging to both the dibenzocyclooctadiene36 and aryltetralines37 series. In the first case 
(scheme 13), the chirality of the oxazolidine was used to induce diastereoselective coupling of 
the two aryl units 63 and 64 furnishing an axially dissymmetric biphenyl derivative 65. The two 
diastereoisomeric biphenils 65 were obtained in a 7:1 ratio which could be increased by 
separation on silica gel chromatography. The synthesis was completed using the major 
diastereomer, affording (−)-steganone (7) in 84% optical purity. The second use of chiral 
oxazolidines involved the asymmetric tandem addition of aryllithium reagents to a chiral 
naphthalene derivative to generate the fully functionalized skeleton of aryltetralines. 
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Scheme 13. Asymmetric synthesis of (−)-steganone by Meyers. 
 
This approach found an efficient application in the first asymmetric synthesis of (−)-
podophyllotoxin (1) (scheme 14). The key step consisted in an asymmetric addition performed 
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on chiral naphthalene 66 using trimethoxyaryllithium, affording approximately 92:8 ratio of 
diastereomer products 67. 
 
N
O
Me
MeO
O
O
1)Trimethoxyaryllithium78%
N
O
Me
MeO
O
O
OAc
OAc
Ar
de = 84%
CO2H
O
O
OTBDMS
Ar
O
7 steps
45%
O
O
Ar
OH
O
O
5.8%
16.5%
66
67 68
ee = 93%
1
Kende
synthesis
 
Scheme 14. Asymmetric synthesis of (−)-podophyllotoxin by Meyers. 
 
After a 7 step sequence lactone 68, an intemediate used by Kende in a synthesis of racemic 
podophyllotoxin,38 was generated in good chemical yield. The synthesis was therefore completed 
analogously to the Kende synthesis. After final recrystallization (−)-podophyllotoxin (1) was 
obtained in 5.8% overall yield and with 93% ee. 
 
1.1.5   α-Amino nitriles in organic synthesis 
 
α-Amino nitriles have played an important role in organic chemistry ever since Strecker´s 
original report in 1850 on the three components reaction, now bearing his name, between 
aldehydes, ammonia, and hydrogen cyanide.39 These bifunctional compounds have subsequently 
turned out to be versatile intermediates in a number of synthetic applications. The various modes 
of reactivity of α-amino nitriles are summarized in scheme 15. One mode of reactivity involves 
functional group interconversions of the nitrile group in which the original carbon atom 
connectivity is preserved. In historical terms, the hydrolysis of the nitrile group to generate α-
amino acids A, might be the most important use of α-amino nitriles. The Strecker synthesis and 
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subsequent nitrile hydrolysis is indeed a very convenient method for generating non-
proteinogenic α-amino acids. 
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Scheme 15. α-Amino nitrile reactivity. 
 
It is also possible to reduce the nitrile group using lithium aluminium hydride, providing a 
convenient method of preparing 1,2-diamines B. A second extremely valuable use of α-amino 
nitriles is as stable precursors to iminium ions, whereby loss of cyanide anion under a variety of 
conditions (e.g. use of silver salts, copper salts, Brønsted or Lewis acids and by thermolysis) 
generates an intermediate iminium species C which in turn may be trapped with nucleophilic 
reagents. Thus, the cyano group can be substituted by a hydrogen atom using a borohydride 
reagent or by a carbon chain using organometallic reagent as in the Bruylants reaction or by 
another carbon nucleophile to provide divers substituted amines D and E, respectively. A third 
mode of reactivity is formally a reversal in polarity (umpolung) at the α-carbon. When the α-
amino nitrile bears an α-hydrogen (R = H), it is possible to deprotonate it at this position using 
strong bases. The nucleophilic carbanion H generated can attack a number of different classes of 
electrophiles. This provides a new α-amino nitrile compound, which may in turn undergo any of 
the aforementioned transformations. For instance, hydrolysis of the resulting α-amino nitrile to 
the corresponding carbonyl compound J corresponds to a nucleophilic acylation, with the 
metallated amino nitrile acting as masked acyl anion equivalent. Alternatively, subsequent 
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replacement of the cyano group by hydrogen or a carbon-based group provides substituted 
amines. 
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Scheme 16. α-amino nitrile in asymmetric synthesis by Enders et al. 
 
Moreover the use of metallated α-amino nitriles as acyl anion equivalents open up the scope for 
asymmetric synthesis, if an enantiomerically pure chiral amine is employed as the α-amino 
group. This renders possible to carry out asymmetric acylation reactions at prochiral 
electrophilic centers as in 1,2-additions to aldehyde and 1,4-additions to α,β-unsaturated 
carbonyl compound. The results of the studies in this kind of asymmetric Umpolung process 
carried out within the Enders group40 over the past few years have been summarized in scheme 
16.  
 
1.1.6   The goal of the study 
 
Based on the previous work of Vivien Lausberg41 and Jochen Kirchhoff,40e who developed a 
general and efficient asymmetric route towards 2,3-disubstituted γ-butyrolactones, we aimed of 
extending this methodology to the asymmetric synthesis of lignans. We anticipated that the 
versatility and efficiency of this novel approach, utilizing a chiral aminonitrile as key 
nucleophile, would allow a straightforward access to all the main classes of lignans including 
furofurans, tetrahydrofurans, aryltetralines, and dibenzocyclooctadienes. 
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1.2   Part two: Introduction 
 
1.2.1   Importance and presence of α-(heteroaryl)alkylamines in nature 
 
Enantiomerically pure amines bearing a stereogenic centre in α-position are fundamental 
structures in organic chemistry. In particular, α-(heteroaryl)alkylamines play a crucial role as 
characteristic structural features in bioactive products and pharmacologically important 
compounds. For example, α-(2-furfuryl)alkylamines constitute the backbone of Nuphar 
alkaloids (fig. 6), whereas α-(3-pyridyl)alkylamines are common subunits in the Tobacco 
alkaloids. The potent antineoplastic agents dolastatin 1042 and vineramides43 are both linear 
peptides containing α-(2-thiazolyl)ethylamine units. In addition a broad range of synthetic 
products incorporating the α-(heteroaryl)alkylamine moiety display powerful and interesting 
biological activities and have been under investigation as potential therapeutic agents44 
(representative examples are reported in fig. 6). 
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Fig. 6. Natural and synthetic biologically active products containing α-(heteroaryl)alkylamine units. 
 
From a synthetic point of view, α-(heteroaryl)alkylamines have proven to be efficient chiral 
ligands in metal complex catalysis45 and furthermore they have been used as starting material in 
the synthesis of important compounds. Particularly interesting are the possible synthetic 
applications of α-(2-furyl)alkylamines 74: oxidative cleavage of the furan ring promoted by 
ozone or metallic oxides (path A, scheme 17), have found widespread application in the 
synthesis of α-aminoacids46 75. Moreover, the aza-Achmatovicz rearrangement47 (path B) offers 
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a straightforward entry into the piperidine skeleton and has thus been used in the synthesis of 
numerous alkaloids48 (77-79) and azasugars49 (80-81). 
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Scheme 17. Synthetic applications of α-(2-furyl)alkylamines. 
 
1.2.2   Asymmetric synthesis of α-(heteroaryl)alkylamines 
 
The broad utility of α-(heteroaryl)alkylamine derivatives has stimulated a relentless pursuit of 
practical asymmetric routes to these valuable compounds. Since the pioneering work of Smith 
and co-workers,50 which was based on a classical resolution of the racemate with an optically 
active acid, there has been a significant growth in this area and thus many reliable synthetic 
methods have been devised. The majority of approaches used in the synthesis of α-
(heteroaryl)alkylamines can be divided in three general classes: 
 • routes utilizing chiral auxiliaries 
 • routes utilizing ligand-induced stereoselectivity 
 • route utilizing enzymatic resolution  
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1.2.2.1   Routes utilizing chiral auxiliaries 
 
Most of the approaches using chiral auxiliaries are based on nucleophilic attack of 
organometallic reagents to imines bearing stereogenic N-substituents.51  
 
MeMe
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H2N H2N
Me Me
CO2Et
H2N
Me
H2N
Me
82 83 84 85  
Fig. 7. Structures of typical chiral auxiliaries. 
 
The enantiopure acyclic and cyclic imines can be prepared by condensation of a chiral amine, 
chosen as auxiliary, with the corresponding carbonyl compound. Frequently, the employed 
amines bear a second heteroatom, usually an O-atom, for possible chelation of the bidentate 
imine to rigidify the transition state of the 1,2-addition. Typical auxiliaries are β-
aminoalcohols, α-aminoacids derivatives and α-arylethylamines (fig. 7). 
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Scheme 18. Asymmetric synthesis of 1-(2-pyridyl)alkylamines by Savoia. 
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Based on the pioneering work of Takashi et al.,52 Savoia and co-workers applied (S)-valine 
derivatives as chiral auxiliaries in the asymmetric synthesis of (S)-1-(2-pyridyl)alkylamines. 
Although (S)-valinate53 (83) gave good results, O-trimethylsilylvalinol proved to be a superior 
chiral auxiliary54 (Scheme 18). The 2-pyridylimine was easily prepared by reaction of pyridine-
2-carboxaldehyde with (S)-valinol (82), which was converted into compound 87 by treatment 
with an equimolar amount of trimethylsilyl chloride. Allowing imine 87 to react with 2 
equivalents of Grignard or alternatively triorganozinc reagent afforded amines 88 in high yields 
and good to excellent diastereoselectivities. It is noteworthy that a great variety of different 
groups could be attached to the imine in efficient stereoselective fashion, the only two 
exceptions being the tert-butyl (de = 40%) and the benzylic group (de = 62%). Finally, the 
auxiliary was easily removed from the secondary amines by oxidative cleavage with periodic 
acid in the presence of methylamine providing the primary amines 89 in good yields. Attempts to 
extend this methodology to the synthesis of α-(2-furyl)alkylamines 92 met moderate success 
(scheme 19).46b  
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Scheme 19. Asymmetric synthesis of 1-(2-furyl)alkylamines by Savoia. 
 
The triorganozincate species displayed poor reactivity and only allylzinc bromide could be 
successfully reacted. Moreover, the use of Grignard reagent afforded poor selectivities, whereas 
the use of lithium species was limited to methyl-and phenyllithium.  
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Scheme 20. Asymmetric synthesis of N-protected α-(2-furyl)alkylamines by Zhou. 
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As part of an ongoing study directed towards the asymmetric synthesis of α-(2-
furyl)alkylamines,55 Zhou explored the use of (1S,2R)-2-amino-1,2-diphenylethanol and its 
enantiomer as chiral auxiliaries56 (scheme 20). Alkylation of chiral aldimine 93 with various 
cerium reagents yielded the amine derivatives 94 in high diastereoselectivities and excellent 
chemical yields. Interestingly, cleavage of the chiral auxiliary was demonstrated only in one case 
and moreover no chemical yield was reported. Another variation to access this class of 
compounds was developed by Harwood and co-workers57 (scheme 21). (S)-5-Phenylmorpholin-
2-one (96) was treated with a range of aliphatic aldehydes 97 to form enantioenriched iminium 
intermediates, which underwent diastereoselective Mannich reactions with 2-furylboronic acid 
(98) to afford the corresponding tertiary amines 99 in low to good yield and high 
diastereoselectivities. 
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Scheme 21. Asymmetric synthesis of N-protected α-(2-furyl)alkylamines by Harwood. 
 
The best results were obtained using linear aldehydes whereas α-branched aldehydes underwent 
sluggish reaction to furnish a single diastereomer albeit in extremely poor yield, possibly 
reflecting a more sterically congested situation. Finally, removal of the chiral template was 
achieved with some difficulty utilizing a six steps sequence to give the desired N-
toluensulfonylfurfurylamines 100 in moderate yield. In addition, simple chiral amines, such as 
(S)-1-phenylethylamine58 (84) or (S)-1-naphtylethylamine59 (85), have been employed as 
auxiliaries but the level of stereocontrol obtained was always moderate. Instead, good results 
were achieved by Moody and co-workes in an asymmetric synthesis of N-protected α-(2-
thiazolyl)alkylamines using chiral oxime ethers derived from (R)-O-(1-phenylbutyl)-
hydroxylamine60 (101) (scheme 22). The E oxime ethers 102 were prepared by condensation of 
101 with the appropriate aldehyde. In all the cases the Z-oxime ether was also formed but could 
be separated by chromatography. Treatment of 102 with 2-lithiothiazole in the presence of boron 
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trifluoride etherate gave hydroxylamines 103 in excellent yields and in general with good level 
of diastereoselectivity. The hydroxylamines were subsequentely converted into t-butoxycarbonyl 
protected amines 104. The conversion was achieved by N-O bond cleavage using the zinc / 
acetic acid / ultrasonic method61 followed by protection of the obtained primary amine with di-
tert-butyl dicarbonate. 
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Scheme 22. Asymmetric synthesis of N-protected α-(2-thiazolyl)alkylamines by Moody. 
 
Shiori and co-workers investigated a conceptually different approach based on an α-alkylation of 
chiral Schiff bases.62 The imines 106 were synthetized by condensation of (−)-(1S,2S,5S)-2-
hydroxy-3-pinanone (105) with primary amines (scheme 23).  
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Scheme 23. Asymmetric synthesis of N-protected α-(heteroaryl)alkylamines by Shiori. 
 
Deprotonation of the benzylic position of 106 followed by treatment with benzyl bromide 
afforded the alkylated products 107 in outstanding selectivity. Finally, removal of the chiral 
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auxiliary was achieved by treating 107 with hydroxylamine and subsequent protection, affording 
carbamates 108 in good overall yields. 
 
1.2.2.2   Routes utilizing ligand–induced stereoselectivity  
 
In the last twenty years the ligand-induced enantioselective synthesis has seen a tremendous 
growth. Particularly, many stoichiometric as well as catalytic processes for the enantioselective 
synthesis of amines have been reported.63,51b In contrast, applications to the enantioselective 
syntheses of α-(heteroaryl)alkylamines remain still rare. The most investigated strategy is 
undoubtedly the asymmetric addition of diethyl zinc to activated α-heteroarylimines. Different 
effective protocols have been developed using aminoalcohols,64 copper amidophosphine 
catalyst,65 and Zr-peptide catalyst.66 The best results with the corresponding ligands are reported 
in scheme 24. It should be mentioned that only 2-furyl and 3-pyridyl groups have been used. To 
the best of our knowledge there are no reports on the use of other heteroarenes in this type of 
reactions.  
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Scheme 24. Asymmetric synthesis of α-(heteroaryl)alkylamines by addition of diethyl zinc to imines. 
 
Burk and co-workers67 developed an alternative approach to the asymmetric 1,2-addition of 
diethyl zinc based on asymmetric hydrogenation of α-heteroarylamides 118a-b (scheme 25). 
They found that Rh catalysts using (S,S)-Me-DuPHOS ligand effected the hydrogenation of 
118a-b to yield α-heteroarylamine derivatives 119 with high enantioselectivities. Notably, 
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isomeric mixtures of both (E)-and (Z)- enamides could be employed in these hydrogenation 
reactions, with no apparent detrimental effect on the selectivity. Moreover the enantioselctivities 
obtained were found to be relatively insensitive to the solvent and to pressure variations. 
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Scheme 25. Catalytic asymmetric synthesis of N-protected α-(heteroaryl)alkylamines by Burk. 
 
Demir46c,d investigated the reduction of furyl ketone oxime ethers 121a-b using chiral boron 
reagents prepared from optically pure amino alcohols and BH3·THF complex (scheme 26). The 
best results were obtained when the enantioselective reduction was carried out with (−)-
norephedrine (120) and BH3·THF complex providing furfuryl amines 122a-b in good chemical  
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Scheme 26. Asymmetric synthesis of α-(2-furyl)alkylamines by Demir. 
 
yields and high enantiomeric excess. The maximum optical purity was obtained when the ratio 
of borane, amino alcohol and oxime ether was circa 2.5:1.25:1.0. Interestingly, changing the 
(E)/(Z)-geometry permitted to access the two different enantiomers. Finally, Brown and co-
workers68 reported two examples of enantioselective allylation of α-heteroarylimine using 
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modified chiral boron reagents affording the corresponding allylamine in 81-86% enantiomeric 
excess. 
 
1.2.2.3   Routes utilizing enzymatic resolution 
 
The use of enzymatic methods for resolving racemic amine substrates has rapidly gained 
prominence. Especially lipases, are eminently suited for such an approach due to their stability 
and ability to operate in mild conditions. These characteristics have made lipases outstanding 
catalysts for biosynthetic transformations as documented by the great number of publications 
appeared on the subject.69 However, only scattered reports on their use in the resolution of 
primary α-(heteroaryl)alkylamines have hitherto appeared. Gotor and co-workers70 carried out 
aminolyses of α-(heteroaryl)alkylamines 123a-c using Candida Antarctica lipase B (CAL-B) as 
biocatalyst (scheme 27). The reactions were performed at 30°C using ethyl acetate as acyl donor 
and solvent. The results demonstrated that CAL catalysed the acetylation of 123b with moderate 
enantioselectivity whereas it was an effective catalyst in the acetylation of 123a and 123c 
providing the corresponding (R)-amides 125a and 125c with very high enantiomeric excesses. 
Moreover, when the reactions were performed in a different solvent, such as 1,4-dioxane, the 
enzyme showed a significantly improved enantioselectivity for 123b affording (R)-amide 125b 
as single enantiomer. 
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Scheme 27. Enzymatic resolution of α-(heteroaryl)alkylamines by Gotor. 
 
McEachern explored the potential of CAL-B in the resolution of bicyclic α-heteroarylamines.71 
The amines were treated at 60°C with CAL-B in the presence of ethyl acetate as acyl donor 
using either isopropyl ether or in neat ethylacetate as solvent. High enantiomeric excesses were 
obtained for both (S)-amines 126a-j and corresponding (R)-amides (fig. 8). It is noteworthy that 
the enantioselectivity obtained was strictly influenced by the size of the cycloalkyl ring where 
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the six member ring provided the best level of selectivity. Decreasing or increasing the size of 
the ring reduced the enantiomeric excesses, with a particularly marked effect for the seven-
member ring. 
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Fig. 8. Enzymatic resolution of bicyclic α-(heteroaryl)amines by McEachern. 
 
1.2.3   The SAMP-/RAMP-hydrazone methodology 
 
The formation of carbon-carbon or carbon-heteroatom bonds adjacent to a carbonyl group in 
regio-, diastereo- and enantioselective manner is one of the most important processes in organic 
synthesis. While the classical carbonyl enolate chemistry is usually accompanied by the problem 
of side reactions, the imine and the hydrazone derivatives afford better yields and selectivities. A 
very useful and versatile asymmetric version of the hydrazone technique is represented by the 
SAMP-/RAMP methodology.72 The chiral auxiliary (S)-1-amino-2-methoxymethylpyrrolidine 
(SAMP) is available via a six step procedure starting from (S)-proline in 60 % overall yield 
whereas the (R)-enantiomer (RAMP) is obtained in six steps in 35% overall yield from (R)-
glutamic acid (scheme 28). The chiral hydrazones 128 are easily obtained by mixing SAMP and 
the carbonyl compound 127 and removing the resulting water (scheme 29). 
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Scheme 28. Synthesis of SAMP and RAMP. 
 
Deprotonation of SAMP-hydrazones by means of lithium bases results in azaenolates that can be 
trapped by electrophiles to obtain diastereomerically enriched compounds 129. Suitable 
electrophiles are alkyl halides, Michael acceptors, carbonyl compounds, halide substituted esters, 
oxiranes, aziridines and various hetero electrophiles.  
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Scheme 29. Asymmetric carbon-carbon bond formation via SAMP-/RAMP methodology. 
 
Subsequent cleavage of the hydrazones restores the original carbonyl moiety to provide 
substituted ketones or aldehydes 130. In addition, SAMP-hydrazones 132 derived from 
aldehydes (131) can also be used for the asymmetric synthesis of amines via nucleophilic 1,2-
addition of organometallic reagents to the CN double bond 67,51b(Scheme 30). The best results are 
obtained using organolithium, organocerium, organo-ytterbium or Grignard reagents. Reductive 
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N-N bond cleavage of the resulting hydrazines 133 gives the primary amines 134 or their 
derivatives in good overall yields and with high diastereo-and enantioselectivities. 
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Scheme 30. Asymmetric synthesis of amines via SAMP-/RAMP-methodology. 
 
2.1.4 The goal of the study 
 
The purpose of this project was to develop a general and efficient asymmetric route for the 
synthesis of α-(heteroaryl)alkylamines. 
 
Three critical points had to be studied: 
 
- 1,2-nucleophilic addition of organometallic reagents to SAMP- or RAMP-hydrazones in 
order to synthesize α-(heteroaryl)alkylhydrazines in highly stereoselective fashion 
- Investigation of an efficient and racemization-free cleavage methodology to remove the 
chiral auxiliary 
- Utilization of the synthesized α-(heteroaryl)alkylamines as building blocks to access 
other interesting classes of compounds, such as α-aminoacids or β-aminosulfones 
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2.1  Part one: Results and discussion 
 
2.1.1  Synthetic approach to lignans 
 
The total synthesis of lignans is of great importance to confirm their structure at an early stage, 
and to get a sufficient amount of material for further studies on the bioactivity, metabolism, 
pharmacokinetics, and fate of these compounds at target tissue animals. Moreover, their 
structural complex architectures represent a great challenge from a chemical point of view. 
Several methodologies have been successfully applied so far to their asymmetric synthesis, but 
often they were hampered by the lengthy sequence of the reactions or by low enantioselective 
control. Thus, it would be of great interest to develop a general and highly efficient asymmetric 
approach to the enantioselective synthesis of the main classes of lignans. 
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Scheme 31. Asymmetric synthesis of lignans, synthetic approach 
 
Our synthetic strategy, shown in scheme 31, consisted in an asymmetric version of the 
diastereoselective conjugate addition to 2-(5H)-furanone but in marked contrast with previous 
routes we planned to install the chirality directly on the nucleophile using a chiral α-aminonitrile 
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B as starting building block. Lithiation of B and subsequent Michael addition to 5H-furan-2-one 
should install in stereoselective fashion the first stereogenic centre on the lactone ring. We 
envisaged to introduce the second centre by aldol or alternatively, alkylation reaction to achieve 
the synthesis of the two key dibenzylate γ-butyrolactones E and F, respectively. These two 
advanced intermediates (E and F) should be amenable to access different classes of lignans by 
modification of the functional groups they bear. 
 
2.1.2  Synthesis of the starting materials 
 
2.1.2.1  Synthesis of the chiral auxiliary 
 
The secondary amine ((S,S)-(2,2-dimethyl-4-phenyl-[1,3]dioxan-5-yl)-methyl-amine) (137) used 
in this work as chiral auxiliary was synthesized in two steps starting from the primary chiral 
amine (S,S)-2,2-dimethyl-4-phenyl-[1,3]-dioxan-5-yl amine (135) in 86% overall yield (scheme 
32). 
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Scheme 32. Synthesis of the chiral auxiliary 
 
The starting material 135 was a very kind donation from the company Boehringer Mannheim: 
(amine 135 is a side product in the synthesis of the antibiotic Chloramphenicol®). After 
resolution of the racemate by recrystallization with tartaric acid 135 was obtained as pure 
enantiomer on a gram scale. The enantiomeric form 141 was synthetized starting from aminodiol 
138 also provided by Boehringer Mannheim. The primary amine was protected as formamide 
139 by reaction with methylorthoformate (scheme 33). Subsequent acetalization with 2,2-
dimethoxypropane and reduction with LiAlH4 afforded 141 in 34% overall yield. 
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Scheme 33. Synthesis of the chiral auxiliary. 
 
2.1.2.2  Synthesis of the Michael acceptor 
 
The 5H-furan-2-one (butenolide) (144) used as Michael acceptor in our methodology was 
synthesized starting from γ-butyrolactone 142 according to a literature procedure73 (scheme 34). 
Bromination of the γ-butyrolactone 142 using a mixture of bromine and red phosphorus afforded 
α-bromobutyrolactone 143, which upon treatment with triethylamine gave, as the result of the 
elimination of hydrogen bromide, the desired butenolide 144 in 33% overall yield. 
 
O
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142 143 144  
Scheme 34. Synthesis of butenolide. 
 
2.1.2.3  Synthesis of benzyl bromides 
 
The benzyl bromides 146a-d were prepared in high yield from the corresponding aromatic 
aldehyde 145a-d in two steps according to a procedure26 reported in the literature (scheme 35). 
In the first step the aldehydes were reduced to their corresponding alcohols with NaBH4 in a 
solution of methanol and dichloromethane and subsequently converted to benzyl bromides 146a-
d with PBr3 in Et2O.  
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Scheme 35. Synthesis of benzyl bromides. 
 
2.1.3  Asymmetric synthesis of 2,3-disubstitued-γ-butyrolactones 
 
The guidelines of the methodology recently developed in our group by J. Kirchhoff and V. 
Lausberg for the synthesis of 2,3-disubstituited γ-butyrolactones74 are depicted in scheme 36. 
The synthesis commenced with an asymmetric Strecker reaction using different aromatic 
aldehydes and the enantiomerically pure secondary amine 137 as starting materials followed by a 
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Scheme 36. Asymmetric synthesis of 3,4-disubstituited γ-butyrolactones. 
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Michael reaction of lithiated 147 to 5H-furan-2-one (144) to give the 1,4-adducts 148 in good 
yields and diastereoselectivities. Alkylation of 148 occurred completely stereoselectively trans 
to the amino nitrile moiety providing the products 149 after cleavage of the auxiliary with 
excellent induction (de ≥ 98%, ee = 96-97%), whereas the syn/anti selectivity of the aldol 
addition (R = OH) (de = 60-75%, the syn isomer predominanting) still required some 
improvement. 
 
2.1.3.1  Improvement of the syn/anti selectivity of the aldol addition 
 
Initial attempts to increase the selectivity of the aldol reaction via transmetalation of the 
intermediate lithium lactone enolate were met with moderate success: ZnBr2, ZnI2, MgBr2, 
ClTi(OiPr)3 and BrTi(NEt2)3, for example, did not improve stereocontrol, whereas ZnCl2 had a 
slightly more favorable effect. However, the use of LiCl as additive improved the stereocontrol. 
The best results were obtained by using 2.2 eq. of LiCl and by adding the aldehyde at −100°C 
resulting in the formation of the alcohol 149a-c in a syn/anti ratio of 87:13 - 93:7 where the 
syn/anti nomenclature refers to the position of the alcohol with respect to the adjacent 
stereocenter (scheme 37).  
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Scheme 37. Improvement of the selectivity of the aldol reaction. 
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Due to the instability of the obtained alcohols 149a-c, a purification of the products was only 
possible after the cleavage of the auxiliary resulting in even higher ratios syn/anti (aldol) of 96:4 
- 99:1 (table 1). The enantiomeric excesses were determined by 1H NMR shift experiments using 
Pirkle-alcohol as chiral cosolvent to be ≥ 98%. 
 
Table 1 Improvement of the syn/anti ratio of the aldol addition. 
 
Product 
 
Ar 
 
Yield 
 
syn/anti 
 
ee 
 
151a 
O
O  
 
65% 
 
≥ 96:4 
 
≥ 98% 
 
151b 
H3CO
H3CO
 
68% 
 
≥ 99:1 
 
≥ 98% 
 
 
151c 
H3CO
H3CO
OCH3
 
 
60% 
 
 
≥ 98:2 
 
 
≥ 98% 
 
2.1.4  Asymmetric synthesis of lignans 
 
2.1.4.1  Asymmetric synthesis of furofurans 
 
With the enantiopure compounds 51a-c in hand, we elected to verify the validity of our synthetic 
plan engaging the asymmetric synthesis of furofurans. We initially examined the stereoselective 
reduction of the carbonyl group of 51a-c. We anticipated that in the reduction of 151a-c with a 
hydride reagent, the hydride would attack preferentially from the sterically less hindered side 
(fig. 9). 
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Fig. 9. Explanation of the observed high diastereoselectivity observed in the reduction with L-selectride. 
 
36 
Results and Discussion 
 
 
Indeed, treatment of 151a-c with tri-sec-butylborohydride (L-Selectride®) at –78°C for 30 
minutes75 afforded in high yields and excellent diastereoselectivities the desired diols 152a-c 
(scheme 38). It is worth mentioning that by purification on flash chromatography 152a-c could 
be completely separated from every trace of other isomers and obtained as virtually single 
products. 
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Scheme 38. Reduction with L-selectride®. 
 
We then examined the reduction of the lactone ring of 152a-c and finally the cyclization to 
furofurans. The reduction with LiAlH4 performed at room temperature according to Ohmizu44a 
 
Table 2 . Reduction with L-selectride. 
 
Product 
 
Ar 
 
Yield 
 
de 
 
ee 
 
152a 
O
O  
 
70% 
 
≥ 98% 
 
≥ 98% 
 
152b 
H3CO
H3CO  
 
75% 
 
≥ 98% 
 
≥ 98% 
 
 
152c 
H3CO
H3CO
OCH3  
 
 
84% 
 
 
≥ 98% 
 
 
≥ 98% 
 
conditions proved to be sluggish and therefore a modified procedure was developed. The diols 
were dissolved in a solution of THF in presence of ten equivalents of LiAlH4 and the resulting 
mixture was refluxed for 1 hour (scheme 39). After purification the corresponding tetraols 153a-
c were obtained in acceptable yields without any trace of epimerization.  
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Scheme 39. Asymmetric synthesis of furofurans. 
 
Finally, mesylation of the primary hydroxyl groups with methanesulfonyl chloride in pyridine 
followed by spontaneous double cyclization provided (−)-sesamin (154)76 {[α]D22 = −71.0 (c = 
0.30, CHCl3), lit.77 [α]D22 = +68.7 (c = 0.40, CHCl3)}, (−)-methyl piperitol (155)78 {[α]D22 = 
−73.0 (c = 0.60, CHCl3), lit.79 [α]D22 = +73.6 (c = 0.35, CHCl3)} and (-)-aschantin (156) {[α]D22 
= −64.0 (c = 0.55, CHCl3), lit.48 [α]D22 = +65.0 (c = 0.40, CHCl3)} in high optical purity. To the 
best of our knowledge, this constitutes the first asymmetric synthesis of aschantin (156) and the 
first asymmetric synthesis of methyl piperitol (155). 
 
2.1.4.2  Asymmetric synthesis of (+)-yatein 
 
We wished to extend our methodology to the synthesis of other lignans. The most plausible way 
to reach this goal was to synthesize (+)-Yatein (42), which is a springboard to other classes of 
lignans. A suitable starting material for this was the trans-2,3-disubstituited γ-butyrolactone 
157a, which could be synthesized by our methodology in virtually diastereo-and enantiopure 
form (vide supra). We initially concentrated our efforts to synthesize (+)-yatein (42) by direct 
reduction of the carbonyl moiety of 157a to hydrocarbon. A straightforward route to perform this 
transformation turned out to be hydrogenolysis of 157a in acid media following the Magnusson 
protocol.80  
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Scheme 40. Attempts to synthetize (+)-yatein.  
 
This route initially gave promising results: when 157a was hydrogenated in acetic acid, using 20 
% of palladium on carbon as catalyst and under 4 atmospheres of hydrogen, (+)-yatein (42) was 
obtained as a single product in 91% yield (scheme 40). Unfortunately attempts to repeat the 
reaction proved to be fruitless; the conversion of the starting material resulted, in all the 
conditions screened, in a slow and exclusive formation of the benzylic alcohol. Irrespective of 
the catalyst loading or of the hydrogen pressure, the reaction failed. With the disappointing 
demise of the hydrogenolysis reaction, we decided to test the Srikrishna method.81 Indeed, 
ketone 157a was treated with 4 equivalents of cyanoborohydride in presence of an equimolar 
amount of BF3·Et2O, and the reaction mixture was refluxed overnight (scheme 41). 
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Scheme 41. Reduction with cyano borohydride. 
 
Control on TLC showed clearly the formation of a main product but with a different polarity 
than the one expected. After purification tetraline 158a was isolated as single isomer in 40% 
chemical yield. A possible explanation that addresses the issue of the formation of tetraline 158a 
is provided in scheme 42. Treatment of 157a with hydride presumably led to the reduction of the 
ketone in benzylic alcohol 159 which could be coordinated by the Lewis acid to give, after 
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elimination of the hydroxyl group, formation of a stable benzylic carbocation 161. At this point 
spontaneous intramolecular Friedel-Crafts-like cyclization could occur, affording only the most 
stable trans isomer 158a (Ward82 and Iwasaki83 have reported similar reactions on benzylic 
alcohols). The trans configuration was suggested by the observed value of the coupling constant 
between the two vicinal protons Hγ and Hβ, (being 10.9 Hz), consistant with an axial-axial 
configuration, and confirmed by Noe experiment, showing strong Noe between proton Hγ and 
Hα. Although this reaction represented a very efficient way to access to the aryltetraline skeleton, 
it failed to fulfill our aim, the synthesis of yatein. The difficulties encountered in the direct 
reduction of 157a prompted us to consider an alternative two steps route. 
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Scheme 42. Intramolecular cyclization: mechanism and Noe. 
 
Ketone 157a was reduced with sodium borohydride in methanol to give the alcohol 159 as a 
mixture of two epimers (87:13) in 80% yield (scheme 43). Subsequent catalytic hydrogenolysis 
of 159, performed in presence of a catalytic amount of perchloric acid,84 proceeded smoothly 
affording (+)-yatein85 (42) in very good yield (88%, over an average of three trials) and optical 
purity {[α]20D = + 30.6 (c = 1.1, CHCl3), lit.86 {[α]20D = − 30.0 (c = 0.15, CHCl3). 
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Scheme 43. Asymmetric synthesis of (+)-yatein. 
 
2.1.4.3  Asymmetric synthesis of (+)-dihydroclusin, (+)-burseran and (−)-isostegane 
 
Having developed a very efficient access to the lignan (+)-yatein (42), we decided to apply the 
methodology to the synthesis of the disubstituted tetrahydrofuran (+)-burseran (163). (+)-Yatein 
(42) was subjected to reductive conditions with lithium aluminium hydride to give the known 
diol, (+)-dihydroclusin87 (162) in excellent yield (91%) (scheme 44). Refluxing 162 in a 
methanolic solution containing HCl afforded in straightforward way the anti-tumor (+)-
burseran88 (163) {[α]22D = 37.8 (c = 2.0, CHCl3); lit.87 [α]22D = −34.8 (c = 0.93, CHCl3)} in 85% 
yield.  
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Scheme 44. Asymmetric synthesis of (+)-burseran. 
 
We were also interested in accessing the dibenzocyclooctadiene type compound (−)-isostegane 
(43) by subjecting (+)-yatein (42) to oxidative coupling conditions. Modification of the oxidative 
coupling developed by Planchenault89 et al. of 42 with Tl2O3 in presence of BF3·Et2O in neat 
TFA gave (−)-isostegane90 (43) {[α]22D = −156.9 (c = 2.8, CHCl3); lit.60 [α]22D = +154.0  
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Scheme 45. Asymmetric synthesis of (−)-isostegane. 
 
(c = 0.7, CHCl3)} in very good yield (77%) (scheme 45). This also constitutes a formal synthesis 
of the known anti-tumor lignan steganacin (44), as Koga and coworkers elegantly achieved it 
earlier.25 The efficiency of the oxidative coupling deserves some comment. The reaction time 
was shorter than in all the other protocols used for this type of reactions.91  
 
O
O
O
O
OCH3
OCH3
CH3O
42
O
O
O
O
H3CO
H3CO
H3CO 43
O
O
O
O
OCH3
OCH3
CH3O
1
2
3
4
6
5
+
−e, −H+
O
O
O
O
OCH3
OCH3
CH3O
+
O
OCH3
H3CO OCH3
O
O
+
OH
O
OCH3
H3CO OCH3
O
O
O
Tl2O3
BF3
.Et2O O
O
O
O
OCH3
OCH3
CH3O
BF3
O
O
O
O
H3CO
H3CO
H3CO 170
O
O
O
O
OCH3
OCH3
CH3O
BF3
Tl2O3
+
TlX2
−BF3
+
H H
−2H+, −e
−H+
164
165 166 167
168 169
path a
path b
TlX2
 
Scheme 46. Proposed mechanisms for intramolecular oxidative coupling of biaryles promoted by tallium (III). 
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Basically, after work up traces of starting material could still be detected by TLC analysis, but it 
was observed that a longer reaction time under oxidative conditions resulted in the formation of 
orthoquinone species,92 decreasing the yield of the reaction. Moreover, the presence of the Lewis 
acid was found to be a conditio sine qua non to avoid the formation of deoxyisopodophyllotoxin 
167 as main product. The different outcomes of the reactions in the presence or absence of boron 
trifluoride etherate seems to reflect the propensity of thallium (III) to act as a one or two-electron 
oxidant. In the oxidative coupling of yatein with thallium (III) oxide/trifluoroacetic acid it was 
suggested that two one-electron transfers from only the 3,4,5-trimethoxyaryl ring led to the 
intramolecular cyclization scheme (scheme 46, path a). An initial one-electron transfer could 
give the radical cation 164. However as a result of the steric hindrance, disfavouring the 
intramolecular coupling at C2 and C6 of the radical cation moiety in 164, combined with the 
instability of thallium (II) species and the favorable reduction potential for the thallium 
(III)/(thallium (I) couple (E0 = 1.25 V), a second one-electron transfer should occur prior to 
dissociation of the radical cation-thallium (II) charge-transfer complex. Loss of a benzylic proton 
and intramolecular cyclization of the newly formed trienonium ion 165 would subsequently lead 
the formation of deoxyisopodophyllotoxin 167. On the other hand, the presence of boron 
trifluoride etherate altered completely the reactivity of the system. One possible explanation for 
the remarkable control exerted by boron trifluoride etherate would be that its presence should 
result in the preferential oxidation of the benzodioxolyl ring of 42 over the 3,4,5-trimethoxyaryl 
ring. In 42 it was anticipated that the 3,4,5-trimethoxyaryl ring would not only have a higher 
potential than the benzodioxolyl ring, but also would be more basic. Thus, during the addition of 
boron trifluoride etherate to a solution of (+)-yatein (42) in trifluoroacetic acid, it was expected 
that the Lewis acid would preferentially coordinate to the more basic 3,4,5-trimethoxyaryl ring 
thereby lowering its reduction potential. Addition of a solution of 42 and boron trifluoride 
etherate to a suspension of thallium (III) oxide in trifluoroacetic acid would generate a one-
electron transfer from the benzodioxol ring of (+)-yatein to give the radical cation-thallium(II) 
charge-transfer complex 38 (scheme 16, path b). The radical cation moiety 169 is undoubtedly 
less sterically hindred than the radical cation in the charge-transfer complex 164 resulting from 
one-electron oxidation of the 3,4,5-trimethoxyaryl ring of (+)-yatein (42). As a Consequence, 
intramolecular coupling of 169 to give the bridged radical cation 170 would probably occur 
before a second one-electron transfer from 169 could take place. Subsequent oxidation and 
deprotonation of the briged radical cation 170 gave isostegane 43. 
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2.1.4.4  Asymmetric synthesis of (+)-acon, (+)-lintetralin and (−)-dihydrosesamin 
 
During our attempts to synthesize (+)-yatein (42) we found out that treatment of the ketone 157a 
with NaBH3CN in the presence of boron trifluoride etherate afforded in stereoselective fashion 
the aryltetraline (158a) (vide supra). Preliminary studies performed on different ketones 157a-c, 
easily generated in their enantiopure form by using our methodology, confirmed the versatility of 
the reaction. It should be noted that a moderate increase of the chemical yield could be obtained 
by modifying the reaction conditions and the reducing agent (scheme 47). The best results were 
obtained performing the reaction in trifluoroacetic acid and triethylsilane at 45°C overnight 
(table 3). Among the possible synthetic targets accessible from the Friedel-Crafts cyclization 
pathway (+)-lintetralin drew our attention. The aryltetraline (+) lintetralin was isolated from 
Phyllantus niruri Linn.93, a well-known medicinal plant and is known as an herbal drug for liver-
protecting effects.94 Its structure was assigned on the basis of mass spectroscopic evidence 
combined with 1H and 13C NMR data and finally confirmed through synthetic work. However 
the absolute configuration had not been determined unambiguously. Lintetralin was in theory 
accessible from the synthesized aryltetraline 24b in two steps, however the moderate yield of the 
cyclization suggested that an alternative route had to be explored. 
 
O
O
O
O
O
R1
R2
R3
O
O
O
O
R1
R2
R3
CF3COOH, 
Et3SiH, 45°C
42-48%
157a-c 158a-c  
Scheme 47. Asymmetric synthesis of aryltetralines. 
 
Table 3. Asymmetric synthesis of aryltetraline. 
 
Product 
 
R1 
 
R2 
 
R3 
 
Yield 
 
de 
 
ee 
 
158a 
 
OCH3 
 
OCH3 
 
OCH3 
 
48% 
 
≥ 98% 
 
≥ 98% 
 
158b 
 
H 
 
OCH3 
 
OCH3 
 
47% 
 
≥ 98% 
 
≥ 98% 
 
158c 
 
OCH2O 
 
H 
 
42% 
 
≥ 98% 
 
≥ 98% 
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Thus, we elected to reduce the ketone and the lactone moieties of 157b in a one pot reaction, 
using lithium aluminium hydride and to attempt the cyclization directly on the triol 171. 
Reduction of 157b proceeded smoothly using 4 equivalents of LiAlH4 at room temperature for 5 
h and gave the desired triol 171 as a 2:1 mixture of diastereomers in a 95% crude yield (scheme 
48). No attempt was made to purify the triol 171 due to the high purity of the crude product and 
because the new stereogenic center would be lost at some stage of the envisioned carbocationic 
cyclization. When 171 was treated with an excess of boron trifluoride etherate in 
dicloromethane, at room temperature for 1 h, the carbocationic cyclization took place affording 
the known diol 172 in excellent 87% yield as virtually a single product. Subsequent 
deprotonation of the diols with NaH and methylation with MeI furnished (−)-lintetralin (173) in 
92% yield. The spectroscopic data (NMR, IR, Ms) were in accordance with those of the natural 
product. Although the value of the optical rotations ([α]24D = − 4.0 (c = 0.1, CHCl3) lit.63 [α]28D 
= + 2.6 (CHCl3)) differed, the opposite sign established for the first time the absolutely 
configuration of the natural (+)-lintetralin to be R,S,R. Pleasantly surprised by the high efficiecy 
of the Friedel-Crafts type cyclization on the triol 171 we decided to apply the same procedure to 
the ketone 157c. However, after reduction of the ketone 157c with LiAlH4 we realized with 
some disappointment that the triol 174 was not soluble in CH2Cl2.  
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MeO
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O
MeO
MeO
OH
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O
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O
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O
MeO
MeO
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O
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95%
BF3
.Et2O
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LiAlH4
de = 2:1
39% overall
de, ee ≥ 98%
157b 171
de, ee ≥ 98%
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(−)-173
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Scheme 48. Asymmetric synthesis of (−)-lintetralin. 
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Consequently, the cyclization was performed in a mixture of THF and CH2Cl2 (1:4) (scheme 49). 
The reaction resulted slow and after 4 h a room temperature, TLC control showed the formation 
of a main product but with a polarity different than the one expected. After work up, purification 
on flash chromatography gave (−)-dihydrosesamin95 (175) {[α]22D = −16.5, (c = 0.5 pyridine) 
lit.96 [α]25D = −15.9, (c = 0.67 pyridine)} in 40% yield. 
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Scheme 49. Asymmetric synthesis of (−)-dihydrosesamin. 
 
The different outcome of the reaction clearly resulted from the presence of the THF as co-
solvent, probably reducing the coordination between the aromatic ring and the Lewis acid  
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O
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O
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ee > 98%
137
176 177
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Ar = 3-methoxy-4-benzyloxy-phenyl  
Scheme 50. Asymmetric synthesis of 2,3-disubstituited γ-butyrolactone 57. 
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disfavouring the Friedel-Crafts type cyclization over the intramolecular nucleophilic attack of 
the hydroxyl group.97 In the end, this carbocationic cyclization was applied to the synthesis of a 
compound of the retrolignan series: (+)-α-coninendrin (180).98. The required starting ketone 178, 
was synthetized in 4 steps in its enantiopure form but with poor overall yield due to the low level 
of stereocontrol observed in the Michael addition on the butenolide (scheme 50). Attempts to 
cyclize ketone 178 surprisingly failed. The reaction afforded a complex mixture of products 
preventing the isolation of the desired aryltetraline 179. An alternative two steps route was 
therefore envisaged; ketone 178 was first reduced with NaBH4 and then treated with 
trifluoroacetic acid in CH2Cl2 afforded tetraline 179 in excellent yield (scheme 51). Catalytic 
hydrogenation accomplished the total synthesis of (+)-α-coninendrin (180) in high optical purity 
{[α]22D = +54.0, (c = 0.5 acetone) lit.99 [α]25D = −52.5, (c = 1.05 acetone)}. 
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O
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Scheme 51. Asymmetric synthesis of (+)-α-coninendrin. 
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2.1.5 Conclusion 
 
In summary, we demonstrated the generality and the applicability of the methodology previously 
developed in our group for the synthesis of 2,3-disubstituted γ-butyrolactones, applying it to the 
asymmetric synthesis of the main classes of lignans. Noteworthy ten different natural products 
could be successfully synthesized in good overall yields and outstanding diastereo-and 
enantioselectivities. 
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Scheme 52. Asymmetric synthesis of lignans. 
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2.1.5 Outlook 
 
Sauchinones 181 (Fig. 10) are a group of lignans isolated from Saurus Chinesis100 a well-known 
medical plant used in folk medicine for the treatment of edema, jaundice and gonorrhea.101 They 
are hexaciclic molecules with six contiguous stereogenic centers and no formal element of 
symmetry.  
 
O
O O
O
O
O
H
R1
R2
Sauchinone  R1 = H R2 = H
Sauchinone A  R1 = H R2 = H
1´-epi-Sauchinone A  R1 = H R2 = H
181
 
Fig. 10. Structure of sauchinones. 
 
The beautiful architecture combined with the biological activity renders sauchinones a perfect 
target to extend our methodology. Our proposed retrosynthetic approach is depicted in scheme 
53. Basically a disconnection of the acetal moiety revealed that aryltetraline B could be a 
possible precursor. B is in theory accessible by our methodology through the 3,4-substituted γ-
butyrolactone A. 
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Scheme 53. Retrosynthetic approach. 
 
The possible synthetic route is depicted in scheme 54. The precursor 183 could be synthetized 
from α-amino nitrile 182 in 4 steps. Friedel-Crafts type cyclization performed on 183 should 
yield the desired aryltetraline 184. At this point a three steps procedure consisting in reduction of 
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the lactone ring, mesylation of the primary hidroxyl groups and still reduction, is envisioned to 
transform the lactone moiety into methyl groups. Finally after deprotection of the phenolic 
groups, an oxidative cyclization should install in a one pot reaction the three desired stereogenic 
centres concluding the synthesis of sauchinones 181. 
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Scheme 54. Asymmetric synthesis of sauchinones. 
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2.2   Part two: Results and discussion 
 
2.2.1  Retrosynthetic analysis of α-(heteroaryl)alkylamines  
 
Chiral α-(heteroaryl)alkylamines are often critical components of biologically active 
compounds. Moreover, their use as ligands in catalytic processes as well as synthetic 
applications are well documented. Thus, it would be of great interest to develop a general and 
highly efficient asymmetric approach to gain access to these compounds. To approach the 
problem, we have conducted a retrosynthetic analysis, which is depicted in scheme 55. Two 
possible strategies could be devised to achieve the synthesis of the target compounds: path a, to 
incorporate the heteroarenyl moiety in the substrate C or path b, to use a metallated heteroarene 
D as organometallic reagent. Although the former approach has found wide application in 
literature (vide supra), it presented well-known problems, which possibly could reduce the 
available substitution patterns. We reasoned that the synthesis of branched or functionalized 
organometallic species would not be a trivial affair and moreover they may display poor 
reactivity towards hydrazones. On the basis of our experience, we envisioned that the 1,2-
nucleophilic addition of heteroarenyllithium species or their cerium derivatives to functionalized 
SAMP/RAMP hydrazones (Path b), could furnish a general approach due to the great diversity 
and high reactivity of the organolithium species.  
 
R
NH2
HetAr
RM
NR1
HetArH
+
R
NH2
HetAr
NR1
HR
HetArM +
SAMP Alkylation
Path a
Path b
A B
A D
C
E
 
Scheme 55. Asymmetric synthesis of α-(heteroaryl)alkylamines: retrosynthetic approaches. 
 
Furthermore, the 1,2-nucleophilic addition could be combined with the SAMP-α-alkylation to 
insert in a straightforward manner a new stereogenic centre at the α-position of the CN double 
bond, offering an entry into more complex architectures. 
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2.2.2 Synthesis of SAMP-/RAMP-hydrazones 
 
The chiral hydrazones 187a-m used as substrates in our methodology were synthesized by direct 
condensation between aldehydes 186a-m and SAMP or RAMP. The reactions were performed in 
diethyl ether at room temperature in the presence of magnesium sulfate (scheme 56). After 
purification via flash chromatography or alternatively by distillation, the hydrazones were 
obtained in almost quantitative yields. Hydrazones 187m-n and 187h-l were kindly donated by 
Dr Christoph Thiebes and Dr Volker Braig, respectively. 
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Scheme 56. Synthesis of SAMP-/RAMP-hydrazones. 
 
Finally, hydrazones 188a,b were obtained in good chemical yields and high diastereoselectivities 
by treatment of 187 f,g with LDA and trapping the obtained azaenolate with MeI102 (scheme 57). 
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Scheme 57. Asymmetric synthesis of hydrazones by SAMP-/RAMP-α-alkylation. 
 
2.2.3 Asymmetric synthesis of α-(heteroaryl)alkylamines 
 
2.2.3.1 Asymmetric synthesis of α-(heteroaryl)propylhydrazines 
 
Our efforts were principally concentrated on establishing useful protocols exploring 
organolithium reagents. We selected as study compound the simple SAMP-hydrazone 187b and  
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Scheme 58. Asymmetric synthesis of α-(heteroaryl)-propylhydrazines. 
 
treated it with 13 different lithium derivatives 189a-m prepared by modified literature 
procedures103 (scheme 58). Due to the different nature, basicity104 and reactivity of the 
heteroaryllithium species 189a-m it was not possible to establish a common protocol and 
optimal reaction conditions had to be searched for each case.  
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Table 4. Asymmetric synthesis of α-(heteroaryl)propylhydrazines. 
 
Entry 
 
Product 
 
HetArLi 
 
Equiv. 
 
Solvent 
 
T[(°C)] 
 
Time 
 
Conv.a 
 
dea 
 
1 
 
190a 
S Li  
 
3.2 
 
Et2O 
 
−78 to rt
 
2 h 
 
≥ 95% 
 
≥ 95% 
 
2 
 
190b 
S Li
 
3.2 
 
Et2O 
 
−78 to rt
 
2 h 
 
≥ 95% 
 
93% 
 
3 
 
190c 
S
Li
 
 
3.2 
 
Et2O 
 
−78 to rt
 
5 h 
 
≥ 95% 
 
94% 
 
4 
 
190d 
S LiCl  
 
3.2 
 
Et2O 
 
−78 to rt
 
5 h 
 
≥ 95% 
 
≥ 95% 
 
5 
 
190e 
N Li  
 
8.0 
 
Et2O 
 
−100 
 
5 h 
 
≥ 95% 
 
≥ 95% 
 
6 
 
190f 
N
Li
 
 
5.0 
 
Et2O 
 
−78 
 
14 h 
 
≥ 95% 
 
≥ 95% 
 
7 
 
190g N
Me
Li
 
 
3.2 
 
THF 
 
−78 to rt
 
14 h 
 
70% 
 
88% 
 
8 
 
190h 
N
Me
Li
 
3.2 
 
THF 
 
−78 to rt
 
14 h 
 
75% 
 
94% 
 
9 
 
190i 
N
N
Me
Li
 
 
3.2 
 
THF 
 
−78 to rt
 
14 h 
 
≥ 95% 
 
≥ 95% 
 
10 
 
190j N
N
Me
Li
 
3.2 
 
THF 
 
−78 to rt
 
14 h 
 
≥ 95% 
 
92% 
 
11 
 
190k 
O Li  
 
3.2 
 
THF 
 
−78 to rt
 
2 h 
 
≥ 95% 
 
≥ 95% 
 
12 
 
190l 
O Li
 
3.2 
 
Et2O 
 
−78 to rt
 
2 h 
 
≥ 95% 
 
≥ 95% 
a) Determined by 1H and 13C NMR. 
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We found that addition of 2-thienyllithium (189a) and derivatives 189b-d was ideally carried out 
using Et2O as reaction solvent (table 4, entry 1-4). Highest conversions and selectivities were 
obtained by treating 187b with three equivalents of organolithium 189a-4d at –78°C for 30 
minutes after which allowing the reaction to warm up to room temperature. Both 2-
pyridyllithium (189e) and 3-pyridyllithium (189f) reacted well with the hydrazone in Et2O at low 
temperature but 8 and 5 equivalents of organolithium species had to be used, respectively (entry 
5-6). THF was preferred as reaction solvent in the case of 1-methyl-2-lithiopyrrole (189g), 1-
methyl-2-lithio-indole (189h), 1-methyl-2-lithioimidazole (189i) and 1-methyl-2-lithiobenzyl-
imidazole (189j) providing highest selectivities when the reactions were allowed to reach room 
temperature overnight (entry 7-10). Surprisingly, 2-furyllithium (189k) and 2-benzofuryllithium 
(189l) showed very different behavior by the former preferred THF as solvent and the latter Et2O 
(entry 11-12). Finally, 2-lithiothiazole (189m) did not react at all. The failure could be explained 
considering the low reactivity of 2-lithiothiazole combined with its high instability, which did 
not permit to increase the temperature of the reaction. Attempts to overcome the problem using 
2-trimethylsilylthiazole according to the Dondoni method105 failed as well. Due to the high 
instability of the obtained products we decided to use the crude hydrazines 190a-l directly in the 
next steps without any purification. 
 
2.2.3.2 Cleavage of the chiral auxiliary. 
 
With the series of hydrazines 190a-l in our hands, the attention was focused on the removal of 
the chiral template. The problem appeared extremely complicated due to the different nature of 
the heteroaryles. We reasoned that use of hydrogenation procedures106 should be avoided 
especially with heteroaryles containing sulfur, which in case of partial decomposition, could 
easily poison the catalyst. Furthermore, the reductive N-N bond cleavage with lithium107 or  
 
2) BH3
.THF, THF
    reflux 6-18 h
3) H2O/THF, K2CO3
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N
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HN
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O
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64-80%
ee = 88-99%
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Scheme 59. BH3·THF promoted N-N bond cleavage. 
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sodium108 in ammonia should also be excluded due to a possible competitive Birch reduction. 
Therefore we focused our attention on the BH3·THF promoted N-N bond cleavage.109 We were 
pleased to find that cleavage of the chiral auxiliary proceeded smoothly without detectable 
racemization by refluxing hydrazines 190a-d,g with a large excess of BH3·THF complex for 6-
18 hours (scheme 59).  
 
Table 5. BH3·THF promoted N-N bond cleavage. 
 
Entry 
 
Product 
 
HetAr 
 
Yielda 
 
eeb 
 
Conf. 
 
1 
 
191a 
S  
 
76% 
 
99% 
 
S 
 
2 
 
191b 
S  
 
76% 
 
93% 
 
S 
 
3 
 
191c 
S  
 
70% 
 
94% 
 
S 
 
4 
 
191d 
SCl  
 
80% 
 
96% 
 
S 
 
5 
 
191e N
Me  
 
64% 
 
88% 
 
S 
a. Overall yield over two steps; b. measured by HPLC over chiral stationary phase. 
 
The corresponding polar amines were not isolated but directly protected with CbzCl to afford 
carbamates 191a-e, which could be easily purified by flash column chromatography on silica 
gel. Chemical yields over two steps as well as enantiomeric excesses are reported in table 5.  
 
1) Et2O, −78°C
    to rt, 2 h
2) BH3
.THF, THF
    reflux 16 h
3) Et2O, Et3N, 
    ClCOCH3
192
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MeNN
H
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187b
MeO
+ S
S Li
O
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189a
75%
 
Scheme 60. Determination of the absolute configuration. 
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To establish the absolute configuration of the obtained carbamates, the known N-acetylamine 
192 was synthesized according to an analogous procedure (Scheme 60) and its absolute 
configuration was found to be S as expected by comparing the sign of optical rotation with the 
literature value.67 Unfortunately, hydrazines 190e-f,h-l did not exhibit comparable reactivity and 
thus treatment with BH3·THF gave extremely poor results. Attempts to overcome the problem 
using Zn in acetic acid61 met the same fate. In order to find suitable conditions capable of 
removing the chiral auxiliary it was decided to examine the SmI2 promoted N-N bond 
cleavage.110 For this purpose the tertiary hydrazines 190e-f,h-l had to be activated by conversion 
to benzoyl derivatives 193a-g (scheme 61). To this end, 190e-f,h-l were reacted with benzoyl 
chloride using an equimolar amount of Et3N as base and a catalytic amount of DMAP. The 
obtained N-benzoyl hydrazides 193a-g were very stable and could be isolated after purification 
as a mixture of amide E/Z-isomers in high yields (Table 6).  
 
190e-f,h-l
PhCOCl, Et3N,
DMAP, CH2Cl2
rt, 16 h
193a-g
N
N
HetAr
Me
MeO
BzNHN
HetAr
Me
MeO
70-90%
de = 92-> 95%_
 
Scheme 61. Protection of hydrazines with benzoyl chloride. 
 
Table 6. Protection of hydrazines with benzoyl chloride. 
 
Entry 
 
Product 
 
HetAr 
 
Yield 
 
de 
 
1 
 
193a 
N  
 
76% 
 
≥ 95% 
 
2 
 
193b 
N  
 
70% 
 
≥ 95% 
 
3 
 
193c 
N
Me  
 
86% 
 
94% 
 
4 
 
193d 
N
N
Me  
 
90% 
 
≥ 95% 
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5 
 
193e N
N
Me  
 
85% 
 
92% 
 
6 
 
193f 
O  
 
90% 
 
≥ 95% 
 
7 
 
193g 
O  
 
81% 
 
≥ 95% 
 
Indeed, when N-benzoyl hydrazides 193a-g were treated with 2-3 equivalents of SmI2 with an 
equimolar amount of DMPU, cleavage of the chiral auxiliary took place smoothly affording after 
purification the corresponding benzoyl amides 194a-g in yields greater than 70% (Scheme 62, 
Table 7). More importantly, analysis on HPLC over a chiral stationary phase showed that the 
reaction took place without detectable amount of epimerization or racemization. 
 
194a-g
SmI2, DMPU,
THF, rt, 1 h
193a-g
N
N
HetAr
Me
MeO
Bz HN
HetAr
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O
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Scheme 62. Samarium promoted N-N bond cleavage. 
 
Table 7. Samarium promoted N-N bond cleavage. 
 
Entry 
 
Product 
 
HetAr 
 
Yield 
 
ee 
 
1 
 
194a 
N  
 
77% 
 
96% 
 
2 
 
194b 
N  
 
83% 
 
99% 
 
3 
 
194c 
N
Me  
 
72% 
 
94% 
 
4 
 
194d 
N
N
Me  
 
87% 
 
99% 
58 
Results and Discussion 
 
 
 
5 
 
194e N
N
Me  
 
78% 
 
92% 
 
6 
 
194f 
O  
 
83% 
 
99% 
 
7 
 
194g 
O  
 
85% 
 
97% 
 
2.2.3.3 Screening of different SAMP-hydrazones 
 
In order to demonstrate the generality of our approach, we performed the 1,2-nucleophilic 
addition on a range of differently substituted hydrazones 187c-f,h,m. First experiments were 
conducted using 2-thienyllithium (189a) as a nucleophile. As depicted in Scheme 63, the 
application of our established three step protocol afforded in all the cases the desired carbamates 
196a-f in high overall yields and outstanding enantiomeric excesses (Table 8).  
 
1) BH3
.THF, reflux
    15-48h
2) ClCbz, K2CO3, 
   THF/H2O, 24h
Cbz
N
R
H
S
ee = 93-95%
49-83%
Li
S
N
HN
R
MeO
N
N
R
MeO
H
Et2O, − 78°C
to rt, 2h.
de = 93-95%
95% conv S
187b-e,g,k 189a 195a-f 196a-f
 
Scheme 63. Asymmetric synthesis of N-protected α-(2-thienyl)alkylamines. 
 
Table 8. Asymmetric synthesis of N-protected α-(2-thienyl)alkylamines. 
 
Entry 
 
Product 
 
R 
 
Yield 
 
ee 
 
1 
 
196a 
 
Me  
 
70% 
 
94% 
 
2 
 
196b Ph  
 
83% 
 
95% 
 
3 
 
196c 
Me
Me
 
 
73% 
 
93% 
 
4 
 
196d 
Me
Me
 
 
78% 
 
94% 
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5 
 
196e 
Me
Me
Me
 
 
57% 
 
93% 
 
6 
 
196f Fe
 
 
49% 
 
≥ 95% 
 
It is remarkable that in the addition step the rates of formation of the tertiary hydrazines 195a-f 
as well as the selectivities were not significantly altered by the presence of bulky groups on the 
hydrazones. A second series of experiments were conducted with 1-methyl-2-lithiopyrrole 
(189g) (Scheme 64). In agreement with the observations made in our trial system, we found that 
although the desired carbamates 198a-d could be obtained with good to excellent selectivities, 
the overall yields were moderate (Table 9).  
 
1) BH3
.THF, reflux
    6-12h
2) ClCbz, K2CO3, 
   THF/H2O, 24h
Cbz
N
R
H
N
ee = 88-99%
25-53%
Me
+
Li
N
Me
N
HN
R
MeO
N
N
R
MeO
H N
Me
THF, − 78°C 
to rt, 14h.
de = 88-99%
50-80% conv
187d-f,m 189g 197a-d 198a-d
 
Scheme 64. Asymmetric synthesis of N-protected 1-(1-methyl-1H-pyrrol-2-yl)alkylamines. 
 
The decreased level of efficiency was mainly due to the insufficient conversion obtained in the 
first step confirming the lower reactivity of 1-methyl-2-lithiopyrrole (189g) compared with that 
of 2-thienyllithium (189a). 
 
Table 9. Asymmetric synthesis of N-protected 1-(1-methyl-1H-pyrrol-2-yl)alkylamines. 
 
Entry 
 
Product 
 
R 
 
Yield 
 
ee 
 
1 
 
198a 
 
Me  
 
35% 
 
92% 
 
2 
 
198b Ph  
 
36% 
 
99% 
 
3 
 
198c 
Me
Me
Me
 
 
25% 
 
88% 
 
4 
 
198d 
Me
Me
 
 
53% 
 
90% 
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The results above show that the methodology applied is truely general, tolerating a large range of 
substitution patterns. Therefore, our attention was focused on exploring possible synthetic 
applications. 
 
2.2.4 Asymmetric synthesis of α-(heteroaryl)alkylamines: synthetic  
applications 
 
2.2.4.1 Asymmetric synthesis of α-amino acids 
 
α-Amino acids represent an extremely important class of naturally occurring compounds, not 
only as components of protein and enzymes, but also as essential building blocks of numerous 
synthetically and clinically interesting compounds. As disclosed in the introduction, the 
synthesis of α-(2-furyl)alkylamines could represent a straightforward entry into this compound 
class as the furan moiety is a synthetic equivalent of the carboxylic acid functionality.46 Intrigued 
by this possibility and confident that our methodology could provide a flexible solution we 
decided to embark an asymmetric synthesis of α-amino acids.  
 
187a,d-f,n,188a-b
1) 2-furyllithium,
   THF, −78°C 
    to rt, 2-18 h
2) PhCOCl, Et3N.
    DMAP, CH2Cl2
    rt, 12-48h
201a-h
N
N
HR
MeO
N
N
R
MeO
Bz
O
NH
R
O
NH
COOHR
Ph
O
O
Ph
SmI2, DMPU,
THF, 1 h, rt
2% RuCl3
.H2O
H2O/CH2Cl2/CH3CN
NaIO4, 2h, rt
30-88%
de = 90-> 96%_ ee = 90-99%
40-90%
70-90%
23-59%
199a-g 200a-h
ee = 96-99%
 
Scheme 65. Asymmetric synthesis of α-amino acids. 
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The reaction sequence to synthesize the target compounds is outlined in scheme 65. SAMP-
hydrazones 187a,d-f,n,188a-b were treated with 3.2 equivalents of 2-furyllithium 189k in THF 
at –78°C. After 30 minutes the cooling bath was removed and the reaction mixture was allowed 
to rise to room temperature. NMR analysis of the crude product showed that the corresponding 
hydrazines were obtained with perfect stereocontrol. Moreover, some of them were stable during 
flash column chromatography and hence could be isolated (see experimental part). However, due 
to their air sensitivity best results were obtained by directly protecting the crude hydrazines as N-
benzoyl hydrazides 199a-g (Table 10). Surprisingly, hydrazide 199f (entry 6) was obtained in 
very poor yield. Therefore, we chose to adopt a different pathway to transfer the methyl group by 
reacting hydrazone 187i with MeLi. When the reaction was performed in Et2O, the methyl group 
could be transferred with excellent diastereoselectivity and high chemical yield (Scheme 66). 
 
Table 10. Asymmetric synthesis of N-protected 1-(2-furyl)alkylhydrazines. 
 
Entry 
 
Product 
 
R 
 
Yield 
 
de 
 
Conf. 
 
1 
 
199a 
 
Me  
 
75% 
 
≥ 96% 
 
S,S 
 
2 
 
199b Ph  
 
75% 
 
≥ 96% 
 
S,S 
 
3 
 
199c 
Me
Me
Me
 
 
72% 
 
≥ 96% 
 
S,S 
 
4 
 
199d 
Me
Me  
 
88% 
 
≥ 96% 
 
S,R,S 
 
5 
 
199e 
Me
Me  
 
85% 
 
≥ 96% 
 
R,S,Ra 
 
6 
 
199f Me  
 
30% 
 
≥ 96% 
 
S,S 
 
7 
 
199g OTBDMS  
 
45% 
 
90% 
 
S,S 
a) RAMP hydrazone was used. 
 
Moreover, as expected, NMR analysis showed that 199h and 199f were diastereomers. Thus, we 
could confirm that by using only the SAMP chiral auxiliary we had access to both the 
enantiomers of α-(2-furyl)-alkylamines. 
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N
N
H
MeO
O
1) MeLi, Et2O,
    −78°C to rt, 2 h
2) PhCOCl, Et3N,
    CH2Cl2, DMAP
    rt, 16 h NN
Me
MeO
O
Bz
187i 199h
87%
de = 98%
 
Scheme 66. Nucleophilic 1,2-addition of MeLi to 1-(2-furyl)-SAMP-hydrazone. 
 
The N-N bond cleavage was achieved using the above reported SmI2-method affording the N-
protected amines in good to excellent yield and optical purity greater than 96% (Table 11). It is 
noteworthy that when compound 199g was used as substrate, the corresponding amine 200g was 
obtained in 40 % yield (Entry 7) together with 20 % of the O-deprotected compound. Moreover, 
the S configuration of our products was reconfirmed when comparing analytical data and the 
optical rotation of the known product 200f (Entry 6) with the literature value.  
 
Table 11 SmI2 promoted N-N bond cleavage. 
 
Entry 
 
Product 
 
R 
 
Yield 
 
de 
 
ee 
 
Conf. 
 
1 
 
200a 
 
Me
 
84% 
 
- 
 
96% 
 
S 
 
2 
 
200b Ph  
 
80% 
 
- 
 
96% 
 
S 
 
3 
 
200c 
Me
Me
Me
 
 
76% 
 
- 
 
98% 
 
S 
 
4 
 
200d 
Me
Me
 
80% 
 
≥ 96% 
 
99% 
 
S,R 
 
5 
 
200e 
Me
Me
 
83% 
 
≥ 96% 
 
98% 
 
R,S 
 
6 
 
200f Me  
 
90% 
 
- 
 
98% 
 
S 
 
7 
 
200g OTBDMS  
 
40% 
 
- 
 
90% 
 
S 
 
8 
 
200h Me  
 
81% 
 
- 
 
98% 
 
R 
 
Finally, conversion into α-amino acids was carried out by treatment of 200a-f,h,9f with a 
catalytic amount of RuCl3·H2O46a in the presence of a large excess of NaIO4 in a mixture of 
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H2O/CH2Cl2/CH3CN. After two hours at room temperature the reaction was completed. Work-up 
and subsequent purification either by recrystallization or flash column chromatography provided 
the α-amino acids as optical pure products in excellent overall yields (fig. 11). Notably, products 
201d,e demonstrated that our methodology is compatible with the SAMP-α-alkylation allowing 
us to generate α-amino acids with two chiral centres. A final detail should be addressed: 
regardless of extensive experimentation we were not able to synthesize aromatic α-amino acids. 
 
N
Me COOH
N
Me COOH
N
COOH
Me
N
COOHPh
N
COOH
Me
N
COOH
Bz
Me
Me
N
COOH
Me
Me Me
N
COOH
y = 86%
ee = 98%
y = 70%
y = 79%
y = 77%
y = 84%
H Bz H Bz
BzH
H Bz
H Bz
BzH
BzH H
Me
Me
201f
201a
201g201h
201c
201e
y = 85%
ee = 99% ee = 98%
ee = 96%
y = 90%
201b
ee = 96% ee = 98%
y = 82%
201d
de > 96%, ee = 99%_
de > 96%, ee = 98%_
 
Figure 11. Oxidation with RuCl3·H2O and NaIO4. 
 
Even by changing the solvent, temperature and aromatic substituents the reaction between 
aromatic hydrazone 201j-l and 2-furyllitihum (189k) did not take place (Scheme 67). 
 
N
N
H
MeO
187j-l
R
O
Li
Et2O or THF,−78°C or rt NHN
MeO
R
O
+
189k  
Scheme 67. Attempts to add 2-furyllithium to aromatic-SAMP-Hydrazones. 
 
2.2.4.2 Studies towards the Aza-Achmatowicz rearrangement 
 
Having developed a very efficient synthesis of N-benzoyl protected 1-(2-furyl)alkylamines 200a-
h,9f, we decided to continue by exploring the aza-Achmatowicz rearrangment. For this purpose, 
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amides 200a-c,9f were treated with 2 equivalents of dry m-CPBA in dry CH2Cl2 according to the 
O´Doherty protocol.49a Unfortunately, the reaction was very sluggish and after 12 hours NMR 
analysis of the crude product showed a complex mixture of products. To circumvent the problem 
several conditions were screened, including using m-CPBA of different water content, but in 
every case the chemical yields were very poor. Moreover, products 202 could not be obtained in 
pure form due to the presence of a side product with equal polarity. We reasoned that the 
reaction conditions were not compatible with the protecting group on the nitrogen resulting in 
cleavage of the benzoyl group and subsequent formation of a substituted pyridine 203, which 
was probably lost during the work-up of the reaction (Scheme 68). 
 
O
NBz
R
m-CPBA dry,
CH2Cl2, rt 
12 h
N
Bz
R
O
HO30%
crude
+
N
OH
R
200a-c,9f 202 203
 
Scheme 68. Attempts towards aza-Achmatowicz rearrangment. 
 
Therefore, we decided to test a modified protocol using dimethyldioxirane111 as an alternative 
neutral oxidating agent. Dimethyldioxirane was generated in situ112 (H2O/CH2Cl2/Acetone) in 
the reaction mixture already containing the furfurylamide that was to be oxidized, by reacting 
acetone with Oxone® (2KHSO5·KHSO4·K2SO4), in the presence of potassium hydrogen 
carbonate. Opening of the furan moiety took place smoothly affording to our surprise aldeydes 
204a-f together with a side product 205a-f (scheme 69). 
 
NHBz
R
NHBz
O O O
H
oxone, NaHCO3,
H2O/CH2Cl2/acetone
rt, 5 h
R +
R
NHBz
O
204a-f 205a-f200a-c,f-g,194f  
Scheme 69. Oxidation with oxone. 
 
No trace of the Aza-achmatowicz product could be detected by NMR analysis. Furthermore, 
formation of imides 205a-f were inversely proportioned to the steric hindrance and to the 
electron donor power of the substituents on the furfurylamides. When a methyl group was the 
substituent, 205a was the predominant product in the reaction mixture and after purification 
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could be isolated in 50% chemical yield (table 12, entry 1). In the case of the ethyl group still 
10% of 205b was formed whereas only traces of analogous products were detected with the 
other substituents. It is noteworthy that the reaction was very clean with 204c and 204e 
providing the Z-unsaturated aldehydes in almost quantitative yield and high purity as shown by 
the elemental analysis performed on the crude products (see experimental part). 
 
Table 12. Oxidation with dimethyldioxirane. 
 
Entry 
 
Product 
 
R 
 
Yield 
204 
 
Yield 
205 
 
ee 
 
 
1 
 
 
a 
 
Me  
 
 
traces 
 
 
50% 
 
 
98% 
 
2 
 
b Me  
 
85% 
 
10% 
 
99% 
 
3 
 
c 
Me
Me
Me
 
 
96% 
 
- 
 
98% 
 
4 
 
d 
 
Ph  
 
94% 
 
traces 
 
96% 
 
5 
 
e OTBDMS  
 
98% 
 
- 
 
90% 
 
6 
 
f Me  
 
96% 
 
traces 
 
96% 
 
Unfortunately, purification of the other aldehydes was not possible due to their high instability 
during flash column chromatography. Surprisingly, intramolecular cyclization of the aldehydes 
204b-f did not take place either during storage over a period of time or warming in CH2Cl2.  
 
NHBz
O O
H
R
H2NNH2, EtOH
R
NHBz
N
N
NHBz
O O
H
R
NHBz
COOR1
O
R
MnO2, NaCN, 
MeOH or t-BuOH
NaOCl, NaH2PO4,
2-methyl-butene
204d-e
204d  
Scheme 70. Attempts to oxidize and condensate the unsaturated aldehydes. 
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Moreover, attempts to obtain the corresponding biologically active ester113 or acid, by oxidation 
of the aldehydes 204d-e using Corey’s114 or Kobayashi’s115 conditions, failed (Scheme 70). 
Trials to condensate 204d with hydrazine met the same fate. In the light of these disappointing 
results we decided not to investigate further these reactions. 
 
2.2.4.3 Asymmetric synthesis of ß-amino sulfones 
 
Sulfones are a major class of organosulfur compounds116 that have been extensively used as 
versatile intermediates in organic synthesis.117 The importance of the sulfone moiety has evoked 
interest in the development of new methodologies regarding introduction of the sulfone 
functionality into an organic molecules as well as the further synthetic transformation of the 
sulfone intermediates. Furthermore, in last ten years vinylic118 and cyclic sulfones119 have 
emerged as key subunits and scaffolds of biologically active molecules such as protease and ß-
lactamase inhibitors. In the search for synthetically and biologically interesting compounds, we 
reasoned that our methodology offered a straightforward entry in a particular class of cyclic ß-
amino sulfones by oxidating the thiophene or benzothiophene ring.120 Preliminary experiments 
conducted on previously synthesized N-protected thienylamines 196a-f gave disappointing 
results. Using either m-CPBA121 or dimethyldioxirane122 as oxidanting agent, the reaction was 
very sluggish and moreover complex mixtures of products were obtained. Two reasons for the 
failure of the reaction can be suggested: (1) the high resonance energy of the thiophene was 
probably responsible for the inertness of the substrates, (2) the high tendency of the desired 
sulfones to dimerize122 by Diels-Alder reaction could account the formation of complex product 
mixtures. We reasoned that both problems could be in theory overcome by replacing the 
thiophene ring with the benzothiophene. The desired N-protected α-benzothienyl amines 187a-h 
were easily synthesized in three steps including 1,2-nucleophilic addition of 2-
benzothienyllithium to SAMP-hydrazones 187c-f,h-l, subsequent BH3·THF promoted N-N bond 
cleavage and final protection as carbamates (Scheme 71). Surprisingly, also different aromatic 
SAMP-hydrazones 187j-l reacted but the chemical yields and enantioselectivities obtained were 
moderate. Further studies showed that the 1,2-nucleophilic addition of 189b on these substrates 
started to take place at about –10°C instead of the usual −50°C observed with alkyl-hydrazones. 
In addition, performing the reaction at –10°C was quite sluggish and no improvement of the 
selectivities was observed. However, in the case of 206e we were able to increase the 
enantioselectivity to 88% by recrystallization. Oxidation of the carbamates 206b-h,191b 
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proceeded smoothly using the above reported Oxone® protocol,112 affording the vinyl sulfones 
207a-h in almost quantitative yields (Scheme 72). 
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N
H
S
Cbz
N
H
S
Cbz
N
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H
S
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yield 46%(30%)a yield 72% yield 60%
yield 45%
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N
H
S
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H3CO
Cbz
N
H
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F3C
N
N
OCH3R H
1) Et2O − 78°C to
   rt,5h.
2) BH3
.THF, reflux
    9-24h
3) ClCbz, K2CO3, 
   THF/H2O, 24h
Cbz
N
R
H
S
ee = 22-99%
30-77%
+
S
Li
Fe
ee = 77%(88%)a ee = 95%ee = 66%
ee = 22%ee > 95% ee = 93%
206a 206b 206c 206d
206e 206f 206g 206h
189b187c-f,2h-l
ee = 91%
ee = 99%
yield 40% yield 62% yield 77%
a = after crystallization
206a-h
_
 
Scheme 71. Asymmetric synthesis of N-protected 1-(2-benzothienyl)amines. 
 
Interestingly, the reaction was extremely clean and in nearly every case the sulfone did not 
require purification via flash column chromatography. Finally, reduction of the double bond was 
more challenging than expected. Use of NaBH4 as reducing agent resulted in a sluggish reaction 
affording after four days extremely poor conversion (circa 20%) as shown by NMR analysis. A 
major improvement was achieved by employing NaBH4 in the presence of a catalytic amount of 
NiCl2 in MeOH. The reduction took place smoothly and the corresponding products 208a-e 
could be isolated in excellent yields (Scheme 72, Table 13). Especially with compounds 207a,c,g 
the reduction proceeded with very high selectivity affording the corresponding trans 
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diastereomers 208a-c (entry 1-3) as a mixture of carbamate isomers in a ratio of approximately 
2:1. Increasing the steric hindrance of the substituents resulted in a drastic decrease of the 
diastereoselectivity in the reaction. The effect was particularly marked with the tert-butyl group. 
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N
R
H
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Cbz
N
R
H
SO
O
206b-h,191b 207a-h
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207e 207f 207g 207h
207d207c207b207a
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ee = 22% ee = 93% ee = 99%
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Scheme 72. Oxidation with oxone. 
 
When 207h was treated with NaBH4 in the presence of NiCl2, longer reaction time was 
necessary and the reaction afforded three products as shown by NMR analysis of the crude 
mixture.  
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NiCl2, NaBH4, 
MeOH −10°C to rt
3-14h
60-89%
Cbz
N
R
H
SO
O
Cbz
N
R
H
SO
O
de = 15-> 95%
ee = 88-96%−
207a,c,e,g,h 208a-e
 
Scheme 72. Reduction with NaBH4 in presence of NiCl2. 
 
Purification by flash column chromatography gave two fractions: the former was the desired 
diastereomer 208e as a mixture of carbamate isomers, the latter the opposite diastereomer as a 
single product (no carbamate isomer could be detected). 
 
Table 13. Reduction with NaBH4 in the presence of NiCl2. 
 
Entry 
 
Product 
 
Ra 
 
Time 
 
Yield 
 
dea 
 
ee 
 
Conf 
 
1 
 
208a 
 
Me  
 
3 h 
 
89% 
 
≥ 96% 
 
93% 
 
S,R 
 
2 
 
208b Me
 
3 h 
 
79% 
 
≥ 96% 
 
93% 
 
S,R 
 
3 
 
208c Ph  
 
3 h 
 
87% 
 
≥ 96% 
 
95% 
 
S,R 
 
4 
 
208d 
 
 
3 h 
 
60% 
 
90% 
 
88% 
 
S,R 
 
5 
 
208e 
Me
Me
Me
 
 
14 h 
 
70% 
 
15% 
 
91% 
 
S,R 
a) determined by 1H and 13C NMR. 
 
The diastereomers were produced in a disappointing ratio of approximately 1.3:1. To overcome 
the problem, a screening of different hydrides and solvents was commenced: best results were 
achieved when the reductions were performed using L-selectride® in THF at low temperature. 
The desired products 208a-f were obtained in good yields and oustanding stereocontrol (de ≥ 
96%) (Scheme 73). 
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208a 208b
208f
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208c
ee = 88%
de > 96%_
208d
ee = 95%
de > 96%_
208e
ee = 91%
de > 96%_
ee = 88-99%
de > 96%_
207a,c-e,g,h 208a-f
 
Scheme 73. Reduction with L-selectride®. 
 
Finally, the absolute configuration of the newly formed stereogenic centres was assigned as R by 
the NOE experiment performed on the deprotected ß-amino sulfone 209. Selected NOE 
interactions are depicted in scheme 74. 
 
S
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HH
H
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Me
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H
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96%
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ee = 91%−
23e 24
 
 Scheme 74. Removal of the protecting group and NOE interactions. 
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2.2.5 Conclusion 
 
In summary, we have achieved a highly efficient asymmetric synthesis of α-
(heteroaryl)alkylamines based on nucleophilic 1,2-additon of heteroarenyllithium species to 
SAMP-/RAMP-hydrazones followed by N-N bond cleavage of the hydrazines (scheme 75). 
 
N
N
OCH3H
O
H
N
H2N
OCH3
HetArLi N
N
OCH3HetAr
H
Pg
N
HetAr
H
BH3.THF,
CbzCl, or 
BzCl, SmI2
Me
quant.
Me
Me
Me
44-80%
ee = 88-99%
65%-quant.
58-80%
186b 191a-e,194a,g
187b 190a-l
de = 88-99%
 
Scheme 75. Asymmetric synthesis of α-(heteroaryl)alkylamines 
 
Twelve different heteroaryles were used with success. In addition, screening of different 
hydrazones was presented demonstrating the efficiency and the generality of the novel method 
developed in this study. The method was successfully applied in the synthesis of biologically 
interesting compounds. In particular, we achieved an asymmetric synthesis of α-amino acids in 
four steps including a highly diastereoselective 1,2-addition of 2-furyllithium to SAMP-RAMP-
hydrazones followed by protection of the obtained hydrazine with benzoylchloride and 
subsequent SmI2 promoted N-N bond cleavage. Finally, oxidation of the furan moiety with an 
metal oxide provided the desired α-aminoacids in high overall yield and excellent optical purity. 
It is noteworthy that combining the aldehyde-SAMP-hydrazone-α-alkylation and the newly 
developed method, α-amino acids with two stereogenic centres could be synthesized as well. In 
addition, we achieved an asymmetric synthesis of a novel class of ß-amino sulfones by oxidation 
of the synthesized N-protected 1-(2-benzothienyl)amines. 
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199a-h,190k 200a-h,194f
 
Scheme 76. Asymmetric synthesis of α-amino acids. 
 
Subsequent reduction of the double bond performed with L-selectride® as reducing agent 
afforded the desired β-amino sulfones in good yields and high selectivities. 
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Scheme 77. Asymmetric synthesis of β-amino sulfones. 
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2.2.6 OUTLOOK 
α,ß-Unsaturated sulfones have been widely used as building blocks in synthetic organic 
chemistry. The utility of these starting materials to give access to highly functionalized systems 
has been exploited via both cyclic and acyclic vinyl sulfones. In particular, they have found 
widespread application as Michael acceptors. Either carbon or heteroatom nucleophiles 
(alcohols, thiols or amines) have been successfully used in the conjugate addition of unsaturated 
sulfones.123 During our studies we have developed a very efficient asymmetric synthesis of ß-
amino vinyl sulfones.  
 
H
N
R
Cbz
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O
RLi, CuCN,
H
N
R
Cbz
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O
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H
N
R
Cbz
R
A B C  
Scheme 78. Asymmetric synthesis of chiral amines. 
 
These compounds could represent a powerful building block to enter different classes of γ-
substituted chiral amines. The retrosynthetic analysis depicted in scheme 78 is extremely simple. 
The sequence commences with an asymmetric Michael addition on the vinyl sulfone A utilizing 
a carbon nucleophile (e.g. organocuprate) which should add in stereoselective fashion an alkyl 
group at the γ-position. Subsequent desulfurization provides in straightforward manner the 
desired chiral amine C. Naturally, by using heteroatom nucleophiles one could enter different 
classes of compounds, as for example α,γ-diamines or α,γ-amino ethers. 
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3   Experimental Section 
 
3.1  General Remarks 
 
All reactions, involving air- or moisture-sensitive compounds, and subsequent work-up were 
carried out under nitrogen using standard Schlenk techniques. The solvents were dried and 
purified by standard methods. They were deoxygenated and stored under nitrogen. Reagents and 
solvents were transferred under nitrogen via syringe or cannula. Thin-layer chromatography (tlc) 
was performed on silica gel 60 (Merck F254), coated on aluminium plates and visualized by UV 
or permanganate treatment. Flash chromatography was performed on silica gel 60 particle size 
0.040-0.063 mm (230-240 mesh, flash) (Merck). Solutions of crude reactions mixture were 
filtered through Celite (Fluka 535).  
 
3.1.1  Chemicals  
 
n-BuLi (1.6 N solution in n-Hexane), t-BuLi (1.6 N solution in n-Hexane), L-Selectride®, LAH, 
AgNO3, NaBH4, BF3٠Et2O, Furan, Benzofuran, Thiophene, Benzothiophene, 2-Bromopyridine, 
3-Bromopyridine, N-methylimidazole, N-methylbenzoimidazole, 3-Bromothiophene, 2-Bromo-
5-clorothiophene, N-Methylindole and N-Methylpyrrole were purchased by Merck, Aldrich, 
Acros, Fluka, Degussa and Sigma. (R,R)-5-amino-1-phenyl-1,3-propandiol was provided by 
Boehringer Mannheim GmbH. 
 
3.1.2  Characterization of the Products 
 
1H-NMR Spectroscopy:  Varian VXR 300 and Gemini (300 MHz), Varian Inova 400 (400 
MHz), Varian Unity 500 (500 MHz). Internal Standard: 
Tetramethylsilan. 
13C-NMR Spectroscopy:  Varian VXR 300 and Gemini (75 MHz), Varian Inova 400 (100 
MHz), Varian Unity 500 (125 MHz). Internal Standard: 
Tetramethylsilan. 
Mass Spectrometry: mass spectra were obtained with a Finnigan MAT 212 
spectrometer by electron impact (EI) or fast atom bombardment 
(FAB). HR-MS: Finnigan MAT 95 
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Infrared Spectroscopy: IR spectra were recorded on a Perkin Elmer 1760, Perkin Elmer 
1750. 
Elemental Analysis: Heraeus CHN-O-RAPID and Elemental Vario EL 
Optical Rotatory Power: optical rotations were measured on a Perkin Elmer 241 Polarimeter 
at λ = 589 nm using CHROMASOLV® grade solvents. 
Fusion Point: Tottoli, Büchi 510. 
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3.2  General procedures 
 
3.2.1  GP1: Synthesis of benzylbromides 
 
To a stirred solution of aromatic aldehyde (50 mmol) in 50 ml of CH2Cl2 was added 2.3 g of 
NaBH4 (62 mmol) in 25 ml of MeOH. After stirring for 1 h, the reaction mixture was poured into 
100 ml of water extracted with CH2Cl2 (three times), dried over MgSO4 and concentrated under 
reduced pressure. The resulting crude alcohol was dissolved in 100 ml of ether before 15.5 g of 
PB3 were added dropwise in 35 ml of ether. After stirring for 3 h at room temperature, the 
reaction mixture was poured in 100 ml of water, then extracted with CH2Cl2 (three times), dried 
over MgSO4 and concentrated. Crystallization from n-Hexane afforded the corresponding 
benzylbromide as a colorless solid. 
 
3.2.2   GP2: Synthesis of α-amino nitrile 
 
To a solution of amine 137 (0.15 mol) in 150 ml of water was cautiously added HCl until PH 5. 
To the reaction mixture was added 1 equivalent of aromatic aldehyde (pure or dissolved in 
MeOH) followed by 1 equivalent of KCN. After stirring the mixture for 24 h at room 
temperature HCl was added until the solution reached PH 5. The aqueous phase was extracted 
three times with Et2O and the combined organic layers were washed with brine, dried over 
MgSO4 and evaporated in vacuo. The crude product was purified either via column 
chromatography or recrystallization. 
 
3.2.3   GP3: Synthesis of Michael adducts 
 
A solution of amino nitrile (10 mmol) in THF (40 ml) or Et2O (100 ml) was treated with a 
solution of LDA (11 mmol) in the appropriate solvent (10 ml) at – 78°C. After 1 h furan-2(5H)-
one (1.01 g, 12 mmol) was added, and the solution was allowed to react for 4 h. After hydrolysis 
with saturated aqueous NH4Cl, the aqueous phase was extracted with Et2O, the combined 
organic layers were washed with brine and dried (MgSO4). Concentration under reduced 
pressure yielded crude adducts as colorless or light yellow solids. 
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3.2.4   GP4: Aldol reaction on the Michael adduct and cleavage of the chiral auxiliary. 
 
In a dried Schlenk-flask were successively added anhydrous LiCl (2.2 equiv.), diisopropyl amine 
(1.2 equiv.) and dry THF (3 mL pro mmol diisopropyl amine). The flask was cooled to −78°C, 
prior to the dropwise addition of n-butyllithium (1.2 equiv., 1.6 M). The solution was stirred at 
0°C for 30 min. This mixture was added via a syringe pump to another flask cooled to −78°C 
containing the Michael-adduct (1 equiv.) in dry THF (10 mL pro mmol Michael adduct). After 
90 min the solution was cooled to −100°C and the corresponding aromatic aldehyde (1.2 equiv.) 
dissolved in dry THF (2 mL pro mmol aldehyde) was added very slowly via a syringe pump. 
After 20 min at −100°C the cooling bath was removed and the reaction was quenched by quickly 
adding saturated aqueous NH4Cl under vigorous stirring. The mixture was allowed to warm to rt 
after which H2O was added and the org. phase was separated. The aq. phase was extracted three 
times with Et2O and the combined org. layers were washed with brine, dried over MgSO4 and 
evaporated in vacuo. The crude product was dissolved in THF (10 mL pro mmol aldol product) 
and the flask was wrapped with aluminium foil. A 2 N AgNO3 solution (4 equivivalents) was 
added and the mixture was stirred 15 min (TLC control) after which Et2O (20 mL pro mmol 
aldol product) was added and the reaction mixture stirred for further 30 min. The Ag-residues 
were removed by filtration and washed with Et2O and H2O. After partitioning, the aq. phase was 
extracted three times with Et2O. The combined org. layers were washed three times with brine, 
dried over MgSO4 and evaporated in vacuo. Column chromatography or recrystallization 
afforded the pure product. 
 
3.2.5   GP5: Alkylation reaction on the Michael adduct and cleavage of the chiral 
auxiliary. 
 
A solution of Michael adduct (1 mmol) in THF (10 ml) was treated with 1.2 mmol of t-
butyllithium at –78°C for 1 h. A solution of benzyl bromide (1 mmol) in THF (5 ml) was added 
at –90°C. The solution was allowed to warm to 0°C overnight and was quenched with saturated 
aqueous NH4Cl. The aqueous phase was extracted three times with Et2O and the combined org. 
layers were washed with brine, dried over MgSO4 and evaporated in vacuo. The crude product 
was dissolved in THF (10 mL pro mmol aldol product) and the flask was wrapped with 
aluminium foil. A 2 N AgNO3 solution (4 equivivalents) was added and the mixture was stirred 
for 15 min (TLC control) after which Et2O (20 mL pro mmol aldol product) was added and the 
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reaction mixture stirred for further 30 min. The Ag-residues were removed by filtration and 
washed with Et2O and H2O. After partitioning, the aq. phase was extracted three times with 
Et2O. The combined org. layers were washed three times with brine, dried over MgSO4 and 
evaporated in vacuo. The crude product was purified via column chromatography. 
 
3.2.6   GP6: Synthesis of the lactone diols  
 
Alcohol (1 equivalent) was dissolved in dry THF (16 mL pro mmol alcohol) and cooled to 
−78°C. L-Selectride (1.3 equivalent) was added dropwise and after 30 min the cooling bath was 
removed. The mixture was quenched with H2O and immediately partitioned with H2O and 
EtOAc. After removing the aqueous phase, the organic layer was washed twice with brine, dried 
over MgSO4 and evaporated in vacuo. The crude product was purified via column 
chromatography. 
 
3.2.7   GP7: Synthesis of the tetraols  
 
To a suspension of LiAlH4 (10 equiv) in dry THF (2 mL pro mmol LiAlH4) in an Schlenk-flask 
equipped with a condenser was added at to 60°C, via syringe pump the diol (1 equiv.) dissolved 
in dry THF (10 mL pro mmol diol). After 1 h at 60°C the solution was allowed to cool to rt, 
quenched with 10% aqueous NaOH and stirred for additional 10 min. The precipitate was 
removed via filtration and was extracted twice by refluxing in THF. The combined filtrates were 
evaporated in vacuo. The crude product was purified via column chromatography. 
 
3.2.8   GP8: Synthesis of furofuran lignans  
 
To the tetraol dissolved in dry CH2Cl2 (10 mL pro mmol tetraol) was added at 0°C pyridine (0.8 
mL pro mmol tetraol) and MsCl (3 equivivalents). The reaction mixture was allowed to warm to 
rt overnight. The mixture was washed once with H2O, twice with a 10% solution of citric acid 
and finally with brine. The organic layer was dried over MgSO4 and evaporated in vacuo. The 
crude product was purified via column chromatography. 
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3.2.9  GP9: Cyclization of keto-butyrolactone  
 
To a solution of ketone in trifluoroacetic acid (1.6 ml for mmol of ketone) were added 2 
equivalents of triethylsilan and the solution was warmed up to 45°C and left overnight. The 
mixture was hydolysed with H2O and extracted two times with EtOAc. The org. layer was then 
washed twice with brine, dried over MgSO4 and evaporated in vacuo. The crude product was 
purified via column chromatography. 
 
3.2.10 GP10: Preparation of the lithiated heteroerenes. 
 
2-Furyllithium: butyllithium (6.4 mmol) was added to a solution of furan (462 mg, 6.8 mmol) in 
20 ml of dry THF at 0°C. The ice bath was removed and the mixture warmed up at 50-60°C for 
60-90 min. 
2-thienyllithium, 2-benzothienyllithium and 2-benzofuryllithium: butyllithium (6.4 mmol) was 
added to a solution of thiophene, benzothiophene or benzofuran (6.8 mmol) in 20 ml of dry Et2O 
at 0°C. After 5 minutes the ice bath was removed and the mixture was stirred for 1 h at rt (90 
min for benzothiophene). 
2-lithio-1-methyl pyrrole and 2-lithio-1-methylindole: Butyllithium (6.4 mmol) was added to a 
solution of N-methylpyrrole or N-methylindole (6.8 mmol) in 20 ml of dry THF at rt. The 
mixture was warmed up at 60°C for 1 h or alternatively stirred at rt overnight. 
 
3.2.11 GP11: Preparation of furfuryl hydrazines. 
 
To a solution of 2-furyllithium (GP10) cooled to –78°C, was added dropwise hydrazone (2 
mmol) in 2 ml of dry THF. After 30 min the cooling bath was removed and the temperature 
allowed to warm to rt and stirred for an additional 2-18 h. The mixture was hydrolyzed with 
saturated aqueous NH4Cl and extracted three times with Et2O. The org. layer was then washed 
twice with sat. NaCl soln, dried with MgSO4 and evaporated in vacuo. The crude product was 
either purified via column chromatography, or used as crude in the next step.  
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3.2.12 GP12: Protection of hydrazines. 
 
Crude hydrazine was dissolved in dry CH2Cl2 (10 ml pro mmol) in presence of a catalitic amount 
of DMAP and 4 equivalents of dry Et3N. Benzoyl chloride (4 equivalents) was added dropwise 
to the stirred mixture at rt. After 12-48 h the solvent was evaporated in vacuo and the crude 
product was purified via column chromatography. 
 
3.2.13 GP13: SmI2 promoted cleavage. 
 
To a solution of protected hydrazide in dry THF (riquoreous strict anaerobic conditions are 
required!!!!!) (10 ml pro mmol of hydrazine) were added two equivalents of DMPU followed by 
two-three equivalents of SmI2. After 2 h at room temperature the reaction mixture was quenched 
with a mixture of diluted NaHCO3 solution and CH2Cl2 (5:2), extracted with CH2Cl2, dried over 
MgSO4 and concentrated in vacuo. Crude product was purified via column chromatography. 
 
3.2.14 GP14: Synthesis of 1-(2-thienyl)alkylcarbamates and 1-(2-benzothienyl)alkyl 
carbamates. 
 
To a solution of 2-thienyllithium or 2-benzothienyllithium (GP10) cooled to –78°C, was added 
dropwise hydrazone (2 mmol) in 2 ml of dry Et2O. After 30 min the cooling bath was removed 
and the temperature allowed to warm to room temperature and the reaction mixture stirred for an 
additional 2-9 h. The mixture was quenched with saturated aqueous NH4Cl and extracted three 
times with Et2O. The org. layer was then washed twice with brine, dried over MgSO4 and 
evaporated in vacuo. The crude hydrazine was dissolved in dry THF (10 ml pro mmol of 
hydrazine) and heated up to reflux with 10 or 20 equivalents of BH3·THF (1.0 mol in THF) for 
9-36 h. The reaction was cooled to room temperature, acidified with aqueous HCl (1N) and 
stirred for 1 h. The THF was evaporated under reduced pressure and the aqueous solution was 
basified with a saturated solution of K2CO3 and extracted with methylene chloride. The organic 
layers were concentrated in vacuo and the residue was dissolved in a mixture of H2O and THF 
(1:1). 2 equivalents of potassium carbonate were added followed by 1.8 equivalents of benzyl 
chloroformate and the heterogeneous solution was stirred at room temperature overnight. Et2O 
was added to the mixture, the layers were separated and the aqueous layer was washed with two 
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further portions of Et2O. The combined organic extracts were dried (MgSO4) and evaporated. 
Crude product was purified via column chromatography. 
 
3.2.15 PG15: Synthesis of 1-(1-methyl-1H-pyrrol-2-yl)alkyl carbamates 
 
To a solution of 2-lithio-1-methylpyrrole (GP10) cooled to –78°C, was added dropwise 
hydrazone (2 mmol) in 2 ml of dry THF. The solution was allowed to warm to room temperature 
overnight. The mixture was quenched with saturated aqueous NH4Cl and extracted three times 
with Et2O. The organic layer was then washed twice with brine, dried with MgSO4 and 
evaporated in vacuo. The crude hydrazine was dissolved in dry THF (10 ml pro mmol of 
hydrazine) and heated up to reflux with 10 or 20 equivalents of BH3·THF (1.0 mol in THF) for 
6-12 h. The reaction was cooled to room temperature, acidified with aqueous HCl (1 N) and 
stirred for 1 h. The THF was evaporated under reduced pressure and the aqueous solution was 
basified with a saturated solution of K2CO3 and extracted with methylene chloride. The organic 
layers were concentrated in vacuo and the residue was dissolved in a mixture of H2O and THF 
(1:1). 2 equivalents of potassium carbonate were added followed by 1.8 equivalents of benzyl 
chloroformate and the heterogeneous solution was stirred at room temperature overnight. Et2O 
was added to the mixture, the layers separated and the aqueous layer was washed with two 
further portions of Et2O. The combined organic extracts were dried (MgSO4) and evaporated. 
The crude product was purified via column chromatography. 
 
3.2.16 PG16: Oxidation of furfuryl amides to N-protected α-amino acids. 
 
RuCl3·H2O (2 mol%) was added to a mixture of NaIO4 (15 equivalents) in CH2Cl2/MeCN/H2O 
(1.0:0.04:0.7) and the mixture was stirred 0.5 h. A solution of furfuryl amide in CH2Cl2 was 
rapidly added to the mixture via cannula. Upon completion of the reaction after 2 h, the organic 
phase was separated and aqueous phase was washed with CH2Cl2. The collected organic layers 
were washed with saturated aqueous NaHSO3 and brine, dried (MgSO4) and concentrated in 
vacuo. Crude product was purified by column chromatography or recrystallization. 
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3.2.17 PG17: Oxidation oxone® promoted. 
 
To a 2 neck flask equipped with an efficient stirrer and a condenser charged with H2O (20 ml pro 
mmol), acetone (16 ml pro mmol) and NaHCO3 (1.2 g pro mmol) was added a solution of 
furfuryl amide (or 1-(2-benzothienyl)alkylcarbamates) in CH2Cl2 (18 ml pro mmol). To the 
resulting heterogeneous mixture oxone was carefully added over 5 min (2g pro mmol). The 
reaction mixture was stirred at rt for 2-7 h before water was added to dissolve most of the 
inorganic residues. The decanted aqueous layer, and all remaning solids were extracted with 
CH2Cl2, the combined organic phases washed with water and dried over MgSO4. The solvent 
was removed in vacuo and the crude product directly used in the next step without any 
purification. 
 
3.2.18 PG18: Reduction of β-vinylaminosulfones with NaBH4 in presence of NiCl2. 
 
β-vinylaminosulfone was dissolved in MeOH (10 ml pro mmol) in presence of a catalytic 
amount of NiCl2 (20 mol%) and the obtained solution was cooled to –20°C. 4 equivalents of 
NaBH4 were carefully added to the mixture under vigorous stirring. After 2-7 h the solvent was 
removed under reduced pressure and the residue was dissolved in a solution of CH2Cl2 and 
water. The layers were separated and the aqueous phase extracted three times with CH2Cl2. The 
combined organic extracts were washed with brine and dried over MgSO4. The solvent was 
removed in vacuo and the crude product purified by flash chromatography. 
 
3.2.19 PG19: Reduction of β-aminosulfones with L-Selectride®. 
 
To a solution of β-vinylaminosulfone in THF (10 ml pro mmol) were added dropwise 2 
equivalents of L-selectride at – 78°C. The solution was slowly allowed to warm to – 20°C and 
after 2-9 h was quenched by addition of AcOH. The solvent was removed under reduced 
pressure and the residue was diluted with CH2Cl2. The organic layer was washed with brine and 
dried over MgSO4. The solvent was removed in vacuo and the crude product purified on silica 
gel chromatography. 
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3.3   Michael acceptor 
 
3.3.1   5H-furan-2-one (144) 
 
O
O  
 
In a 500 ml three-necked flask fitted with a mechanical stirrer, a reflux condenser, and a 250 ml 
dropping funnel containing a solution of 61 g (0.6 moles) of triethylamine in 70 ml of dry ether, 
a solution of 83 g (0.5 moles) of α-bromo-γ-butyrolactone (143) and 200 ml of dry diethylether 
was heated to reflux with stirring. The amine solution is added, slowly, during 5 h. The brown 
precipitate was removed by filtration. Most of the solvent was removed from the filtrate by 
concentration under reduced pressure. The liquid residue is distilled under reduced pressure and 
the 5H-furan-2-one (144) is collected at 107-109°C (24 mm). 
 
Yield: orange oil, 25 g, 60% 
 
1H-NMR (300 MHz, CDCl3): 
δ = 4.94 (dd, 2H, J = 1.7, 2.4 Hz, CH2OC=O), 6.17 (dt, 1H, J = 2.4, 5.7 Hz, CHC=O), 7.69 (dt, 
1H, J = 1.7, 5.7 Hz, CHCH2O) ppm. 
 
13C-NMR (75 MHz, CDCl3): 
δ = 72.37 (CH2OC=O), 121.26 (CHCH2O), 153.56 (CHC=O), 179.93 (C=O) ppm. 
 
3.4   Benzylbromides 
 
3.4.1   5-Bromomethyl-benzo[1,3]dioxole (146a) 
 
O
O
Br
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5-Bromomethyl-benzo[1,3]dioxole (146a) was synthesized according to GP1. Starting form 7.5 
g (50 mmol) of piperonal (145a), pure 146a (7.8 g, 36.5 mmol) was obtained after 
recrystallization from n-Hexane as a colorless solid. 
 
Yield: colorless solid, 7.8 g, 73% 
Mp: 48°C 
 
1H-NMR (300 MHz, CDCl3): 
δ = 4.45 (s, 2H, CH2Br), 5.95 (s, 2H, OCH2CO), 6.74 (dd, 1H, J = 1.4, 7.7 Hz, arom CH), 6.84 
(d, J = 1.4 Hz, 1H, arom CH), 6.85 (d, 1H, J = 7.7 Hz, arom CH) ppm. 
 
13C-NMR (75 MHz, CDCl3): 
δ = 34.22 (CH2Br), 101.35 (OCH2O), 108.32, 109.48, 122.78 (arom CH), 131.53, 147.83, 147.93 
(arom C) ppm. 
 
The rest of the analytical data are in agreement with those previously reported.26c 
 
3.4.2   4-(Bromomethyl)-1,2-dimethoxybenzene (146b) 
 
Br
H3CO
OCH3  
 
4-(Bromomethyl)-1,2-dimethoxybenzene (146b) was synthesized according to GP1. Starting 
form 9.9 g (60 mmol) of 3,4-dimethoxybenzoaldehyde (145b), pure 146b (11.2 g, 48.6 mmol) 
was obtained after recrystallization from n-Hexane as a colorless solid. 
 
Yield: colorless solid, 11.2 g, 81% 
 
1H-NMR (300 MHz, CDCl3): 
δ = 3.87 (s, 3H, OCH3), 3.88 (s, 3H, OCH3), 4.49 (s, 2H, CH2Br), 6.80 (d, 1H, J = 8.1 Hz, arom 
CH), 6.91 (d, 1H, J = 2.0 Hz, arom CH), 6.94 (dd, 1H, J = 2.0, 8.1 Hz, arom CH) ppm. 
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13C-NMR (75 MHz, CDCl3): 
δ = 34.41 (CH2Br), 55.88, 55.90 (OCH3), 111.01, 112.07, 121.55 (arom CH), 130.23, 149.06, 
149.23 (arom C) ppm. 
 
The rest of the analytical data are in agreement with those previously reported.26c 
 
3.4.3   5-Bromomethyl-1,2,3-trimethoxy-benzene (146c) 
 
Br
H3CO
OCH3
H3CO
 
 
5-Bromomethyl-1,2,3-trimethoxy-benzene (146c) was synthesized according to GP1. Starting 
form 19.8 g (100 mmol) of 3,4,5-trimethoxybenzoaldehyde (145c), pure 146c (12.7 g, 70 mmol) 
was obtained after recrystallization from n-Hexane as a colorless solid. 
 
Yield: colorless solid, 12.7 g, 70% 
 
1H-NMR (300 MHz, CDCl3): 
δ = 3.84 (s, 3H, p-OCH3), 3.87 (s, 6H, m-OCH3), 4.46 (s, 2H, CH2Br), 6.62 (s, 2H, arom CH) 
ppm. 
 
13C-NMR (75 MHz, CDCl3): 
δ = 34.32 (CH2Br), 56.13 (m-OCH3), 60.87 (p-OCH3), 106.10 (arom CH), 133.22, 138.13, 
153.30 (arom C) ppm. 
 
The rest of the analytical data are in agreement with those previously reported.26c 
 
3.4.4   1-(Benzyloxy)-4-(bromomethyl)-2-methoxybenzene (146d) 
 
Br
BnO
H3CO
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1-(Benzyloxy)-4-(bromomethyl)-2-methoxybenzene (146d) was synthesized according to GP1. 
Starting form 12.1 g (60 mmol) of 4-benzyloxy-3-methoxy-benzaldehyde (145d), pure 146d 
(13.0 g, 50.4 mmol) was obtained after recrystallization from n-Hexane as a colorless solid. 
 
Yield: colorless solid, 13.0 g, 84% 
Mp: 70-73°C 
 
1H-NMR (300 MHz, CDCl3): 
δ = 3.92 (s, 3H, OCH3), 4.50 (s, 2H, CH2Br), 5.17 (s, 2H, OCH2), 6.81-6.96 (m, 3H, arom CH), 
7.27-7.46 (m, 5H, arom CH) ppm. 
 
13C-NMR (75 MHz, CDCl3): 
δ = 34.38 (CH2Br), 56.03 (OCH3), 70.93 (OCH2), 112.59, 113.71, 121.49, 127.22, 128.58 (arom 
CH), 130.68, 136.86, 148.38, 149.68 (arom C) ppm. 
 
The rest of the analytical data are in agreement with those previously reported.26c 
 
3.5  α-Aminonitriles 
 
3.5.1  (4S,5S,R/S)-(+)-Benzo[1,3]dioxol-5-yl-[(2,2-dimethyl-4-phenyl[1,3]dioxan-5-
yl)methylamino]-acetonitrile (147) 
 
O
O
N
CN
H3C O
OPh CH3
CH3
*
 
33.4 g (150 mmol) of amine 137 were treated with 22.5 g (150 mmol) of piperonal (145a) and 
9.8 g of KCN (150 mmol) according to GP2. After work-up and recrystallization 41,3 g (109.5 
mmol) of 147 were obtained as a colorless solid. 
 
Yield: colorless solid, 41.3 g, 73% 
Mp: 118°C 
TLC: Rf = 0.45 (Et2O:Pentane = 1:1) 
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Diastereomeric excess: de = 91% (1H-NMR and 13C-NMR) 
Optical rotation: [α] 22  = +105.0 (c = 1.04, CHClD 3) 
 
The rest of the analytical data are in agreement with those previously reported.74 
 
3.5.2 (4S,5S,R/S)-(+)-4-(benzyloxy)-3-methoxyphenyl-[(2,2-dimethyl-4-phenyl 
[1,3]dioxan-5-yl]methylamino]acetonitrile (176) 
 
N
CN
H3C O
OPh CH3
CH3
*
BnO
MeO
 
 
22 g (100 mmol) of amine 137 were treated with 24.0 g (100 mmol) of 4-benzyloxy-3-methoxy-
benzaldehyde (145d) and 6.5 g of KCN (100 mmol) according to GP2. After work-up and 
recrystallization 28,3 g (60 mmol) of 176 were obtained as a colorless solid. 
 
Yield: colorless solid, 28.3 g, 60% 
Mp: 88°C 
TLC: Rf = 0.27 (Et2O:Pentane = 1:1) 
Diastereomeric excess: de = 2% (1H-NMR and 13C-NMR) 
Optical rotation: [α] 22  = +89.0 (c = 1.04, CHClD 3) 
 
The rest of the analytical data are in agreement with those previously reported.41 
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3.6   Michael-Adducts 
 
3.6.1  (4S,5S,4R/S,R)-(–)-benzo[1,3]dioxo-5-yl[(2,2-Dimethyl-4-phenyl[1,3]dioxan-5-yl)-
methylamino](5-oxotetrahydrofuran-3-yl)-acetonitrile (148a) 
 
O
O
CNNH3C
O
O
CH3
CH3
O
O
 
 
147 (3.80 g, 10 mmol) was treated with furan-2(5H)-one (144) (1.01 g, 12 mmol) in Et2O 
according to GP3. Flash chromatography (Et2O: pentane = 3:1, 4% Et3N) yielded 3.68 g (7.9 
mmol) of 148a as a colorless solid. 
 
Yield: colorless solid, 3.68 g, 79% 
Mp: 141°C 
TLC: Rf = 0.31 (Et2O:Pentane = 3:1) 
Diastereomeric excess: de = 88% (1H-NMR and 13C-NMR) 
          de = 98% (after flash Chromatography, 1H-NMR) 
Optical rotation: [α] 22  = –17.7 (c = 1.00, CHClD 3) 
 
The rest of the analytical data are in agreement with those previously reported.41 
 
3.6.2 (4S,5S,4R/S,R)-(-)-(4-benzyloxy-3-methoxy-phenyl)-[(2,2-dimethyl-4-phenyl-[1,3] 
dioxan-5-yl)-methyl-amino]-( 5-oxo-tetrahydro-furan-3-yl)-acetonitrile (177) 
 
O
O
CNNH3C
O
O
CH3
CH3
BnO
OCH3  
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176 (2.40 g, 5 mmol) was treated with furan-2(5H)-one (144) (1.01 g, 12 mmol) in THF 
according to the GP3. Flash chromatography (Et2O: pentane = 10:1, 4% Et3N) yielded 1.11 g (2 
mmol) of 177 as a colorless solid. 
 
Yield: colorless solid, 1.11 g, 40% 
Mp: 95°C 
TLC: Rf = 0.80 (Et2O:Pentane = 10:1) 
Diastereomeric excess: de = 65% (1H-NMR and 13C-NMR), de ≥ 98% (after chromatography) 
Optical rotation: [α] 22  = –29.1 (c = 1.03, CHClD 3) 
 
The rest of the analytical data are in agreement with those previously reported.41 
 
3.7   2-Substituited-3-aroyl-γ-butyrolactone 
 
3.7.1  (3S,4S)-(–)-4-[benzo[1,3]dioxol-5-carbonyl)-3-(benzo-[1,3]dioxol-5-yl)methyl]-4,5-
dihydrofuran-2(3H)-one (157c) 
O
O
O
O
O
O
O  
2,32 g (5 mmol) of 148a were subjected to alkylation conditions with 2,14 g (10 mmol) of 5-
(bromomethyl)benzo[1,3]dioxolane (146a) in THF, followed by cleavage of the chiral auxiliary 
according to GP5. Flash chromatography yielded 1,48 g (4.0 mmol) of 157c as a colorless solid. 
 
Yield: colorless solid, 1,48 g, 80% 
Mp: 83°C 
TLC: Rf = 0.18 (Et2O:Pentane = 2:1) 
Diastereomeric excess: de = 98% (1H-NMR and 13C-NMR) 
Enantiomeric excess: ee ≥ 98% (1H- Shift-NMR) 
Optical rotation: [α] 22  = –30.3 (c = 0.93, CHClD 3) 
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The rest of the analytical data are in agreement with those previously reported.41 
 
3.7.2 (3S,4S)-(–)-4-(Benzo[1,3]dioxol-5-carbonyl)-3-(3,4,5-trimethoxybenzyl)-4,5-
dihydrofuran-2(3H)-one (157a) 
 
O
O
O
O
O
H3CO
OCH3
OCH3
 
 
2,32 g (5 mmol) of 148a were subjected to the alkylation conditions with 2,62 g (10 mmol) of 5-
Bromomethyl-1,2,3-trimethoxy-benzene (146c) in THF, followed by the cleavage of the chiral 
auxiliary according to GP5. Flash chromatography yielded 1,62 g (3.9 mmol) of 157a as a 
colorless solid. 
 
Yield: colorless solid, 1,62 g, 78% 
Mp: 122°C 
TLC: Rf = 0.16 (Et2O:Pentane = 5:1) 
Diastereomeric excess: de = 98% (1H-NMR and 13C-NMR) 
Enantiomeric excess: ee ≥ 98% (1H- Shift-NMR) 
Optical rotation: [α] 22  = –11.1 (c = 0.86, CHClD 3) 
 
The rest of the analytical data are in agreement with those previously reported.41 
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3.7.3  (3S,4S)-4-(Benzo[1,3]dioxole-5-carbonyl)-3-(3,4-dimethoxybenzyl)-dihydro-furan-
2-one (157b) 
 
O
O
O
O
O
OCH3
OCH3
 
 
696 mg (1.5 mmol) of 148a were subjected to the alkylation conditions with 415 mg (1.8 mmol) 
of 4-(Bromomethyl)-1,2-dimethoxybenzene (146b) in THF, followed by the cleavage of the 
chiral auxiliary according to GP5. Flash chromatography yielded 405 mg (1.05 mmol) of 157b 
as a colorless solid. 
 
Yield: colorless solid, 405 mg, 70% 
Mp: 116°C 
TLC: Rf = 0.16 (Et2O:Pentane = 5:1) 
Diastereomeric excess: de = 98% (1H-NMR and 13C-NMR) 
Enantiomeric excess: ee ≥ 98% (1H- Shift-NMR) 
Optical rotation: [α] 22  = –26.0 (c = 1.01, CHClD 3) 
 
1H-NMR (400 MHz, CDCl3):  
δ = 2.95 (dd, 1H, J = 7.4, 14.1 Hz,  CHHCHCO2), 3.08 (dd, 1H, J = 5.4, 14.1 Hz, CHHCHCO2), 
3.51 (ddd, 1H, J = 5.4, 7.4, 8.7 Hz, CHCO2), 3.75 (s, 3H, OCH3), 3.81 (s, 3H, OCH3), 4.01 (td, 
1H,  J = 8.4, 8.7 Hz, CHCH2OC=O), 4.12 ( t, 1H, J = 8.4 Hz, CHHOC=O), 4.38 (t, 1H, J = 8.4 
Hz, CHHOC=O), 6.05 (s, 2H, OCH2O), 6.60-6.72 (m, 3H, arom. CH), 6.78 ( d, 1H, J = 8.1 Hz, 
arom. CH), 7.19 (d, 1H, J = 1.7 Hz, arom. CH), 7.22 (dd, 1H, J = 1.7, 8.1 Hz, arom. CH) ppm. 
 
13C-NMR (100 MHz, CDCl3): 
δ = 34.47 (CH2CHCO2), 44.74 (CHCO2), 46.76 (CHCH2OC=O), 55.72 (OCH3), 55.85 (OCH3), 
68.18 (CH2OC=O), 102.19 (OCH2O), 107. 94 (arom. CH), 107.97 (arom. CH), 111.31 (arom. 
CH), 112.39(arom. CH), 121.53 (arom. CH), 124.79(arom. CH), 129.57 (arom. C), 130.37 
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(arom. C), 148.07 (arom. C), 148.56(arom. C), 149.10 (arom. C), 152.68 (arom. C), 177.22 
(OCO), 194.58 (CO) ppm. 
 
IR (CHCl3):  
ῦ = 3081 (m), 3016 (m), 2969 (m), 2938 (m), 2897 (s), 2841 (m), 1776 (vs), 1669 (vs), 1624 (m), 
1603 (s), 1518 (vs), 1503 (v), 1487 (m), 1445 (vs), 1417 (m), 1375 (m), 1351 (m), 1307 (m), 
1291 (m), 1253 (vs), 1194 (m), 1178 (s), 1143 (s), 1108 (m), 1036 (s), 1023 (vs), 940 (m), 828 
(m) cm-1. 
 
MS (EI, 70 eV):  
m/z (%) = 385 (8) [M+• +1], 384 (38) [M+•], 235 (9), 209 (13), 208 (100), 193 (8), 191 (10), 152 
(7), 151 (65), 150 (5), 149 (52), 135 (5), 121 (24), 108 (5), 107 (12), 106 (6), 105 (5), 91 (10), 77 
(5), 65 (19), 63 (6). 
 
Elemental Analysis: 
Anal. Calcd for C21H20O7:  C = 65.62  H = 5.24 
Found:        C = 65.24  H = 5.24 
 
3.7.4 (3S,4S)-4-(4-benzyloxy-3-methoxy-benzoyl)-3-(4-benzyloxy-3-methoxy-benzyl)-
dihydrofuran-2-one (178) 
 
O
O
O
OBn
OCH3
BnO
H3CO
 
 
560 mg (1.0 mmol) of 177 were subjected to the alkylation conditions with 614 mg (2.0 mmol) 
of 1-(Benzyloxy)-4-(bromomethyl)-2-methoxybenzene (146d) in THF, followed by the cleavage 
of the chiral auxiliary according to GP5. Flash chromatography yielded 300 mg (0.53 mmol) of 
178 as a colorless solid. 
 
Yield: colorless solid, 300 mg, 53% 
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Mp: 100-102°C 
TLC: Rf = 0.20 (Et2O:Pentane = 4:1) 
Diastereomeric excess: de = 98% (1H-NMR and 13C-NMR) 
Enantiomeric excess: ee ≥ 98% (1H- Shift-NMR) 
Optical rotation: [α] 22  = –6.0 (c = 0.05, CHClD 3) 
 
1H-NMR (400 MHz, CDCl3): 
δ = 2.90 (ddd, 2H, J = 5.5, 6.8, 14.3, CH2CHCO2), 3.42-3.46 (m, 1H, CH2CHCO2), 3.61 (s, 3H, 
OCH3), 3.80 (s, 3H, OCH3),3.91-4.01 (m, 2H, CHCHHCO2, CHCH2CO2), 4.23-4.27 (m, 1H, 
CHCHHCO2), 4.93 (s, 2H, ArCH2O), 5.12 (s, 2H, ArCH2O), 6.44 (dd, 1H, J = 1.9, 8.0, Arom 
CH), 6.53 (d, 1H, J = 1.9, Arom CH), 6.56 (d, 1H, J = 8.0, Arom CH), 6.72 (d, 1H, J = 8.5, 
Arom CH), 7.05 (dd, 1H, J = 2.2, 8.5, Arom CH), 7.17-7.34 (m, 11H, Arom CH) ppm. 
 
13C-NMR (100 MHz, CDCl3): 
δ = 34.51 (CH2CHCO2), 44.86 (CH2CHCO2), 46.70 (COCHCH2), 55.98, 56.28 (OCH3), 68.53 
(CHCH2OC=O), 71.06, 71.24 (CH2CHCO2), 110.56, 112.14, 113.03, 114.17, 121.78, 122.99, 
127.42, 127.51, 128.08, 128.49, 128.76, 128.97 (Arom CH), 129.21, 130.40, 136.16, 137.30, 
147.36, 149.92, 150.09, 153.51 (Arom C), 177.52 (CO2), 195.22 (C=O) ppm. 
 
IR (CHCl3):  
ῦ = 2937 (m), 2919 (m), 2873 (m), 1783 (s), 1675 (s), 1591 (s), 1513 (vs), 1422 (s), 1382 (m), 
1263 (vs), 1232 (s), 1202 (s), 1186 (m), 1142 (vs), 1017 (s), 994 (s), 743 (s) cm-1.  
 
MS (EI, 70 eV):  
m/z (%) = 553 (3) [M+• +1], 552 (8) [M+•], 241 (11), 92 (8), 91 (100). 
 
Elemental Analysis: 
Anal. Calcd for C34H32O7:  C = 73.90  H = 5.84 
Found:        C = 73.58  H = 6.07 
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3.7.5  (3R,4S)-4-(1,3-Benzodioxol-5-ylcarbonyl)-3-[(R)-1-(1,3-benzodioxol-5-yl)-1-
hydroxymethyl]tetrahydro-2-furanone (151a) 
 
O
O
O
O
O
OH
O
O  
 
Compound 148a (1.020 g, 2.20 mmol) was subjected to the aldol reaction conditions followed 
by the cleavage of the auxiliary according to GP4. Work-up and recrystallization from CH2Cl2 
gave 148a (550 mg, 1.43 mmol) as a colorless solid. 
 
Yield: colorless solid, 550 mg, 65% 
Mp: 146°C 
TLC: Rf = 0.61 (Et2O) 
Diastereomeric excess: de = syn:anti (aldol) = 88:12 (1H NMR); ≥ 96:4 (after recrystallization,
         1H NMR); 
Enantiomeric excess: ee ≥ 98% (1H- Shift-NMR) 
Optical rotation: [α] 22  = +74.0 (c = 1.00, acetone) D
 
The analytical data are identical to those reported earlier.41 
 
3.7.6 (3R,4S)-4-(1,3-Benzodioxol-5-ylcarbonyl)-3-[(R)-1-(3,4-dimethoxyphenyl)-1-
hydroxymethyl]tetrahydro-2-furanone (151b) 
 
O
O
O
O
O
OH
OCH3
H3CO
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Compound 148a (1.020 g, 2.20 mmol) was subjected to the aldol reaction conditions followed 
by the cleavage of the auxiliary according to GP4. Work-up and column chromatography 
(Et2O:pentane 10:1) gave 151b (600 mg, 1.5 mmol) as a colorless solid. syn:anti (aldol) = 93:7 
(1H NMR); ≥ 99:1 (after column chromatography, 1H NMR); ee ≥ 98% (determined with 1H 
NMR shift reagent: Pirkle-alcohol). 
 
Yield: colorless solid, 600 mg, 68% 
Mp: 133°C 
TLC: Rf = 0.26 (Et2O:Pentane = 10:1) 
Diastereomeric excess: de = syn:anti (aldol) = 93:7 (1H NMR); ≥ 99:1 (after column    
          chromatography, 1H NMR and 13C-NMR) 
Enantiomeric excess: ee ≥ 98% (1H- Shift-NMR) 
Optical rotation: [α] 22  = +62.0 (c = 0.99, CHClD 3) 
 
The analytical data are identical to those reported earlier.41 
 
3.7.7 (3R,4S)-4-(1,3-Benzodioxol-5-ylcarbonyl)-3-[(R)-1-hydroxy-1-(3,4,5-trimethoxy 
phenyl)methyl]tetrahydro-2-furanone (151c) 
 
O
O
O
O
O
OH
OCH3
OCH3H3CO
 
 
Compound 148a (1.020 g, 2.20 mmol) was subjected to the aldol reaction conditions followed 
by the cleavage of the auxiliary according to GP4. Work-up and column chromatography 
(Et2O:pentane 30:1) gave 151c (570 mg, 1.32 mmol) as a colorless solid. 
 
Yield: colorless solid, 570 mg, 60% 
Mp: 143°C 
TLC: Rf = 0.61 (Et2O:pentane = 30:1) 
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Diastereomeric excess: de = syn:anti (aldol) = 87:13 (1H NMR); ≥ 98:2 (after column   
          chromatography, 1H NMR); 
Enantiomeric excess: ee ≥ 98% (1H- Shift-NMR) 
Optical rotation: [α] 22  = +58.0 (c = 1.01, CHClD 3) 
 
The analytical data are identical to those reported earlier.41 
 
3.8   Reduction of the Ketones 
 
3.8.1  (3R,4S)-3,4-Di[(R)-1-(1,3-benzodioxol-5-yl)-1-hydroxymethyl]tetrahydro-2-
furanone (152a) 
 
O
O
O
OH
O
OH
O
O
 
 
Ketone 151a (480 mg, 1.25 mmol) was reduced with L-Selectride according to GP6. Work-up 
and column chromatography (CH2C12:MeOH = 30:1) gave 152a (340 mg, 0.88 mmol) as a 
colorless solid. 
 
Yield: colorless solid, 340 mg, 70% 
Mp: 186°C 
TLC: Rf = 0.44 (CH2Cl2:MeOH = 30:1) 
Diastereomeric excess: de ≥ 98  
Enantiomeric excess: ee ≥ 98% (1H- Shift-NMR) 
Optical rotation: [α] 22  = +26.6 (c = 1.01, acetone) D
 
1H-NMR (400 MHz, DMSO-d6):  
δ = 2.50 (m, br., 1 H, CHCO2), 2.54 (m, br., 1 H, CHCH2OC=O), 4.23 (dd, 1 H, J = 1.9, 8.3 Hz, 
CHHOC=O), 4.35 (dd, 1 H, J = 8.2, 8.3 Hz, CHHOC=O), 4.56 (m, br., 1 H, CHOH), 4.91 (m, 
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br., 1 H, CHOH), 5.49 (d, 1 H, J = 4.1 Hz, OH), 5.67 (d, 1 H, J = 3.8 Hz, OH), 5.90 (d, 1 H, J = 
1.1 Hz, OCHHO), 5.91 (d, 1 H, J = 1.1 Hz, OCHHO), 5.93 (d, 1 H, J = 1. 1 Hz, OCHHO), 5.95 
(d, 1 H, J = 1. 1 Hz, OCHHO), 6.36 (d, 1 H, J = 1. 1 Hz, arom. CH), 6.43 (s, 1 H, arom. CH), 
6.44 (d, 1 H, J = 8.2 Hz, arom. CH), 6.49 (dd, 1 H, J = 1.1, 8.0 Hz, arom. CH), 6.57 (d, 1 H, J = 
8.0 Hz, arom. CH), 6.59 (d, 1 H, J = 8.0 Hz, arom. CH) ppm. 
 
13C-NMR (100 MHz, DMSO-d6):  
δ = 41.19 (CHCH2OC=O), 47.65 (CHCO2), 71.36 (CHOH), 71.72 (CH2OC=O), 72.62 (CHOH), 
100.57, 100.64 (OCH2O), 105.40, 105.48, 106.94, 107.03, 117.90, 117.98 (arom. CH), 136.17, 
136.26, 145.40, 145.55, 146.43, 146.50 (arom. C), 178.53 (OC=O) ppm. 
 
IR (KBr):  
ν~  = 3559 (vs, OH), 3414 (vs, br, OH), 3067 (w), 2969 (m), 2903 (s), 1753 (vs, C=Olactone), 1501 
(vs), 1443 (s), 1395 (m), 1318 (w), 1257 (vs), 1234 (s), 1192 (m), 1109 (w), 1093 (w), 1076 (m), 
1068 (m), 1035 (s), 993 (w), 938 (m), 906 (w), 866 (vw), 810 (w), 785 (w), 661 (vw) cm-1. 
 
MS (EI, 70 eV):  
m/z (%) = 386 (1) [M+•], 236 (23), 152 (9), 151 (84), 150 (77), 149 (100), 132 (6), 131 (6), 123 
(18), 122(6), 121 (35), 119 (7), 103 (9), 93 (47), 91 (14), 77 (11), 66 (6), 65(47), 64 (9), 63 (42), 
62 (17), 61 (10), 58 (5), 57 (13), 55 (6), 53 (10), 51 (11), 50 (9). 
 
Elemental Analysis: 
Anal. Calcd for C20H18O8:  C = 62.18  H = 4.70 
Found:        C = 62.67  H = 5.07 
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3.8.2  (3R,4S)-4-[(R)-1-(1,3-Benzodioxol-5-yl)-1-hydroxymethyl]-3-[(R)-1-(3,4-
dimethoxyphenyl)-1-hydroxymethyl]tetrahydro-2-furanone (152b) 
 
O
O
O
OH
O
OH
OMe
OMe
 
 
Ketone 151b (550 mg, 1.37 mmol) was reduced with L-selectride according to GP6. Work-up 
and column chromatography (CH2C12:MeOH = 30:1) gave 152b (410 mg, 1.02 mmol) as a 
colorless solid. 
 
Yield: colorless solid, 410 mg, 75% 
Mp: 165°C 
TLC: Rf = 0.15 (CH2Cl2:MeOH = 30:1) 
Diastereomeric excess: de ≥ 98  
Enantiomeric excess: ee ≥ 98% (1H- Shift-NMR) 
Optical rotation: [α] 22  = +20.7 (c = 0.95, acetone) D
 
1H-NMR (300 MHz, CDC13):  
δ = 2.10 (d, 1 H, J = 2.7 Hz, OH), 2.76 (dddd, 1 H, J = 4.0, 4.0, 4.4, 8.4 Hz, CHCH2OC=O), 2.77 
(d, 1 H, J = 4.7 Hz, OH), 2.94 (dd, 1 H, J = 3.7, 4.4 Hz, CHCO2), 3.80 (s, 3H, OCH3), 3.87 (s, 
3H, OCH3), 4.17 (dd, 1 H, J = 4.4, 9.0 Hz, CHHOC=O), 4.29 (dd, 1 H, J = 8.4, 8.7 Hz, 
CHHOC=O), 4.62 (dd, 1 H, J = 4.0, 4.7 Hz, CHOH), 5.21 (dd, 1 H, J = 3.0, 5.0 Hz, CHOH), 
5.93 (d, 1 H, J = 1.7 Hz, OCHHO), 5.96 (d, 1 H, J = 1.7 Hz, OCHHO), 6.39 (d, 1 H, J = 1.4 Hz, 
arom. CH), 6.58 (dd, 1 H, J = 1.7, 8.4 Hz, arom. CH), 6.60 (d, 1 H, J = 1.7 Hz, arom. CH), 6.63 
(d, 1 H, J = 8.1 Hz, arom. CH), 6.76 (d, 1 H, J = 8.4 Hz, arom. CH), 6.83 (dd, 1 H, J = 1.4, 8.4 
Hz, arom. CH) ppm. 
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13C-NMR (75 MHz, CDC13):  
δ = 42.59 (CHCH2OC=O), 48.94 (CHCO2), 55.67, 55.76 (OCH3), 70.62 (CH2OC=O), 73.16, 
75.09 (CHOH), 101.37 (OCH2O), 105.80, 107.82, 108.53, 110.73, 117.61, 118.73 (arom. CH), 
133.39, 134.74, 147.30, 147.91, 148.47, 148.85 (arom. C), 178.61 (OC=O) ppm. 
 
IR (KBr):  
ν~  = 3500 (vs, br., OH), 3055 (w), 3005 (m), 2962 (m), 2941 (m), 2910 (m), 2836 (m), 1742 (vs, 
C=Olactone), 1640 (w), 1609 (w), 1595 (m), 1517 (vs), 1505 (vs), 1487 (s), 1469 (s), 1439 (s), 
1414 (m), 1398 (m), 1307 (s), 1256 (vs), 1236 (vs), 1217 (vs), 1199 (vs), 1153 (m), 1135 (s), 
1081 (s), 1028 (vs), 989 (m), 940 (m), 916 (m), 864 (m), 818 (m), 790 (m) cm-1. 
 
MS (EI, 70 eV):  
m/z (%) = 402 (0.3) [M+•], 167 (14), 166 (100), 165 (52), 151 (27), 149 (10), 137 (7), 123 (8), 
122 (5), 121 (5), 119 (6), 109 (6), 107 (5), 105 (6), 95 (30), 93 (8), 85 (5), 83 (6), 80 (5), 79 (15), 
77 (24), 71 (6), 69 (7), 67 (9), 65 (12), 63 (7). 
 
Elemental Analysis: 
Anal. Calcd for C21H22O8:  C = 62.88  H = 5.51 
Found:        C = 62.30  H = 5.63 
 
3.8.3. (3R,4S)-4-[(R)-1-(1,3-Benzodioxol-5-yl)-1-hydroxymethyl]-3-[(R)-1-hydroxy-1-
(3,4,5-trimethoxyphenyl)methyl]tetrahydro-2-furanone (152c) 
 
O
O
O
OH
O
OH
OMe
OMeMeO
 
 
Ketone 151c (486 mg, 1.13 mmol) was reduced with L-Selectride according to GP6. Work-up 
and column chromatography (CH2C12:MeOH = 30:1) gave 152c (410 mg, 0.95 mmol) as a 
colorless solid. 
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Yield: colorless solid, 410 mg, 84% 
Mp: 174°C 
TLC: Rf = 0.23 (CH2Cl2:MeOH = 30:1) 
Diastereomeric excess: de ≥ 98  
Enantiomeric excess: ee ≥ 98% (1H- Shift-NMR) 
Optical rotation: [α] 22  = +18.4 (c = 1.0, acetone) D
 
1H-NMR (400 MHz, CDC13):  
δ = 2.72 (dddd, 1 H, J = 3.6, 3.8, 4.1, 8.2 Hz, CHCH2OC=O), 2.84 (dd, 1 H, J = 3.6, 3.8 Hz, 
CHCO2), 3.16 (d, 1 H, J = 3.3 Hz, OH), 3.65 (d, 1 H, J = 5.2 Hz, OH), 3.76 (s, 9H, OCH3), 4.22 
(dd, 1 H, J = 3.8, 8.8 Hz, CHHOC=O), 4.36 (dd, 1 H, J = 8.2, 8.8 Hz, CHHOC=O), 4.61 (dd, 1 
H, J = 3.6, 3.8 Hz, CHOH), 5.11 (dd, 1 H, J = 3.8, 4.1 Hz, CHOH), 5.89 (d, 1 H, J = 1.4 Hz, 
OCHHO), 5.94 (d, 1 H, J = 1.6 Hz, OCHHO), 6.34 (s, 2H, arom. CH), 6.35 (d, 1 H, J = 1.4 Hz, 
arom. CH), 6.50 (dd, 1 H, J = 1.4, 8.0 Hz, arom. CH), 6.54 (d, 1 H, J = 8.0 Hz, arom. CH) ppm. 
 
13C-NMR (100 MHz, CDC13):  
δ = 42.56 (CHCH2OC=O), 48.82 (CHCO2), 56.00 (m-OCH3), 60.78 (p-OCH3), 71.26 
(CH2OC=O), 73.04, 74.73 (CHOH), 101.40 (OCH2O), 102.45, 105.68, 107.65, 118.50 (arom. 
CH), 134.85, 136.83, 136.92, 147.07, 147.78, 152.98 (arom. C), 179.31 (OC=O) ppm. 
 
IR (KBr):  
ν~  = 3478 (s, br., OH), 2971 (m), 2941 (m), 2907 (w), 2840 (w,), 1758 (vs, C=Olactone), 1595 (s), 
1506 (vs), 1492 (s), 1461 (s), 1420 (s), 1389 (m), 1334 (m), 1238 (vs), 1191 (s), 1127 (vs), 1080 
(s), 1035 (vs), 926 (m) cm-1. 
 
MS (EI, 70 eV): 
m/z (%) = 432 (4) [M+•], 236 (10), 219 (7), 198 (5), 197 (29), 196 (100), 195 (6), 182 (6), 181 
(53), 169 (8), 153 (9), 152 (6), 151 (33), 150 (10), 149 (17), 138 (7), 135 (6), 125 (26), 123 (11), 
121 (7), 111 (5), 110 (18), 97 (6), 95 (12), 93 (31), 91 (5), 85 (6), 83 (6), 82 (5), 81 (6), 79 (6), 
77 (10), 71 (6), 70 (6), 69 (8), 67 (7), 66 (5), 65 (14), 63 (5), 57 (14), 56 (5), 55 (13), 53 (7), 51 
(7), 45 (5). 
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Elemental Analysis: 
Anal. Calcd for C22H24O9:  C = 61.11  H = 5.99 
Found:        C = 61.15  H = 5.97 
 
3.8.4  (3S,4S)-4-[(R)-1-(1,3-Benzodioxol-5-yl)-1-hydroxymethyl]-3-(3,4,5-trimethoxy 
benzyl)tetrahydro-2-furanone (159) 
 
O
O
OH
O
O
H3CO
OCH3
OCH3
 
To a solution of ketone 157a (307.2 mg, 0.74 mmol) in MeOH (30 mL) was added NaBH4 (90 
mg, 2.34 mmol). After 2 h, the reaction mixture was partitioned with CH2Cl2 and H2O. The 
aqueous phase was extracted three times with CH2Cl2. The combined organic layers were dried 
with MgSO4 and evaporated in vacuo. The crude product was purified via column 
chromatography (Et2O:pentane 1:1 – 3:1) to give 159 (248.4 mg, 0.59 mmol) as a mixture of 
diastereomers (83:17). For analytical purposes a small sample was purified via preparative 
HPLC to yield the major diastereomer (α-alcohol) in pure form. 
 
Yield: colorless solid, 248 mg, 80% 
Mp: 141°C 
TLC: Rf = 0.19 (CH2Cl2:MeOH = 25:1) 
Diastereomeric excess: de = 13:87 (1H-NMR); de ≥ 2:98 (After HPLC, 1H-NMR) 
Enantiomeric excess: ee ≥ 98% (1H- Shift-NMR) 
Optical rotation: [α] 22  = +1.1 (c = 0.93, acetone) D
 
1H-NMR (400 MHz, CDCl3):  
δ = 2.00 (d, 1 H, J = 2.8 Hz, OH), 2.63 (ddd, 1 H, J = 7.1, 7.2, 7.4 Hz, CHCO2), 2.95 (m, 2H, 
CHHCHCO2, CHCH2OC=O), 3.06 (m, 1 H, CHHCHCO2), 3.83 (s, 9 H, OCH3), 3.95 (d, 2 H, J 
= 7.7 Hz, CH2OC=O), 4.63 (dd, 1 H, J = 2.5, 6.9 Hz, CHOH), 5.97 (d, 1 H, J = 1.4 Hz, 
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OCHHO), 5.98 (d, 1 H, J = 1.4 Hz, OCHHO), 6.39 (s, 2 H, arom. CH), 6.73 (m, 3 H, arom. CH) 
ppm. 
 
13C-NMR (100 MHz, CDCl3):  
δ = 35.59 (CH2CHCO2), 43.69 (CHCO2), 45.02 (CHCH2OC=O), 56.09 (m-OCH3), 60.85 (p-
OCH3), 68.36 (CH2OC=O), 75.34 (CHOH), 101.38 (OCH2O), 106.17, 106.74, 108.23, 119.29 
(arom. CH), 133.28, 135.46, 147.65, 148.19, 153.11 (arom. C), 179.04 (OC=O) ppm. 
 
IR (KBr):  
ν~  = 3471 (m, br., OH), 2939 (m), 2839 (w), 1763 (vs, C=Olactone), 1592 (s), 1507 (s), 1490 (s), 
1460 (s), 1423 (s), 1385 (w), 1325 (m), 1242 (vs), 1187 (s), 1127 (vs), 1036 (s), 1008 (s), 928 
(m), 815 (w), 783 (w), 738 (m), 672 (m) cm-1. 
 
MS (EI, 70 eV):  
m/z (%) = 417 (26) [M+• +1], 416 (100) [M+•], 238 (5), 221 (7), 183 (5), 182 (40), 181 (80), 177 
(6), 169 (6), 168 (6), 167 (10), 161 (5), 152 (5), 151 (38), 149 (9), 148 (8), 135 (6), 131 (8), 123 
(5), 93 (17), 65 (12). 
 
Elemental Analysis: 
Anal. Calcd for C22H28O9:  C = 63.45  H = 5.81 
Found:        C = 63.09  H = 5.84 
 
3.9  Tetraols 
 
3.9.1  (1R,2S,3S,4R)-1,4-Di(1,3-benzodioxol-5-yl)-2,3-di(hydroxymethyl)butan-1,4-diol 
(153a) 
 
O
O
OH
OH
OH
OH
O
O
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Diol 152a (170 mg, 0.44 mmol) was reduced with LiAlH4 (167 mg, 4.40 mmol) according to 
GP7. Purification via column chromatography (CH2Cl2:MeOH = 10:1) gave 153a (100 mg, 0.26 
mmol) as a colorless solid. 
 
Yield: colorless solid, 100 mg, 58% 
Mp: 208°C 
TLC: Rf = 0.30 (CH2Cl2:MeOH = 10:1) 
Diastereomeric excess: de ≥ 98 (1H-NMR) 
Enantiomeric excess: ee ≥ 98% (1H- Shift-NMR) 
Optical rotation: [α] 22  = +26.0 (c = 0.98, MeOH) D
 
1H-NMR (400 MHz, DMSO-d6):  
δ = 1.94 (m, 2 H, CHCH2OH), 3.51 (m, 4 H, CH2OH), 4.65 (dd, 2 H, J = 3.9, 4.7 Hz, CHOH), 
5.04 (m, 2 H, CH2OH), 5.40 (d, 2 H, J = 4.7 Hz, CHOH), 5.93 (s, 2 H, OCH2O) 5.94 (s, 2 H, 
OCH2O), 6.43 (s, 2 H, arom. CH), 6.49 (d, 2 H, J = 8.0 Hz, arom. CH) 6.66 (d, 2 H, J = 8.0 Hz, 
arom. CH) ppm. 
 
13C-NMR (100 MHz, DMSO-d6): 
δ = 44.25 (CHCH2OH), 59.30 (CH2OH), 71.03 (CHOH), 100.42 (OCH2O), 106.01, 106.95, 
118.56 (arom. CH), 138.90, 145.14, 146.44 (arom. C) ppm. 
 
IR (KBr):  
ν~  = 3228 (vs, br., OH), 2991 (m), 2911 (s), 2888 (s), 1502 (vs), 1492 (vs), 1440 (vs), 1372 (m), 
1334 (m), 1314 (m), 1078 (s), 1038 (vs), 992 (m), 936 (vs), 860 (w), 814 (s), 787 (m), 770 (m), 
734 (w), 721 (w), 677 (w), 612 (m), 565 (w), 531 (vw) cm-1. 
 
MS (EI, 70 eV):  
m/z (%) = 390 (6), 372 (13), 354 (11), 324 (5), 294 (11), 255 (10), 222 (28), 204 (20), 194 (11), 
191 (14), 178 (9), 176 (8), 175 (7), 174 (36), 173 (21), 161 (12), 152 (12), 151 (100), 150 (41), 
149 (50), 148 (8), 144 (7), 143 (9), 135 (24), 131 (11), 123 (13), 122 (7), 121 (13), 116 (6), 115 
(10), 103 (7), 93 (36), 91 (6), 77 (7), 65 (22), 63 (6). 
 
 
  104
Experimental Part 
 
 
Elemental Analysis: 
Anal. Calcd for C20H22O8:  C = 61.53  H = 5.68 
Found:        C = 61.28  H = 5.90 
 
3.9.2  (1R,2S,3S,4R)-1-(1,3-Benzodioxol-5-yl)-4-(3,4-dimethoxyphenyl)-2,3-
di(hydroxymethyl)butan-1,4-diol (153b) 
 
O
O
OH
OH
OH
OH
OCH3
OCH3
 
 
Diol 152b (241 mg, 0.60 mmol) was reduced with LiAlH4 (228 mg, 6.00 mmol) according to 
GP3. Purification via column chromatography (CH2Cl2:MeOH = 10:1) gave 153b (135 mg, 0.33 
mmol) as a colorless solid. 
 
Yield: colorless solid, 135 mg, 55% 
Mp: 181°C 
TLC: Rf = 0.30 (CH2Cl2:MeOH = 10:1) 
Diastereomeric excess: de ≥ 98 (1H-NMR) 
Enantiomeric excess: ee ≥ 98% (1H- Shift-NMR) 
Optical rotation: [α] 22  = +37.0 (c = 1.00, acetone) D
 
1H-NMR (400 MHz, DMSO-d6):  
δ = 1.94 (m, 1 H, CHCH2OH), 1.99 (m, 1 H, CHCH2OH), 3.52 (m, 4 H, CH2OH), 3.60 (s, 3 H, 
OCH3), 3.72 (s, 3 H, OCH3), 4.64 (dd, 1 H, J = 4.7, 5.2 Hz, CHOH), 4.66 (dd, 1 H, J = 4.4, 5.0 
Hz, CHOH), 5.05 (t, 1 H, J = 4.4 Hz, CH2OH), 5.08 (t, 1 H, J = 4.4 Hz, CH2OH), 5.38 (d, 1 H, J 
= 5.0 Hz, CHOH), 5.42 (d, 1 H, J = 5.2 Hz, CHOH), 5.91 (d, 1 H, J = 1.1 Hz, OCHHO), 5.95 (d, 
1 H, J = 1.4 Hz, OCHHO), 6.33 (d, 1 H, J = 1.4 Hz, arom. CH), 6.43 (d, 1 H, J = 1.7 Hz, arom. 
CH), 6.51 (dd, 1 H, J = 1.1, 8.2 Hz, arom. CH), 6.53 (dd, 1 H, J = 1.7, 8.5 Hz, arom. CH), 6.54 
(d, 1 H, J = 8.2 Hz, arom. CH), 6.75 (d, J = 8.5 Hz, 1 H, arom. CH) ppm. 
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13C-NMR (100 MHz, DMSO-d6):  
δ = 44.19, 44.33 (CHCH2OH), 54.77, 55.24 (OCH3), 59.32, 59.39 (CH2OH), 71.10, 71.18 
(CHOH), 100.46 (OCH2O), 105.91, 106.81, 109.07, 110.57, 117.61, 118.47 (arom. CH), 137.21, 
138.81, 145.10, 146.46, 146.94, 147.88 (arom. C) ppm. 
 
IR (KBr):  
ν~  =  3414 (s, br., OH), 3071 (w), 3007 (m), 2959 (m), 2941 (m), 2892 (m), 2860 (s), 1518 (vs), 
1491 (s), 1465 (s), 1438 (m), 1413 (m), 1381 (w), 1365 (w), 1323 (m), 1257 (vs), 1236 (vs), 
1208 (m), 1157 (m), 1138 (s), 1105 (w), 1066 (s), 1026 (vs), 991 (w), 927 (m), 892 (m), 874 (w), 
857 (w), 819 (m), 786 (w), 764 (w), 676 (m), 591 (w) cm-l. 
 
MS (EI, 70 eV):  
m/z (%) = 406 (8) [M+•], 238 (16), 222 (38), 210 (7), 207 (8), 194 (7), 192 (6), 191 (11), 189 
(17), 177 (6), 174 (17), 168 (9), 167 (50), 165 (5), 151 (100), 150 (27), 139 (31), 135 (7), 131 
(5), 123 (16), 121 (6), 108 (9), 97 (6), 95 (5), 93 (23), 91 (6), 85 (5), 81 (5), 79 (5), 77 (6), 69 (5), 
65 (10). 
 
Elemental Analysis: 
Anal. Calcd for C21H26O8:  C = 62.06  H = 6.45 
Found:        C = 62.18  H = 6.58 
 
3.9.3  (1R,2S,3S,4R)-1-(1,3-Benzodioxol-5-yl)-2,3-di(hydroxymethyl)-4-(3,4,5-
trimethoxyphenyl)butan-1,4-diol (153c) 
 
O
O
OH
OH
OH
OH
OCH3
OCH3H3CO
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Diol 152c (240 mg, 0.55 mmol) was reduced with LiAlH4 (209 mg, 5.50 mmol) according to 
GP7. Purification via column chromatography (CH2Cl2:MeOH = 10:1) gave 153c (145 mg, 0.34 
mmol) as a colorless solid. 
 
Yield: colorless solid, 145 mg, 61% 
Mp: 174°C 
TLC: Rf = 0.29 (CH2Cl2:MeOH = 10:1) 
Diastereomeric excess: de ≥ 98 (1H-NMR) 
Enantiomeric excess: ee ≥ 98% (1H- Shift-NMR) 
Optical rotation: [α] 22  = +45.0 (c = 1.01, MeOH) D
 
1H-NMR (400 MHz, DMSO-d6):  
δ = 1.96 (m, 2 H, CHCH2OH), 3.51 (m, 2 H, CH2OH), 3.58 (m, 2 H, CH2OH), 3.63 (s, 3 H, p-
OCH3), 3.67 (s, 6 H, m-OCH3), 4.67 (m, 2 H, CHOH), 5.06 (t, 1 H, J = 4.7 Hz, CH2OH), 5.07 (t, 
1 H, J = 4.4 Hz, CH2OH), 5.42 (d, 1 H, J = 5.2 Hz, CHOH), 5.44 (d, 1 H, J = 5.0 Hz, CHOH), 
5.91 (s, 1 H, OCHHO), 5.94 (s, 1 H, OCHHO), 6.28 (s, 2 H, arom. CH), 6.42 (s, 1 H, arom. CH), 
6.46 (d, 1 H, J = 8.0 Hz, arom. CH), 6.62 (d, 1 H, J = 8.0 Hz, arom. CH) ppm. 
 
13C-NMR (100 MHz, DMSO-d6):  
δ = 44.31, 44.36 (CHCH2OH), 55.39 (m-OCH3), 59.32, 59.37 (CH2OH), 59.76 (p-OCH3), 71.10, 
71.42 (CHOH), 100.46 (OCH2O), 102.83, 105.95, 106.90, 118.47 (arom. CH), 135.48, 138.91, 
140.56, 145.03, 146.42, 151.97 (arom. C) ppm. 
 
IR (KBr):  
ν~  = 3221 (vs, br., OH), 2943 (s), 2895 (s), 2834 (m), 1596 (s), 1506 (vs), 1491 (s), 1452 (vs), 
1417 (m), 1331 (m), 1256 (s), 1233 (s), 1130 (vs), 1086 (m), 1071 (m), 1038 (vs), 1006 (s), 931 
(m), 838 (vw), 822 (w), 812 (m), 782 (w), 716 (m), 666 (w), 644 (w), 552 (vw) cm-1. 
 
MS (EI, 70 eV):  
m/z (%) = 436 (14) [M+•], 418 (36), 400 (26), 370 (12), 340 (10), 339 (14), 308 (10), 301 (13), 
268 (12), 250 (10), 237 (10), 224 (32), 222 (32), 220 (13), 219 (18), 207 (15), 204 (23), 198 (27), 
197 (100), 196 (31), 195 (16), 191 (22), 189 (18), 188 (10), 182 (11), 181 (27), 174 (49), 173 
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(21), 169 (65), 161 (11), 154 (25), 153 (10), 152 (14), 151 (81), 150 (28), 149 (29), 139 (12), 138 
(26), 135 (23), 131 (10), 123 (12), 121 (10), 93 (27), 91 (7), 77 (10), 65 (17), 55 (10). 
 
Elemental Analysis: 
Anal. Calcd for C22H28O9:  C = 60.54  H = 6.47 
Found:        C = 60.95  H = 6.48 
 
3.10  Friedel-Crafts-type cyclizations 
 
3.10.1  (3aS,4R,9aS)-4-Benzo[1,3]dioxol-5-yl-5,6,7-trimethoxy-3a,4,9,9a-tetrahydro-3H-
naphto[2,3-c]furan-1-one (158a) 
 
O
O
O
O
CH3O
H3CO
H3CO
 
 
Ketone 157a (200 mg, 0.48 mmol) was treated with triethylsilane (116 mg, 1.0 mmol) in 
trifluoroacetic according to GP9. Purification via column chromatography (Et2O:pentane = 5:1) 
gave 158a (92 mg, 0.23 mmol) as a colorless solid. 
 
Yield: colorless solid, 60 mg, 42% 
Mp: 219°C 
TLC: Rf = 0.42 (Et2O:pentane = 5:1) 
Diastereomeric excess: de ≥ 98 (1H-NMR) 
Enantiomeric excess: ee ≥ 98% (1H- Shift-NMR) 
Optical rotation: [α] 22  = +103.0 (c = 0.75, CHClD 3). 
 
The analytical data are identical to those reported earlier.41 
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3.10.2   (3aS,4R,9aS)4-benzo[1,3]dioxol-5-yl-6,7-dimethoxy-3a,4,9,9a-tetrahydro 
-3H-naphto[2,3-c]furan-1-one (158b) 
 
H3CO
H3CO
O
O
O
O
 
 
Ketone 157b (180 mg, 0.47 mmol) was treated with triethylsilane (116 mg, 1.00 mmol) in 
trifluoroacetic according to GP9. Purification via column chromatography (Et2O:pentane = 5:1) 
gave 158b (80 mg, 0.34 mmol) as a colorless solid. 
 
Yield: colorless solid, 80 mg, 47% 
Mp: 165°C 
TLC: Rf = 0.41 (Et2O:pentane = 5:1) 
Diastereomeric excess: de ≥ 98 (1H-NMR) 
Enantiomeric excess: ee ≥ 98% (1H- Shift-NMR) 
Optical rotation: [α] 22  = +112.0 (c = 1.00, CHClD 3). 
 
The analytical data are identical to those reported earlier.41 
 
3.10.3 (5aS,8aS,9R)-9-Benzo[1,3]dioxol-5-yl-5,8,8a,9-Tetrahydro-5aH-furo[3l,4l:6,7] 
naphto[2,3-d][1,3]dioxol-6-one (158c) 
 
O
O
O
O
O
O
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Ketone 157c (180 mg, 0.40 mmol) was treated with triethylsilane (93 mg, 0.80 mmol) in 
trifluoroacetic according to GP9. Purification via column chromatography (Et2O:pentane = 2:1) 
gave 158c (60 mg, 0.17 mmol) as a colorless solid. 
 
Yield: colorless solid, 60 mg, 42% 
Mp: 188°C 
TLC: Rf = 0.55 (Et2O:pentane = 2:1) 
Diastereomeric excess: de ≥ 98 (1H-NMR) 
Enantiomeric excess: ee ≥ 98% (1H- Shift-NMR) 
Optical rotation: [α] 22  = +126.0 (c = 0.97, CHClD 3). 
 
The analytical data are identical to those reported earlier.41 
 
3.10.4  (1R,2R,3S)-Bishydroxymethyl-6,7-dimethoxy-1- (3,4-methylendioxyphenyl)-1,2,3,4-
tetrahydrophtalene 
 
H3CO
H3CO
O
O
OH
OH
 
 
To a stirred suspension of LiAlH4 (80 mg, 2.1 mmol) in THF (10 ml) was added at 0°C lactone 
157b (200 mg, 0.5 mmol) dissolved in 5 ml of  dry THF. The ice bath was removed and the 
mixture was stirred at room temperature for 5 h. EtOAc was added dropwise after which 
saturated aqueous NH4Cl (5ml) and then H2O (5ml) were added. The mixture was filtred and the 
filtrate was extracted three times with EtOAc. The combined org. layers were dried over MgSO4 
and evaporated in vacuo. The crude triols 171 (192 mg, 95% crude yield) was then dissolved in 
10 ml of CH2Cl2. Three equivalents of BF3·Et2O were slowly added and the solution was stirred 
at rt for 1 h. The reaction was then quenched by adding 5 ml of a saturated aqueous solution of 
NaHCO3. The aqueous layer was extracted three times with CH2Cl2 after which the combined 
org. layers were dried with MgSO4 and evaporated in vacuo. The crude product was purified via 
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column chromatography (EtOAc) to afford 172 (160 mg, 87% yield) as a colorless solid (1H 
NMR and 13C NMR). 
 
Yield: colorless solid, 160 mg, 87% 
Mp: 72-75°C 
TLC: Rf = 0.35 (EtOAc) 
Diastereomeric excess: de ≥ 98 (1H-NMR) 
Enantiomeric excess: ee ≥ 98% (1H- Shift-NMR) 
Optical rotation: [α] 22  = –18.25 (c = 0.40, CHClD 3). 
 
1H-NMR (400 MHz, CDCl3):  
δ = 1.65-1.72 (m, 1H, CH2CHCH2), 1.89-1.94 (m, 1H, CHCHCH2OH), 2.57-2.62 (m, 2H, 
CH2CHCHOH), 2.86 (s, 2H, OH), 3.40 (dd, 1H, J = 5.19, 11.37, CH2CHCHHOH), 3.76 (s, 3H, 
OCH3), 3.57-3.71 (m, 4H, CHCHCH2OH, CH2OH), 3.75 (s, 3H, OCH3), 5.83 (s, 2H, OCH2O), 
6.13, (s, 1H, CH arom.), 6.47 (s, 1H, CH arom.), 6.50 (s, 1H, CH arom.), 6.57 (d, 1H, J = 7.67, 
CH arom.), 6.65 (d, 1H, J = 7.67, CH arom.) ppm.  
 
13C-NMR (75 MHz, CDCl3):  
δ = 33.49 (CH2CH), 40.12 (CHCH), 48.26, (CH2CH), 48.76 (CHCH2), 56.07 (OCH3), 56.12 
(OCH3), 62.76 (CH2OH), 66.57 (CH2OH), 101.14 (OCH2O), 108.16 (arom. CH), 109.41 (arom. 
CH), 111.12 (arom. CH), 113.22 (arom. CH), 123.04 (arom. CH), 128.57 (arom. C), 131.93 
(arom. C), 139.58 (arom. C), 146.33 (arom. C), 147.41 (arom. C), 147.48 (arom. C), 
148.10(arom. C) ppm.  
 
IR (CHCl3):  
ῦ = 3422 (s), 2896 (s), 1610 (m), 1512 (vs), 1487 (vs), 25.68 (s), 18.23 (s), 1243 (vs), 1104 (s), 
1038 (vs), 997 (s), 931 (m) cm-1.  
 
MS (EI, 70 eV): 
m/z (%) = 373 (23) [ M+• +1], 372 (100) [M+•], 353 (7%), 324 (13%), 323 (46%), 296 (14%), 283 
(9%), 254 (8%), 253 (12%), 189 (10%), 135 (11%).  
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Elemental Analysis: 
Anal. Calcd for C21H26O6:  C = 67.63  H = 6.50 
Found:        C = 67.70  H = 6.64 
 
3.10.5  (3aS,4R,9aS)-6-Benzyloxy-4-(4-benzyloxy-3-methoxy-phenyl)-7-methoxy-3a,4,9,9a-
tetrahydro-3H-naphtho[2,3-c]furan-1-one (179) 
 
O
OBn
OCH3
BnO
H3CO
O
 
 
To a solution of ketone 178 (160 mg, 0.29 mmol) was dissolved in THF (30 mL) was added 
NaBH4 (45 mg, 1.15 mmol). After 24 h, the reaction mixture was partitioned with Et2O and H2O. 
The aq. phase was extracted three times CH2Cl2. The combined org. layers were dried over 
MgSO4 and evaporated in vacuo. The crude alcohol (155 mg, 96% crude yield) was then 
dissolved in a solution of trifluoroacetic acid and CH2Cl2 (1:1), and the resulting mixture was 
stirred at 0°C for 40 min. Then the reaction was quenched by adding 5 ml of a saturated aqueous 
solution of NaHCO3. The ac. Layer was extracted three times with CH2Cl2 after which the 
combined org. layers were dried with MgSO4 and evaporated in vacuo. The crude product was 
purified via column chromatography (EtOAc:pentane = 3:2) to afford 179 (128 mg, 82% yield 
from the ketone 178). 
 
Yield: colorless solid, 128 mg, 82% 
Mp: 66-68°C 
TLC: Rf = 0.30 (Penatne:EtOAc = 3:2) 
Diastereomeric excess: de ≥ 98 (1H-NMR) 
Enantiomeric excess: ee ≥ 98% (1H- Shift-NMR) 
Optical rotation: [α] 22  = +73.33 (c = 0.45, CHClD 3). 
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1H-NMR (400 MHz, CDCl3):  
δ = 2.37-2.52 (m, 2H, CHCHCH2O, CHC=O), 2.85 (dd, J = 11.1, 15.5, 1H, CHHCHC=O), 3.10 
(dd, J = 4.7,15.5, 1H, CHHCHC=O), 3.62 (s, 3H, OCH3), 3.72 (d, J = 9.9, CHCHCH2O); 3.79 (s, 
3H, OCH3), 3.88 (dd, J = 8.9, 10.3, 1H, CHHCHC=O), 4.09 (dd, J = 6.4, 8.9, 1H, CHHCHC=O), 
4.78 (dd, J = 12.6, 23.7, 2H arylCH2O), 5.09 (s, 2H, arylCH2O),6.20 (s, 1H, arom CH), 6.35 (d, J 
= 1.7, 1H, arom CH); 6.48 (dd, J = 2.0, 8.2, 1H, arom CH), 6.59 (s, 1H, arom CH), 6.73 (d, J = 
8.2, 1H, arom CH), 7.04-7.41 (m, 10H, arom CH) ppm. 
 
13C-NMR (75 MHz, CDCl3):  
δ = 29.58 (CH2CHCO2), 42.20 (CHC=O), 47.71 (CHCHCH2O), 50.25 (CHCH2OC=O), 56.29 
(OCH3), 56.36 (OCH3), 71.11 (arylCH2O), 71.34 (arylCH2O), 72.16 (CHCH2OC=O), 111.25, 
112.57, 114.13, 115.26, 120.96, 127.44, 127.53 (arom CH), 127.66 (arom C), 127.93, 128.17, 
128.59, 128.82 (arom CH), 130.87, 135.31, 137.04, 137.34, 146.65, 147.58, 148. 62, 150.23 
(arom C), 177.08 (C=O) ppm. 
 
IR (KBr):  
ῦ = 2933 (m), 2901 (m), 2852 (m), 1779 (vs), 1511 (vs), 1455 (m), 1251 (s), 1218 (s), 1156 (m), 
1138 (s), 1107 (m), 1087 (m), 1026 (m), 988 (s), 735 (21), 697 (m) cm-1. 
 
MS (EI, 70 eV): 
m/z (%) = 537 (12) [ M+• +1], 536 (35) [M+•], 445 (5%), 181 (9%), 92 (7%), 91 (100%). 
 
Elemental Analysis: 
Anal. Calcd for C34H42O6:  C = 76.10  H = 6.01 
Found:        C = 76.29  H = 5.64 
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3.11   Lignans 
 
3.11.1 (−)-Sesamin (154) 
 
O
O
HH
O
O
O
O
 
 
Tetraol 153a (80 mg, 0.20 mmol) was treated according to GP8 with methanesulfonyl chloride 
(69 mg, 0.60 mmol) and pyridine (0.16 mL). Work-up and column chromatography 
(Et2O:pentane = 9:1) gave 154 (35 mg, 0.098 mmol) as a colorless solid. 
 
Yield: colorless solid, 35 mg, 49% 
Mp: 122°C 
TLC: Rf = 0.38 (Et2O:pentane = 9:1) 
Diastereomeric excess: de ≥ 98 (1H-NMR) 
Enantiomeric excess: ee ≥ 98% (1H- Shift-NMR) 
Optical rotation: [α] = −71.0 (c = 0.30, CHCl22D 3), lit.77 [α] = +68.7 (c = 0.40, CHCl22D 3). 
 
1H-NMR (300 MHz, CDCl3):  
δ = 2.52 (m, 2H, CHCH2O), 3.31 (dd, 2H, J = 7.1, 9.3 Hz, CH2OCH), 3.49 (dd, 2H, J = 7.1, 9.1 
Hz, CH2OCH), 4.33 (d, 2H, J = 9.3 Hz, CHOCH2), 5.97 (s, 4H, OCH2O), 6.75 (s, 2H, arom. 
CH), 6.76 (s, 2H, arom. CH), 6.87 (s, 2H, arom. CH). 
 
13C-NMR (75 MHz, CDC13):  
δ = 52.47 (CHCH2O), 71.73 (CH2OCH), 76.74 (CHOCH2), 101.14 (OCH2O), 106.80, 108.09, 
120.29 (arom. CH), 136.85, 147.44, 147.99 (arom. C). 
 
IR (KBr):  
ν~  = 2973 (w), 2882 (m), 1610 (w), 1503 (vs), 1488 (vs), 1444 (vs), 1382 (m), 1315 (m), 1245 
(vs), 1190 (m), 1101 (m), 1038 (vs), 925 (s), 861 (w), 809 (m), 788 (m), 731 (m), 716 (m) cm-1. 
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HRMS: m/z calcd for C20H18O6 (M+): 354.1103. Found: 354.1101. 
 
The rest of the analytical data are in agreement with those previously reported.124 
 
3.11.2 (−)-Methyl Piperitol (155) 
 
O
O
HH
O
O
OCH3
OCH3
 
 
Tetraol 153b (130 mg, 0.32 mmol) was treated according to GP8 with methanesulfonyl chloride 
(110 mg, 0.96 mmol) and pyridine (0.26 mL). Work-up and column chromatography 
(Et2O:MeOH = 70:1) gave 155 (65 mg, 0.17 mmol) as a colorless solid. 
 
Yield: colorless solid, 65 mg, 54% 
Mp: 74°C 
TLC: Rf = 0.26 (Et2O:MeOH = 70:1) 
Diastereomeric excess: de ≥ 98 (1H-NMR) 
Enantiomeric excess: ee ≥ 98% (1H- Shift-NMR) 
Optical rotation: [α] 22  = −73.0 (c = 0.60, CHClD 3), lit.79 [α] = +73.6° (c = 0.35, CHCl20D 3). 
 
1H-NMR (400 MHz, CDCl3):  
δ = 2.60 (m, 2H, CHCH2O), 3.89 (s, 3H, OCH3), 3.92 (s, 3H, OCH3), 4.31 (m, 2H, CH2OCH), 
4.41 (m, 2H, CH2OCH), 5.00 (d, 1 H, J = 7.7 Hz, CHOCH2), 5.02 (d, 1 H, J = 8.0 Hz, 
CHOCH2), 5.97 (s, 2H, OCH2O), 6.78-6.98 (m, 6H, arom. CH) ppm. 
 
13C-NMR (100 MHz, CDCl3):  
δ = 49.74, 49.89 (CHCH2O), 55.99, 56.03 (OCH3), 67.24, 67.33 (CH2OCH), 81.92, 82.04 
(CHOCH2), 101.24 (OCH2O), 106.40, 108.36, 109.17, 111.17, 118.55, 119.82 (arom. CH), 
132.54, 134.29, 147.65, 148.24, 149.09, 149.42 (arom. C) ppm. 
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HRMS: m/z calcd for C21H22O6 (M+): 370.1416. Found: 370.1417. 
The rest of the analytical data are in agreement with those previously reported.79 
 
3.11.3 (−)-Aschantin (156) 
 
O
O
HH
O
O
OCH3
OCH3
OCH3
 
 
Tetraol 153c (144 mg, 0.33 mmol) was treated according to GP4 with methanesulfonyl chloride 
(113 mg, 0.99 mmol) and pyridine (0.27 mL). Work-up and column chromatography (Et2O) 
gave 156 (70 mg, 0.174 mmol) as a colorless solid. 
 
Yield: colorless solid, 70 mg, 53% 
Mp: 122°C 
TLC: Rf = 0.21 (Et2O) 
Diastereomeric excess: de ≥ 98 (1H-NMR) 
Enantiomeric excess: ee ≥ 98% (1H- Shift-NMR) 
Optical rotation: [α] = −64.0 (c = 0.55, CHCl22D 3), lit.48 [α] = +65.0 (c = 0.40, CHCl22D 3). 
 
1H-NMR (300 MHz, CDCl3):  
δ = 2.58 (m, 2H, CHCH2O), 3.35 (dd, 1 H, J = 7.1, 9.3 Hz, CHHOCH), 3.40 (dd, 1 H, J = 7.1, 
9.4 Hz, CHHOCH), 3.55 (dd, 1 H, J = 7.7, 9.3 Hz, CHHOCH), 3.56 (dd, 1 H, J = 7.7, 9.3 Hz, 
CHHOCH), 3.84 (s, 3H, p-OCH3), 3.87 (s, 6H, m-OCH3), 4.40 (d, 1 H, J = 7.4 Hz, CHOCH2), 
4.43 (d, 1 H, J = 7.1 Hz, CHOCH2), 5.97 (s, 2H, OCH2O), 6.57 (s, 2H, arom. CH), 6.76 (d, 1 H, 
J = 7.7 Hz, arom. CH), 6.80 (dd, 1 H, J = 1.4, 8.0 Hz, arom. CH), 6.90 (d, 1 H, J = 1.0 Hz, arom. 
CH) ppm. 
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13C-NMR (75 MHz, CDC13):  
δ = 52.44, 52.56 (CHCH2O), 56.15 (m-OCH3), 60.85 (p-OCH3), 71.73 (CH2OCH), 76.86, 77.35 
(CHOCH2), 101.19 (OCH2O), 103.46, 106.76, 108.15, 120.29 (arom. CH), 136.76, 137.68, 
138.51, 147.54, 148.07, 153.35 (arom. C) ppm. 
 
IR (KBr):  
ν~  = 2938 (m), 2882 (m), 1593 (m), 1505 (s), 1488 (s), 1462 (s), 1422 (m), 1329 (m), 1242 (vs), 
1127 (vs), 1038 (vs), 1008 (m), 929 (m), 815 (m), 788 (m), 683 (m) cm-1. 
 
HRMS: m/z calcd for C22H24O7 (M+): 400.1522. Found: 400.1523. 
 
The rest of the analytical data are in agreement with those previously reported.124 
 
3.11.4 (+)-Yatein (42) 
 
O
O
O
O
OCH3
OCH3
CH3O
 
 
The epimeric mixture of alcohol 159 (200 mg, 0.48 mmol) was dissolved in dry EtOH (30 ml) 
and two drops of aq HClO4 was added. The mixture was hydrogenated using 10% Pd/C (60 mg) 
as catalyst at 4 atm. After 16 h, the solution was neutralized with solid Na2CO3 and the catalyst 
was filtered off. The solvent was evaporated in vacuo and the crude product was purified via 
column chromatography (Et2O:pentane 1:1) to give 42 (170 mg, 88%) as a colorless oil. 
 
Yield: colorless solid, 170 mg, 88% 
TLC: Rf = 0.34 (Et2O:pentane 1:1) 
Diastereomeric excess: de ≥ 98 (1H-NMR) 
Enantiomeric excess: ee ≥ 98% (1H- Shift-NMR) 
Optical rotation: [α] = +30.6 (c = 1.10, CHCl22D 3); lit.86 [α] = −30.0 (c = 0.15, CHCl23D 3) 
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1H-NMR (300 MHz, CDCl3):  
δ = 2.46-2.64 (d, 4 H, CH2), 2.88-2.94 (m, 2H, CH), 3.06 (m, 1 H, CHHCHCO2), 3.83 (s, 9 H, 
OCH3), 3.88 (dd, 1 H, J = 7.4, 9.0 Hz, CHHOC=O), 4.18 (dd, 1 H, J = 7.2, 9.3 Hz, CHHOC=O), 
5.94 (dd, 2 H, J = 1.4, 3 Hz, OCH2O), 6.36 (s, 2 H, arom. CH), 6.46-6.49 (m, 2 H, arom. CH), 
6.69 (dd, 1 H, J = 1.0, 6.9 Hz arom. CH) ppm. 
 
13C-NMR (75 MHz, CDCl3):  
δ = 35.23 (CH2CHCO2), 38.33 (CH2CHCH2OC=O), 41.01 (CHCH2OC=O), 46.44 (CHCO2), 
56.09 (m-OCH3), 60.88 (p-OCH3), 71.20 (CH2OC=O), 101.10 (OCH2O), 106.16, 108.31, 
108.77, 121.54 (arom. CH), 131.53, 133.34, 136.80, 146.40, 147.92, 153.24 (arom. C), 178.56 
(OC=O) ppm. 
 
IR (KBr): 
ν~  = 3015 (m), 2938 (m), 2840 (m), 1767 (vs, C=Olactone), 1591 (s), 1504 (s), 1490 (s), 1244 (vs), 
1188 (vs), 755 (vs) cm-1. 
 
MS (EI, 70 eV):  
m/z (%) = 401 (22) [M+• +1], 400 (100) [M+•], 182 (23), 181 (49), 151 (5), 136 (5), 135 (19), 77 
(5). 
HRMS: m/z calcd for C22H24O7 (M+): 400.15220. Found: 400.15223. 
 
3.11.5 (−)-Isostegane (43) 
 
O
O
H3CO
CH3O
CH3O
O
O
 
 
(+)-Yatein (42) (90 mg, 0.22 mmol) dissolved in TFA (1 ml) was rapidly added at 0°C to a 
solution containing Tl2O3 (283 mg, 0.62 mmol) and BF3⋅OEt2 (0.06 mL, 0.5 mmol) in TFA (1.5 
mL). The reaction was quenched after 10 s by adding satureted aqueous NaHCO3. The aqueous 
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layer was extracted three times with CH2Cl2 then the combined organic layers were dried over 
MgSO4 and evaporated in vacuo. The crude product was purified via column chromatography 
(Et2O:pentane 1:1) to give 43 (69 mg, 77%) as a colorless solid. 
 
Yield: colorless solid, 69 mg, 77% 
Mp: 171-172°C 
TLC: Rf = 0.40 (Et2O:pentane 1:1) 
Diastereomeric excess: de ≥ 98 (1H-NMR) 
Enantiomeric excess: ee ≥ 98% (1H- Shift-NMR) 
Optical rotation: [α] 22 = −156.9 (c = 2.8, CHClD 3); lit.60 [α] = +154.0 (c = 0.7, CHCl23D 3). 
 
1H-NMR (400 MHz, CDCl3):  
δ = 2.00-2.17 (m, 2 H, CH), 2.22 (dd, 1 H, J = 9.3, 13.6 Hz, CHHCHCO2), 2.32 (dd, 1 H, J = 
9.6, 13.2 Hz, CHHCHCO2), 2.57 (d, 1 H, J = 12.9 Hz, CHHCH2CO2), 3.06 (d, 1 H, J = 13.2 Hz, 
CHHCH2CO2), 3.50 (s, 1 H, OCH3), 3.70 (dd, 1 H, J = 8.5, 11.0 Hz, CHHOC=O), 3.81 (s, 3 H, 
OCH3), 3.82 (s, 3 H, OCH3), 4.29 (dd, 1 H, J = 6.6, 8.2 Hz, CHHOC=O), 5.90 (d, 1 H, J = 1.3 
Hz, OCHHO), 5.93 (d, 1 H, J = 1.3 Hz, OCHHO), 6.55 (s, 1 H, arom. CH), 6.56 (s, 1 H, arom. 
CH), 6.63 (s, 1 H, arom. CH) ppm. 
 
13C-NMR (75 MHz, CDCl3):  
δ = 32.55 (CH2CHCO2), 34.39 (CH2CHCH2OC=O), 47.27 (CHCO2), 50.33 (CHCH2OC=O), 
56.30 (OCH3), 61.07 (OCH3), 61.23 (OCH3), 70.31 (CH2OC=O), 101.46 (OCH2O), 107.74, 
109.05, 112.02 (arom. CH), 126.70, 128.58, 132.74, 136.33, 146.16, 147.93, 152.14, 153.60 
(arom. C), 176.83 (OC=O) ppm. 
 
IR (KBr):  
ν~  = 2931 (m), 1778 (vs, C=Olactone), 1595 (m), 1484 (vs), 1455 (s), 1403 (s), 1224 (vs), 1105 
(vs), 1038 (vs), 997 (s) cm-1. 
 
MS (EI, 70 eV):  
m/z (%) = 399 (24) [M+• +1], 398 (100) [M+•]. 
 
HRMS: m/z calcd for C22H22O7 (M+): 398.13655. Found: 398.13663. 
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3.11.6 (+)-Dihydroclusin (162) 
 
O
O
OCH3
OCH3
CH3O
OH
OH
 
 
To a suspension of LiAlH4 (80 mg, 2.1 mmol) in dry THF was added at 0°C (+)-yatein (42) (105 
mg, 0.26 mmol) dissolved in dry THF (3 mL). The ice-bath was removed and the mixture stirred 
for 3 h at rt. EtOAc was added dropwise after which saturated aqueous NH4Cl (10 mL) and H2O 
(5 mL) were added. The mixture was filtered and the filtrate was extracted three times with 
EtOAc. The combined organic layers were dried over MgSO4 and evaporated in vacuo. The 
crude product was purified via column chromatography (Et2O) to give 162 (96 mg, 91%) as a 
colorless solid. 
 
Yield: colorless solid, 96 mg, 91% 
Mp: 98-100°C 
TLC: Rf = 0.35 (Et2O) 
Diastereomeric excess: de ≥ 98 (1H-NMR) 
Enantiomeric excess: ee ≥ 98% (1H- Shift-NMR) 
Optical rotation: [α] 22 = +27.0 (c = 1.15, CHClD 3); lit.125 [α] = −27.13 (c = 0.24, CHCl25D 3). 
 
1H-NMR (400 MHz, CDCl3): 
δ = 1.77-1.85 (m, 2 H, CH), 2.58 (ddd, 2 H, J = 1.9, 6.3, 8.5 Hz, ArCH2), 2.68 (t, 1 H, J = 8 Hz, 
ArCH2), 2.71 (t, 1 H, J = 7.7 Hz, ArCH2) , 2.98 (br s, 2 H, OH), 3.48 (dd, 2 H, J = 3.9, 11.3 Hz, 
CH2OH) 3.75 (s, 6 H, OCH3), 3.76 (s, 3 H, OCH3), 3.74-3.77 (m, 2 H, CH2OH), 5.85 (s, 2 H, 
OCH2O), 6.29 (s, 2 H, arom. CH), 6.53 (dd, 1 H, J = 1.6, 8.0 Hz arom. CH), 6.57 (d, 1 H, J = 1.4 
Hz arom. CH), 6.64 (d, 1 H, J = 8.0 Hz arom. CH) ppm. 
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13C-NMR (75 MHz, CDCl3):  
δ = 36.16 (ArCH2), 36.86 (ArCH2), 43.96 (ArCH2CH), 44.33 (ArCH2CH), 56.31 (m-OCH3), 
60.56 (CH2OH), 61.15 (p-OCH3), 101.08 (OCH2O), 103.49, 106.11, 108.34, 109.56, 122.13 
(arom. CH), 134.58, 136.36, 136.66, 145.98, 147.84, 153.30 (arom. C) ppm. 
 
IR (KBr):  
ν~  = 3248 (m), 2938 (m), 2892 (m), 1591 (s), 1512 (s), 1486 (vs), 1458 (s), 1433 (s), 1241 (vs), 
1130 (vs), 1034 (s), 1005 (vs), 925 (m), 908 (m), 815 (m) cm-1. 
 
MS (EI, 70 eV):  
m/z (%) = 405 (20) [M+• +1], 404 (100) [M+•], 209 (6), 183 (8), 182 (75), 181 (80), 167 (10), 151 
(12), 136 (10), 135 (47), 77 (7). 
 
HRMS: m/z calcd for C22H28O7 (M+): 404.18350. Found: 404.18354. 
 
3.11.7 (+)-Burseran (163) 
 
O
O
O
OCH3
OCH3
CH3O
 
 
(+)-Dihydroclusin (162) (52 mg, 0.13 mmol) was dissolved in MeOH (30 mL) and 32% HCl (1 
mL) was added. The solution was heated to reflux for 48 h and then the solvent was evaporated. 
The residue was neutralized with saturated aqueous NaHCO3 and the aqueous phase was 
extracted three times with CH2Cl2. The combined organic layers were dried over MgSO4 and 
evaporated in vacuo. The crude product was purified via column chromatography (Et2O:pentane 
3:1) to give(+)-163 (42 mg, 85%) as colorless oil. 
 
Yield: colorless oil, 42 mg, 85% 
TLC: Rf = 0.30 (Et2O:pentane 3:1) 
Diastereomeric excess: de ≥ 98 (1H-NMR) 
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Enantiomeric excess: ee ≥ 98% (1H- Shift-NMR) 
Optical rotation: [α] 22 = +37.8 (c = 2.0, CHClD 3); lit.87 [α] = −34.8 (c = 0.93, CHCl25D 3). 
 
1H-NMR (400 MHz, CDCl3): 
δ = 2.07-2.16 (m, 2 H, CH), 2.40-2.56 (m, 4H, ArCH2), 3.44 (t, 1 H, J = 6.0 Hz, CH2O), 3.47 (t, 
1 H, J = 6.0 Hz, CH2O), 3.75 (s, 3 H, OCH3), 3.76 (s, 6 H, OCH3), 3.84 (t, 1 H, J = 6.6 Hz, 
CH2O), 3.86 (t, 1 H, J = 6.6 Hz, CH2O), 5.86 (dd, 2 H, J = 1.4, 4.1 Hz, OCH2O), 6.21 (s, 2 H, 
arom. CH), 6.46-6.49 (m, 2 H, arom. CH), 6.63 (d, 1 H, J = 8.0 Hz arom. CH) ppm. 
 
13C-NMR (100 MHz, CDCl3):  
δ = 39.52 (ArCH2), 40.26 (ArCH2), 46.72 (CH), 46.96 (CH), 56.36 (m-OCH3), 61.18 (p-OCH3), 
73.55 (CH2O), 101.14 (OCH2O), 105.78, 108.28, 109.20, 121.69 (arom. CH), 134.28, 136.32, 
136.57, 146.05, 147.84, 153.27, (arom. C) ppm. 
 
IR (KBr): 
ν~  = 3010 (m), 2935 (s), 1590 (vs), 1504 (vs), 1489 (vs), 1462 (s), 1445 (s), 1421 (s), 1243 (vs), 
1128 (vs), 1039 (s), 755 (vs) cm-1. 
 
MS (EI, 70 eV):  
m/z (%) = 387 (20) [M+• +1], 386 (85) [M+•], 183 (11), 182 (100), 181 (25), 167 (13), 151 (17), 
136 (7), 135 (20), 77 (6). 
 
HRMS: m/z calcd for C22H26O6 (M+): 386.17294. Found: 386.17294. 
 
3.11.8 (+)-α-Coninendrin (180) 
 
O
OH
OCH3
HO
H3CO
O
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Aryltetraline 179 (100 mg, 0.186 mmol) was dissolved in dry EtOH (30 mL). The mixture was 
hydrogenated using 10% Pd/C (60 mg) as catalyst at 4 atm. After 16 h, the solution was 
neutralized with solid Na2CO3 and the catalyst was filtered off. The solvent was evaporated in 
vacuo to give 180 (64 mg, 96%) as a colorless solid. 
 
Yield: colorless solid, 64 mg, 96% 
Mp: 256-257°C 
TLC: Rf = 0.65 (Et2O:CH2Cl2 1:1) 
Diastereomeric excess: de ≥ 98 (1H-NMR) 
Enantiomeric excess: ee ≥ 98% (1H- Shift-NMR) 
Optical rotation: [α] 22 = +51.0 (c = 0.5, acetone); lit.D 99 [α] = −50.4 (c = 0.90, acetone) 25D
 
1H-NMR (300 MHz, DMSO-d6): 
δ = 2.55-2.88 (m, 3H, CHC=O, CHCH2O, CHHCHC=O), 2.98 (dd, 1H, J = 4.4, 15.0 Hz, 
CHHCHC=O), 3.69 (d, 1H, J = 6.5 Hz, CHCHCH2O), 4.02 (dd, 2H, J = 2.2, 9.4 Hz, CH2O), 
6.14 (s, 1H, arom CH), 6.57 (dd, 1H, J = 1.7, 7.9 Hz, arom CH), 6.66 (d, 1H, J = 1.7 Hz, arom 
CH), 6.71 (d, 1H, J = 7.9 Hz, arom CH), 6.72 (s, 1H, arom CH), 8.65 (br, 1H, OH), 8.86 (br, 1H, 
OH) ppm. 
 
13C-NMR (75 MHz, DMSO-d6):  
δ = 28.95 (CH2CHC=O), 41.26 (CHC=O), 46.23 (CHCHCH2O), 48.64 (CHCH2O), 71.67 
(CH2O), 112.42, 113.26, 115.88, 116.02, 121.25 (arom CH), 125.79, 132.19, 134.13, 145.04, 
145.74, 146.52, 148.15 (arom C), 177.59 (C=O) ppm. 
 
The rest of the analytical data are in agreement with those previously reported.99 
 
3.11.9 (–)-Lintetralin (173) 
 
MeO
MeO
OMe
OMe
O
O  
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Methyl iodide (200 mg, 1.4 mmol) was added to a stirred solution of the diol 172 (100 mg, 0.27 
mmol ) in dry THF. Sodium Hydride (0.6 g, 60% dispersion in oil was added potion-wise to the 
solution over 20 min, followed by more methyl iodide (110 mg 0.77 mmol). After being stirred 
at room temperature for 2.5 h, the mixture was cooled to 0°C and methanol (5ml) were added. 
Concentration under reduced pressure and flash chromatography afforded 100 mg of (–)-
lintetralin (173) (92%) as a colorless liquid. 
 
Yield: colorless solid, 100 mg, 92% 
TLC: Rf = 0.50 (Et2O:pentane 1:1) 
Diastereomeric excess: de ≥ 98 (1H-NMR) 
Enantiomeric excess: ee ≥ 98% (1H- Shift-NMR) 
Optical rotation: [α]24D = – 4.0 (c = 0.1, CHCl3) lit.63 [α]28D = + 2.6, (CHCl3) 
 
1H-NMR (400 MHz, CDCl3):  
δ = 1.68-1.75 (m, 1H, CHCH), 2.04-2.09 (m, 1H, CH2CH), 2.75 (d, 2H, J = 7.7 Hz, CH2CH), 
3.04 (dd, 1H, J = 3.3, 9.6 Hz, CHHOCH3), 3.2 (s, 3H, OCH3), 3.28 (s, 3H, OCH3), 3.3 (dd, 1H, J 
= 3.0, 9.6 Hz, CHHOCH3), 3.35 (dd, 1H, J = 6.3, 15.6 Hz, CHHOCH3), 3.41 (dd, 1H, J = 3.8, 
9.3 Hz, CHHOCH3), 3.54 (s, 3H, OCH3), 3.76 (s, 3H, OCH3), 3.91 (d, 1H, J = 10.4 Hz, CHCH2), 
5.85 (dd, 2H, J = 1.4, 3.8 Hz, OCH2O), 6.16 (s, 1H, arom. CH), 6.49 (d, 1H, J = 1.6, arom CH), 
6.52 (s, 1H, arom. CH), 6.57 (dd, 1H, J = 1.6, 8.0 Hz, arom. CH), 6.66 (d, 1H, J = 8.0 Hz, arom. 
CH) ppm. 
 
13C-NMR (100 MHz, CDCl3):  
δ = 33.43 (CH2CH), 36.47 (CHCH), 45.29 (CH2CH), 47.44 (CHCH2), 56.00 (OCH3), 56.10 
(OCH3), 59.11 (OCH3), 59.16 (OCH3), 71.33 (CH2OCH3), 75.47 (CH2OCH3), 101.04 (OCH2O), 
108.03 (arom. CH), 109.57  (arom. CH), 111.21, (arom. CH), 113.07 (arom. CH), 122.90 (arom. 
CH), 129.12 (arom. C), 132.06 (arom. C), 139.90 (arom. C), 146.10 (arom. C), 147.23 (arom. C), 
147.35 (arom. C), 147.90 (arom. C) ppm.  
 
IR (CHCl3):  
ῦ = 2893 (vs), 2830 (s), 1609 (m), 1512 (vs), 1486 (vs), 1464 (s), 1442 (s), 1402 (m) 1384 (m), 
1355 (m), 1298 (m), 1243 (vs), 1216 (s), 1191 (m), 1107 (vs), 1039 (s), 1004 (m), 933 (m), 895 
(m), 865 (m), 812 (m), 757 (s) cm-1.  
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MS (EI, 70 eV):  
m/z (%) = 401 (24) [ M+• +1], 400 (100) [M+•], 368 (14), 367 (8), 353 (5), 338 (7), 337 (9), 336 
(9), 324 (14), 323 (67), 321 (5), 309 (5), 308 (10), 306 (10), 305 (8), 297 (6), 296 (24), 293 (5), 
283 (6), 261 (6), 253 (6), 208 (10), 201 (8), 153 (8), 135 (15), 45 (11).  
 
Elemental Analysis: 
Anal. Calcd for C23H28O6:  C = 68.98  H = 7.05 
Found:        C = 68.70  H = 6.83 
 
3.11.10 (–)-Dihydrosesamin (175) 
 
O
OH
O
O
O
O
 
 
To a stirred sospension of LiAlH4 (160 mg, 4.2 mmol) in THF (10 ml) was added at 0°C lactone 
157c (340 mg, 0.88 mmol) dissolved in 5 ml of dry THF. The ice bath was removed and the 
mixture was stirred at room temperature for 5 h. EtOAc was added dropwise followed by 
saturated aqueous NH4Cl (5ml) and then H2O (5ml) were added. The mixture was filtred and the 
filtrate extracted three times with EtOAc. The combined organic layers were dried over MgSO4 
and evaporated in vacuo. The crude triol 174 was then dissolved in a mixture of CH2Cl2 and THF 
(1:1). Three equivalents of BF3·Et2O were slowly added and the solution was stirred at rt for 4 h. 
Then the reaction was quenched by adding 5 ml of a saturated aqueous solution of NaHCO3. The 
aqueous layer was extracted three times with CH2Cl2 and then the combined organic layers were 
dried over MgSO4 and evaporated in vacuo. The crude product was purified via column 
chromatography (EtOAc:pentane 1:1) to afford (–)-dihydrosesamin (175) (126 mg, 40% yield 
from the triols 6) as colorless solid. 
 
Yield: colorless solid, 126 mg, 40% 
Mp: 94-95°C 
TLC: Rf = 0.50 (Et2O:pentane 1:1) 
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Diastereomeric excess: de ≥ 98 (1H-NMR) 
Enantiomeric excess: ee ≥ 98% (1H- Shift-NMR) 
Optical rotation: [α] 22 = −16.5  (c = 0.5, pyridine); lit.D 96 [α] = −15.9 (c = 0.67, pyridine) 25D
 
1H-NMR (400 MHz, CDCl3):  
δ = 1.97 (br, 1H, OH), 2.24 (m, 1H, CHCH2OH), (dd, 1H, J = 10.7, 13.4 Hz, ArCHH), 2.54-2.64 
(m, 1H, CH2CHCH2O), 2.77 (dd, 1H, J = 5.2, 13.4 Hz, ArCHH), 3.60-3.65 (m, 2H, CHHOCH, 
CHHOH), 3.76 (dd, 1H, J = 6.8, 10.7 Hz, CHHOH), 3.94 (dd, 1H, J = 6.6, 8.5 Hz, CHHOCH), 
4.69 (d, 1H, J = 6.3 Hz, ArCHO), 5.84 (d, 4H, J = 2.5 Hz, OCH2O), 6.54 (dd, 1H, J = 1.3, 8.0 
Hz, arom CH), 6.59 (d, 1H, J = 1.4 Hz, arom CH), 6.64 (d, 1H, J = 8.0, arom CH), 6.67 (s, 2H, 
arom CH), 6.74 (s, 1H, arom CH) ppm. 
 
13C-NMR (100 MHz, CDCl3):  
δ = 33.39 (ArCH2), 42.52 (CH2CHCH2), 52.80 (CHCH2OH), 60.91 (CH2OH), 73.08 
(CHCH2OCH), 83.05 (CHOCH2), 101.10, 101.21 (OCH2O), 106.50, 108.27, 108.50, 109.16, 
119.26, 121.65 (arom CH), 134.40, 137.29, 146.14, 147.09, 147.97, 148.04 (arom C) ppm. 
 
IR (CHCl3):  
ῦ = 3412 (m), 2888 (s), 1501 (vs), 1489 (vs), 1443 (s), 1247 (vs), 1192 (m), 1098 (m) 1040 (vs), 
931 (s), 811 (m), 757 (s) cm-1.  
 
MS (EI, 70 eV):  
m/z (%) = 357 (23) [ M+• +1], 356 (100) [M+•], 355 (6), 219 (5), 217 (5), 162 (16), 189 (5), 188 
(5), 178 (14), 173 (7), 151 (15), 150 (5), 149 (18), 148 (8), 136 (14), 135 (55).  
 
Elemental Analysis: 
Anal. Calcd for C23H28O6:  C = 67.41  H = 5.66 
Found:        C = 67.20  H = 6.03 
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3.12  Synthesis of SAMP-/RAMP-Hydrazones 
 
3.12.1 (2S,2'R)-(2-methoxymethylpyrrolidin-1-yl)-(2'-Methyl-pentylidene)-amine (188a) 
 
N
H
N
MeO
Me
Me  
 
To a cooled solution (0°C) of diisopropylamine (600 mg, 6 mmol) in dry THF (10 ml) under 
Argon was slowly added n-BuLi (3.75 mmol, 6 mmol); the mixture was stirred for 1 h. A 
solution of hydrazone 187f (990 mg, 5 mmol) in dry THF (5 ml) was added slowly. After 1 h the 
reaction was cooled to –100°C and MeI (850 mg, 6mmol) added dropwise. After allowing the 
reaction mixture to to warm to room temperature overnight, the reaction was quenched adding 
aqueous NH4Cl, the mixture was diluted with Et2O, the organic phase separated, washed with 
water and brine and dried over MgSO4. After removal of the solvent the crude product was 
purified by column chromatography yielding 188a as colourless liquid. 
 
Yield: colorless liquid, 680 mg, 64% 
TLC: Rf = 0.20 (Et2O:pentane 1:6) 
Diastereomeric excess: de ≥ 96 (1H-NMR) 
Optical rotation: [α] 22 = −123.3  (c = 2.0, CHClD 3) 
 
1H-NMR (300 MHz, CDCl3):  
δ = 0.85 (t, 3H, J = 6,8 Hz, CH3CH2), 0.99 (d, 3H, J = 6.9 Hz, CH3CH), 1.26-1.40 (m, 4H, 
CH3CH2CH2), 1.70-1.94 (m, 4H, CH2CH2CHCH2O), 2.24-2.30 (m, 1H, CH3CH), 2.68 (q, 1H, J 
= 8.2 Hz, CHHN), 3.26-3.42 (m, 6H, CH2OCH3, CHHN), 3.55 (dd, 1H, J = 3.6, 8.8 Hz, 
CHCH2O), 6.47 (d, 1H, J = 6.3 Hz, CH=N) ppm 
 
13C-NMR (100 MHz, CDCl3):  
δ = 14.40 (CH3CH2), 19.30 (CH3CH), 20.52 (CH2CH2CHCH2O), 22.31 (CH3CH2), 26.78 
(CH2CHCH2O), 37.09 (CH3CH), 38.05 (CH2CHCH3), 50.71 (CH2N), 59.42 (OCH3), 63.70 
(CHCH2O), 75.01 (CH2O), (145.03 CH=N) ppm. 
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IR (CHCl3):  
ῦ = 2957 (vs), 2926 (vs), 2873 (vs), 1458 (m), 1197 (m), 1120 (s). 
 
MS (EI, 70 eV):  
m/z (%) = 212 (6) [M+•], 168 (6), 167 (100), 70 (21), 45 (6). 
 
Elemental Analysis: 
Anal. Calcd for C12H24N2O:  C = 67.88  H = 11.39  N = 13.19 
Found:         C = 67.60  H = 11.28  N = 13.31 
 
3.12.2 (2R,2'S)-(2-methoxymethylpyrrolidin-1-yl)-(2'-Methyl-pentylidene)-amine (188b) 
 
N
H
N
MeO
Me
Me  
 
To a cooled solution (0°C) of diisopropylamine (600 mg, 6 mmol) in dry THF (10 ml) under 
Argon was slowly added n-BuLi (3.75 mmol, 6 mmol); the mixture was stirred for 1 h. A 
solution of hydrazone 187g (990 mg, 5 mmol) in dry THF (5 ml) was added slowly. After 1 h the 
reaction was cooled to –100°C and MeI (850 mg, 6mmol) added dropwise. After allowing the 
reaction mixture to to warm to room temperature overnight, the reaction was quenched adding 
aqueous NH4Cl, the mixture was diluted with Et2O, the organic phase separated, washed with 
water and brine and dried over MgSO4. After removal of the solvent the crude product was 
purified by column chromatography yielding 188b as colourless liquid. 
 
Yield: colorless liquid, 640 mg, 60% 
TLC: Rf = 0.20 (Et2O:pentane 1:6) 
Diastereomeric excess: de ≥ 96 (1H-NMR) 
Optical rotation: [α] 22 = +124.0  (c = 2.0, CHClD 3) 
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Elemental Analysis: 
Anal. Calcd for C12H24N2O:  C = 67.88  H = 11.39  N = 13.19 
Found:         C = 67.80  H = 11.45  N = 13.15 
 
The rest of the analytical data are in agreement with those previously reported for compound 
188a 
 
Analytical data of the other hydrazones are consisting with the data reported in literature.126 
 
3.13  Synthesis of Furfuryl-Hydrazines 
 
3.13.1 (S,S)-(1-Furan-2-yl-propyl)-(2-methoxymethyl-pyrrolidin-1-yl)-amine (190k) 
 
HN
N
MeO
O
Me
 
 
Hydrazone 187b (340 mg, 2 mmol) was treated with 2-furyllithium (3.2 equivalents pro mmol) 
according to GP11. After work-up and flash chromatography (Et2O:pentane 1:1) 190k was 
obtained as a pale yellow oil (410 mg, 1.72 mmol). 
 
Yield: pale yellow oil, 410 mg, 87% 
TLC: Rf = 0.31 (Et2O:pentane 1:1) 
Diastereomeric excess: de ≥ 96 (1H-NMR) 
Optical rotation: [α] 22 = −53.7 (c = 1.0, CHClD 3). 
 
1H-NMR (300 MHz, CDCl3):  
δ = 0.86 (t, 3H, J = 7.4 Hz, CH2CH3), 1.50-1.93 (m, 6H, CH2CH2CH2N, CH2CH2CH2N, 
CH2CH3 ), 2.25 (dd, 1H, J = 8.6 Hz, CHHN), 2.60-2.69 (m, 1H, CHCH2OCH3), 2.79 (s, 1H, 
NH),3.15-3.22 (m, 2H, CHHOCH3, CHHN), 3.28 (s, 3H, OCH3), 3.39 (dd, 1H, J = 4.4, 9.1 Hz, 
CHHOCH3), 3.82-3.85 (m, 1H, CHNHN), 6.16 (d, 1H, J = 3.2 Hz, arom CH), 6.30 (dd, 1H, J = 
1.7, 3.2 Hz, arom CH), 7.34 (d, 1H, J = 1.7 Hz, arom CH) ppm. 
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13C-NMR (75 MHz, CDCl3):  
δ = 10.75 (CH2CH3), 21.14 (CH2CH2CHN), 25.87 (CH2CH3), 26.22 (CH2CH2CHN), 57.70 
(CH2N), 58.99 (OCH3), 59.50 (CHNH), 65.93 (CHCH2O), 75.24 (CH2OCH3), 106.47, 109.97, 
140.99, (arom CH), 156.72 (arom C) ppm. 
 
IR (CHCl3):  
ῦ = 3116 (w), 2970 (vs), 2934 (vs), 2876 (vs), 1680 (m), 1462 (s), 1195 (m), 1109 (s) 1012 (m), 
887 (m), 745 (s), 597 (m) cm-1.  
 
MS (EI, 70 eV):  
m/z (%) = 239 (1) [ M+• +1], 238 (7) [M+•], 192 (6), 191 (54), 129 (100), 122 (18), 109 (7), 97 
(23), 94 (9), 85 (9), 82 (6), 81 (6), 71 (12), 70 (7), 55 (5), 45 (13).  
 
Elemental Analysis: 
Anal. Calcd for C13H22N2O2:  C = 65.51  H = 9.30  N = 11.75 
Found:         C = 65.59  H = 9.28  N = 11.73 
 
3.13.2 (S,S)-(1-Furan-2-yl-3-phenyl-propyl)-(2-methoxymethyl-pyrrolidin-1-yl)-amine 
(H1) 
 
HN
N
MeO
O
Ph
 
Hydrazone 187e (492 mg, 2 mmol) was treated with 2-furyllithium (3.2 equivalents pro mmol) 
according to GP11. After work-up and flash chromatography (Et2O:pentane 1:2) H1 was 
obtained as a pale green oil (440 mg, 1.40 mmol). 
 
Yield: pale yellow oil, 440 mg, 70% 
TLC: Rf = 0.33 (Et2O:pentane 1:2) 
Diastereomeric excess: de ≥ 96 (1H-NMR) 
Optical rotation: [α] 22 = −59.0 (c = 1.2, CHClD 3). 
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1H-NMR (300 MHz, CDCl3):  
δ = 1.46 (m, 1H, CHCHHCH2CH2), 1.60-1.72 (m, 2H, CH2CH2CH2CH), 1.80-1.92 (m, 1H, 
CHCHHCH2CH2), 2.02-2.26 (m, 3H, PhCH2CH2, CH2CHHN), 2.60 (t, 2H, J = 7.9 Hz, PhCH2), 
2.61-2.80 (br, 1H, NH), 3.04-3.12 (m, 1H, CH2CHHN), 3.17 (dd, 1H, J = 6.0, 9.3 Hz 
CHHOCH3), 3.27 (s, 3H, OCH3), 3.36 (dd, 1H, J = 4.4, 9.3Hz, CHHOCH3), 3.91-3.96 (m, 1H, 
CHNHN), 6.21 (d, 1H, J = 3.3 Hz, arom CH), 6.32 (m, 1H, arom CH), 7.25-7.30 (m, 5H, arom 
CH), 7.36-7.39 (m, 1H, arom CH) ppm. 
 
13C-NMR (75 MHz, CDCl3):  
δ = 21.13 (CH2CH2CH2CH), 26.18 (CH2CH2CH2CH), 32.45 (PhCH2), 34.38 (PhCH2CH2), 57.16 
(CHNH), 57.78 (NCH2), 58.98 (OCH3), 65.98 (NCHCH2O), 75.28 (CH2OCH3), 106.27, 110.06, 
125.74, 128.80, 128.40, 141.14 (arom CH), 141.70, 156.48 (arom C) ppm. 
 
IR (CHCl3):  
ῦ = 2929 (s), 2875 (s), 2826 (m), 1454 (m), 755 (vs), 700 (m) cm-1. 
 
MS (EI, 70 eV):  
m/z (%) = 314 (7) [M+•], 267 (13), 129 (100), 97 (12), 91 (20), 71 (6), 45 (7). 
 
Elemental Analysis: 
Anal. Calcd for C19H26N2O2:  C = 72.58  H = 8.33  N = 8.91 
Found:         C = 72.77  H = 8.11  N = 8.86. 
 
3.13.3 (S,S)-(furan-2-yl-2,2-dimethyl-propryl)-(2-methoxymethyl-pyrrolidin-1-yl)-amine 
(H2) 
 
HN
N
MeO
O
Me
Me Me  
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Hydrazone 187d (396 mg, 2 mmol) was treated with 2-furyllithium (3.2 equivalents pro mmol) 
according to GP11. After work-up and flash chromatography (Et2O:pentane 1:3) H2 was 
obtained as a pale yellow oil (380 mg, 1.43 mmol). 
 
Yield: pale yellow oil, 380 mg, 71% 
TLC: Rf = 0.36 (Et2O:pentane 1:3) 
Diastereomeric excess: de ≥ 96 (1H-NMR) 
Optical rotation: [α] 22 = −80.4 (c = 1.5, CHClD 3). 
 
1H-NMR (300 MHz, CDCl3):  
δ = 0.92 (s, 9H, t-Bu), 1.46-1.58 (m, 1H, CHHCHCH2O), 1.62-1.74 (m, 2H, CH2CH2N), 1.81-
1.92 (m, 1H, CHHCHCHO), 2.21 (q, 1H, J = 8.6 Hz, CHHN), 2.60-2.64 (m, 1H, CHCH2O), 
2.72-2.88 (br, 1H, NH), 3.04 (dd, 1H, J = 6.9, 9.4 Hz, CHHOCH3), 3.24 (s, 3H, OCH3), 3.30-
3.38 (m, 2H, CHHOCH3, CHHN), 3.63 (s, 1H, CHN), 6.13-6.15 (m, 1H, arom CH), 6.30-6.32 
(m, 1H, arom CH), 7.33 (dd, 1H, J = 1.0, 2.0 Hz, arom CH) ppm. 
 
13C-NMR (75 MHz, CDCl3):  
δ = 21.08 (CH2CH2N), 26.49 (CH2CHCH2O), 27.12 (CH3C), 34.52 (CCHN), 56.37 (CH2N), 
58.96 (OCH3), 65.28 (CHCH2O), 66.90 (CHN), 75.13 (CH2O), 107.07, 109.86, 140.35 (arom 
CH), 156.99 (arom C) ppm. 
 
IR (CHCl3):  
ῦ = 2957 (vs), 2820 (s), 1467 (m), 1198 (m), 1123 (s), 1009 (m), 730 (s) cm-1. 
 
MS (EI, 70 eV):  
m/z (%) = 266 (9) [M+•], 209 (9), 152 (17), 137 (13), 130 (6), 129 (100), 96 (14), 93 (7), 71 (7), 
70 (7), 57 (12), 45 (8). 
 
Elemental Analysis: 
Anal. Calcd for C15H26N2O2:  C = 67.36  H = 9.84  N = 10.51 
Found:         C = 67.76  H = 9.73  N = 10.53 
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3.13.4  (1R)-(1-Furan-2yl-ethyl)-(2S)-(2-methoxymethyl-pyrrolidin-1-yl)-amine (H3) 
 
HN
Me
N
MeO
O  
 
Hydrazone 187i (416 mg, 2 mmol) was treated with 2-methyllithium (3.2 equivalents pro mmol) 
in 20 ml of Et2O at –78°C. After 1h the cooling bath was removed and the temperature allowed 
arising room temperature. After 1h the reaction was quenched by adding a solution of NH4Cl, 
the phases were separated and the aqueous phase extracted three times with Et2O. The organic 
phases were collected, washed with brine and dried over MgSO4. Purification by flash 
chromatography (Et2O:pentane 1:1) yielded H3 as a pale yellow oil (385 mg, 1.79 mmol). 
 
Yield: pale yellow oil, 385 mg, 89% 
TLC: Rf = 0.30 (Et2O:pentane 1:1) 
Diastereomeric excess: de ≥ 96 (1H-NMR) 
Optical rotation: [α] 22 = +22.12 (c = 1.0, CHClD 3). 
 
1H-NMR (300 MHz, CDCl3):  
δ = 1.37 (d, 3H, J = 6.7 Hz, CH3CHN), 1.57-1.95 (m, 4H, CH2CHN, CH2CH2CHN), 2.19 (q, 1H, 
J = 8.9 Hz, CHHN), 2.58-2.68 (m, 1H, CHCH2O), 2.70-2.78 (br, 1H, NH), 3.20-3.26 (m, 1H, 
CHHN), 3.31-3.39 (m, 4H, OCH3, CHHOCH3), 3.55 (dd, 1H, J = 4.0, 9.1 Hz, CHHOCH3), 4.05 
(q, 1H, J = 6.7 Hz, CHN), 6.17 (dt, 1H, J = 0.7, 3.2 Hz, arom CH), 6.30 (dd, 1H, J = 2.0, 3.2 Hz, 
arom CH), 7.33 (dd, 1H, J = 0.7, 2.0 Hz, arom CH) ppm. 
 
13C NMR (75 MHz, CDCl3):  
δ = 17.71 (CHCH3), 21.06 (CH2CH2N), 26.09 (CH2CHCH2O), 52.63 (CHN), 57.22 (CH2N), 
59.10 (OCH3), 65.75 (CHCH2O), 75.07 (OCH3), 105.48, 110.12, 141.24 (arom CH), 157.45 
(arom C) ppm. 
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IR (CHCl3):  
ῦ = 3115 (w), 2971 (vs), 2878 (vs), 1681 (m), 1457 (s), 1363 (m), 1323 (m), 1191 (m), 1110 (s), 
997 (s), 919 (s), 740 (s) cm-1. 
 
MS (EI, 70 eV):  
m/z (%) = 224 (1) [M+•], 222 (12), 178 (5), 177 (100), 129 (26), 110 (7), 108 (48), 97 (7), 95 
(51), 71 (7), 70 (6), 67 (10), 65 (5), 55 (9), 53 (9), 45 (16). 
 
Elemental Analysis: 
Anal. Calcd for C12H20N2O2:  C = 64.26  H = 8.98  N = 12.50 
Found:         C = 64.30  H = 8.84  N = 12.50 
 
3.13.5 (S,S)-(1furan-2-yl-pentyl)-(2-methoxymethyl-pyrrolidin-1-yl)]-amine (H4) 
 
HN
N
MeO
O
Me
 
 
Hydrazone 187f (396 mg, 2 mmol) was treated with 2-furyllithium (3.2 equivalents pro mmol) 
according to GP11. After work-up and flash chromatography (Et2O:pentane 3:7) H4 was 
obtained as a pale yellow oil (400 mg, 1.50 mmol). 
 
Yield: pale yellow oil, 400 mg, 75% 
TLC: Rf = 0.32 (Et2O:pentane 3:7) 
Diastereomeric excess: de ≥ 96 (1H-NMR) 
Optical rotation: [α] 22 = +42.0 (c = 1.5, CHClD 3). 
 
1H-NMR (300 MHz, CDCl3):  
δ = 0.78 (t, 3H, J = 7.4 Hz, CH3CH2), 1.10-1.28 (m, 4H, CH3CH2CH2), 1.38-159 (m, 1H, 
CHHCHCH2O), 1.55-1.69 (m, 4H, CH2CH2NH, CH2CHCH2O), 1.72-1.84 (m, 1H, 
CHHCHCH2O), 2.31 (q, 1H, J = 8.5 Hz, CHHN), 2.50-2.59 (m, 2 H, NH, CHCH2O), 3.03-3.13 
(m, 2H, CHHN, CHHOCH3), 3.19 (s, 3H, OCH3), 3.28 (dd, 1H, J = 4.4, 11.0 Hz, CHHOCH3), 
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3.79 (t, 1H, J = 6.9 Hz, CHNH), 6.07 (d, 1H, J = 3.0 Hz, arom CH), 6.21 (dd, 1H, J = 1.9, 3.0 
Hz, arom CH), 7.26 (dd, 1H, J = 0.8, 1.7 Hz) ppm. 
 
13C-NMR (75 MHz, CDCl3):  
δ = 14.28 (CH2CH3), 21.39 (CH2CH2NNH), 22.95 (CH2CH3), 26.45 (CH2CHCH2O), 28.79 
(CH3CH2CH2), 32.88 (CH2CHNH), 57.92 (CH2NNH), 58.11 (CHNH), 59.26 (OCH3), 65.62 
(CHCH2O), 75.45 (CH2OCH3), 106.59, 110.23, 141.19 (arom CH), 157.28 (arom C) ppm. 
 
IR (CHCl3):  
ῦ = 3116 (w), 2956 (vs), 2870 (vs), 1678 (m), 1464 (s), 1195 (m), 1111 (s) 914 (m) cm-1. 
 
MS (EI, 70 eV):  
m/z (%) = 266 (6) [M+•], 264 (9), 220 (10), 219 (70), 150 (6), 129 (100), 97 (16), 94 (14), 81 
(13), 71 (7), 55 (7), 45 (12). 
 
Elemental Analysis: 
Anal. Calcd for C15H26N2O2:  C = 67.36  H = 9.84  N = 10.51 
Found:         C = 67.38  H = 9.70  N = 10.33 
 
3.13.6  (1S,2R)-(1-Furan-2-yl-2-methyl-pentyl)-(2S)-(2-methoxymethyl-pyrrolidin-1-yl)-
amine (H5) 
 
HN
N
MeO
O
Me
Me  
 
Hydrazone 188a (424 mg, 2 mmol) was treated with 2-furyllithium (3.2 equivalents pro mmol) 
according to GP11. After work-up and flash chromatography (Et2O:pentane 1:3) H5 was 
obtained as a pale yellow oil (470 mg, 1.68 mmol). 
 
Yield: pale yellow oil, 470 mg, 85% 
TLC: Rf = 0.29 (Et2O:pentane 1:3) 
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m/z (%) = 280 (7) [M ], 233 (12), 212 (11), 211 (85), 163 (6), 151 (10), 130 (9), 129 (100), 105 
(10), 97 (11), 95 (10), 94 (14), 81 (31), 71 (5), 70 (16), 69 (5), 59 (8), 55 (13), 45 (23). 
Diastereomeric excess: de ≥ 96 ( H-NMR) 1
Optical rotation: [α] 22 = +25.2 (c = 1.0, CHCl3). 
 
D
1H-NMR (300 MHz, CDCl3):  
δ = 0.85 (t, 3H, J = 7.1 Hz, CH CH ), 0.92 (d, 3H, J = 6.9 Hz, CHCH ), 0.97-1.96 (m, 9H, 
CHCH CH CH , NCH CH CH ), 2.25 (q, 1H, J = 8.8 Hz, CHHN), 2.60-2.69 (m, 2H, NH, 
CHCH O), 3.12 (dd, 1H, J = 7.1, 9.1 Hz, CHHOCH ), 3.27 (s, 3H, OCH ), 3.31-3.40 (m, 2H, 
CHHOCH , CHHN), 3.79 (d, 1H, J = 6.0 Hz, CHNH), 6.16 (d, 1H, J = 3.0 Hz, arom CH), 6.30-
6.32 (m, 1H, arom CH), 7.34-7.35 (m, 1H, arom CH) ppm. 
3 2 3
2 2 3 2 2 2
2 3 3
3
 
13C-NMR (75 MHz, CDCl3):  
δ = 14.52 (CHCH3), 16.71 (CH2CH3), 20.61 (CH2CH2CH3), 21.27 (CH2CH2NNH), 26.58 
(CH2CHCH2O), 35.23 (CH2CHCH3), 36.17 (CHCH3), 57.27 (CH2NNH), 59.23 (OCH3), 63.20 
(CHNH), 65.88 (CHNNH), 75.36 (CH2OCH3), 107.03, 110.10, 140.87 (arom CH), 156.86 (arom 
C) ppm. 
 
IR (CHCl3):  
ῦ = 3398 (w), 2959 (vs), 2872 (s), 1590 (m), 1461 (m), 1114 (m), 756 (s) cm-1. 
 
MS (EI, 70 eV):  
+•
 
Elemental Analysis: 
Anal. Calcd for C16H28N2O2:  C = 68.53  H = 10.06   N = 9.99 
Found:         C = 68.79  H = 9.62   N = 10.05 
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3.14  Synthesis of hydrazides 
 
3.14.1 (S,S)-N-(1-Furan-2-yl-propyl)-N-(2-methoxymethyl-pyrrolidin-1-yl)-benzamide 
(193f) 
 
BzN
N
MeO
O
Me
 
 
Hydrazone 187b (340 mg, 2 mmol) was treated with 2-furyllithium (3.2 equivalents pro mmol) 
according to GP11. After work-up the crude hydrazine was dissolved in dry CH2Cl2 (10 ml pro 
mmol) in presence of a catalytic amount of DMAP and 4 equivalents of dry Et3N and treated 
with 4 equivalents of benzoylchloride according to GP12. Flash chromatography (Et2O:pentane 
1:2.5) gave a mixture of two conformers 193f as a yellow oil (615 mg, 1.8 mmol). 
 
Yield: yellow oil, 615 mg, 90% 
TLC: Rf = 0.33 (Et2O:pentane 1:2.5) 
Diastereomeric excess: de ≥ 96 (1H-NMR) 
Optical rotation: [α] 22 = –42.71 (c = 1.0, CHClD 3). 
1H-NMR: The presence of two amide isomers did not allow an accurate assignment of 1H-NMR.  
 
13C NMR (75 MHz, CDCl3): 
(Signals of major amide isomer are reported): 
δ = 11.50 (CH3CH2), 23.56 (CH2CH2CHN), 23.95 (CH2CHNC=O), 28.03 (CH2CH2CHN), 52.22 
(CH2NNC=O), 59.16 (OCH3), 59.78 (CHNC=O), 60.98 (CHNNC=O), 76.28 (CH2OCH3), 
108.13, 110.61, 126.72, 128.67, 129.40 (arom CH), 138.11 (arom C), 141.71 (arom CH), 153.72 
(arom C), 171.28 (C=O) ppm. 
 
IR (CHCl3):  
ῦ = 2971 (s), 2926 (m), 2875 (s), 1639 (vs), 1386 (s), 1336 (m), 1294 (m), 1156 (m), 1117 (m), 
1096 (s), 1011 (m), 944 (m), 788 (m), 758 (s), 731 (m), 699 (s) cm-1. 
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MS (EI, 70 eV):  
m/z (%) = 342 (1) [M+•], 235 (5), 234 (42), 233 (100), 189 (23), 111 (10), 109 (24), 105 (44), 97 
(7), 81 (12), 80 (5), 77 (9), 71 (12), 45 (12). 
 
Elemental Analysis: 
Anal. Calcd for C20H26N2O3:  C = 70.15  H = 7.65   N = 8.18 
Found:         C = 70.43  H = 7.64   N = 8.31 
 
3.14.2 (S,S)-N-(1-Furan-2-yl-phenyl-propyl)-N-(2-methoxymethyl-pyrrolidin-1-yl)-
benzamide (199b) 
 
BzN
N
MeO
O
Ph
 
 
Hydrazone 187e (492 mg, 2 mmol) was treated with 2-furyllithium (3.2 equivalents pro mmol) 
according to GP11. After work-up the crude hydrazine H1 was dissolved in dry CH2Cl2 (10 ml 
pro mmol) in presence of a catalytic amount of DMAP and 4 equivalents of dry Et3N and treated 
with 4 equivalents of benzoylchloride according to GP12. Flash chromatography (Et2O:pentane 
2:3) gave a mixture of two conformers 199b as a colorless solid (630 mg, 1.5 mmol). 
 
Yield: colorless solid, 630 mg, 75% 
Mp: 63-65°C 
TLC: Rf = 0.36 (Et2O:pentane 2:3) 
Diastereomeric excess: de ≥ 96 (1H-NMR) 
Optical rotation: [α] 22 = –69.84 (c = 1.5, CHClD 3). 
1H-NMR: The presence of two amide isomers did not allow an accurate assignment of 1H-NMR.  
 
13C-NMR (100 MHz, CDCl3): 
(Signals of major amide isomer are reported): 
δ = 23.83 (CH2CH2CHN), 27.47 (CH2CH2CHN), 32.27 (PhCH2), 32.79 (CH2CHNC=O), 52.24 
(CH2NNC=O), 57.51 (CHNC=O), 59.11 (OCH3), 60.88 (CHNNC=O), 76.37 (CH2OCH3), 
  138
Experimental Part 
 
 
108.49, 110.70, 126.27, 126.61, 128.43, 128.67, 129.10, 129.42, 130.78, 134.75 (arom CH), 
137,74, 141.27, (arom C), 141.94 (arom CH), 153.42 (arom C), 171.17 (C=O) ppm. 
 
IR (CHCl3):  
ῦ = 2945 (m), 2875 (m), 1646 (vs), 1450 (m), 1378 (m), 1322 (m), 1212 (m), 1109 (m), 1013 
(m), 737 (s), 701 (s) cm-1. 
 
MS (EI, 70 eV):  
m/z (%) = 418 (1) [M+•], 234 (53), 233 (100), 189 (21), 185 (6), 112 (7), 105 (33), 97 (6), 81 (8), 
77 (10), 71 (8), 57 (5), 45 (12). 
 
Elemental Analysis: 
Anal. Calcd for C26H30N2O3:  C = 74.61  H = 7.22   N = 6.69 
Found:         C = 74.47  H = 7.41   N = 6.62 
 
3.14.3 (S,S)-N-(1-Furan-2-yl-pentyl)-N-(2-methoxymethyl-pyrrolidin-1-yl)-benzamide 
(199a) 
 
BzN
N
MeO
O
Me
 
 
Hydrazone 187f (395 mg, 2 mmol) was treated with 2-furyllithium (3.2 equivalents pro mmol) 
according to GP11. After work-up the crude hydrazine H4 was dissolved in dry CH2Cl2 (10 ml 
pro mmol) in presence of a catalytic amount of DMAP and 4 equivalents of dry Et3N and treated 
with 4 equivalents of benzoylchloride according to GP12. Flash chromatography (Et2O:pentane 
1:2.5) gave a mixture of two conformers 199a as a yellow oil (555 mg, 1.5 mmol). 
 
Yield: yellow oil, 555 mg, 75% 
TLC: Rf = 0.31 (Et2O:pentane 1:2.5) 
Diastereomeric excess: de ≥ 96 (1H-NMR) 
Optical rotation: [α] 22 = –122.52 (c = 1.2, CHClD 3). 
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1H-NMR: The presence of two amide isomers did not allow an accurate assignment of 1H-NMR. 
 
13C-NMR (100 MHz, CDCl3): 
(Signals of major amide isomer are reported): 
δ = 12.94 (CH3CH2), 20.20 (CH3CH2), 22.50 (CH2CH2NN), 26.24 (CH3CH2CH2), 27.30 
(CH2CH2CH2NN), 28.72 (CH3CH2CH2CH2), 50.75 (CH2NNC=O), 56.42 (CHNC=O), 57.71 
(OCH3), 59.56 (CHNNC=O), 74.81 (CH2OCH3), 106.69, 109.52, 125.30, 127.22, 127.99 (arom 
CH), 136.59 (arom C), 140.27 (arom CH), 152.52 (arom C), 169.81 (C=O) ppm. 
 
IR (CHCl3):  
ῦ = 2957 (s), 2929 (s), 2872 (s), 1647 (vs), 1378 (s), 1324 (m), 1146 (m), 1112 (m), 735 (m), 700 
(m). 
 
MS (EI, 70 eV):  
m/z (%) = 235 (6), 234 (50), 233 (100), 189 (28), 137 (15), 112 (9), 105 (42), 97 (7), 81 (23), 77 
(14), 71 (11), 55 (5), 50 (5), 45 (10). 
 
MS (CI, 100eV, Isobutane): 
m/z (%) = 372 (22) [M+•], 371 (100), 258 (7), 235 (8), 234 (5), 233 (5). 
 
Elemental Analysis: 
Anal. Calcd for C22H30N2O3:  C = 71.32  H = 8.16   N = 7.56 
Found:         C = 71.05  H = 7.80   N = 7.91 
 
3.14.4 (S,S)-N-(1-Furan-2-yl-ethyl)-N-(2-methoxymethyl-pyrrolidin-1-yl)-benzamide 
(199f) 
 
BzN
Me
N
MeO
O  
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Hydrazone 187a (624 mg, 4 mmol) was treated with 2-furyllithium (3.2 equivalents pro mmol) 
according to GP11. After work-up the crude hydrazine was dissolved in dry CH2Cl2 (10 ml pro 
mmol) in presence of a catalytic amount of DMAP and 4 equivalents of dry Et3N and treated 
with 4 equivalents of benzoylchloride according to GP12. Flash chromatography (Et2O:pentane 
1:2.5) gave a mixture of two conformers 199f as a colorless solid (400 mg, 1.2 mmol). 
 
Yield: colorless solid, 400 mg, 30% 
Mp: 94-95°C 
TLC: Rf = 0.25 (Et2O:pentane 1:2.5) 
Diastereomeric excess: de ≥ 96 (1H-NMR) 
Optical rotation: [α] 22 = –115.73 (c = 1.5, CHClD 3). 
 
1H-NMR: The presence of two amide isomers did not allow an accurate assignment of 1H-NMR. 
 
13C-NMR (75 MHz, CDCl3): 
(Signals of major amide isomer are reported): 
δ = 15.73 (CH3CHNC=O), 23.10 (CH2CH2CH), 27.59 (CH2CH2CH), 51.51 (CH2N), 53.14 
(CHNC=O), 58.80 (OCH3), 59.54 (CHNNC=O), 76.09 (CH2OCH3), 107.44, 110.39, 126.56, 
128.58, 129.50 (arom CH), 138.02 (arom C), 141.59 (arom CH), 154.62 (arom C), 171.16 
(C=O). 
 
IR (CHCl3):  
ῦ = 3058 (m), 2972 (vs), 2876 (vs), 1645 (vs), 1602 (s), 1579 (m), 1504 (m), 1447 (s), 1381 (vs), 
1316 (vs), 1232 (m), 1196 (s), 1115 (vs), 1059 (m), 1009 (s), 962 (s), 919 (m), 784 (s), 737 (vs), 
701 (vs), 668 (m), 599 (m). 
 
MS (EI, 70 eV):  
m/z (%) = 328 (1) [M+•], 234 (30), 233 (100), 189 (17), 129 (6), 112 (6), 105 (43), 97 (8), 95 
(29), 80 (6), 77 (15), 71 (12), 67 (5), 45 (7). 
 
Elemental Analysis: 
Anal. Calcd for C19H24N2O3:  C = 69.49  H = 7.32   N = 8.53 
Found:         C = 69.78  H = 7.78   N = 8.36 
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HRMS: m/z calcd for C19H24N2O3 (M+): 328.1786. Found: 328.1786. 
 
3.14.5 (1R)-N-(1-Furan-2-yl-ethyl)-N-(2S)-(2-methoxymethyl-pyrrolidin-1-yl)-benzamide 
(199h) 
 
BzN
Me
N
MeO
O  
 
Hydrazone 187i (416 mg, 2 mmol) was treated with 2-methyllithium (3.2 equivalents pro mmol) 
in 20 ml of Et2O at –78°C. After 1h the cooling bath was removed and the temperature allowed 
arising room temperature. After 1h the reaction was quenched by adding a solution of NH4Cl, 
the phases were separated and the aqueous phase extracted three times with Et2O. The organic 
phases were collected, washed with brine and dried over MgSO4. After removing the solvent in 
vacuo the crude hydrazine H3 was dissolved in dry CH2Cl2 (10 ml pro mmol) in presence of a 
catalytic amount of DMAP and 4 equivalents of dry Et3N and treated with 4 equivalents of 
benzoylchloride according to GP12. Flash chromatography (Et2O:pentane 1:2.5) gave a mixture 
of two conformers 199h as a colorless foam (570 mg, 1.74 mmol). 
 
Yield: colorless foam, 570 mg, 1.74% 
TLC: Rf = 0.25 (Et2O:pentane 1:2.5) 
Diastereomeric excess: de ≥ 96 (1H-NMR) 
Optical rotation: [α] 22 = +62.13 (c = 1.2, CHClD 3). 
 
1H-NMR: The presence of two amide isomers did not allow an accurate assignment of 1H-NMR. 
 
13C-NMR (100 MHz, CDCl3): 
(Signals of major amide isomer are reported): 
δ = 17.23 (CH3CHNC=O), 24.54 (CH2CH2CH), 28.60 (CH2CH2CH), 54.42 (CHNC=O), 54.77 
(CH2N), 58.91 (OCH3), 62.09 (CHNNC=O), 75.60 (CH2OCH3), 108.42, 110.93, 126.65, 128.72, 
129.51 (arom CH), 134.75 (arom C), 141.71 (arom CH), 154.66 (arom C), 162.49 (C=O). 
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IR (CHCl3):  
ῦ = 2973 (m), 2874 (m), 1645 (vs), 1383 (s), 1320 (s), 1212 (m), 1147 (m), 1113 (m), 1095 (m), 
1013 (m), 997 (m), 737 (m), 702 (s). 
 
MS (EI, 70 eV):  
m/z (%) = 328 (1) [M+•], 234 (28), 233 (100), 189 (15), 112 (8), 105 (40), 97 (6), 95 (25), 77 
(14), 71 (10), 45 (9). 
 
Elemental Analysis: 
Anal. Calcd for C19H24N2O3:  C = 69.49  H = 7.32   N = 8.53 
Found:         C = 69.29  H = 7.22   N = 8.29 
 
HRMS: m/z calcd for C19H24N2O3 (M+): 328.1786. Found: 328.1785 
 
3.14.6  (1S)-N-(1-Furan-2-yl-2-(2R)-methyl-pentyl)-N-(2S)-(2-methoxymethyl-pyrrolidin-
1-yl)-benzamide (199d) 
 
BzN
N
MeO
O
Me
Me  
 
Hydrazone 188a (425 mg, 2 mmol) was treated with 2-furyllithium (3.2 equivalents pro mmol) 
according to GP11. After work-up the crude hydrazine H5 was dissolved in dry CH2Cl2 (10 ml 
pro mmol) in presence of a catalytic amount of DMAP and 4 equivalents of dry Et3N and treated 
with 4 equivalents of benzoylchloride according to GP12. Flash chromatography (Et2O:pentane 
1:4) gave a mixture of two conformers 199d as a yellow oil (675 mg, 1.76 mmol). 
 
Yield: yellow oil, 675 mg, 88% 
TLC: Rf = 0.29 (Et2O:pentane 1:4) 
Diastereomeric excess: de ≥ 96 (1H-NMR) 
Optical rotation: [α] 22 = –123.40 (c = 1.8, CHClD 3). 
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1H-NMR: The presence of two amide isomers did not allow an accurate assignment of 1H-NMR 
 
13C-NMR (100 MHz, CDCl3): 
(Signals of amide isomers are reported): 
δ = 14.47, 14.62 (CHCH3), 17.17, 17.35 (CH3CH2), 20.17, 20.37 (CH3CH2), 21.96, 24.53 
(CH2CH2NN), 27.90, 28.17 (CH2CH2CH), 33.48, 36.63 (CHCH3), 35.90, 37.33 (CH2CHCH3), 
52.36, 53.03 (CH2N), 59.09, 59.18 (OCH3), 59.70, 62.34 (CHNC=O), 63.29 (CHNNC=O), 
75.09, 76.08 (CH2OCH3), 108.90, 108.97, 110.61, 111.35, 126.72, 127.31, 127.38, 128.61, 
129.04, 129.12 (arom CH), 138.01, 138.10 (arom C), 140.48, 141.83 (arom CH), 153.11, 154.83 
(arom C), 173.31 (C=O) ppm. 
 
IR (CHCl3):  
ῦ = 2959 (s), 2873 (s), 1645 (vs), 1377 (m), 1323 (m), 1309 (m), 1112 (s), 734 (s), 702 (m)  
cm-1. 
 
MS (EI, 70 eV):  
m/z (%) = 235 (5), 234 (43), 233 (100), 189 (22), 151 (15), 111 (8), 105 (37), 97 (6), 95 (7), 80 
(36), 77 (12), 71 (10), 59 (12), 57 (6), 55 (6), 51 (5), 45 (17). 
 
MS (CI):  
m/z (%) = 387 (5) [M+•+1], 386 (24) [M+•], 385 (100), 272 (9), 235 (9), 234 (6), 233 (6), 116 (5). 
 
Elemental Analysis: 
Anal. Calcd for C23H32N2O3:  C = 71.84  H = 8.39   N = 7.29 
Found:         C = 71.93  H = 8.49   N = 7.62 
 
3.14.7  (1R)-N-(1-Furan-2-yl-2-(2S)-methyl-pentyl)-N-(2R)-(2-methoxymethyl-pyrrolidin-
1-yl)-benzamide (199e) 
 
BzN
N
MeO
O
Me
Me  
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Hydrazone 188b (425 mg, 2 mmol) was treated with 2-furyllithium (3.2 equivalents pro mmol) 
according to GP11. After work-up the crude hydrazine was dissolved in dry CH2Cl2 (10 ml pro 
mmol) in presence of a catalytic amount of DMAP and 4 equivalents of dry Et3N and treated 
with 4 equivalents of benzoylchloride according to GP12. Flash chromatography (Et2O:pentane 
1:4) gave a mixture of two conformers 199e as a yellow oil (660 mg, 1.76 mmol). 
 
Yield: yellow oil, 660 mg, 85% 
TLC: Rf = 0.29 (Et2O:pentane 1:4) 
Diastereomeric excess: de ≥ 96 (1H-NMR) 
Optical rotation: [α] 22 = +124.2 (c = 1.0, CHClD 3). 
 
HRMS: m/z calcd for C13H17N2O2 (M+−C10H15O): 233.1290. Found: 233.1291 
 
The rest of the analytical data are in agreement with those previously reported for 199d. 
 
3.14.8 (S,S)-N-(1-furan-2-yl-2,2-dimethyl-propyl)-N-(2-methoxymethyl-pyrrolidin-1-yl)-
benzamide (199c) 
 
BzN
N
MeO
O
Me
Me
Me
 
 
Hydrazone 187b (396 mg, 2 mmol) was treated with 2-furyllithium (3.2 equivalents pro mmol) 
according to GP11. After work-up the crude hydrazine H2 was dissolved in dry CH2Cl2 (10 ml 
pro mmol) in presence of a catalytic amount of DMAP and 4 equivalents of dry Et3N and treated 
with 4 equivalents of benzoylchloride according to GP12. Flash chromatography (Et2O:pentane 
1:4) gave a mixture of two conformers 199c as a yellow oil (530 mg, 1.44 mmol). 
 
Yield: yellow oil, 530 mg, 72% 
TLC: Rf = 0.20 (Et2O:pentane 1:4) 
Diastereomeric excess: de ≥ 96 (1H-NMR) 
Optical rotation: [α] 22 = –37.60 (c = O.9, CHClD 3). 
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1H-NMR: The presence of two amide isomers did not allow an accurate assignment of 1H-NMR. 
 
13C-NMR (100 MHz, CDCl3): 
(Signals of amide isomers are reported): 
δ = 21.82, 24.77 (CH2CH2NN), 27.98, 28.37 (CH2CHN), 28.95, 29.74 (CH3C), 35.70, 36.97 
(CH3C), 52.34, 53.25 (CH2N), 58.82, 59.05 (CHN), 59.23 (OCH3), 63.52, 64.22 (CHCH2O), 
75.14, 76.24 (CH2OCH3), 109.68, 109.98, 110.53, 111.04, 126.63, 126.76, 127.47, 128.49, 
128.58, 128.83, 129.09, 130.28, 130.76, 133.58, 134.74 (arom CH), 140.50, 141.11, 162.51 
(arom C), 170.63 (C=O) ppm. 
 
IR (CHCl3):  
ῦ = 3061 (s), 2960 (vs), 2875 (vs), 1693 (m), 1651 (vs), 1601 (s), 1583 (m), 1498 (m), 1450 (s), 
1395 (m), 1383 (m), 1329 (s), 1213 (vs), 1173 (m), 1159 (m), 1113 (s), 1075 (m), 1039 (s), 1015 
(vs), 995 (s), 781 (s), 735 (s), 705 (vs), 615 (s) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 370 (1) [M+•], 234 (16), 233 (100), 201 (5), 189 (6), 163 (8), 149 (17), 138 (6), 137 
(53), 131 (5), 119 (5), 113 (6), 112 (19), 111 (7), 109 (7), 106 (7), 105 (81), 98 (5), 97 (16), 96 
(5), 95 (16), 91 (6), 85 (9), 84 (6), 83 (10), 82 (8), 81 (14), 80 (13), 79 (5), 77 (26), 74 (28), 73 
(10), 71 (25), 70 (14), 69 (19), 68 (5), 67 (8), 59 (36), 57 (27), 56 (8), 55 (17), 51 (14), 46 (6), 45 
(52). 
 
Elemental Analysis: 
Anal. Calcd for C22H30N2O3:  C = 71.32  H = 8.16   N = 7.56 
Found:         C = 71.46  H = 7.94   N = 7.99 
 
3.14.9 (S,S)-N-[5-(tert-Butyl-dimethyl-silanyoxy)-1-furan-2-yl-butyl]-N-(2-methoxy 
methyl--pyrrolidin-1-yl)-benzamide (199g) 
 
BzN
N
MeO
OOTBDMS  
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Hydrazone 187n (1.256 g, 4 mmol) was treated with 2-furyllithium (3.2 equivalents pro mmol) 
according to GP11. After work-up the crude hydrazine was dissolved in dry CH2Cl2 (10 ml pro 
mmol) in presence of a catalytic amount of DMAP and 4 equivalents of dry Et3N and treated 
with 4 equivalents of benzoylchloride according to GP12. Flash chromatography (Et2O:pentane 
1:2) gave a mixture of two conformers 199g as a yellow oil (880 mg, 1.8 mmol). 
 
Yield: yellow oil, 880 mg, 45% 
TLC: Rf = 0.35 (Et2O:pentane 1:2) 
Diastereomeric excess: de = 90% (1H-NMR) 
Optical rotation: [α] 22 = –174.16 (c = 1.0, CHClD 3). 
 
1H-NMR: The presence of two amide isomers did not allow an accurate assignment of 1H-NMR. 
 
13C-NMR (100 MHz, CDCl3): 
(Signals of major amide isomer are reported): 
δ = 4.91 (CH3Si), 18.67 (CSi), 23.86 (CH2CH2NN), 26.29 (CH3CSi), 27.05 (CH2CHCH2O), 
28.06 (CH2CH2OSi), 29.92 (CH2CHNC=O), 52.16 (CH2NNC=O), 57.86 (CHNC=O), 59.14 
(OCH3), 60.86 (CHCH2OCH3), 62.79 (CH2OSi), 76.32 (CH2OCH3), 108.27, 110.61, 126.73, 
128.70, 129.49 (arom CH), 138.03 (arom C), 141.74 (arom CH), 153.69 (arom C), 166.59 (C=O) 
ppm. 
 
IR (CHCl3):  
ῦ = 2959 (s), 2878 (m), 1718 (vs), 1645 (vs), 1602 (m), 1450 (m), 1382 (m), 1317 (m), 1275 
(vs), 1115 (s), 754 (s), 713 (s) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 234 (43), 233 (100), 189 (24), 121 (25), 112 (8), 105 (55), 77 (20), 71 (9), 55 (5), 45 
(5). 
 
Elemental Analysis: 
Anal. Calcd for C27H42N2O4Si:  C = 66.63  H = 8.70   N = 5.76. 
Found:          C = 66.89  H = 8.52   N = 5.70. 
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3.14.10  (S,S)-N-(2-Methoxymethyl-pirrolidin-1-yl)-N-[1-(1-methyl-1H-indol-2-yl)-propyl]-
benzamide (193 c) 
 
BzN
N
MeO
N
Me
Me
 
 
To a solution of N-methylindole (920 mg, 7 mmol) in 20 ml of THF were added 6.4 mmol of 
BuLi at room temperature. The obtained mixture was warmed to 50-60°C for 1 h and then 
cooled at –78°C. A solution of 2 mmol (340 mg) of hydrazone 187b in two ml of THF was 
added dropwise to the reaction and the temperature was allowed to arise room temperature 
overnight. The reaction was quenched by adding 10 ml of a saturated solution of NH4Cl, the 
phases were separated and the aqueous phase extracted three times with Et2O. The organic 
phases were collected, washed with brine and dried over MgSO4. After removing the solvent in 
vacuo the crude hydrazine was dissolved in dry CH2Cl2 (10 ml pro mmol) in presence of a 
catalytic amount of DMAP and 4 equivalents of dry Et3N and treated with 4 equivalents of 
benzoylchloride according to GP12. Flash chromatography (Et2O:pentane 1:1) gave a mixture of 
two conformers 193c as a colorless foam (525 mg, 1.3 mmol). 
 
Yield: colorless foam, 525 mg, 65% 
TLC: Rf = 0.45(Et2O:pentane 1:1) 
Diastereomeric excess: de = 94% (1H-NMR) 
Optical rotation: [α] 22 = –165.00 (c = 1.0, CHClD 3). 
 
1H-NMR: The presence of two amide isomers did not allow an accurate assignment of 1H-NMR. 
 
13C-NMR (100 MHz, CDCl3): 
(Signals of major amide isomer are reported): 
δ = 11.78, 12.47 (CH3CH2), 22.21, 23.25 (CH2CH2NN), 26.87, 27.45 (CH2CH2CH), 28.00, 
29.08 (CH3CH2), 30.17, 30.33 (NCH3), 52.39, 53.58, (CH2N), 52.74 (CHNC=O), 58.68, 58.75 
(CHCH2O), 59.10, 59.70 (OCH3), 75.92, 76.59 (CH2OCH3), 102.80, 103.19, 109.38, 109.74, 
119.65, 119.79, 120.71, 120.85, 121.78, 122.06, 127.15, 127.34 (arom CH), 127.55 (arom C), 
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127.72, 128.88, 129.31, 130.46 (arom CH), 137.08, 137.40, 137.51, 137.74 (arom C), 170.42, 
174.23 (C=O) ppm. 
 
IR (CHCl3):  
ῦ = 3056 (m), 2969 (vs), 2876 (vs), 1637 (vs), 1467 (vs), 1382 (s), 1341 (s), 1316 (s), 1288 (s), 
1106 (s), 912 (s), 786 (s), 732 (vs), 703 (s) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 405 (0.3) [M+•], 173 (15), 172 (100), 157 (8), 105 (5). 
 
Elemental Analysis: 
Anal. Calcd for C25H31N3O2:  C = 74.04  H = 7.70   N = 10.36 
Found:         C = 74.52  H = 7.29   N = 10.19 
 
3.14.11 (S,S)-N-(2-Methoxymethyl-pyrrolidin-1-yl)-N-[1-(1-methyl-1H-imidazol-2-yl)-
propyl]-benzamide (193d) 
 
BzN
N
MeO
N
NMe
Me  
n-BuLi (6.4 mmol) was added in one portion to a solution of 1-methylimidazole (550 mg 7 
mmol) in 20 ml of THF and cooled at –78°C. The cooling bath was removed and the temperature 
was allowed to arise room temperature. After 20 min. the light yellow solution was recooled at –
78°C and a solution of 2 mmol (340 mg) of hydrazone 187b in two ml of THF was added 
dropwise to the reaction. and the obtained mixture was stirred overnight. The reaction was 
quenched by adding 10 ml of a saturated solution of NH4Cl, the phases were separated and the 
aqueous phase extracted three times with Et2O. The organic phases were collected, washed with 
brine and dried over MgSO4. After removing the solvent in vacuo the crude hydrazine was 
dissolved in dry CH2Cl2 (10 ml pro mmol) in presence of a catalytic amount of DMAP and 4 
equivalents of dry Et3N and treated with 4 equivalents of benzoylchloride according to GP12. 
Flash chromatography (Et2O) gave a mixture of two conformers 193d as a colorless solid (640 
mg, 1.8 mmol). 
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Yield: colorless solid, 640 mg, 90% 
Mp: 73-74°C 
TLC: Rf = 0.20 (Et2O) 
Diastereomeric excess: de ≥ 96 (1H-NMR) 
Optical rotation: [α] 22 = –78.57 (c = 1.1, CHClD 3). 
 
1H-NMR: The presence of two amide isomers did not allow an accurate assignment of 1H-NMR. 
 
13C-NMR (100 MHz, CDCl3): 
(Signals of amide isomers are reported): 
δ = 11.21, 11.76 (CH3CH2), 21.58, 22.98 (CH2CH2N), 25.30, 27.11 (CH2CHNNC=O), 27.69, 
27.93 (CH2CHNC=O), 32.75, 32.89 (NCH3), 50. 91 (CHNC=O), 51.33, 52.93 (CH2N), 58.59, 
58.65 (OCH3), 58.88, 59.45 (CHCH2O), 76.35 (CH2OCH3), 127.08, 127.16, 127.61, 127.83, 
127.89, 128.78, 129.26, 130.42 (arom CH), 137.37, 137.47, 144.56 (arom C), 173.63 (C=O). 
 
IR (CHCl3):  
ῦ = 2969 (s), 2875 (s), 1635 (vs), 1492 (m), 1451 (m), 1387 (s), 1325 (m), 1284 (m), 1105 (s), 
917 (s), 731 (vs). 
 
MS (EI, 70 eV):  
m/z (%) = 243 (24), 242 (9), 233 (18), 215 (5), 214 (8), 138 (21), 124 (8), 123 (100), 105 (32), 77 
(11), 71 (5), 51 (5), 45 (13). 
 
MS (CI, 100eV, Isobutane): 
m/z (%) =  358 (24) [M+•+2], 357 (100) [M+•+1], 356 (1), 244 (5), 243 (6). 
 
Elemental Analysis: 
Anal. Calcd for C20H28N4O2:  C = 67.39  H = 7.92   N = 15.72 
Found:         C = 67.51  H = 7.53   N = 15.59 
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3.14.12  (S,S)-N-(2-Methoxymethyl-pyrrolidin-1-yl)-N-[1-(1-methyl-1H-benzoimidazol-2-
yl)-propyl-benzamide (193e) 
 
BzN
N
MeO
N
NMe
Me
 
 
n-BuLi (6.4 mmol) was added in one portion to a solution of 1-methylbenzoimidazole (930 mg) 
in 20 ml of THF and cooled at –78°C. The cooling bath was removed and the temperature was 
allowed to rise to –20°C. After 20 min. the green dark solution was recooled at –78°C and a 
solution of 2 mmol (340 mg) of hydrazone 187b in two ml of THF was added dropwise. The 
obtained mixture was stirred for an additional hour at –78°C after which the cooling bath was 
removed and the solution was allowed to arise to 0°C. After 5 h at 0°C the reaction was 
quenched by adding 10 ml of a saturated solution of NH4Cl, the phases were separated and the 
aqueous phase extracted three times with Et2O. The organic phases were collected, washed with 
brine and dried over MgSO4. After removing the solvent in vacuo the crude hydrazine was 
dissolved in dry CH2Cl2 (10 ml pro mmol) in presence of a catalytic amount of DMAP and 4 
equivalents of dry Et3N and treated with 4 equivalents of benzoylchloride according to GP12. 
Flash chromatography (Et2O:pentane 3:1) gave a mixture of two conformers 193e as a colorless 
solid (690 mg, 1.7 mmol). 
 
Yield: colorless solid, 690 mg, 85% 
Mp: 46-48°C 
TLC: Rf = 0.30 (Et2O:pentane 3:1) 
Diastereomeric excess: de = 94% (1H-NMR) 
Optical rotation: [α] 22 = –109.22 (c = 0.9, CHClD 3). 
 
1H-NMR: The presence of two amide isomers did not allow an accurate assignment of 1H-NMR. 
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13C-NMR (100 MHz, CDCl3): 
(Signals of amide isomers are reported): 
δ = 11.09, 11.65 (CH3CH2), 21.58, 22.74 (CH2CH2N), 25.08, 26.73 (CH2CHNNC=O), 27.59, 
27.64 (CH2CHNC=O), 29.90, 29.96 (NCH3), 50.53 (CHNC=O), 51.71, 53.05 (CH2N), 58.34, 
58.70 (OCH3), 59.58 (CHCH2O), 76.02, 76.38 (CH2OCH3), 109.20, 109.74, 119.70, 120.06, 
122.20, 122.90, 123.05, 127.07, 127.76, 128.19, 128.74, 129.26, 129.85, 130.45, 132.47 (arom 
CH), 135.55, 137.05, 142.09, 150.96, 151.42 (arom C), 168.55, 173.68 (C=O) ppm. 
 
IR (KBr):  
ῦ = 2968 (s), 2875 (s), 1705 (m), 1639 (vs), 1466 (s), 1384 (s), 1329 (m), 1285 (m), 1239 (m), 
1103 (s), 744 (s) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 377 (7), 361 (5), 294 (15), 293 (74), 292 (16), 278 (8), 265 (17), 264 (29), 233 (46), 
212 (5), 189 (5), 188 (67), 174 (14), 173 (100), 169 (8), 160 (6), 159 (11), 158 (5), 157 (9), 146 
(5), 145 (21), 133 (6), 132 (8), 131 (7), 114 (6), 112 (10), 105 (78), 97 (7), 80 (6), 77 (27), 71 
(5), 45 (8). 
 
MS (CI, 100 eV, isobutane): 
m/z (%) =  408 (28) [M+•+2], 407 (100) [M+•+1], 406 (2) [M+•], 294 (11), 293 (16), 233 (6), 203 
(5), 175 (21), 173 (12), 116 (8), 114 (13), 84 (8). 
 
Elemental Analysis: 
Anal. Calcd for C24H30N4O2:  C = 70.91  H = 7.44   N = 13.78 
Found:         C = 70.98  H = 7.56   N = 13.69 
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3.14.13 (S,S)-N-(1-Benzofuran-2-yl-propyl)-N-(2-methoxymethyl-pyrrolidin-1-yl)-
benzamide (193g) 
 
BzN
N
MeO
O
Me
 
Benzofuran (830 mg, 7 mmol) was dissolved in ether (20 ml) and cooled to 0 ºC. n-Butyllithium 
(1.6 M, 4 ml, 6.4 mmol) was added dropwise to the solution over 5 min. The cooling bath was 
removed and the solution was warmed up to room temperature. The mixture was stirred for 
additional 50 minutes and then cooled to –78 ºC. Hydrazone 187b (340 mg, 2 mmol) in 4 ml of 
Et2O was slowly added to the solution and after 20 minutes the cooling bath was removed. The 
mixture was stirred for two hours and then quenched with 5 ml of saturated aqueous NH4Cl. 
After separation of the layers, three extractions with Et2O were carried out. The combined 
organic solutions were dried over MgSO4, and the solvent was removed under reduced pressure. 
The crude hydrazine was dissolved in dry CH2Cl2 (10 ml pro mmol) in presence of a catalytic 
amount of DMAP and 4 equivalents of dry Et3N and treated with 4 equivalents of 
benzoylchloride according to GP12. Flash chromatography (Et2O:pentane 1:2) gave a mixture of 
two conformers 193g as a colorless solid (635 mg, 1.62 mmol). 
 
Yield: colorless solid, 635 mg, 81% 
Mp: 46-48°C 
TLC: Rf = 0.22 (Et2O:pentane 1:2) 
Diastereomeric excess: de ≥ 96 (1H-NMR) 
Optical rotation: [α] 22 = –119.28 (c = 0.14 CHClD 3). 
 
1H-NMR: The presence of two amide isomers did not allow an accurate assignment of 1H-NMR. 
 
13C-NMR (100 MHz, CDCl3): 
(Signals of the major amide isomer are reported): 
δ = 11.56 (CH3CH2), 23.44 (CH2CH2N), 24.04 (CH2CHNC=O), 28.08 (CH2CHNNC=O), 52.61 
(CH2N), 59.20 (OCH3), 60.10 (CHNC=O), 61.37 (CHCH2O), 76.27 (CH2OCH3), 105.08, 
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111.44, 121.15, 122.96, 124.46, 126.81 (arom CH), 128.39 (arom C), 129.56 (arom CH), 138.02, 
154.56, 156.59 (arom C), 171.48 (C=O) ppm. 
 
IR (CHCl3):  
ῦ = 2970 (s), 2878 (m), 1642 (vs), 1453 (s), 1381 (m), 1327 (m), 1255 (m), 1107 (m), 754 (vs), 
702 (m) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 392 (0.6) [M+•], 234 (33), 233 (100), 189 (11), 160 (5), 159 (44), 144 (7), 131 (16), 
112 (9), 105 (40), 97 (6), 80 (5), 77 (14), 71 (10), 45 (10). 
 
Elemental Analysis: 
Anal. Calcd for C24H28N2O3:  C = 73.44  H = 7.19   N = 7.14 
Found:         C = 73.27  H = 7.33   N = 6.90 
 
3.14.14  (S,S)-N-(2-Methoxymethyl-pyrrolidin-1-yl)-N-(1-pyridin-2yl-propyl)-benzamide 
(193a) 
 
BzN
N
MeO
Me
N  
 
2-Bromopyridine (2.50 g, 16 mmol) was dissolved in ether (40ml) and cooled to –100ºC. tert-
Butyllithium (1.6 M, 10 ml, 16 mmol) was added dropwise to the solution over 5 min and the 
temperature was slowly allowed to rise –78°C. The mixture was then cooled to –100 ºC and 
hydrazone 187b (340 mg, 2 mmol) in 4 ml of Et2O was slowly added to the solution. The 
reaction was stirred for additional 5 h at –78°C and then quenched with 5 ml of saturated 
aqueous NH4Cl. After separation of the layers, three extractions with Et2O were carried out. The 
combined organic solutions were dried over MgSO4, and the solvent was removed under reduced 
pressure. The crude hydrazine was dissolved in dry CH2Cl2 (10 ml pro mmol) in presence of a 
catalytic amount of DMAP and 4 equivalents of dry Et3N and treated with 4 equivalents of 
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benzoylchloride according to GP12. Flash chromatography (Et2O:pentane 3:2) gave a mixture of 
two conformers 193a as a yellow liquid (495 mg, 1.40 mmol). 
 
Yield: yellow liquid, 495 mg, 70% 
TLC: Rf = 0.24 (Et2O:pentane 3:2) 
Diastereomeric excess: de ≥ 96 (1H-NMR) 
Optical rotation: [α] 22 = –65.66 (c = 1.5, CHClD 3). 
 
1H-NMR: The presence of two amide isomers did not allow an accurate assignment of 1H-NMR. 
 
13C-NMR (100 MHz, CDCl3): 
(Signals of amide isomers are reported): 
δ = 11.41, 12.51 (CH3CH2), 21.62, 23.83 (CH2CH2N), 24.07, 27.15 (CH2CHNC=O), 27.54, 
28.15 (CH2CHNNC=O), 52.58, 53.14 (CH2N), 59.17 (OCH3), 59.50, 60.96 (CHCH2O), 65.47, 
66.67 (CHNC=O), 75.30, 76.21 (CH2OCH3), 122.59, 122.82, 123.53, 127.05, 127.37, 128.50, 
128.60, 129.12, 129.50, 130.16, 133.16, 136.51, 137.39 (arom CH), 138.15 (arom C), 148.28, 
149.10 (arom CH), 159.00, 161.18 (arom C), 171.43, 173.93 (C=O) ppm. 
 
IR (CHCl3):  
ῦ = 2971 (s), 2877 (s), 1639 (vs), 1597 (s), 1448 (m), 1386 (m), 1331 (m), 1276 (m), 1113 (m), 
755 (vs), 714 (s) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 309 (9), 308 (43), 248 (16), 241 (11), 240 (26), 239 (9), 234 (9), 233 (54), 212 (17), 
211 (43), 189 (25), 147 (6), 137 (5), 135 (17), 131 (5), 122 (7), 119 (7), 118 (6), 114 (60), 113 
(5), 112 (18), 107 (6), 106 (21), 105 (100), 97 (8), 92 (10), 83 (5), 82 (5), 78 (11), 77 (40), 71 
(20), 70 (10), 69 (8), 68 (8), 61 (5), 59 (8), 55 (8), 51 (27), 45 (48). 
 
MS (CI, 100eV, isobutane):  
m/z (%) = 355 (24) [M+•+2], 354 (100) [M+•+1]. 
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Elemental Analysis: 
Anal. Calcd for C21H27N3O2:  C = 71.36  H = 7.70   N = 11.89 
Found:         C = 70.92  H = 7.32   N = 11.56 
 
3.14.15 (S,S)-N-(2-Methoxymethyl-pyrrolidin-1-yl)-N-(1-pyridin.3.yl.propyl)-benzamide 
(193b) 
 
BzN
N
MeO
Me
N  
 
3-Bromopyridine (1.57 g, 10 mmol) was dissolved in ether (40ml) and cooled to –100ºC. tert-
Butyllithium (1.6 M, 6 ml, 9.6 mmol) was added dropwise to the solution over 5 min and the 
temperature was slowly allowed to rise –78°C. Hydrazone 187b (340 mg, 2 mmol) in 4 ml of 
Et2O was slowly added to the solution and the obtained mixture was stirred overnight. The 
reaction was then quenched by adding 5 ml of saturated solution of NH4Cl. After separation of 
the layers, three extractions with Et2O were carried out. The combined organic solutions were 
dried over MgSO4, and the solvent was removed under reduced pressure. The crude hydrazine 
was dissolved in dry CH2Cl2 (10 ml pro mmol) in presence of a catalytic amount of DMAP and 4 
equivalents of dry Et3N and treated with 4 equivalents of benzoylchloride according to GP12. 
Flash chromatography (Et2O) gave a mixture of two conformers 193b as a yellow liquid (540 
mg, 1.52 mmol). 
 
Yield: yellow liquid, 540 mg, 76% 
TLC: Rf = 0.32 (Et2O) 
Diastereomeric excess: de ≥ 96 (1H-NMR) 
Optical rotation: [α] 22 = –108.75 (c = 0.30 CHClD 3). 
 
1H-NMR: The presence of two amide isomers did not allow an accurate assignment of 1H-NMR. 
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13C-NMR (100 MHz, CDCl3): 
(Signals of the major amide isomer are reported): 
δ = 11.42 (CH3CH2), 23.74 (CH2CH2N), 25.19 (CH2CHNC=O), 28.15 (CH2CHNNC=O), 53.94 
(CH2N), 59.17 (OCH3), 61.05 (CHCH2O), 63.52 (CHNC=O), 76.03 (CH2OCH3), 123.59, 
126.24, 127.32, 128.97, 129.71 (arom CH), 134.89 (arom C), 136.71 (arom CH), 138.01 (arom 
C) 149.10, 150.33 (arom CH), 173.74 (C=O) ppm. 
 
IR (CHCl3):  
ῦ = 2971 (s), 2877 (m), 1640 (s), 1597 (s), 1383 (m), 1112 (m), 755 (vs), 712 (m) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 353 (1) [M+•], 308 (16), 248 (19), 234 (16), 233 (100), 189 (25), 120 (10), 114 (17), 
112 (10), 106 (7), 105 (59), 97 (9), 92 (15), 80 (6), 77 (22), 71 (14), 70 (6), 51 (6), 45 (18). 
 
Elemental Analysis: 
Anal. Calcd for C21H27N3O2:  C = 71.36  H = 7.70   N = 11.89 
Found:         C = 71.05  H = 7.41   N = 11.60 
 
3.15  Synthesis of benzoyl protected amines 
 
3.15.1 (S)-N-(1-Furan-2-yl-propyl)-benzamide (194f) 
 
N
H
Me
O
O
Ph
 
A solution of hydrazide 193f (342 mg, 1 mmol) in 10 ml of THF was treated with two 
equivalents of SmI2 (0.1M in THF) and an equimolar amount of DMPU according to GP13. 
After work-up and flash chromatography (Et2O:pentane 1:2) 194f was obtained as a colorless 
solid (190 mg, 0.83 mmol). 
 
Yield: colorless solid, 190 mg, 83% 
Mp: 86-88°C 
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TLC: Rf = 0.31 (Et2O:pentane 1:2) 
Enantiomeric excess: ee ≥ 99 (HPLC) 
Optical rotation: [α] 22 = –62.36 (c = 1.1, CHClD 3). 
 
1H-NMR (400 MHz, CDCl3): 
δ = 0.86 (t, 3H, J = 7.4 Hz, CH3CH2), 1.77-1.94 (m, 2H, CH3CH2), 5.12-5.18 (m, 1H, CHNH), 
6.14 (d, 1H, J = 3.0 Hz, CHCO), 6.23 (dd, 1H, J = 1.6, 3.0 Hz, CHCHO), 6.44-6.48 (br, 1H, 
NH), 7.25-7.26 (m, 1H, arom CH), 7.29-7.33 (m, 2H, arom CH), 7.37-7.41 (m, 1H, arom CH), 
7.68-7.71 (m, 2H, arom CH) ppm. 
 
13C-NMR (100 MHz, CDCl3): 
δ = 10.84 (CH3CH2), 27.56 (CH3CH2), 49.37 (CHN), 106.79, 110.42 , 127.22, 128.73, 131.69 
(arom CH), 134.64 (arom C), 142.03 (arom CH), 154.38 (arom C), 166.87 (C=O) ppm. 
 
IR (CHCl3):  
ῦ = 3291 (s), 2968 (m), 1635 (vs), 1534 (s), 1339 (m), 1301 (m), 1153 (m), 1011 (m), 803 (m), 
697 (s) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 230 (5) [M+•+1], 229 (31) [M+•], 200 (34), 106 (8), 105 (42), 77 (27). 
 
Elemental Analysis: 
Anal. Calcd for C14H15NO2:  C = 73.34  H = 6.59   N = 6.11 
Found:         C = 73.11  H = 6.79   N = 6.03 
 
3.15.2   (S)-N-(1-Furan-2-yl-3-phenyl-propyl)-benzamide (200b) 
 
N
H
O
O
Ph
Ph
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A solution of hydrazide 199b (420 mg, 1 mmol) in 10 ml of THF was treated with two 
equivalents of SmI2 (0.1M in THF) and an equimolar amount of DMPU according to GP13. 
After work-up and flash chromatography (Et2O:pentane 1:2) 200b was obtained as a colorless 
solid (245 mg, 0.80 mmol). 
 
Yield: colorless solid, 245 mg, 80% 
Mp: 120-121°C 
TLC: Rf = 0.35 (Et2O:pentane 1:2) 
Enantiomeric excess:  ee = 96% (HPLC) 
Optical rotation: [α] 22 = –34.80 (c = 1.2, CHClD 3). 
 
1H-NMR (400 MHz, CDCl3): 
δ = 2.12-2.20 (m, 2H, CH2CHN), 2.50-2.63 (m, 2H, PhCH2), 5.24-5.31 (m, 1H, CHNH), 6.12 (d, 
1H, J = 3.3 Hz, CHCHCO), 6.21 (dd, 1H, J = 1.9, 3.3 Hz, CHCHO), 6.60-6.63 (br, 1H, NH), 
7.05-7.08 (m, 3H, arom CH), 7.14-7.17 (m, 2H, arom CH), 7.22-7.28 (m, 3H, arom CH), 7.33-
7.37 (m, 1H, arom CH), 7.61-7.63 (m, 2H, arom CH) ppm. 
 
13C-NMR (100 MHz, CDCl3): 
δ = 32.68 (PhCH2CH2), 35.88 (CH2CH2), 47.88 (CHN), 106.86, 110.51, 126.24, 127.29, 128.62, 
128.69, 128.71, 131.72 (arom CH), 134.52, 141.50 (arom C), 142.13 (arom CH), 154.31 (arom 
C), 166.88 (C=O) ppm. 
 
IR (KBr):  
ῦ = 3309 (s), 1631 (vs), 1577 (m), 1523 (vs), 1488 (s), 1341 (m), 1283 (m), 744 (s), 697 (s) cm−1. 
MS (EI, 70 eV):  
m/z (%) = 306 (8) [M+•+1], 305 (37) [M+•], 214 (18), 201 (12), 200 (16), 184 (5), 105 (100), 91 
(8), 77 (24). 
 
Elemental Analysis: 
 
Anal. Calcd for C20H19NO2:  C = 78.66  H = 6.27   N = 4.58 
Found:         C = 78.56  H = 6.11   N = 4.50 
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3.15.3 (S)-N-(1-Furan-2-yl-2,2-dimethyl-propyl)-benzamide (200c) 
 
N
H
Me
O
O
Ph
Me
Me
 
 
A solution of hydrazide 199c (370 mg, 1 mmol) in (5 ml) THF was treated with two equivalents 
of SmI2 (0.1M in THF) and an equimolar amount of DMPU according to GP13. After work-up 
and flash chromatography (Et2O:pentane 1:3) 200c was obtained as a colorless solid (195 mg, 
0.76 mmol). 
 
Yield: colorless solid, 195 mg, 76% 
Mp: 87-89°C 
TLC: Rf = 0.34 (Et2O:pentane 1:3) 
Enantiomeric excess: ee = 98% (HPLC) 
Optical rotation: [α] 22 = –43.07 (c = 1.3, CHClD 3). 
 
1H-NMR (400 MHz, CDCl3): 
δ = 0.92 (s, 9H, CH3C), 5.08 (d, J = 9.9 Hz, 1H, CHN), 6.10 (d, 1H, J = 3.3 Hz, CHCHCO), 6.21 
(dd, 1H, J = 1.9, 3.3 Hz, CHCHO), 6.62-6.64 (br, 1H, NH), 7.23-7.24 (m, 1H, arom CH), 7.29-
7.33 (m, 2H, arom CH), 7.35-7.40 (m, 1H, arom CH), 7.67-7.70 (m, 2H, arom CH) ppm. 
 
13C-NMR (100 MHz, CDCl3): 
δ = 27.07 (CH3C), 36.27 (CH3C), 56.04 (CHN), 107.80, 110.28, 127.19, 128.78, 131.69 (arom 
CH), 134.90 (arom C), 141.61 (arom CH), 153.28 (arom C), 166.86 (C=O) ppm. 
 
IR (KBr):  
ῦ = 3325 (s), 2966 (s), 1638 (vs), 1603 (m), 1578 (m), 1544 (vs), 1503 (s), 1448 (m), 1473 (m), 
1334 (m), 1148 (m), 1010 (m), 725 (s), 691 (s), 658 (m) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 257 (8) [M+•], 201 (22), 200 (87), 106 (7), 105 (100), 77 (22), 50 (5). 
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Elemental Analysis: 
Anal. Calcd for C16H19NO2:  C = 74.68  H = 7.44   N = 5.44 
Found:         C = 74.54  H = 7.67   N = 5.42 
 
3.15.4 (S)-N-(1-Furan-2-yl-pentyl)-benzamide (200a) 
 
N
H
O
O
Ph
Me
 
 
A solution of hydrazide 199a (370 mg, 1 mmol) in 10 ml of THF was treated with two 
equivalents of SmI2 (0.1M in THF) and an equimolar amount of DMPU according to GP13. 
After work-up and flash chromatography (Et2O:pentane 2:3) 200a was obtained as a colorless 
solid (215 mg, 0.84 mmol). 
 
Yield: colorless solid, 215 mg, 84% 
Mp: 95-96°C 
TLC: Rf = 0.36 (Et2O:pentane 2:3) 
Enantiomeric excess: ee = 96% (HPLC) 
Optical rotation: [α] 22 = –60.00 (c = 1.2, CHClD 3). 
 
1H-NMR (400 MHz, CDCl3): 
δ = 0.81 (t, 3H, J = 7.0 Hz, CH3CH2), 1.21-1.31 (m, 4H, CH3CH2CH2), 1.81-1.89 (CH2CHN), 
5.20-5.27 (m, 1H, CHN), 6.10 (dt, 1H, J = 0.8, 3.0 Hz, CHCHCO), 6.21 (dd, 1H, J = 1.6, 3.0 Hz, 
CHCHO), 6.40-6.44 (br, 1H, NH), 7.27 (dd, 1H, J = 0.8,1.6 Hz, arom CH), 7.31-7.36 (m, 2H, 
arom CH), 7.39-7.43 (m, 1H, arom CH), 7.69-7.71 (m, 2H, arom CH) ppm. 
 
13C-NMR (100 MHz, CDCl3): 
δ = 14.33 (CH3CH2), 22.74 (CH3CH2), 28.44 (CH3CH2CH2), 34.16 (CH2CHN), 47.96 (CHN), 
106.55, 110.41, 127.20, 128.72, 131.69 (arom CH), 134.64 (arom C), 141.97 (arom CH), 154.63 
(arom C), 166.74 (C=O) ppm. 
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IR (KBr):  
ῦ = 3297 (s), 2954 (m), 2932 (m), 2856 (m), 1635 (vs), 1579 (s), 1537 (vs), 1465 (s), 1382 (m), 
1340 (s), 1308 (s), 1222 (m), 1183 (m), 1151 (m), 1077 (m), 1008 (m), 802 (m), 731 (s), 696 (s) 
cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 257 (7) [M+•], 200 (14), 106 (8), 105 (100), 77 (28). 
 
Elemental Analysis: 
Anal. Calcd for C16H19NO2:  C = 74.68  H = 7.44   N = 5.44 
Found:         C = 74.41  H = 7.42   N = 5.42 
 
3.15.5 (1S,2R)-N-(1-Furan-2-yl-2-methyl-pentyl)-benzamide (200d) 
 
N
H
O
O
Ph
Me
Me  
 
A solution of hydrazide 199d (384 mg, 1.0 mmol) in 10 ml of THF was treated with two 
equivalents of SmI2 (0.1M in THF) and an equimolar amount of DMPU according to GP13. 
After work-up and flash chromatography (Et2O:pentane 1:4) 200d was obtained as a colorless 
solid (217 mg, 0.80 mmol). 
 
Yield: colorless solid, 217 mg, 80% 
Mp: 95-96°C 
TLC: Rf = 0.25 (Et2O:pentane 1:4) 
Diastereomeric excess: de ≥ 96% (1H-NMR) 
Enantiomeric excess: ee = 99% (HPLC) 
Optical rotation: [α] 22 = –45.27 (c = 1.0, CHClD 3). 
 
 
 
  162
Experimental Part 
 
 
1H-NMR (400 MHz, CDCl3): 
δ = 0.79 (t, 3H, J = 6.9 Hz, CH3CH2), 0.90 (d, 2H, J = 6.9 Hz, CH3CH), 1.00-1.35 (m, 4H, 
CH3CH2CH2), 2.01-2.08 (m, 1H, CHCH3), 5.23 (dd, 1H, J = 6.7, 9.4 Hz, CHN), 6.12 (dt, 1H, J = 
0.7, 3.2 Hz, CHCHCO), 6.23 (dd, 1H, J = 1.7, 3.2 Hz, CHCHO), 6.39 (d, 1H, J = 9.4 Hz, NH), 
7.26 (dd, 1H, J = 0.7, 1.7 Hz, arom CH), 7.32-7.44 (m, 3H, arom CH), 7.69-7.72 (m, 2H, arom 
CH) ppm. 
 
13C-NMR (100 MHz, CDCl3): 
δ = 14.62 (CH3CH2), 16.03 (CH3CH), 20.59 (CH3CH2), 35.89 (CH3CH2CH2), 37.25 (CHCH3), 
52.34 (CHN), 106.93, 110.02, 127.17, 128.81, 131.74 (arom CH), 134.80 (arom C), 141.80 
(arom CH), 154.06 (arom C), 166.88 (C=O) ppm. 
 
IR (KBr):  
ῦ = 3350 (s), 2957 (s), 2930 (s), 2871 (m), 1634 (vs), 1579 (m), 1524 (vs), 1487 (s), 1463 (m), 
1329 (m), 1289 (m), 1148 (m), 1013 (m), 805 (m), 736 (s), 716 (m), 691 (m) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 271 (11) [M+•], 233 (10), 201 (10), 200 (77), 106 (7), 105 (100), 77 (23). 
 
Elemental Analysis: 
Anal. Calcd for C17H21NO2:  C = 75.25  H = 7.80   N = 5.16 
Found:         C = 75.00  H = 7.99   N = 5.07 
 
3.15.6 (1R,2S)-N-(1-Furan-2-yl-2-methyl-pentyl)-benzamide (200e) 
 
N
H
O
O
Ph
Me
Me  
 
A solution of Hydrazide 199e (384 mg, 1 mmol) in 10 ml of THF was treated with two 
equivalents of SmI2 (0.1M in THF) and an equimolar amount of DMPU according to GP13. 
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After work-up and flash chromatography (Et2O:pentane 1:4) 200e was obtained as a colorless 
solid (225 mg, 0.83 mmol). 
 
Yield: colorless solid, 225 mg, 83% 
Mp: 95-96°C 
TLC: Rf = 0.25 (Et2O:pentane 1:4) 
Diastereomeric excess: de ≥ 96% (1H-NMR) 
Enantiomeric excess: ee = 99% (HPLC) 
Optical rotation: [α] 22 = +45.69 (c = 1.5, CHClD 3). 
 
Elemental Analysis: 
Anal. Calcd for C17H21NO2:  C = 75.25  H = 7.80   N = 5.16. 
Found:         C = 74.95  H = 7.69   N = 4.97 
 
The rest of the analytical data are in agreement with those previously reported for 200d. 
 
3.15.7 (1S)-N-(1-Furan-2-yl-ethyl)-benzamide (200f) 
 
N
Me
H
O
O
Ph
 
 
A solution of hydrazide 199f (328 mg, 1 mmol) in 10 ml of THF was treated with two 
equivalents of SmI2 (0.1M in THF) and an equimolar amount of DMPU according to GP13. 
After work-up and flash chromatography (Et2O:pentane 1:1) 200f was obtained as a colorless 
solid (195 mg, 0.90 mmol). 
 
Yield: colorless solid, 195 mg, 90% 
Mp: 105-106°C 
TLC: Rf = 0.36 (Et2O:pentane 1:1) 
Enantiomeric excess: ee = 98% (HPLC) 
Optical rotation: [α] 22 = –53.4 (c = 1.3, CHClD 3), lit.46b [α] = –52.0 (c = 1.11, CHCl22D 3). 
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1H-NMR (400 MHz, CDCl3): 
δ = 1.51 (d, 3H, J = 6.9 Hz, CH3CH), 5.30-5.42 (m, 1H, CHN), 6.16 (dt, 1H, J = 0.7, 3.2 Hz, 
CHCHCO), 6.25 (dd, 1H, J = 1.7, 3.2 Hz, CHCHO), 6.31-6.34 (br, 1H, NH), 7.29 (dd, 1H, J = 
0.7, 1.7 Hz, arom CH), 7.30-7.44 (m, 3H, arom CH), 7.68-7.71 (m, 2H, arom CH) ppm. 
 
13C-NMR (100 MHz, CDCl3): 
δ = 20.10 (CH3CH), 43.78 (CHN), 106.05, 110.50, 127.18, 128.76, 131.74 (arom CH), 134.59 
(arom C), 142.18 (arom CH), 155.45 (arom C), 166.40 (C=O) ppm. 
 
IR (KBr):  
ῦ = 3339 (s), 1636 (vs), 1578 (m), 1520 (vs), 1485 (s), 1316 (s), 1151 (m), 1008 (m), 925 (m), 
813 (m), 740 (s), 720 (s), 695 (s) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 216 (6) [M+•+1], 215 (40) [M+•], 189 (5), 106 (8), 105 (100), 95 (11), 94 (10), 77 (29), 
50 (12). 
 
Elemental Analysis: 
Anal. Calcd for C13H13NO2:  C = 72.54  H = 6.09   N = 6.51 
Found:         C = 72.54  H = 6.26   N = 6.46 
 
3.15.8 (1R)-N-(1-Furan-2-yl-ethyl)-benzamide (200h) 
 
N
Me
H
O
O
Ph
 
 
A solution of hydrazide 199h (328 mg, 1 mmol) in 10 ml of THF was treated with two 
equivalents of SmI2 (0.1M in THF) and an equimolar amount of DMPU according to GP13. 
After work-up and flash chromatography (Et2O:pentane 1:1) 200h was obtained as a colorless 
solid (175 mg, 0.81 mmol). 
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Yield: colorless solid, 175 mg, 81% 
Mp: 105-106°C 
TLC: Rf = 0.36 (Et2O:pentane 1:1) 
Enantiomeric excess: ee = 98% (HPLC) 
Optical rotation: [α] 22 = +52.9 (c = 0.8, CHClD 3). 
 
Elemental Analysis: 
Anal. Calcd for C13H13NO2:  C = 72.54  H = 6.09   N = 6.51 
Found:         C = 72.36  H = 6.18   N = 6.45 
 
The other analytic data correspond to those reported for compound 200f 
 
3.15.9 (S)-N-[4-(tert-Butyl-dimethyl-silanyloxy)-1-furan-2-yl-butyl]-benzamide (200g) 
 
HN
OOTBDMS
O
Ph
 
 
A solution of hydrazide 199g (486 mg, 1 mmol) in 10 ml of THF was treated with two 
equivalents of SmI2 (0.1 M in THF) and an equimolar amount of DMPU according to GP13. 
After work-up and flash chromatography (Et2O:pentane 3:7, then AcOEt) two products were 
obtained: 200g (150 mg, 0.40 mmol) and 200i (52 mg, 0.20 mmol) as colorless solids. 
 
Yield: colorless solid, 150 mg, 40% 
Mp: 102-104°C 
TLC: Rf = 0.25 (Et2O:pentane 3:7) 
Enantiomeric excess: ee = 90% (Based on 1H-NMR of the corresponding hydrazine) 
Optical rotation: [α] 22 = –40.0 (c = 1.1, CHClD 3). 
 
1H-NMR (300 MHz, CDCl3): 
δ = 0.01 (s, 6H, CH3Si), 0.89 (s, 9H, (CH3)3CSi), 1.53-1.71 (m, 2H, CH2CH2OSi), 1.95-2.07 (m, 
2H. CH2CHNH), 3.66 (dt, 2H, J = 1.4, 6.3 Hz, CH2OSi), 5.30-5.38 (m, 1H, CHN), 6.25 (d, 1H, J 
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= 3.3 Hz, CHCHCO), 6.30 (dd, 1H, J = 1.9, 3.3 Hz, CHCHO), 6.49 (d, 1H, J = 8.2 Hz, NH), 
7.36-7.52 (m, 4H, arom CH), 7.76-7.79 (m, 2H, arom CH) ppm. 
 
13C-NMR (75 MHz, CDCl3): 
δ = –5.29, –5.27 (CH3Si), 18.35 (CSi), 25.98 (CH3CSi), 29.17 (CH2CH2OSi), 30.55 
(CH2CHNH), 47.52 (CHN), 62.69 (CH2OSi), 106.39, 110.23, 127.02, 128.56, 131.51 (arom 
CH), 134.55 (arom C), 141.86 (arom CH), 154.44 (arom C), 166.65 (C=O) ppm. 
 
IR (KBr):  
ῦ = 3316 (s), 2953 (s), 2931 (s), 2886 (m), 2859 (m), 1635 (vs), 1604 (m), 1580 (m), 1538 (vs), 
1492 (m), 1470 (m), 1304 (m), 1254 (s), 1098 (s), 1008 (m), 838 (vs), 776 (s), 733 (m), 695 (s) 
cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 373 (2) [M+•], 316 (19), 269 (12), 268 (59), 195 (12),180 (5), 179 (15), 178 (100), 165 
(13), 136 (30), 135 (7), 121 (8), 105 (40), 77 (17), 75 (18). 
 
Elemental Analysis: 
Anal. Calcd for C21H31NO3Si:  C = 67.52  H = 8.36   N = 3.75 
Found:          C = 67.63  H = 8.11   N = 3.77 
 
3.15.10 (S)-N-(1-Furan-2-yl-4-hydroxy-butyl)-benzamide (200i) 
 
HN
OOH
O
Ph
 
 
Yield: colorless solid, 52 mg, 20% 
Mp: 100-102°C 
TLC: Rf = 0.34 (AcOEt) 
Enantiomeric excess: ee = 90% (Based on 1H-NMR of the corresponding hydrazine) 
Optical rotation: [α] 22 = –48.8 (c = 0.8, CHClD 3). 
  167
Experimental Part 
 
 
1H-NMR (300 MHz, CDCl3): 
δ = 1.55-1.68 (m, 2H, CH2CH2OH), 2.01 (q, 2H, J = 7.4 Hz, CH2CHNH), 2.80-2.90 (br, 1H, 
OH), 3.64 (t, 2H, J = 6.2 Hz, CH2OH), 5.28-5.37 (m, 1H, CHN), 6.21 (d, 1H, J = 3.2 Hz, 
CHCHCO), 6.29 (dd, 1H, J = 2.0, 3.2 Hz, CHCHO), 6.90-6.95 (br, 1H, NH), 7.32-7.48 (m, 4H, 
arom CH), 7.74-7.78 (m, 2H, arom CH) ppm. 
 
13C-NMR (75 MHz, CDCl3): 
δ = 28.67 (CH2CH2OH), 30.52 (CH2CHNH), 47.49 (CHN), 62.06 (CH2OSi), 106.46, 110.25, 
127.08, 128.51, 131.57 (arom CH), 134.22 (arom C), 141.89 (arom CH), 154.23 (arom C), 
167.04 (C=O) ppm. 
 
IR (KBr):  
ῦ = 3292 (vs), 3058 (m), 2946 (s), 2924 (s), 1632 (vs), 1530 (s), 1488 (m), 1055 (s), 1007 741 
(m), 700 (s) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 259 (4) [M+•], 200 (16), 155 (5), 154 (60), 138 (6), 106 (8), 105 (100), 77 (26). 
 
Elemental Analysis: 
Anal. Calcd for C15H17NO3:  C = 69.48  H = 6.61   N = 5.40 
Found:         C = 69.11  H = 6.57   N = 5.40 
 
3.15.11 (1S)-N-[1-(1-Methyl-1H-imidazol-2-yl)-propyl]-benzamide (194d) 
 
N
H
N
N
O
Ph
Me
Me
 
 
A solution of hydrazide 193d (356 mg, 1 mmol) in 10 ml of THF was treated with two 
equivalents of SmI2 (0.1M in THF) and an equimolar amount of DMPU according to GP13. 
After work-up and flash chromatography (AcOEt) 194d was obtained as a colorless solid (210 
mg, 0.87 mmol). 
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Yield: colorless solid, 210 mg, 87% 
Mp: 115-116°C 
TLC: Rf = 0.29 (AcOEt) 
Enantiomeric excess: ee = 99% (Chiral GC) 
Optical rotation: [α] 22 = –25.0 (c = 1.2, CHClD 3). 
 
1H-NMR (300 MHz, CDCl3): 
δ = 0.86 (t, 3H, J = 7.4 Hz, CH3CH2), 1.90-2.00 (m, 2H, CH3CH2), 3.61 (s, 3H, NCH3), 5.25 (q, 
1H, J = 7.2 Hz, CHN), 6.68 (d, 1H, J = 1.1 Hz, CH=CHN), 6.78 (d, 1H, J = 1.1 Hz, CH=CHN), 
7.22-7.36 (m, 3H, arom CH), 7.72-7.75 (m, 3H, NH, arom CH) ppm. 
 
13C NMR (75 MHz, CDCl3): 
δ = 9.35 (CH3CH2), 26.86 (CH2CHN), 31.69 (NCH3), 45.56 (CHN), 119.85, 125.94, 126.18, 
127.34, 130.43 (arom CH), 132.85, 147.08 (arom C), 165.73 (C=O) ppm. 
 
IR (KBr):  
ῦ = 3212 (s), 3042 (s), 2966 (s), 2932 (s), 2873 (s), 1651 (vs), 1600 (s), 1577 (s), 1540 (vs), 1491 
(vs), 1458 (s), 1381 (m), 1334 (s), 1295 (s), 1186 (m), 1139 (m), 1114 (m), 1093 (m), 891 (m), 
812 (m), 750 (s), 715 (vs), 672 (m), 649 (m) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 244 (6) [M+•+1], 243 (29) [M+•], 214 (14), 138 (75), 123 (6), 121 (12), 106 (8), 105 
(100), 83 (5), 77 (41), 51 (7). 
 
Elemental Analysis: 
Anal. Calcd for C14H17N3O:  C = 69.11  H = 7.04  N = 17.27 
Found:         C = 68.81  H = 6.79   N = 17.08 
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3.15.12 (1S)-N-[1-(1-Methyl-1H-benzoimidazol-2-yl)-propyl]-benzamide (194e) 
 
N
H
N
N
O
Ph
Me
Me
 
 
A solution of hydrazide 193e (406 mg, 1 mmol) in 10 ml of THF was treated with two 
equivalents of SmI2 (0.1M in THF) and an equimolar amount of DMPU according to GP13. 
After work-up and flash chromatography (AcOEt) 194e was obtained as a colorless solid (230 
mg, 0.78 mmol). 
 
Yield: colorless solid, 230 mg, 78% 
Mp: 163-164°C 
TLC: Rf = 0.50 (AcOEt) 
Enantiomeric excess: ee = 92% (HPLC) 
Optical rotation: [α] 22 = –32.54 (c = 1.1, CHClD 3). 
 
1H-NMR (300 MHz, CDCl3): 
δ = 1.02 (t, 3H, J = 7.4 Hz, CH3CH2), 2.08-2.32 (m, 2H, CH3CH2), 3.85 (s, 3H, NCH3), 5.58 (dt, 
1H, J = 6.9, 8.4 Hz, CHN), 7.21-7.30 (m, 3H, arom CH), 7.39-7.55 (m, 4H, arom CH, NH), 
7.62-7.66 (m, 1H, arom CH), 7.87-7.90 (m, 2H, arom CH) ppm. 
 
13C-NMR (75 MHz, CDCl3): 
δ = 10.21 (CH3CH2), 28.03 (CH2CHN), 29.98 (NCH3), 47.09 (CHN), 109.56, 119.13, 122.31, 
122.82, 127.23, 128.58, 131.76 (arom CH), 133.80, 135.50, 139.96 (arom C), 166.85 (C=O) 
ppm. 
 
IR (KBr):  
ῦ = 3291 (s), 3054 (m), 2966 (s), 2932 (s), 2872 (m), 1654 (vs), 1528 (vs), 1488 (s), 1332 (s), 
1290 (s), 1236 (m), 842 (m), 741 (vs), 700 (vs), 655 (m) cm−1. 
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MS (EI, 70 eV):  
m/z (%) = 294 (12) [M+•+1], 293 (59) [M+•], 278 (8), 264 (8), 189 (12), 188 (100), 171 (5), 160 
(7), 133 (8), 131 (6), 106 (6), 105 (75), 77 (40). 
 
Elemental Analysis: 
Anal. Calcd for C18H19N3O:  C = 73.69  H = 6.53  N = 14.32 
Found:         C = 74.07  H = 6.64   N = 14.31 
 
3.15.13 (1S)-N-(1-pyridin-2-yl-propyl)-benzamide (194a) 
 
N
H
O
Ph
Me
N  
 
A solution of hydrazide 193a (355 mg, 1 mmol) in 10 ml of THF was treated with two 
equivalents of SmI2 (0.1M in THF) and an equimolar amount of DMPU according to GP13. 
After work-up and flash chromatography (Et2O:pentane 95:5) 194a was obtained as a colorless 
solid (185 mg, 0.77 mmol). 
 
Yield: colorless solid, 185 mg, 77% 
Mp: 69-70°C 
TLC: Rf = 0.50 (Et2O:pentane 95:5) 
Enantiomeric excess: ee = 96% (HPLC) 
Optical rotation: [α] 22 = –16.0 (c = 1.0, CHClD 3). 
 
1H-NMR (400 MHz, CDCl3): 
δ = 0.76 (t, 3H, J = 7.4 Hz, CH3CH2), 1.78-1.96 (m, 2H, CH3CH2), 5.09-5.16 (m, 1H, CHN), 
7.07 (ddd, J = 1.4, 4.9, 7.7 Hz, 1H, arom CH), 7.15-7.17 (m, 1H, arom CH), 7.26-7.39 (m, 3H, 
arom CH), 7.54 (dt, 1H, J = 1.7, 8.7 Hz, arom CH) 7.63 (d, 1H, J = 7.4 Hz, NH), 7.57-7.78 (m, 
2H, arom CH), 8.44-8.46 (m, 1H, arom CH). 
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13C-NMR (100 MHz, CDCl3): 
δ = 10.12 (CH3CH2), 29.70 (CH2CHN), 55.52 (CHN), 122.58, 127.28, 128.67, 131.54 (arom 
CH), 134.92 (arom C), 136.84, 149.32 (arom CH), 160.01 (arom C), 166.93 (C=O) ppm. 
 
IR (KBr):  
ῦ = 3325 (s), 2966 (m), 1634 (vs), 1588 (s), 1576 (s), 1525 (vs), 1487 (s), 1467 (s), 1433 (s), 
1346 (m), 1309 (s), 1148 (m), 1076 (m), 770 (m), 749 (m), 724 (m), 695 (s), 664 (s), 645 (m) 
cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 240 (12) [M+•], 212 (13), 211 (44), 135 (13), 120 (6), 118 (6), 107 (7), 106 (8), 105 
(100), 78 (5), 77 (40), 51 (9). 
 
Elemental Analysis: 
Anal. Calcd for C15H16N2O:  C = 74.93  H = 6.71  N = 11.66 
Found:         C = 74.86  H = 6.88   N = 11.59 
 
3.15.14 (1S)-N-(1-pyridin-3-yl-propyl)-benzamide 
 
N
H
O
Ph
Me
N  
 
A solution of hydrazide 193b (355 mg, 1 mmol) in 10 ml of THF was treated with two 
equivalents of SmI2 (0.1M in THF) and an equimolar amount of DMPU according to GP13. 
After work-up and flash chromatography (Et2O) 194b was obtained as a colorless solid (200 mg, 
0.83 mmol). 
 
Yield: colorless solid, 200 mg, 83% 
Mp: 72-73°C 
TLC: Rf = 0.20 (Et2O) 
  172
Experimental Part 
 
 
Enantiomeric excess: ee = 99% (HPLC) 
Optical rotation: [α] 22 = +11.71 (c = 1.4, CHClD 3). 
 
1H-NMR (400 MHz, CDCl3): 
δ = 0.84 (t, 3H, J = 7.3 Hz, CH3CH2), 1.73-1.86 (m, 2H, CH3CH2), 4.95 (q, 1H, J = 7.7 Hz, 
CHN), 7.10 (dd, J = 4.9, 8.0 Hz, 1H, arom CH), 7.21-7.25 (m, 2H, arom CH), 7.31-7.35 (m, 2H, 
NH, arom CH), 7.54 (dt, 1H, J = 1.7, 8.7 Hz, arom CH) 7.66-7.68 (m, 2H, arom CH), 8.33 (dd, 
1H, J = 1.7, 4.8 Hz, arom CH), 8.44 (d, 1H, J = 1.9 Hz, arom CH) ppm. 
 
13C-NMR (100 MHz, CDCl3): 
δ = 11.11 (CH3CH2), 29.04 (CH2CHN), 53.66 (CHN), 123.71, 127.35, 128.65, 131.70 (arom 
CH), 134.52 (arom C), 134.71 (arom CH), 138.37 (arom C), 148.56, 148.59 (arom CH), 167.63 
(C=O) ppm. 
 
IR (KBr):  
ῦ = 3319 (s), 2966 (m), 1639 (vs), 1603 (m), 1578 (m), 1533 (vs), 1480 (m), 1459 (m), 1325 (m), 
1334 (m), 1001 (m), 795 (m), 715 (s), 690 (s) cm−1. 
 
MS (EI, 70 eV):  
m/z (%)= 240 (15) [M+•], 211 (17), 106 (8), 105 (100), 77 (33), 51 (7). 
 
Elemental Analysis: 
Anal. Calcd for C15H16N2O:  C = 74.93  H = 6.71  N = 11.66 
Found:         C = 74.72  H = 6.58   N = 11.46 
 
3.15.15 (1S)-N-(1-benzofuran-2-yl-propyl)-benzamide (194g) 
N
H
O
O
Ph
Me
 
 
  173
Experimental Part 
 
 
A solution of hydrazide 193g (392 mg, 1 mmol) in 10 ml of THF was treated with two 
equivalents of SmI2 (0.1M in THF) and an equimolar amount of DMPU according to GP13. 
After work-up and flash chromatography (Et2O:pentane 1:3) 194g was obtained as a colorless 
solid (238 mg, 0.85 mmol). 
 
Yield: colorless solid, 238 mg, 85% 
Mp: 132-133°C 
TLC: Rf = 0.36 (Et2O:pentane 1:3) 
Enantiomeric excess: ee = 97% (HPLC) 
Optical rotation: [α] 22 = –85.4 (c = 0.9, CHClD 3). 
 
1H-NMR (400 MHz, CDCl3): 
δ = 0.89 (t, 3H, J = 7.4 Hz, CH3CH2), 1.83-2.00 (m, 2H, CH3CH2), 5.23-5.29 (m, 1H, CHN), 
6.50 (s, 3H, arom CH), 6.71 (d, 1H, J = 8.8 Hz, NH), 7.07-7.16 (m, 2H, arom CH), 7.24-7.41 (m, 
5H, arom CH) 7.69-7.71 (m, 2H, arom CH) ppm. 
 
13C-NMR (100 MHz, CDCl3): 
δ = 10.76 (CH3CH2), 27.26 (CH2CHN), 49.73 (CHN), 103.69, 111.36, 121.24, 123.06, 124.27, 
127.34 (arom CH), 128.42 (arom C), 128.79, 131.85 (arom CH), 134.52, 155.00, 157.16 (arom 
C), 167.20 (C=O) ppm. 
 
IR (KBr):  
ῦ = 3291 (s), 1633 (vs), 1600 (m), 1578 (m), 1527 (vs), 1487 (m), 1452 (s), 1341 (m), 1290 (m), 
1255 (m), 1157 (m), 805 (m), 754 (s), 695 (s) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 280 (7) [M+•+1], 279 (33) [M+•], 251 (5), 250 (34), 158 (5), 106 (8), 105 (100), 77 
(33). 
 
Elemental Analysis: 
Anal. Calcd for C18H17NO2:  C = 77.40  H = 6.13  N = 5.01 
Found:         C = 77.29  H = 6.08   N = 4.93 
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3.15.16 (1S)-N-[1-(1-Methyl-1H-indol-2-yl)-propyl]-benzamide (194c) 
 
N
H
N
O
Ph
Me
Me
 
 
A solution of hydrazide 193c (405 mg, 1 mmol) in 10 ml of THF was treated with two 
equivalents of SmI2 (0.1M in THF) and an equimolar amount of DMPU according to GP13. 
After work-up and flash chromatography (Et2O:pentane 3:2) 194c was obtained as a colorless 
solid (210 mg, 0.72 mmol). 
 
Yield: colorless solid, 210 mg, 72% 
Mp: 165-166°C 
TLC: Rf = 0.51 (Et2O:pentane 3:2) 
Enantiomeric excess: ee = 94% (HPLC) 
Optical rotation: [α] 22 = –120.2 (c = 1.6, CHClD 3). 
 
1H-NMR (400 MHz, CDCl3): 
δ = 1.02 (t, 3H, J = 7.4 Hz, CH3CH2), 1.95-2.12 (m, 2H, CH3CH2), 3.64 (s, 3H, NCH3), 5.39 (q, 
1H, J = 7.4 Hz, CHN), 6.14-6.16 (br, 1H, NH), 6.41 (s, 1H, arom CH), 7.00-7.04 (m, 1H, arom 
CH), 7.11-7.42 (m, 5H, arom CH), 7.50 (d, 1H, J = 7.7 Hz, arom CH), 7.49-7.66 (m, 2H, arom 
CH) ppm. 
 
13C NMR (100 MHz, CDCl3): 
δ = 11.42 (CH3CH2), 28.10 (CH2CHN), 30.16 (NCH3), 47.44 (CHN), 99.23, 109.52, 119.88, 
120.67, 122.04, 127.10 (arom CH), 127.45 (arom C), 128.83, 131.87 (arom CH), 134.30, 137.83, 
140.48 (arom C), 166.61 (C=O) ppm. 
 
IR (KBr):  
ῦ = 3286 (s), 2929 (m), 1632 (vs), 1457 (m), 1385 (m), 1338 (m), 1314 (m), 1295 (m), 1272 (m), 
1152 (m), 783 (m), 748 (m), 731 (s), 712 (m), 696 (s) cm−1.  
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MS (EI, 70 eV):  
m/z (%) = 293 (15) [M+•+1], 292 (72) [M+•], 264 (14), 263 (75), 187 (13), 171 (10), 160 (8), 157 
(8), 156 (6), 132 (24), 130 (6), 106 (7), 105 (100), 77 (33). 
 
Elemental Analysis: 
Anal. Calcd for C19H20N2O:  C = 78.05  H = 6.89  N = 9.58 
Found:         C = 77.71  H = 6.84   N = 9.53 
 
3.16  Synthesis of Cbz-protected amines 
 
3.16.1 (1S)-[1-(1-Methyl-1H-pyrrol-2-yl)-propyl]-carbamic acid benzyl ester (191e) 
 
Me
HN
N
Me
O
O
 
 
To a solution of 2-lithio-1-methylpyrrole (6.4 mmol) in 20 ml of THF was added hydrazone 
187b (340 mg, 2.0 mmol) in 4 ml of THF according to GP14. After cleavage of the chiral 
auxiliary purification by column chromatography (Et2O:pentane 1:3) gave 191e (245 mg, 0.90 
mmol) as a colorless solid. 
 
Yield: colorless solid, 245 mg, 45% 
Mp: 70-71°C 
TLC: Rf = 0.35 (Et2O:pentane 1:3) 
Enantiomeric excess: ee = 88% (HPLC) 
Optical rotation: [α] 22 = –62.4 (c = 1.8 CHClD 3). 
 
1H-NMR (400 MHz, CDCl3): 
δ = 0.98 (t, 3H, J = 7.4 Hz, CH3CH2), 1.80-1.95 (m, 2H, CH3CH2), 3.54 (s, 3H, NCH3), 4.67-
4.76 (m, 2H, CHN, NH), 5.09 (s, 2H, CH2OC=O), 6.00-6.49 (m, 2H, arom CH), 6.54-6.55 (m, 
1H, arom CH), 7.27-7.35 (m, 5H, arom CH) ppm. 
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13C-NMR (100 MHz, CDCl3): 
δ = 11.36 (CH3CH2), 28.51 (CH3CH2), 34.15 (NCH3), 48.90 (CHN), 66.98 (CH2OC=O), 105.89, 
106.95, 122.79, 128.22, 128.32, 128.73 (arom CH), 133.19, 136.81, (arom C), 155.86 (C=O) 
ppm. 
 
IR (KBr):  
ῦ = 3309 (s), 1684 (vs), 1540 (s), 1305 (m), 1266 (m), 1248 (s), 1077 (m), 718 (s), 696 (s) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 273 (6) [M+•+1], 272 (36) [M+•], 243 (28), 199 (25), 181 (16), 172 (7), 137 (9), 122 
(7), 107 (8), 92 (7), 91 (100), 82 (14), 65 (5). 
 
Elemental Analysis: 
Anal. Calcd for C16H20N2O2:  C = 70.56  H = 7.41  N = 10.28 
Found:         C = 70.49  H = 7.35   N = 10.10 
 
3.16.2 (1S)-[1-(1-Methyl-1H-pyrrol-2-yl)-pentyl]-carbamic acid benzyl ester (198a) 
 
HN
N
Me
O
O
Me
 
To a solution of 2-lithio-1-methylpyrrole (6.4 mmol) in 20 ml of THF was added hydrazone 187f 
(396 mg, 2.0 mmol) in 4 ml of THF according to GP14. After cleavage of the chiral auxiliary 
purification by column chromatography (Et2O:pentane 1:2) gave 198a (210 mg, 0.70 mmol) as a 
colorless solid. 
 
Yield: colorless solid, 210 mg, 35% 
Mp: 67-68°C 
TLC: Rf = 0.40 (Et2O: pentane 1:2) 
Enantiomeric excess: ee = 92% (HPLC) 
Optical rotation: [α] 22 = –65.3 (c = 1.0, CHClD 3). 
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, CDCl
MS (EI, 70 eV):  
 
1H-NMR (300 MHz, CDCl3): 
δ = 0.89 (t, 3H, J = 7.4 Hz, CH3CH2), 1.32-1.40 (m, 4H, CH3CH2CH2), 1.78-1.95 (m, 2H, 
CH2CHN), 3.55 (s, 3H, NCH3), 4.69-4.82 (m, 2H, CHN, NH), 5.09 (s, 2H, CH2OC=O), 6.02-
6.05 (m, 2H, arom CH,), 6.56-6.57 (m, 1H, arom CH), 7.27-7.33 (m, 5H, arom CH) ppm. 
13C-NMR (75 MHz 3): 
δ = 14.28 (CH3CH2), 22.76 (CH3CH2), 28.73 (CH3CH2CH2), 34.07 (NCH3), 35.14 (CH2CHN), 
47.27 (CHN), 66.92 (CH2OC=O), 105.86, 106.93, 122.79, 128.26, 128.36, 128.76 (arom CH), 
133.45, 136.85, (arom C), 155.90 (C=O) ppm. 
 
IR (KBr):  
ῦ = 3313 (s), 2950 (s), 2925 (m), 2869 (m), 2858 (m), 1682 (vs), 1532 (vs), 1466 (m), 1412 (m), 
1335 (m), 1298 (s), 1247 (s), 1231 (s), 1100 (m), 1047 (s), 1009 (m), 750 (m), 721 (vs), 697 (s), 
669 (m) cm−1. 
 
m/z (%) = 301 (7) [M+•+1], 300 (36) [M+•], 244 (6), 243 (40), 209 (13), 199 (30), 165 (12), 107 
(8), 94 (8), 92 (8), 91 (100), 82 (15). 
Elemental Analysis: 
Anal. Calcd for C18H24N2O2:  C = 71.97  H = 8.05  N = 9.32 
Found:         C = 71.72  H = 7.69   N = 9.08 
 
3.16.3 (1S)-[2,2-Dimethyl-1-(1-methyl-1H-Pyrrol-2-yl)-propyl]-carbamic acid  
benzyl ester (198c) 
 
Me
NH
N
Me
Me
Me
O
O
 
 
To a solution of 2-lithio-1-methylpyrrole (6.4 mmol) in 20 ml of THF was added hydrazone 
187d (396 mg, 2.0 mmol) in 4 ml of THF according to GP14. After cleavage of the chiral 
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auxiliary purification by column chromatography (Et2O:pentane 1:2) gave 198c (150 mg, 0.50 
mmol) as a colorless oil. 
 
Yield: colorless oil, 150 mg, 25% 
TLC: Rf = 0.37 (Et2O: pentane 1:2) 
Enantiomeric excess: ee = 88% (HPLC) 
Optical rotation: [α] 22 = –18.6 (c = 1.0, CHClD 3). 
1H-NMR (400 MHz, CDCl3): 
δ = 0.96 (s, 9H, (CH3)3C), 3.64 (s, 3H, NCH3), 4.65 (d, 1H, J = 9.6 Hz, CHN), 5.01-5.15 (m, 3H, 
NH, CH2OC=O), 5.97 (dd, 1H, J = 1.6, 3.6 Hz, arom CH,), 6.06 (t, 1H, J = 3.6 Hz arom CH), 
6.50-6.52 (m, 1H, arom CH), 7.27-7.33 (m, 5H, arom CH) ppm. 
13C NMR (100 MHz, CDCl3): 
δ = 26.79 (CH3C), 34.79 (NCH3), 36.57 (CCHN), 55.50 (CHN), 67.19 (CH2OC=O), 106.14, 
106.95, 121.59, 128.37, 128.41, 128.75 (arom CH), 132.92, 136.61, (arom C), 156.33 (C=O) 
ppm. 
IR (CHCl3):  
ῦ = 3332 (m), 3032 (m), 2958 (vs), 2871 (s), 1713 (vs), 1511 (vs), 1455 (s), 1419 (m), 1394 (s), 
1365 (s), 1325 (s), 1304 (s), 1234 (vs), 1125 (s), 1091 (m), 1050 (vs), 1028 (m), 1007 (s), 915 
(m), 774 (s), 753 (s), 698 (vs), 678 (m), 610 (m) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 300 (10) [M+•], 244 (14), 243 (90), 200 (5), 199 (39), 172 (12), 135 (7), 107 (7), 92 
(9), 91 (100). 
 
Elemental Analysis: 
Anal. Calcd for C18H24N2O2:  C = 71.97  H = 8.05  N = 9.32 
Found:         C = 71.74  H = 8.16   N = 9.01 
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3.16.4 (1S)-[2-Ethyl-1-(1-methyl-1H-pyrrol-2-yl)-butyl]-carbamic acid benzyl ester (198d) 
 
HN
N
Me
O
O
Me
Me  
 
 
 
 
To a solution of 2-lithio-1-methylpyrrole (6.4 mmol) in 20 ml of THF was added hydrazone 
187m (424 mg, 2.0 mmol) in 4 ml of THF according to GP14. After cleavage of the chiral 
auxiliary purification by column chromatography (Et2O:pentane 1:2) gave 198d (333 mg, 1.06 
mmol) as a colorless oil. 
 
Yield: colorless oil, 333 mg, 53% 
TLC: Rf = 0.35 (Et2O: pentane 1:2) 
Enantiomeric excess: ee = 90% (HPLC) 
Optical rotation: [α] 22 = –27.7 (c = 1.5, CHClD 3). 
1H-NMR (400 MHz, CDCl3): 
δ = 0.89 (t, 6H, J = 7.4 Hz, CH3CH2), 1.69-1.86 (m, 4H, CH3CH2), 3.44 (s, 3H, NCH3), 4.58-
4.72 (m, 2H, CHN, NH), 4.99 (s, 2H, CH2OC=O), 5.91-5.95 (m, 2H, arom CH), 6.44-6.45 (m, 
1H, arom CH), 7.17-7.26 (m, 5H,arom CH) ppm. 
13C-NMR (100 MHz, CDCl3): 
δ = 11.40 (CH3CH2), 28.51 (CH3CH2), 34.16 (NCH3), 48.91 (CHN), 66.98 (CH2OC=O), 105.94, 
106.97, 122.80, 128.24, 128.33, 128.74 (arom CH), 133.17, 136.86, (arom C), 155.92 (C=O) 
ppm. 
IR (CHCl3):  
ῦ = 3338 (m), 2961(s), 2933 (s), 2875 (s), 1702 (vs), 1530 (s), 1456 (s), 1329 (m), 1298 (m), 
1253 (vs), 1136 (m), 1092 (m), 1021 (m), 736 (m), 698 (s) cm−1. 
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m/z (%) = 314 (14) [M 10), 107 (7), 94 (5), 92 (8), 91 
(100). 
 
MS (EI, 70 eV):  
+•], 244 (16), 243 (99), 199 (41), 172 (
Elemental Analysis: 
Anal. Calcd for C19H26N2O2:  C = 72.58  H = 8.33  N = 8.91 
Found:         C = 73.03  H = 8.55  N = 8.90 
 
3.16.5 (1S)-[1-(1-Methyl-1H-pyrrol-2-yl)-3-phenyl-propyl]-carbamic acid benzylester 
(198b) 
 
HN
N
Me
O
O
Ph
 
To a solution of 2-lithio-1-methylpyrrole (6.4 mmol) in 20 ml of THF was added hydrazone 
187e (492 mg, 2.0 mmol) in 4 ml of THF according to GP14. After cleavage of the chiral 
auxiliary purification by column chromatography (Et2O:pentane 1:2) gave 198b (250 mg, 0.72 
mmol) as a colorless solid. 
 
Yield: colorless solid, 250 mg, 36% 
Mp: 92-93°C 
TLC: Rf = 0.40 (Et2O: pentane 1:2) 
Enantiomeric excess: ee = 99% (HPLC) 
Optical rotation: [α] 22 = –48.1 (c = 2.0, CHClD 3). 
 
 
1H-NMR (400 MHz, CDCl3): 
δ = 2.12-2.29 (m, 2H, CH2CH2CH), 2.80 (t, 2H, J = 8.3 Hz, PhCH2), 3.57 (s, 3H, NCH3), 4.89-
4.93 (m, 2H, CHN, NH), 5.19 (s, 2H, CH2OC=O), 6.13-6.15 (m, 2H, arom CH), 6.63-6.64 (m, 
1H, arom CH), 7.18-7.44 (m, 10 H, arom CH) ppm. 
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Found:         C = 75.41  H = 6.72  N = 7.86. 
13C-NMR (100 MHz, CDCl3): 
δ = 33.13 (PhCH2), 34.19 (NCH3), 37.26 (CH2CH), 47.14 (CHN), 67.11 (CH2OC=O), 106.14, 
107.16, 122.95, 126.28, 128.33, 128.44, 128.73, 128.82 (arom CH), 132.92, 136.83, 141.76 
(arom C), 155.84 (C=O) ppm. 
 
IR (KBr):  
ῦ = 3309 (s), 1681 (vs), 1535 (s), 1495 (m), 1454 (m), 1331 (m), 1297 (m) 1255 (s), 1244 (s), 
1045 (s), 1029 (m), 754 (m), 720 (s) 699 (s) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 349 (11) [M+•+1], 348 (46) [M+•], 257 (11), 243 (33), 213 (11), 199 (29), 107 (6), 92 
(7), 91 (100), 82 (8), 65 (5). 
 
Elemental Analysis: 
Anal. Calcd for C22H24N2O2:  C = 75.83  H = 6.94  N = 8.04. 
 
3.16.6 (1S)-(1-Thiophen-2-yl-propyl)-carbamic acid benzyl ester (191a) 
 
Me
HN
S
O
O
 
 
 
TLC: R 2O: pentane 1:2) 
To a solution of 2-lithio-thiophene (6.4 mmol) in 20 ml of Et2O was added hydrazone 187b (340 
mg, 2.0 mmol) in 4 ml of Et2O according to GP15. After cleavage of the chiral auxiliary 
purification by column chromatography (Et2O:pentane 1:2) gave 191a (420 mg, 1.52 mmol) as a 
colorless solid. 
Yield: colorless solid, 420 mg, 76% 
Mp: 69-70°C 
f = 0.33 (Et
Enantiomeric excess: ee = 99% (HPLC) 
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Optical rotation: [α] 22 = –57.8 (c = 1.4 CHClD 3). 
1H-NMR (400 MHz, CDCl3): 
δ = 0.96 (t, 3H, J = 7.4 Hz, CH3CH2), 1.85-1.96 (m, 2H, CH3CH2), 4.91-5.14 (m, 4H, NH, 
CHNH, CH2OC=O), 6.93-6.97 (m, 2H, arom CH), 7.18-7.20 (m, 1H, arom CH), 7.29-7.34 (m, 
5H, arom CH) ppm. 
13C-NMR (100 MHz, CDCl3): 
δ = 10.97 (CH3), 30.49 (CH3CH2), 52.80 (CHN), 67.15 (CH2OC=O), 124.31, 124.47, 126.98, 
128.34, 128.73, (arom CH), 136.58, 146.18 (arom C), 155.83 (C=O) ppm. 
 
IR (KBr):  
ῦ = 3309 (s), 3115 (m), 3090 (m), 3066 (m), 3032 (m), 2971 (s), 2934 (s), 2878 (s), 1708 (vs), 
1685 (vs), 1535 (vs), 1499 (s), 1467 (s), 1454 (s), 1443 (s), 1352 (m), 1327 (s), 1298 (s), 1266 
(vs), 1238 (vs), 1176 (m), 1143 (m), 1128 (m), 1081 (s), 1045 (s), 1029 (s), 974 (s), 915 (m), 847 
(m), 832 (m), 779 (m), 767 (m), 752 (s) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 275 (1) [M+•], 246 (6), 202 (9), 185 (5), 184 (50), 140 (11), 97 (6), 92 (9), 91 (100), 85 
(5), 65 (9), 56 (10). 
 
Elemental Analysis: 
Anal. Calcd for C15H17NO2S: C = 65.43  H = 6.22  N = 5.09 
Found:         C = 65.50  H = 6.16  N = 4.99 
 
3.16.7 (1S)-N-(1-Thiophen-2-yl-propyl)-acetamide (192) 
 
Me
HN
S
O
Me
 
 
  183
Experimental Part 
 
 
 
 
 
To a solution of 2-lithio-thiophene (6.4 mmol) in 20 ml of Et2O was added hydrazone 187b (340 
mg, 2.0 mmol) in 4 ml of Et2O according to GP15. After cleavage of the chiral auxiliary the 
crude amine was dissolved in 10 ml of CH2Cl2 in presence of two equivalents of Et3N and a 
catalytic amount of DMAP. The resulting mixture was cooled to 0°C and 2 mmol of 
acetylchloride were dropwise added and the reaction was allowed to reach room temperature. 
After stirring for 12 h a room temperature, the reaction mixture was poured in 10 ml of water 
and extracted with CH2Cl2 (three times); the organic layer was dried over MgSO4 and evaporated 
under reduced pressure. Crystallization from Et2O afforded 192 (275 mg, 1.5 mmol) as a 
colorless solid. 
 
Yield: colorless solid, 275 mg, 75% 
Mp: 126-127°C 
Optical rotation: [α] 22 = –149.8 (c = 0.2, CHClD 3), lit. [α] = –148.0 (c = 0.14, CHCl22D 3) 
1H-NMR (400 MHz, CDCl3): 
δ = 0.87 (t, 3H, J = 7.4 Hz, CH3CH2), 1.78-1.86 (m, 2H, CH3CH2), 1.90 (s, 3H, COCH3), 5.08-
5.14 (m, 1H, CHNH), 5.94-5.96 (br, 1H, NH), 6.85-6.88 (m, 3H, arom CH), 7.10-7.13 (m, 2H, 
arom CH) ppm. 
13C-NMR (100 MHz, CDCl3): 
δ = 11.07 (CH3), 22.67 (CH3CO), 30.06 (CH3CH2), 50.65 (CHN), 124.25, 124.59, 127.00 (arom 
CH), 146.21 (arom C), 169.46 (C=O) ppm. 
The rest of the analytical data are in agreement with those reported in literature.67 
 
3.16.8 (1S)-(1-Thiophen-2-yl-pentyl)-carbamic acid benzyl ester (196a) 
 
HN
S
O
O
Me
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Enantiomeric excess: ee = 94% (HPLC) 
 
 
 
To a solution of 2-lithio-thiophene (6.4 mmol) in 20 ml of Et2O was added hydrazone 187f (396 
mg, 2.0 mmol) in 4 ml of Et2O according to GP15. After cleavage of the chiral auxiliary 
purification by column chromatography (Et2O:pentane 1:4) gave 196a (425 mg, 1.40 mmol) as a 
colorless solid. 
 
Yield: colorless solid, 425 mg, 70% 
Mp: 56-57°C 
TLC: Rf = 0.32 (Et2O: pentane 1:4) 
Optical rotation: [α] 22 = –48.0 (c = 2.1, CHCl3). D
1H-NMR (400 MHz, CDCl3): 
δ = 1.12 (t, 3H, J = 7.0 Hz, CH3CH2), 1.50-1.66 (m, 4H, CH3CH2CH2), 2.08-2.13 (m, 2H, 
CH2CH), 5.21-5.39 (m, 4H, CHN, NH, CH2OC=O), 7.16-7.19 (m, 2H, arom CH), 7.42-7.44 (m, 
1H, arom CH), 7.51-7.57 (m, 5H, arom CH) ppm. 
13C-NMR (100 MHz, CDCl3): 
δ = 14.46 (CH3), 22.84 (CH3CH2), 28.71 (CH3CH2CH2), 37.37 (CH2CH), 51.53 (CHN), 67.35 
(CH2OC=O), 124.57, 124.70, 127.28, 128.64, 129.03, (arom CH), 136.92, 147.17 (arom C), 
156.14 (C=O) ppm. 
IR (CHCl3):  
ῦ = 3336 (s), 2951 (s), 2936 (s), 2885 (m), 2857 (m), 1688 (vs), 1527 (vs), 1465 (s), 1455 (m), 
1433 (m), 1333 (s), 1300 (m), 1286 (s), 1248 (vs), 1225 (s), 1140 (m), 1123 (m), 1102 (m), 1045 
(m), 1028 (s), 1011 (m), 749 (s), 701 (s), 650 (m). 
 
MS (EI, 70 eV):  
m/z (%) = 303 (1) [M+•], 246 (12), 212 (65),  202 (20), 168 (11), 97 (7), 92 (8), 91 (100), 84 (5), 
65 (6). 
 
Elemental Analysis: 
Anal. Calcd for C17H21NO2S: C = 67.29  H = 6.97  N = 4.61. 
Found:         C = 67.21  H = 6.82  N = 4.56. 
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3.16.9 (1S)-(2,2-Dimethyl-1-thiophen-2-yl-propyl)-carbamic acid benzyl ester (196e) 
 
Me
HN
S
O
O
Me
Me  
 
 
 
 
To a solution of 2-lithio-thiophene (6.4 mmol) in 20 ml of Et2O was added hydrazone 187d (396 
mg, 2.0 mmol) in 4 ml of Et2O according to GP15. After cleavage of the chiral auxiliary 
purification by column chromatography (Et2O:pentane 1:3) gave 196e (345 mg, 1.14 mmol) as a 
colorless solid. 
 
Yield: colorless solid, 345 mg, 57% 
Mp: 59-60°C 
TLC: Rf = 0.50 (Et2O: pentane 1:3) 
Enantiomeric excess: ee = 93% (HPLC) 
Optical rotation: [α] 22 = –8.1 (c = 1.5, CHClD 3). 
1H-NMR (400 MHz, CDCl3): 
δ = 1.23 (s, 9H, CH3C), 5.10 (d, 1H, J = 9.9 Hz, CHNH), 5.28 (d, 1H, JAB = 12 Hz CHHOC=O), 
5.35 (d, 1H, JAB = 12 Hz CHHOC=O), 5.45-5.48 (br, 1H, NH), 7.15-7.20 (m, 2H, arom. CH), 
7.42 (dd, 1H, J = 1.4, 5.0 Hz, arom CH), 7.57-7.69 (m, 5H, arom CH) ppm. 
13C-NMR (100 MHz, CDCl3): 
δ = 27.13 (CH3), 35.67 (CH3C), 60.71 (CHN), 67.49 (CH2OC=O), 124.27, 126.45, 126.85, 
128.74, 129.06, (arom CH), 136.84, 144.09 (arom C), 156.41 (C=O) ppm. 
IR (CHCl3):  
ῦ = 3331 (m), 2965 (s), 2869 (m), 1707 (vs), 1526 (s), 1510 (s), 1477 (m), 1465 (m), 1455 (m), 
1398 (m), 1367 (m), 1332 (s), 1239 (vs), 1110 (m), 1055 (s), 1007 (s), 777 (m), 736 (m), 697 (s) 
cm−1. 
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MS (EI, 70 eV):  
m/z (%) = 303 (4) [M+•], 247 (7), 246 (46), 202 (23), 92 (8), 91 (100), 65 (5). 
 
Elemental Analysis: 
Anal. Calcd for C17H21NO2S: C = 67.29  H = 6.97  N = 4.61 
Found:         C = 67.29  H = 7.16  N = 4.59 
 
3.16.10 (1S)-(2-Methyl-1-thiophen-2-yl-propyl)-carbamic acid benzyl ester (196 c) 
 
Me
HN
S
O
O
Me  
 
 
 
 
To a solution of 2-lithio-thiophene (6.4 mmol) in 20 ml of Et2O was added hydrazone 187c (368 
mg, 2.0 mmol) in 4 ml of Et2O according to GP15. After cleavage of the chiral auxiliary 
purification by column chromatography (Et2O:pentane 1:2) gave 196c (422 mg, 1.46 mmol) as a 
colorless oil. 
 
Yield: colorless oil, 422 mg, 73% 
TLC: Rf = 0.40 (Et2O: pentane 1:2) 
Enantiomeric excess: ee = 93% (HPLC) 
Optical rotation: [α] 22 = –43.3 (c = 1.2, CHClD 3). 
1H-NMR (400 MHz, CDCl3): 
δ = 1.19 (t, 6H, J = 7.7 Hz, CH3CH), 2.29-2.35 (m, 1H, CH3CH), 5.06-5.11 (m, 1H, CHN), 5.30-
5.41 (m, 3H, NH, CH2OC=O), 7.15-7.20 (m, 2H, arom CH), 7.43 (dd, 1H, J = 1.1, 5.0 Hz, arom 
CH), 7.51-7.58 (m, 5H, arom CH) ppm. 
13C-NMR (100 MHz, CDCl3): 
δ = 18.78, 20.17 (CH3), 34.87 (CH3CH), 57.41 (CHN), 67.43 (CH2OC=O), 124.42, 125.02, 
127.23, 128.67, 129.05, (arom CH), 136.92, 146.12 (arom C), 156.45 (C=O) ppm. 
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m/z (%) = 289 (3) [M
IR (CHCl3):  
ῦ = 3321 (s), 2957 (s), 2934 (m), 2870 (m), 1688 (vs), 1540 (vs), 1466 (m), 1455 (m), 1331 (m), 
1309 (s), 1273 (s), 1242 (s), 1024 (s), 747 (m), 697 (s). 
 
MS (EI, 70 eV):  
+•], 246 (53), 202 (27), 198 (9), 92 (8), 91 (100). 
 
Elemental Analysis: 
Anal. Calcd for C16H19NO2S: C = 66.41  H = 6.62  N = 4.84 
Found:         C = 66.16  H = 6.98  N = 4.77 
 
3.16.11 (1S)-(2-Ethyl-1-thiophen-2-yl-butyl)-carbamic acid benzyl ester (196d) 
 
HN
S
O
O
Me
Me
 
 
Yield: colorless solid, 495 mg, 78% 
 
To a solution of 2-lithio-thiophene (6.4 mmol) in 20 ml of Et2O was added hydrazone 187m 
(424 mg, 2.0 mmol) in 4 ml of Et2O according to GP15. After cleavage of the chiral auxiliary 
purification by column chromatography (Et2O:pentane 3:7) gave 196d (495 mg, 1.56 mmol) as a 
colorless solid. 
 
Mp: 59-60°C 
TLC: Rf = 0.39 (Et2O: pentane 3:7) 
Enantiomeric excess: ee = 94% (HPLC) 
Optical rotation: [α] 22 = –43.7 (c = 2.0, CHClD 3). 
1H-NMR (400 MHz, CDCl3): 
δ = 0.86-0.95 (m, 6H, CH3CH2), 1.19-1.49 (m, 4H, CH3CH2), 1.58-1.63 (m, 1H, CHCHN), 5.00-
5.17 (m, 4H, NH, CHNH, CH2OC=O), 6.90-6.93 (m, 1H, arom CH), 6.94 (dd, 1H, J = 3.5, 5.0 
Hz, arom CH), 7.18 (dd, 1H, J = 1.1, 5.0 Hz, arom CH) 7.26-7.35 (m, 5H, arom CH) ppm. 
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13C-NMR (100 MHz, CDCl3): 
δ = 11.67, 11.70 (CH3), 21.93, 22.74 (CH3CH2), 47.43 (CHCHN), 53.40 (CHN), 67.13 
(CH2OC=O), 124.12, 126.63, 127.02, 128.37, 128.78, (arom CH), 136.82, 146.62 (arom C), 
156.30 (C=O) ppm. 
IR (CHCl3):  
ῦ = 3361 (s), 2965 (s), 2939 (s), 2875 (m), 1690 (vs), 1522 (vs), 1456 (m), 1316 (m), 1267 (s), 
1252 (s), 1227 (s), 1134 (m), 1022 (s), 746 (m), 712 (s), 699 (m) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 317 (4) [M+•], 247 (5), 246 (32), 226 (6), 202 (24), 92 (8), 91 (100). 
 
Elemental Analysis: 
Anal. Calcd for C23H21NO2SFe:  C = 68.10  H = 7.30  N = 4.41 
Found:          C = 67.96  H = 7.45  N = 4.45 
 
3.16.12 (1S)-(3-Phenyl-1-thiophen-2-yl-propyl)-carbamic acid benzyl ester (196b) 
 
HN
S
O
O
Ph
 
 
Optical rotation: [α = –36.5 (c = 1.4, CHCl
To a solution of 2-lithio-thiophene (6.4 mmol) in 20 ml of Et2O was added hydrazone 187e (492 
mg, 2.0 mmol) in 4 ml of Et2O according to GP15. After cleavage of the chiral auxiliary 
purification by column chromatography (Et2O:pentane 1:2) gave 196b (585 mg, 1.66 mmol) as a 
colorless solid. 
 
Yield: colorless solid, 585 mg, 83% 
Mp: 56-57°C 
TLC: Rf = 0.35 (Et2O: pentane 1:2) 
Enantiomeric excess: ee = 95% (HPLC) 
] 22D 3). 
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IR (CHCl   
1H-NMR (400 MHz, CDCl3): 
δ = 2.10-2.22 (m, 2H, CH2CH2), 2.60-2.73 (m, 2H, PhCH2), 5.03-5.28 (m, 4H, NH, CHNH, 
CH2OC=O), 6.93-6.96 (m, 2H, arom CH), 7.14-7.35 (m, 11H, arom CH) ppm. 
13C NMR (100 MHz, CDCl3): 
δ = 32.78 (PhCH2), 39.13 (CH2CH2), 51.09 (CHN), 67.23 (CH2OC=O), 124.56, 124.74, 126.32, 
127.09, 128.40, 128.61, 128.71, 128.76 (arom CH), 136.54, 141.23, 146.02 (arom C), 155.74 
(C=O) ppm. 
3):
ῦ = 3312 (s), 3029 (m), 2944 (m), 1684 (vs), 1538 (vs), 1497 (s), 1453 (s), 1436 (m), 1326 (s), 
1282 (s), 1261 (s), 1250 (s), 1134 (m), 1051 (s), 1028 (s), 750 (s), 698 (vs), 657 (m), 575 (m) 
cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 351 (1) [M+•], 260 (28), 202 (7), 199 (14), 156 (6), 92 (8), 91 (100), 65 (6). 
 
Elemental Analysis: 
Anal. Calcd for C21H21NO2S: C = 71.76  H = 6.03  N = 3.99 
Found:         C = 71.72  H = 6.00  N = 3.76 
 
3.16.13   (1S)-(Ferrocenyl-thiophen-2-yl-methyl)-carbamic acid benzyl ester (196f) 
 
Fe
HN
S
O
O
 
 
To a solution of 2-lithio-thiophene (3.2 mmol) in 10 ml of Et2O was added hydrazone 187h (326 
mg, 1.0 mmol) in 2 ml of Et2O according to GP15. After cleavage of the chiral auxiliary 
purification by column chromatography (Et2O:pentane 1:6) gave 196f (210 mg, 0.49 mmol) as 
an orange solid. 
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Yield: orange solid, 210 mg, 49% 
Mp: 85-87°C 
TLC: Rf = 0.30 (Et2O: pentane 1:6) 
Enantiomeric excess: ee ≥ 95% (based on 1H.NMR of the corresponding hydrazine) 
Optical rotation: [α] 22 = –38.8 (c = 1.1, CHClD 3). 
1H-NMR (300 MHz, CDCl3): 
δ = 4.10-4.56 (m, 9H, CH Fc), 5.16 (d, 1H, JAB  = 12.3 Hz, CHHOC=O), 5.24 (d, 1H, JAB = 12.3 
Hz CHHOC=O), 5.56-5.59 (br 1H, CHN), 5-97-6.00 (br, 1H, NH), 6.95-6.98 (m, 2H, arom CH), 
7.23-7.28 (m, 1H, arom CH), 7.38-7.42 (m, 5H, arom CH) ppm. 
13C-NMR (75 MHz, CDCl3): 
δ = 50.26 (CHN), 66.89 (CH, Fc), 67.13 (CH2O), 67.29, 68.10, 68.16, 69.03 (CH, Fc), 90.34 (C, 
Fc), 124.31, 125.05, 126.43, 128.17, 128.54 (arom CH), 136.45, 146.15 (arom C), 155.25 (C=O) 
ppm. 
IR (CHCl3):  
ῦ = 3355 (s), 1693 (vs), 1514 (s), 1227 (vs), 1019 (m), 819 (m), 751 (m), 698 (s), 485 (s) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 433 (9) [M+•+2], 432 [M+•+1], 431 (100) [M+•], 429 (7), 296 (12), 230 (8), 226 (11), 
217 (9), 212 (19), 160 (7), 121 (11), 91 (13), 56 (6). 
 
Elemental Analysis: 
Anal. Calcd for C23H21FeNO2S:  C = 64.04  H = 4.91  N = 3.25 
Found:          C = 64.34  H = 5.21  N = 3.16 
 
3.16.14 (1S)-(1-Thiophen-3-yl-propyl)-carbamic acid benzyl ester (191c) 
 
Me
HN
O
O
S  
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To a solution of 3-bromothiophene (1.127 g, 7 mmol) in 20 ml of ether 6.4 mmol of n-BuLi were 
added dropwise at –78°C and the obtained mixture was stirred for 90 min. hydrazone 187b (340 
mg, 2.0 mmol) in 4 ml of Et2O was added to the mixture according to GP15. After cleavage of 
the chiral auxiliary purification by column chromatography (Et2O:pentane 1:2) gave 191c (385 
mg, 1.48 mmol) as a colorless solid. 
 
Yield: colorless solid, 385 mg, 70% 
Mp: 76-77°C 
TLC: Rf = 0.40 (Et2O: pentane 1:2) 
Enantiomeric excess: ee = 94% (HPLC) 
Optical rotation: [α] 22 = –47.4 (c = 1.1, CHClD 3). 
1H-NMR (300 MHz, CDCl3): 
δ = 0.87 (t, 3H, J = 7.4 Hz, CH3), 1.70-1.83 (m, 2H, CH3CH2), 4.68-4.80 (m, 1H, CHNH), 5.02 
(d, 1H, JAB = 12.4 Hz CHHOC=O), 5.08 (d, 1H, JAB = 12.4 Hz CHHOC=O), 5.35 (d, 1H, J = 8.7 
Hz, NH), 6.96 (d, 1H, J = 4.2 Hz, arom CH), 7.03-7.06 (m, 1H, arom CH), 7.20 (dd, 1H, J = 3.0, 
5.2 Hz, arom CH), 7.22-7.30 (m, 5H, arom CH) ppm. 
13C NMR (75 MHz, CDCl3): 
δ = 10.72 (CH3), 29.21 (CH3CH2), 52.70 (CHN), 66.79 (CH2OC=O), 120.98, 126.15, 126.28, 
128.18, 128.62 (arom CH), 136.74, 143.78 (arom C), 156.12 (C=O) ppm. 
 
IR (KBr):  
ῦ = 3341 (s), 1683 (vs), 1533 (s), 1268 (s), 1239 (m), 1083 (m), 776 (m) cm−1. 
MS (EI, 70 eV):  
m/z (%) = 275 (7) [M+•], 246 (24), 202 (15), 184 (16), 140 (6), 97 (5), 92 (8), 91 (100), 65 (6). 
 
Elemental Analysis: 
Anal. Calcd for C15H17NO2S: C = 65.43  H = 6.22  N = 5.09 
Found:         C = 65.54  H = 6.09  N = 5.04 
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3.16.15 (1S)-[1-(5-Chloro-thiophen-2-yl-propyl)]-carbamic acid benzyl ester (191d) 
 
Me
HN
O
O
S
Cl  
 
TLC: R
 
 
To a solution of 2-bromo-5-chloro-thiophene (1.365 g, 7 mmol) in 20 ml of Et2O 6.4 mmol of n-
BuLi were added dropwise at –78°C and the obtained mixture was stirred for additional 90 min. 
Hydrazone 187b (340 mg, 2.0 mmol) in 4 ml of Et2O was added to the mixture in according to 
GP15. After cleavage of the chiral auxiliary purification by column chromatography 
(Et2O:pentane 1:2) gave 191d (495 mg, 1.60 mmol) as a colorless solid. 
 
Yield: colorless solid, 495 mg, 80% 
Mp: 65-66°C 
f = 0.30 (Et2O: pentane 1:2) 
Enantiomeric excess: ee = 96% (HPLC) 
Optical rotation: [α] 22 = –49.7 (c = 1.4, CHClD 3). 
1H-NMR (400 MHz, CDCl3): 
δ = 0.95 (t, 3H, J = 7.4 Hz, CH3), 1.74-1.86 (m, 2H, CH3CH2), 4.76-4.78 (m, 1H, CHNH), 5.05-
5.13 (m, 3H, NH, CH2CO=O), 6.70-6.73 (m, 2H, arom CH), 7.27-7.36 (m, 5H, arom CH) ppm. 
13C-NMR (100 MHz, CDCl3): 
δ = 10.71 (CH3), 29.79 (CH3CH2), 52.86 (CHN), 67.09 (CH2OC=O), 123.61, 125.77, 128.12, 
128.21, 128.55 (arom CH), 136.29, 145.14 (arom C), 155.61 (C=O) ppm. 
 
IR (KBr):  
ῦ = 3446 (m), 3311 (s), 1684 (vs), 1536 (s), 1263 (s), 700 (m) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 309 (7) [M ], 220 (23), 219 (6), 218 (61), 174 (10), 92 (7), 91 (100), 65 (5), 56 (14). +•
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Elemental Analysis: 
Anal. Calcd for C15H16ClNO2S:  C = 58.15  H = 5.21  N = 4.52 
Found:          C = 57.84  H = 5.53  N = 4.46 
 
3.16.16 (1S)-(1-Benzo[b]thiophen-2-yl-propyl)-carbamic acid benzyl ester (191b) 
 
Me
HN
O
O
S
 
 
Mp: 86-87°C 
 
 
13C-NMR (75 MHz, CDCl
δ = 10.83 (CH 3CH CHN), 67.26 (CH
124.44, 124.61, 128.47, 128.82 (arom CH), 136.60, 139.39, 139.86, 147.20 (arom C), 156.04 
(C=O) ppm. 
 
To a solution of 2-lithio-benzothiophene (6.4 mmol) in 20 ml of Et2O was added hydrazone 
187b (340 mg, 2.0 mmol) in 4 ml of Et2O according to GP15. After cleavage of the chiral 
auxiliary purification by column chromatography (Et2O:pentane 1:3) gave 191b (495 mg, 1.52 
mmol) as a colorless solid. 
 
Yield: colorless solid, 495 mg, 76% 
TLC: Rf = 0.25 (Et2O:pentane 1:3) 
Enantiomeric excess: ee = 93% (HPLC) 
Optical rotation: [α] 22 = –46.80 (c = 0.25 CHClD 3). 
1H-NMR (300 MHz, CDCl3): 
δ = 0.89 (t, 3H, J = 7.4 Hz, CH3), 1.82-1.87 (m, 2H, CH3CH2), 4.92-5.08 (m, 4H, CHNH, NH, 
CH2CO=O), 7.08-7.25 (m, 8H, arom CH), 7.58-7.66 (m, 1H, arom CH), 7.67-7.69 (m, 1H, arom 
CH) ppm. 
3): 
3), 30.01 (CH 2), 53.43 ( 2OC=O), 121.29, 122.65, 123.74, 
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IR (KBr):  
ῦ = 3289 (s), 1715 (m), 1690 (vs), 1541 (s), 1271 (s), 1235 (s), 1040 (m), 974 (m), 746 (s), 696 
(m) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 326 (7) [M+•+1], 325 [M+•], 252 (11), 235 (8), 234 (53), 191 (5), 190 (37), 147 (6), 
135 (13), 92 (7), 91 (100), 65 (5), 56 (10). 
 
Elemental Analysis: 
Anal. Calcd for C19H19NO2S: C = 70.12  H = 5.88  N = 4.30 
Found:         C = 70.00  H = 5.71  N = 4.22 
 
3.16.17 (1S)-(1-Benzo[b]thiophen-2-yl-pentyl)-carbamic acid benzyl ester (206c) 
 
HN
O
O
S
Me
 
 
To a solution of 2-lithio-benzothiophene (6.4 mmol) in 20 ml of Et 187f 
(396 mg, 2.0 mmol) in 4 ml of Et ge of the chiral auxiliary 
purification by column chromatography (Et 206c (440 mg, 1.24 mmol) as a 
colorless solid. 
 
2O was added hydrazone 
2O ccording to GP15. After cleava
2O:pentane 1:3) gave 
 
Yield: colorless solid, 440 mg, 62% 
Mp: 89-90°C 
TLC: Rf = 0.35 (Et2O: pentane 1:3) 
Enantiomeric excess: ee = 93% (HPLC) 
Optical rotation: [α] 22 = –52.0 (c = 1.0, CHClD 3). 
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1H-NMR (400 MHz, CDCl3): 
δ = 0.76 (t, 3H, J = 6.8 Hz, CH3CH2), 1.22-1.30 (m, 4H, CH3CH2CH2), 1.67-1.74 (m, 2H, 
CH2CH), 4.93-5.08 (m, 3H, CHN, CH2OC=O), 5.20 (d, 1H, J = 8.2 Hz, NH), 7.03 (s, 1H, arom 
CH), 7.12-7.20 (m, 7H, arom CH), 7.54 (d, 1H, J = 7.7 Hz, arom CH), 7.62 (d, 1H, J = 9.0 Hz, 
arom CH) ppm. 
13C-NMR (100 MHz, CDCl3): 
δ = 14.25 (CH3), 22.65 (CH3CH2), 28.44 (CH3CH2CH2), 36.64 (CH2CH), 51.99 (CHN), 67.20 
(CH2OC=O), 121.18, 122.65, 123.75, 124.40, 124.59, 128.42, 128.80 (arom CH), 136.69, 
139.40, 139.89, 147.68 (arom C), 156.06 (C=O) ppm. 
 
IR (KBr):  
ῦ = 3310 (s), 2953 (m), 2925 (m), 2855 (m), 1684 (vs), 1537 (s), 1456 (m), 1294 (m), 1256 (s), 
1046 (m), 749 (s), 725 (m), 696 (m), 663 (m) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 353 (16) [M+•], 263 (6), 262 (41), 252 (11), 245 (10), 218 (30), 189 (6), 188 (46), 160 
(7), 147 (12), 135 (9), 108 (6), 92 (8), 91 (100), 89 (7), 84 (5), 79 (5), 77 (5), 65 (6). 
 
Elemental Analysis: 
Anal. Calcd for C21H23NO2S: C = 71.36  H = 6.56 N = 3.96 
Found:         C = 71.02  H = 6.26  N = 3.80 
 
3.16.18 (1S)-(1-Benzo[b]thiophen-2-yl-2,2-dimethyl-propyl)-carbamic acid benzyl ester 
(206h) 
 
Me
HN
S
O
O
Me
Me
 
 
To a solution of 2-lithio-benzohiophene (6.4 mmol) in 20 ml of Et2O was added hydrazone 187d 
(396 mg, 2.0 mmol) in 4 ml of Et2O according to GP15. After cleavage of the chiral auxiliary 
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purification by column chromatography (Et2O:pentane 1:3) gave 206h (425 mg, 1.20 mmol) as a 
colorless solid. 
 
Yield: colorless solid, 425 mg, 60% 
Mp: 73-74°C 
TLC: Rf = 0.35 (Et2O: pentane 1:3) 
Enantiomeric excess: ee = 91% (HPLC) 
Optical rotation: [α] 22 = –12.2 (c = 1.2, CHCl3). D
1H-NMR (300 MHz, CDCl3): 
δ = 1.04 (s, 9H, CH3C), 4.90 (d, 1H, J = 9.3 Hz, CHNH), 5.03 (d, 1H, JAB = 12.1 Hz 
CHHOC=O), 5.10 (d, 1H, JAB = 12.1 Hz CHHOC=O), 5.26 (d, 1H, J = 9.3 Hz, NH), 7.15 (s, 1H, 
arom CH), 7.23-7.35 (m, 7H, arom CH), 7.68-7.71 (m, 1H, arom CH), 7.74-7.79 (m, 1H, arom 
CH) ppm. 
13C-NMR (75 MHz, CDCl3): 
δ = 26.78 (CH3), 35.10 (CH3C), 60.93 (CHN), 67.06 (CH2OC=O), 122.08, 122.87, 123.34, 
124.07, 124.25, 128.25, 128.54 (arom CH), 136.26, 139.10, 139.24, 144.41 (arom C), 155.93 
(C=O) ppm. 
IR (CHCl3):  
ῦ = 3277 (m), 2957 (m), 1706 (vs), 1402 (m), 1342 (s), 1053 (m), 741 (m), 696 (m) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 353 (3) [M+•], 297 (5), 296 (28), 252 (27), 160 (5), 129 (10), 92 (7), 91 (100), 57 (7). 
 
Elemental Analysis: 
Anal. Calcd for C21H23NO2S: C = 71.36  H = 6.56  N = 3.96 
Found:         C = 70.96  H = 6.44  N = 4.07 
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3.16.19 (1S)-(1-benzo[b]thiophen-2-yl-2-methyl-propyl)-carbamic acid benzyl ester (206d) 
 
Me
HN
S
O
O
Me
 
 
 
 
To a solution of 2-lithio-benzothiophene (6.4 mmol) in 20 ml of Et2O was added hydrazone 187c 
(520 mg, 2.0 mmol) in 4 ml of Et2O according to GP15. After cleavage of the chiral auxiliary 
purification by column chromatography (Et2O:pentane 1:3) gave 206d (520 mg, 1.54 mmol) as a 
colorless solid. 
 
Yield: colorless solid, 520 mg, 77% 
Mp: 77-78°C 
TLC: Rf = 0.36 (Et2O:pentane 1:3) 
Enantiomeric excess: ee = 99% (HPLC) 
Optical rotation: [α] 22 = –43.7 (c = 1.4,  CHClD 3). 
1H-NMR (300 MHz, CDCl3): 
δ = 0.98 (t, 6H, J = 6.5 Hz, CH3CH), 2.05-2.16 (m, 1H, CH3CH), 4.86-4.91 (m, 1H, CHN), 5.05-
5.16 (m, 3H, NH, CH2OC=O), 7.14 (s, 1H, arom CH), 7.24-7.34 (m, 7H, arom CH), 7.68 (d, 1H, 
J = 7.4 Hz, arom CH), 7.76 (d, 1H, J = 7.4 Hz, arom CH) ppm. 
13C NMR (75 MHz, CDCl3): 
δ = 18.17, 19.75 (CH3), 34.00 (CH3CH), 57.56 (CHN), 67.03 (CH2OC=O), 121.26, 122.28, 
123.38, 124.05, 124.29, 128.17, 128.53 (arom CH), 136.29, 139.11, 139.54, 146.43 (arom C), 
155.94 (C=O) ppm. 
 
IR (KBr):  
ῦ = 3429 (m), 3327 (s), 1685 (vs), 1537 (s), 1271 (s), 1243 (m) cm−1. 
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MS (EI, 70 eV):  
m/z (%) = 339 (6) [M+•], 296 (16), 252 (25), 248 (5), 231 (32), 190 (8), 189 (22), 188 (82), 162 
(5), 161 (12), 160 (17), 149 (10), 147 (12), 135 (7), 134 (6), 133 (18), 111 (8), 109 (7), 105 (5), 
99 (6), 97 (10), 95 (8), 92 (9), 91 (100), 89 (24), 85 (11), 83 (10), 82 (5), 81 (7), 79 (27), 77 (17), 
71 (14), 70 (5), 69 (15), 65 (7), 63 (5), 60 (5), 57 (28), 56 (6), 55 (12), 51 (10), 45 (8). 
 
Elemental Analysis: 
Anal. Calcd for C20H21NO2S: C = 70.77  H = 6.24  N = 4.13 
Found:         C = 70.90  H = 6.38  N = 3.98 
 
3.16.20 (1S)-(1-Benzo[b]thiophen-2-yl-3-phenyl-propyl)-carbamic acid benzyl ester (206g) 
 
HN
S
O
O
Ph
 
 
 
 
To a solution of 2-lithio-benzothiophene (6.4 mmol) in 20 ml of Et2O was added hydrazone 187e 
(492 mg, 2.0 mmol) in 4 ml of Et2O according to GP15. After cleavage of the chiral auxiliary 
purification by column chromatography (Et2O:pentane 1:2.5) gave 206g (580 mg, 1.44 mmol) as 
a colorless solid. 
 
Yield: colorless solid, 580 mg, 72% 
Mp: 113-114°C 
TLC: Rf = 0.20 (Et2O: pentane 1:2.5) 
Enantiomeric excess: ee = 95% (HPLC) 
Optical rotation: [α] 22 = –29.0 (c = 0.9, CHClD 3). 
1H-NMR (300 MHz, CDCl3): 
δ = 2.09-2.17 (m, 2H, CH2CH2), 2.54-2.67 (m, 2H, PhCH2), 4.97-5.08 (m, 4H, NH, CHNH, 
CH2OC=O), 6.99-7.26 (m, 13H, arom CH), 7.60 (d, 1H, J = 7.2 Hz, arom CH), 7.69 (d, 1H, J = 
7.2 Hz, arom CH) ppm. 
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13C-NMR (75 MHz, CDCl3): 
δ = 32.39 (PhCH2), 38.40 (CH2CH2), 51.51 (CHN), 67.10 (CH2OC=O), 121.33, 122.48, 123.60, 
124.35, 124.48, 126.23, 128.26, 128.47, 128.60 (arom CH), 136.34, 139.20, 139.60, 140.93, 
146.71 (arom C), 155.69 (C=O) ppm. 
IR (CHCl3):  
ῦ = 3313 (s), 1686 (vs), 1533 (s), 1454 (m), 1260 (s), 744 (s), 698 (m). 
 
MS (EI, 70 eV):  
m/z (%) = 401 (5) [M+•], 309 (30), 265 (16), 251 (10), 250 (5), 248 (25), 187 (6), 159 (6), 134 
(7), 92 (7), 90 (100), 65 (6). 
 
Elemental Analysis: 
Anal. Calcd for C21H21NO2S: C = 74.78  H = 5.77  N = 3.49 
Found:         C = 75.05  H = 6.10  N = 3.29 
 
3.16.21 (1S)-(1-Benzo[b]thiophen-2-yl-ferrocenyl-methyl)-carbamic acid benzyl ester 
(206a) 
 
Fe
HN
S
O
O
 
 
To a solution of 2-lithio-benzothiophene (3.2 mmol) in 10 ml of Et2O was added hydrazone 
187h (326 mg, 1.0 mmol) in 2 ml of Et2O according to GP15. After cleavage of the chiral 
auxiliary purification by column chromatography (Et2O:pentane 1:3) gave 206a (220 mg, 0.46 
mmol) as an orange solid. 
 
Yield: colorless solid, 220 mg, 46% 
Mp: 128-129°C 
TLC: Rf = 0.40 (Et2O: pentane 1:3) 
Enantiomeric excess: ee ≥ 95% (based on 1H.NMR of the corresponding hydrazine) 
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Optical rotation: [α] 22 = –9.1 (c = 1.1, CHClD 3). 
1H-NMR (300 MHz, CDCl3): 
δ = 4.07-4.15 (m, 9H, CH Fc), 5.03 (d, 1H, JAB = 12.2 Hz, CHHOC=O), 5.12 (d, 1H, JAB = 12.2 
Hz, CHHOC=O), 5.51-5.53 (br, 1H, NH), 5-89-5.91 (br 1H, CHN), 7.05-7.28 (m, 8H, arom 
CH), 7.56-7.59 (m, 1H, arom CH), 7.66-7.69 (m, 1H, arom CH) ppm. 
13C-NMR (75 MHz, CDCl3): 
δ = 50.91 (CHN), 66.78 (CH, Fc), 67.25 (CH2O), 67.44, 68.23, 69.11 (CH, Fc), 89.68 (C, Fc), 
121.75, 122.42, 123.65, 124.28, 124.36, 128.34, 128.66 (arom CH), 136.38, 139.39 139.49, 
146.87 (arom C), 155.39 (C=O) ppm. 
IR (CHCl3):  
ῦ = 3428 (s), 1696 (vs), 1509 (vs), 1307 (m), 1284 (m), 1233 (s) 1044 (m), 1024 (m), 823 (m), 
751 (s), 700 (m) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 483 (10) [M+•+2], 482 (33) [M+•+1], 481 (100) [M+•], 479 (7), 346 (20), 280 (10), 267 
(7), 226 (8), 212 (13), 210 (6), 209 (8), 121 (7), 91 (13). 
 
Elemental Analysis: 
Anal. Calcd for C27H23FeNO2S:  C = 67.35  H = 4.81  N = 2.91 
Found:          C = 67.44  H = 5.18  N = 2.73 
 
3.16.22 (1S)-(1-Benzo[b]thiophen-2-yl-phenyl-methyl)-carbamic acid benzyl ester (206e) 
 
HN
S
O
O
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, CDCl3): 
 
To a solution of 2-lithio-benzothiophene (6.4 mmol) in 20 ml of Et2O was added hydrazone 187j 
(436 mg, 2.0 mmol) in 2 ml of Et2O according to GP15. After cleavage of the chiral auxiliary 
purification by column chromatography (Et2O:pentane 1:2) gave 206e (345 mg, 0.92 mmol,) as a 
colorless solid.  
 
Yield: colorless solid, 345 mg, 46% (225 mg, 30% after single recrystallization) 
Mp: 101-103°C 
TLC: Rf = 0.37 (Et2O: pentane 1:2) 
Enantiomeric excess: ee = 77% (88% after recrystallization, HPLC) 
Optical rotation: [α] 22 = –7.27 (c = 1.1, CHClD 3). 
1H-NMR (300 MHz, CDCl3): 
δ = 5.13 (s, 2H, CH2OC=O), 5.58-5.61 (br, 1H, NH), 6.23-6.26 (br 1H, CHN), 7.03 (s, 1H, arom 
CH), 7.21-7.37 (m, 12H, arom CH), 7.61-7.67 (m, 1H, arom CH), 7.72-7.75 (m, 1H, arom CH) 
ppm. 
13C NMR (75 MHz
δ = 55.64 (CHN), 67.22 (CH2O), 122.25, 122.30, 123.59, 124.34, 124.40, 127.08, 128.17, 
128.53, 128.82 (arom CH), 136.13, 139.39 139.74, 140.57, 146.42 (arom C), 155.38 (C=O) ppm. 
IR (CHCl3):  
ῦ = 3318 (s), 1688 (vs), 1527 (s), 1240 (s), 1041 (m), 744 (m), 700 (m) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 374 (6) [M+•+1], 373 (24) [M+•], 283 (17), 282 (100), 239 (11), 238 (61), 223 (9), 221 
(10), 160 (6), 135 (11), 104 (42), 91 (43), 77 (8), 65 (6). 
 
Elemental Analysis: 
Anal. Calcd for C23H19NO2S: C = 73.97  H = 5.13 N = 3.75 
Found:         C = 73.72  H = 5.27 N = 3.71 
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3.16.23 (1S)-[1-Benzo[b]thiophen-2-yl-(4-methoxy-phenyl)-methyl]-carbamic acid benzyl 
ester (206f) 
 
HN
S
O
O
MeO
 
 
 
 
 
To a solution of 2-lithio-benzothiophene (6.4 mmol) in 20 ml of Et2O was added hydrazone 
187k (496 mg, 2.0 mmol) in 2 ml of Et2O according to GP15. After cleavage of the chiral 
auxiliary purification by column chromatography (Et2O:pentane 1:2) gave 206f (375 mg, 0.76 
mmol,) as a colorless solid.  
 
Yield: colorless solid, 375 mg, 38%  
Mp: 142-143°C 
TLC: Rf = 0.31 (Et2O: pentane 1:2) 
Enantiomeric excess: ee = 66% (HPLC of the corresponding sulfone) 
Optical rotation: [α] 22 = +5.5 (c = 1.1, CHClD 3). 
1H-NMR (300 MHz, CDCl3): 
δ = 3.77 (s, 3H, OCH3), 5.13 (d, 2H, J = 1.0 Hz, CH2OC=O), 5.58-5.62 (br, 1H, NH), 6.17-6.20 
(br 1H, CHN), 6.83-6.88 (m, 2H, arom CH), 7.02 (s, 1H, arom CH), 7.21-7.32 (m, 9H, arom 
CH), 7.61-7.64 (m, 1H, arom CH), 7.70-7.73 (m, 1H, arom CH). 
13C NMR (75 MHz, CDCl3): 
δ = 55.22 (CHN), 55.37 (OCH3), 67.25 (CH2O), 114.22, 122.11, 122.40, 123.63, 124.36, 124.45, 
128.28, 128.45, 128.61 (arom CH), 132.90, 136.27, 139.54 139.84, 147.02 (arom C), 155.48 
(C=O), 159.48 (arom C). 
IR (CHCl3):  
ῦ = 3317 (s), 1689 (vs), 1514 (s), 1457 (s), 1294 (m), 1245 (vs), 1044 (m), 1028 (m), 833 (m), 
741 (m). 
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MS (EI, 70 eV):  
m/z (%) = 404 (8) [M+•+1], 403 (21) [M+•], 313 (19), 312 (100), 269 (11), 268 (68), 253 (13), 
160 (18), 135 (7), 134 (39), 109 (6), 91 (47), 65 (5). 
 
Elemental Analysis: 
Anal. Calcd for C24H21NO2S: C = 71.44  H = 5.25 N = 3.47 
Found:         C = 71.76  H = 5.16 N = 3.51 
 
3.16.24  (1S)-[1-Benzo[b]thiophen-2-yl-(4-trifluoromethyl-phenyl)-methyl]-carbamic acid 
benzyl ester (206b) 
 
HN
S
O
O
F3C
 
 
 
 
To a solution of 2-lithio-benzothiophene (6.4 mmol) in 20 ml of Et2O was added Hydrazone 
206b (572 mg, 2.0 mmol) in 2 ml of Et2O according to GP15. After cleavage of the chiral 
auxiliary purification by column chromatography (Et2O:pentane 1:2) gave 187l (460 mg, 0.80 
mmol,) as a colorless solid.  
 
Yield: colorless solid, 460 mg, 40%  
Mp: 176-177°C 
TLC: Rf = 0.31 (Et2O: pentane 1:2) 
Enantiomeric excess: ee = 66% (HPLC of the corresponding sulfone) 
Optical rotation: [α] 22 = –20.0 (c = 1.0, CHClD 3). 
1H-NMR (300 MHz, CDCl3): 
δ = 5.12 (d, 2H, J = 2.0 Hz, CH2OC=O), 5.50-5.63 (br, 1H, NH) 6.27-6.30 (br 1H, CHN), 7.00 
(s, 1H, arom CH), 7.24-7.35 (m, 7H, arom CH), 7.49 (d, 2H, J = 8.1 Hz, arom CH), 7.60-7.68 
(m, 3H, arom CH), 7.73-7.77 (m, 1H, arom CH) ppm. 
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, CDCl
 
 
13C-NMR (75 MHz, CDCl3): 
δ = 55.26 (CHN), 67.43 (CH2OC=O), 122.83, 122.86, 123.75, 124.66, 124.74, 125.78, 125.83, 
127.40, 128.26, 128.35, 128.58, (arom CH), 130.15, 130.57, 135.91, 139.20, 139.70, 144.55, 
144.85 (CF3, arom C), 155.32 (C=O) ppm. 
19F-NMR (282 MHz 3): 
δ = −62.49 ppm. 
IR (CHCl3):  
ῦ = 3305 (s), 1690 (vs), 1534 (s), 1333 (vs), 1291 (s), 1245 (s), 1172 (m), 1152 (m), 1111 (s), 
1070 (m), 1048 (m) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 442 (5) [M+•+1], 441 (9) [M+•], 352 (6), 351 (19), 350 (100), 307 (14), 306 (77), 291 
(7), 221 (5), 172 (27), 135 (20), 134 (5), 91 (28), 89 (5), 65 (5). 
 
Elemental Analysis: 
Anal. Calcd for C24H18F3NO2S:  C = 65.30  H = 4.11 N = 3.17 
Found:          C = 65.54  H = 4.53 N = 3.08 
 
3.17  Sulfones 
3.17.1 (S)-[1-(1,1-Dioxo-1H-1λ6-benzo[b]thiophen-2-yl)-propyl]-carbamic acid  
benzyl ester (207a) 
 
HN
SO
O
Me
O
O
 
 
To a well stirred solution of carbamate 191b (325 mg, 1.0 mmol) in 54 ml of a 
H2O/Acetone/CH2Cl2 (1/0.8/0.9) mixture, were added 1.2 g of NaHCO3 followed by 2 g of 
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oxone, according to GP17. After work-up, removal of the solvent in vacuo afforded 207a (350 
mg, 0.98 mmol) as a colorless solid. 
 
Yield: colorless solid, 350 mg, 98% 
Mp: 68-69°C 
TLC: Rf = 0.32 (AcOEt: pentane 1:2) 
Enantiomeric excess: ee = 93% (HPLC) 
Optical rotation: [α] 22 = –72.8 (c = 1.7, CHClD 3). 
1H-NMR (400 MHz, CDCl3): 
δ = 1.00 (t, 3H, J = 7.4 Hz, CH3), 1.85-1.94 (m, 1H, CH3CHH), 2.02-213 (m, 1H, CH3CHH), 
4.72-4.78 (m, 1H, CHNH,), 5.07 (d, 1H, JAB = 12.4 Hz, CHHOC=O), 5.13 (d, 1H, JAB = 12.4 Hz, 
CHHOC=O), 5.62 (d, J =8.5 Hz, NH), 6.96 (s, 1H, CHCSO2), 7.23-7.34 (m, 6H, arom CH), 
7.38-7.49 (m, 2H, arom CH), 7.60 (d, J = 7.4 Hz, 1H, arom CH) ppm. 
13C-NMR (100 MHz, CDCl3): 
δ = 10.38 (CH3), 26.22 (CH3CH2), 50.87 (CHN), 66.85 (CH2OC=O), 120.91, 124.84, 127.69 
127.78, 127.89, 128.26, 129.80 (arom CH, CHCSO2), 130.26 (CSO2), 133.41 (arom CH), 
136.02, 137.03, 143.32 (arom C), 155.50 (C=O) ppm. 
 
IR (KBr):  
ῦ = 3348 (m), 2970 (m), 1710 (vs), 1524 (vs), 1456 (s), 1299 (vs), 1235 (s), 1149 (vs), 1125 (m), 
756 (vs), 700 (m) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 357 [M+•], 284 (9), 222 (7), 192 (5), 181 (5), 148 (7), 137 (5), 108 (5), 92 (7), 91 
(100), 65 (6). 
 
Elemental Analysis: 
Anal. Calcd for C19H19NO4S: C = 63.85  H = 5.36 N = 3.92 
Found:         C = 63.50  H = 5.61 N = 3.67 
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3.17.2 (S)-[1-(1,1-Dioxo-1H-1λ6-benzo[b]thiophen-2-yl)-pentyl]-carbamic acid  
benzyl ester (207c) 
 
HN
SO
O
O
O
Me
 
To a well stirred solution of carbamate 206c (353 mg, 1.0 mmol) in 54 ml of a 
H2O/Acetone/CH2Cl2 (1/0.8/0.9) mixture, were added 1.2 g of NaHCO3 followed by 2 g of 
oxone, according to GP17. After work-up, removal of the solvent in vacuo afforded 207c (377 
mg, 0.98 mmol) as a colorless foam. 
 
Yield: colorless foam, 377 mg, 98% 
TLC: Rf = 0.25 (Et2O: pentane 3:2) 
Enantiomeric excess: ee = 93% (HPLC) 
 
 
Optical rotation: [α] 22 = –52.7 (c = 1.4, CHClD 3). 
1H-NMR (400 MHz, CDCl3): 
δ = 0.90 (t, 3H, J = 7.2 Hz, CH3), 1.34-1.47 (m, 4H, CH3CH2CH2), 1.85-1.96 (m, 1H, 
CHHCHN), 2.01-2.09 (m, 1H, CHHCHN), 4.79-4.85 (m, 1H, CHNH,), 5.07 (d, 1H, JAB = 12.1 
Hz, CHHOC=O), 5.14 (d, 1H, JAB = 12.1 Hz, CHHOC=O), 5.45 (d, 1H, J =8.5 Hz, NH), 6.97 (s, 
1H, CHCSO2), 7.26-7.33 (m, 6H, arom. CH), 7.42-7.52 (m, 2H, arom CH), 7.64 (d, 1H, J = 7.4 
Hz, arom CH) ppm. 
13C-NMR (100 MHz, CDCl3): 
δ = 14.08 (CH3), 22.34 (CH3CH2), 28.20 (CH3CH2CH2), 32.82 (CH2CHN), 49.90 (CHN), 67.13 
(CH2OC=O), 121.22, 125.05, 127.85 128.06, 128.14, 128.50, 130.07 (arom CH, CHCSO2), 
130.56 (CSO2), 133.63 (arom CH), 136.24, 137.38, 143.73 (arom C), 155.63 (C=O) ppm. 
 
IR (KBr):  
ῦ = 3418 (vs), 2956 (s), 2930 (s), 2856 (s), 1705 (s), 1527 (s), 1456 (m), 1384 (m), 1301 (s), 
1258 (s), 1149 (s), 1123 (s), 1037 (m), 755 (s), 699 (m) cm−1. 
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MS (EI, 70 eV):  
m/z (%) = 284 (7), 250 (7), 236 (5), 235 (16), 230 (6), 222 (6), 221 (6), 220 (40), 213 (8), 194 
(5), 185 (6), 184 (20), 181 (6), 179 (6), 178 (7), 176 (10), 172 (11), 171 (29), 170 (29), 169 (5), 
157 (6), 156 (11), 151 (7), 150 (7), 149 (27), 144 (7), 143 (26), 142 (8), 141 (7), 139 (6), 138 (7), 
137 (20), 136 (9), 131 (10), 130 (21), 129 (18), 128 (13), 127 (7), 122 (7), 121 (11), 117 (5), 116 
(6), 115 (14), 113 (6), 111 (7), 109 (18), 108 (63), 107 (42), 105 (7), 102 (12), 101 (14), 97 (7), 
95 (6), 92 (7), 91 (100), 90 (6), 89 (13), 85 (8), 83 (7), 80 (6), 79 (58), 78 (8), 76 (5), 75 (6), 71 
(8), 65 (12), 63 (7), 57 (21), 55 (13), 53 (5), 51 (23), 50 (7). 
 
MS (CI, 100eV, methane):  
m/z (%) = 386 (6) [M+•+1], 342 (6), 238 (5), 237 (35), 236 (6), 235 (35), 217 (6), 119 (6), 108 
(7), 107 (14), 93 (6), 92 (10), 91 (100), 79 (23). 
 
Elemental Analysis: 
Anal. Calcd for C21H23NO4S: C = 65.43  H = 6.01 N = 3.63 
Found:         C = 65.37  H = 6.10 N = 3.60 
3.17.3  (S)-[1-(1,1-Dioxo-1H-1λ6-benzo[b]thiophen-2-yl)-2,2-dimethyl-propyl]-
carbamic acid benzyl ester (207h) 
t-Bu
HN
S
O
O
O
O  
 
To a well stirred solution of carbamate 206h (353 mg, 1.0 mmol) in 54 ml of a 
H2O/Acetone/CH2Cl2 (1/0.8/0.9) mixture, were added 1.2 g of NaHCO3 followed by 2 g of 
oxone, according to GP17. After work-up, removal of the solvent in vacuo afforded 207h (375 
mg, 0.97 mmol) as a colorless solid. 
 
Yield: colorless solid, 375 mg, 97% 
Mp: 75°C 
TLC: Rf = 0.25 (Et2O: pentane 3:2) 
Enantiomeric excess: ee = 91% (HPLC) 
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Optical rotation: [α] 22 = –54.3 (c = 1.3 CHClD 3). 
1H-NMR (400 MHz, CDCl3): 
δ = 1.10 (s, 9H, (CH3)3C), 4.72 (d, 1H, J = 9.9 Hz, CHNH,), 5.04 (d, 1H, JAB = 12.1 Hz, 
CHHOC=O), 5.13 (d, 1H, JAB = 12.1 Hz, CHHOC=O), 5.64 (d, 1H, J = 9.6 Hz, NH), 7.03 (s, 
1H, CHCSO2), 7.25-7.33 (m, 6H, arom. CH), 7.39-7.49 (m, 2H, arom CH), 7.61 (d, 1H, J = 7.5 
Hz, arom CH) ppm. 
13C NMR (100 MHz, CDCl3): 
δ = 26.84 (CH3), 35.31 (CH3C), 59.23 (CHN), 66.97 (CH2OC=O), 120.98, 124.78, 127.79 
127.85, 128.24, 129.96 (arom CH, CHCSO2), 130.15 (CSO2), 133.37 (arom CH), 136.00, 
136.64, 142.98 (arom C), 155.67 (C=O) ppm. 
 
IR (KBr):  
ῦ = 3350 (s), 2964 (s), 1702 (vs), 1527 (vs), 1455 (s), 1300 (vs), 1235 (vs), 1149 (vs), 1126 (s), 
1067 (m), 1009 (m), 756 (s), 548 (m) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 385 (1) [M+•], 284 (6), 268 (10), 239 (11), 238 (88), 195 (6), 194 (56), 137 (5), 92 (5), 
91 (100), 65 (7), 57 (12). 
 
Elemental Analysis: 
Anal. Calcd for C21H23NO4S: C = 65.43  H = 6.01 N = 3.63 
Found:         C = 65.42  H = 6.24 N = 3.55 
3.17.4  (S)-[1-(1,1-Dioxo-1H-1λ6-benzo[b]thiophen-2-yl)-2-methyl-propyl]-carbamic acid 
benzyl ester (207d) 
i-Pr
HN
S
O
O
O
O  
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To a well stirred solution of carbamate 206d (340 mg, 1.0 mmol) in 54 ml of a 
H2O/Acetone/CH2Cl2 (1/0.8/0.9) mixture, were added 1.2 g of NaHCO3 followed by 2 g of 
oxone, according to GP17. After work-up, removal of the solvent in vacuo afforded 207d (365 
mg, 0.98 mmol) as a colorless foam. 
 
Yield: colorless foam, 375 mg, 98% 
TLC: Rf = 0.28 (Et2O:pentane 3:2) 
Enantiomeric excess: ee = 99% (HPLC) 
Optical rotation: [α] 22 = –74.3 (c = 1.6, CHClD 3). 
1H-NMR (400 MHz, CDCl3): 
δ = 0.99 (d, 3H, J = 6.6 Hz, CH3CH), 1.02 (d, 3H, J = 6.3 Hz, CH3CH), 2.35-2.43 (m, 1H, 
CH3CH), 4.66 (t, 1H, J = 8.9 Hz, CHNH,), 5.07 (d, 1H, JAB = 12.3 Hz, CHHOC=O), 5.15 (d, 1H, 
JAB = 12.2Hz, CHHOC=O), 5.69 (d, J = 8.9 Hz, NH), 6.96 (s, 1H, CHCSO2), 7.21-7.31 (m, 6H, 
arom CH), 7.41 (dt, J = 7.4, 28.3 Hz, 2H, arom CH), 7.58 (d, 1H, J = 7.2 Hz, arom CH) ppm. 
13C-NMR (100 MHz, CDCl3): 
δ = 18.02, 19.88 (CH3), 30.48 (CH3CH), 55.62 (CHN), 66.83 (CH2OC=O), 120.86, 124.78, 
127.71 127.85, 128.05, 128.24, 129.75 (arom CH, CHCSO2), 130.25 (CSO2), 133.41 (arom CH), 
136.05, 136.98, 143.18 (arom C), 155.74 (C=O) ppm. 
 
IR (KBr):  
ῦ = 3351 (s), 3063 (m), 3030 (m), 2966 (s), 2934 (m), 1711 (vs), 1523 (vs), 1458 (s), 1300 (vs), 
1237 (vs), 1149 (vs), 1125 (m), 1099 (m), 1021 (m), 756 (vs), 700 (m), 545 (m) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 371 (1) [M+•], 328 (15), 284 (22), 238 (6), 194 (7), 92 (7), 91 (100), 65 (6). 
 
Elemental Analysis: 
Anal. Calcd for C20H21NO4S: C = 64.67  H = 5.70 N = 3.77 
Found:         C = 64.58  H = 6.09 N = 3.51 
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3.17.5  (S)-[1-(1,1-Dioxo-1H-1λ6-benzo[b]thiophen-2-yl)-2-phenyl-propyl]-carbamic acid 
benzyl ester (207g) 
 
HN
S
O
O
O
O  
 
 
 
To a well stirred solution of carbamate 206g (401 mg, 1.0 mmol) in 54 ml of a 
H2O/Acetone/CH2Cl2 (1/0.8/0.9) mixture, were added 1.2 g of NaHCO3 followed by 2 g of 
oxone, according to GP17. After work-up, removal of the solvent in vacuo afforded 207g (425 
mg, 0.98 mmol) as a colorless solid. 
 
Yield: colorless solid, 425 mg, 98% 
Mp: 43-44°C 
TLC: Rf = 0.32 (Et2O:pentane 2:1) 
Enantiomeric excess: ee = 95% (HPLC) 
Optical rotation: [α] 22 = –50.2 (c = 1.2, CHClD 3). 
1H-NMR (300 MHz, CDCl3): 
δ = 2.19 (m, 2H, CH2CH), 2.73 (t, 2H, J = 7.4 Hz, PhCH2), 4.82-4.85 (m, 1H, CHNH,), 5.05 (d, 
1H, JAB = 12.3 Hz, CHHOC=O), 5.13 (d, 1H, JAB = 12.3 Hz, CHHOC=O), 5.66 (d, J = 8.4 Hz, 
NH), 6.93 (s, 1H, CHCSO2), 7.17-7.48 (m, 13H, arom CH), 7.60 (d, 1H, J = 7.4 Hz, arom CH) 
ppm. 
13C-NMR (75 MHz, CDCl3): 
δ = 31.03 (PhCH2), 34.62 (CH2CHN), 49.74 (CHN), 67.15 (CH2OC=O), 121.28, 125.25, 126.30 
128.15, 128.26, 128.47, 128.59, 128.65, 130.25 (arom CH, CHCSO2), 130.56 (CSO2), 133.79 
(arom CH), 136.32, 137.37, 140.58, 143.26 (arom C), 155.79 (C=O) ppm 
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IR (KBr):  
ῦ = 3335 (m), 3062 (m), 3027 (s), 2951 (m), 1711 (vs), 1522 (vs), 1454 (s), 1300 (vs), 1240 (vs), 
1149 (vs), 1047 (s), 756 (vs), 701 (s) cm−1. 
MS (EI, 70 eV):  
m/z (%) = 433 (1) [M+•], 238 (18), 194 (24), 137 (5), 105 (8), 92 (9), 91 (100), 79 (5), 77 (6), 65 
(7). 
 
Elemental Analysis: 
Anal. Calcd for C25H23NO4S: C = 69.26  H = 5.35 N = 3.23 
Found:         C = 69.29  H = 5.53 N = 3.09 
3.17.6 (S)-[1-(1,1-Dioxo-1H-1λ6-benzo[b]thiophen-2-yl)-phenyl-methyl]-carbamic acid  
benzyl ester (207e) 
 
HN
S
O
O
O
O  
 
 
To a well stirred solution of carbamate 206e (375 mg, 1.0 mmol) in 54 ml of a 
H2O/Acetone/CH2Cl2 (1/0.8/0.9) mixture, were added 1.2 g of NaHCO3 followed by 2 g of 
oxone, according to GP17. After work-up, removal of the solvent in vacuo afforded 207e (390 
mg, 0.96 mmol) as a colorless solid. 
 
Yield: colorless solid, 390 mg, 96% 
Mp: 63-65°C 
TLC: Rf = 0.40 (Et2O:pentane 3:1) 
Enantiomeric excess: ee = 88% (HPLC) 
Optical rotation: [α] 22 = –22.0 (c = 1.5, CHClD 3). 
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1H-NMR (300 MHz, CDCl3): 
δ = 5.09 (s, 1H, CH2OC=O), 5.99-6.03 (br, 2H, CHN, NH), 6.64 (s, 1H, CHCSO2), 7.10-7.49 
(m, 13H, arom CH), 7.60-7.63 (m, 1H, arom CH) ppm. 
13C-NMR (75 MHz, CDCl3): 
δ = 51.17 (CHN), 66.23 (CH2OC=O), 120.36, 124.20, 126.18 127.10, 127.44, 127.61, 128.00 
(arom CH, CHCSO2), 129.03 (CSO2), 129.26 132.65 (arom CH), 135.03, 136.33, 136.45, 142.86 
(arom C), 154.34 (C=O) ppm. 
 
IR (KBr):  
ῦ = 3430 (vs), 1718 (vs), 1523 (s), 1455 (m), 1303 (vs), 1243 (s), 1149 (vs), 1127 (m), 757 (m), 
702 (s), 545 (m) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 405 (1) [M+•], 271 (12), 270 (67), 256 (14), 250 (11), 240 (12), 233 (6), 210 (6), 208 
(5), 207 (6), 206 (8), 205 (6), 204 (13), 196 (5), 191 (6), 189 (7), 180 (5), 179 (11), 178 (11), 165 
(9), 137 (10), 108 (7), 106 (6), 104 (7), 92 (9), 91 (100), 89 (5), 79 (8), 77 (13), 65 (9), 51 (6). 
 
Elemental Analysis: 
Anal. Calcd for C23H19NO4S: C = 68.13  H = 4.72 N = 3.45 
Found:         C = 68.26  H = 4.92  N = 3.38 
3.17.7  (S)-[1-(1,1-Dioxo-1H-1λ6-benzo[b]thiophen-2-yl)-(4-methoxy-phenyl)-methyl]-
carbamic acid benzyl ester (207f) 
 
HN
S
O
O
O
O
H3CO
 
 
To a well stirred solution of carbamate 206f (405 mg, 1.0 mmol) in 54 ml of a 
H2O/Acetone/CH2Cl2 (1/0.8/0.9) mixture, were added 1.2 g of NaHCO3 followed by 2 g of 
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oxone, according to GP17. Flash chromatography (Et2O:pentane 3:1) afforded 207f (385 mg, 
0.88 mmol) as colorless solid. 
 
Yield: colorless solid, 385 mg, 88% 
Mp: 60-62°C 
TLC: Rf = 0.30 (Et2O:pentane 3:1) 
Enantiomeric excess: ee = 66% (HPLC) 
Optical rotation: [α] 22 = –2.5 (c = 1.0 CHClD 3). 
1H-NMR (400 MHz, CDCl3): 
δ = 3.79 (s, 3H, OCH3), 5.11 (s, 2H, CH2OC=O), 5.80-5.84 (br, 1H, NH), 5.96-6.00 (br, 1H, 
CHN), 6.67 (s, 1H, CHCSO2), 6.88-6.92 (m, 2H, arom CH), 7.18-7.36 (m, 13H, arom CH), 7.44 
(ddt, 2H,J = 1.1, 7.4, 21.4, arom CH), 7.61-7.63 (m, 1H, arom CH) ppm. 
13C-NMR (75 MHz, CDCl3): 
δ = 51.73 (CHN), 55.19 (OCH3), 67.10 (CH2OC=O), 114.20, 121.17, 124.96 127.90, 128.25, 
128.32, 128.55 (arom CH, CHCSO2), 129.29, 129.94 (CSO2, arom C), 129.99 133.41 (arom 
CH), 135.91, 137.27, 144.09 (arom C), 155.06 (C=O), 159.48 (arom C) ppm. 
 
IR (KBr):  
ῦ = 3349 (m), 1717 (vs), 1512 (vs), 1457 (m), 1303 (vs), 1248 (vs), 1148 (vs), 1125 (m), 835 
(m), 757 (s), 700 (m), 546 (m) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 344 (10), 327 (14), 301 (11), 236 (6), 137 (6), 135 (5), 109 (8), 108 (9), 107 (6), 91 
(37), 79 (8), 77 (8). 
 
Elemental Analysis: 
Anal. Calcd for C24H21NO5S: C = 66.19  H = 4.86 N = 3.22 
Found:         C = 66.15  H = 5.18  N = 3.05 
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3.17.8  (S)-[1-(1,1-Dioxo-1H-1λ6-benzo[b]thiophen-2-yl)-(4-trifluoromethyl-phenyl)-
methyl]-carbamic acid benzyl ester (207b) 
 
HN
S
O
O
O
O
F3C
 
 
 
 
 
To a well stirred solution of carbamate 206b (450 mg, 1.0 mmol) in 54 ml of 
H2O/Acetone/CH2Cl2 (1/0.8/0.9) were added 1.2 g of NaHCO3 followed by 2 g of oxone, 
according to GP17. After work-up, removal of the solvent in vacuo afforded 207b (455 mg, 0.96 
mmol) as a colorless solid. 
 
Yield: colorless solid, 455 mg, 96% 
Mp: 53-55°C 
TLC: Rf = 0.28 (Et2O:pentane 3:1) 
Enantiomeric excess: ee = 22% (HPLC) 
Optical rotation: [α] 22 = –2.9 (c = 1.0, CHClD 3). 
1H-NMR (400 MHz, CDCl3): 
δ = 5.09 (s, 2H, CH2OC=O), 6.11-6.22 (br, 2H, CHN, NH), 6.67 (s, 1H, CHCSO2), 7.21-7.33 
(m, 6H, arom CH), 7.42-7.52 (m, 4H, arom CH), 7.60-7.69 (m, 3H, arom CH) ppm. 
13C-NMR (100 MHz, CDCl3): 
δ = 51.73 (CHN), 67.35 (CH2OC=O), 121.29 (arom CH), 123.70 (q, J = 272 Hz, CF3), 125.23 
125.77, 125.81, 127.45, 127.88 128.05, 128.31, 129.45 (arom CH, CHCSO2), 129.66 (CSO2), 
130.39 (arom CH), 130.67 (arom C), 133.64 (arom CH), 135.69, 136.95, 141.30, 142.63 (arom 
C), 155.22 (C=O) ppm. 
19F-NMR (376 MHz, CDCl3): 
δ = −62.51ppm. 
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MS (EI, 70 eV):  
 
IR (KBr):  
ῦ = 3360 (s), 1719 (s), 1524 (s), 1326 (vs), 1246 (m), 1151 (vs), 1125 (vs), 1066 (s), 757 (m), 
700 (m). 
 
m/z (%) = 473 (1) [M+•], 338 (36), 324 (8), 318 (9), 137 (9), 108 (6), 107 (12), 92 (5), 91 (100), 
65 (5). 
 
Elemental Analysis: 
Anal. Calcd for C24H18F3NO4S:  C = 60.88  H = 3.83 N = 2.96 
Found:          C = 60.45  H = 4.15  N = 2.85 
 
3.18  Synthesis of ß-aminosulfones 
3.18.1  (1S,2R)-[1-(1,1-Dioxo-2,3-dihydro-1H-1λ6-benzo[b]thiophen-2-yl)-propyl]-
carbamic acid benzyl ester (208a) 
 
HN
SO
O
Me
O
O
 
 
 
 
a) To a well stirred solution of carbamate 207a (140 mg, 0.39 mmol) in 10 ml of MeOH at –
20°C, was added a catalytic amount of NiCl2 (10 mg, 20 % mol), followed by 4 equivalents of 
NaBH4 (60 mg, 1.56 mmol), according to GP17. After work-up, purification by flash column 
chromatography (AcOEt: pentane 1:2) afforded 208a (125 mg, 0.35 mmol) as a colorless solid. 
b) To a well stirred solution of carbamate 207a (140 mg, 0.39 mmol) in 10 ml of THF at –78°C, 
were added dropwise 0.78 ml of L-selectride® (1M solution in THF), according to GP17. After 
work-up, purification by flash column chromatography (AcOEt: pentane 1:2) afforded 208a (93 
mg, 0.26 mmol) as a colorless solid. 
Yield: colorless solid, 125 mg, 89%a, 93 mg, 66%b 
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Mp: 101-103°C 
TLC: Rf = 0.32 (AcOEt: pentane 1:2) 
Diastereomeric excess: de ≥ 96%a,b (1H-NMR) 
Enantiomeric excess: ee = 93%a,b (HPLC) 
Optical rotation: [α] 22 = –9.4 (c = 1.0, CHClD 3). 
1H-NMR (300 MHz, CDCl3): 
(signals of carbamate isomers are reported): 
δ = 0.98 (t, 3H, J = 7.2 Hz, CH3), 1.06 (t, 3H, J = 7.2 Hz, CH3), 1.80-2.04 (m, 2H, CH3CH2), 
3.24-3.37 (m, 2H, CH2CHSO2), 3.64 (q, 1H, J = 8.2 Hz, CHSO2), 3.77 (dt, 1H, J = 4.2, 8.5 Hz, 
CHSO2), 4.07-4.18 (m, 1H, CHN), 5.01-5.13 (m, 2H, NH, CH2OC=O), 5.23 (d, 1H, J = 9.2 Hz, 
NH), 5.79 (d, 1H, J = 10.1 Hz, NH) 7.25-7.38 (m, 6H, aromCH), 7.39-7.46 (m, 1H, arom CH), 
7.51-7.58 (m, 1H, arom CH), 7.65-7.71 (m, 1H, arom CH) ppm. 
13C-NMR (75 MHz, CDCl3): 
δ = 10.39, 11.13 (CH3), 25.38, 26.80 (CH3CH2), 29.82, 30.71 (CH2CHSO2), 52.65, 53.08 
(CHN), 63.57, 65.01 (CHSO2), 66.95, 67.08 (CH2OC=O), 121.91, 121.63, 127.03 127.20, 
127.92 128.16, 128.33, 128.54, 128.64, 128.77, 128.85, 133.60, 133.65 (arom CH), 136.34, 
136.41, 139.00, 139.44 ( arom C), 156.21, 156.82 (C=O) ppm. 
 
IR (KBr):  
ῦ = 3346 (s), 2966 (m), 1686 (vs), 1527 (vs), 1457 (m), 1290 (vs), 1243 (s), 1151 (s), 1125 (m), 
1098 (m), 757 (m), 543 (m) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 359 (7) [M+•], 108 (42), 92 (5), 91 (100), 58 (5). 
 
Elemental Analysis: 
Anal. Calcd for C19H21NO4S: C = 63.49  H = 5.89 N = 3.90. 
Found:         C = 63.79  H = 5.51 N = 3.88. 
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3.18.2  (1S,2R)-[1-(1,1-Dioxo-2,3-dihydro-1H-1λ6-benzo[b]thiophen-2-yl)-pentyl]-carbamic 
acid benzyl ester (208b) 
 
HN
SO
O
O
O
Me
 
 
 
 
 
 
a) To a well stirred solution of carbamate 207c (190 mg, 0.49 mmol) in 10 ml of MeOH at –
20°C, was added a catalytic amount of NiCl2 (13 mg, 20 %), followed by 4 equivalents of 
NaBH4 (75 mg, 1.97 mmol), according to GP17. After work-up, purification by flash column 
chromatography (Et2O: pentane 3:2) afforded 208b (150 mg, 0.38 mmol) as a colorless solid. 
b) To a well stirred solution of carbamate 207c (190 mg, 0.49 mmol) in 10 ml of THF at –78°C, 
was added dropwise 1.00 ml of L-selectride® (1M solution in THF), according to GP17. After 
work-up, purification by flash column chromatography (Et2O: pentane 3:2) afforded 208b (134 
mg, 0.34 mmol) as a colorless solid. 
Yield: colorless solid, 150 mg, 79%a, 134 mg, 70%b 
Mp: 82-84°C 
TLC: Rf = 0.25 (Et2O: pentane 3:2) 
Diastereomeric excess: de ≥ 96%a,b (1H-NMR) 
Enantiomeric excess: ee = 93%a,b (HPLC) 
Optical rotation: [α] 22 = –14.2 (c = 1.7, CHClD 3). 
1H-NMR (300 MHz, CDCl3): 
(signals of the major carbamate isomer are reported): 
δ = 0.86 (t, 3H, J = 6.7 Hz, CH3), 1.21-1.43 (m, 4H, CH3CH2, CH3CH2CH2), 1.55-1.72 (m, 1H, 
CHHCHNH), 1.79-1.82 (m, 1H, CHHCHNH), 3.17-3.38 (m, 2H, CH2CHSO2), 3.62 (q, 1H, J = 
8.2 Hz, CHSO2), 4.09-4.20 (m, 1H, CHN), 5.12 (s, 2H, CH2OC=O), 5.24 (d, 1H, J = 9.4 Hz, 
NH), 7.25-7.43 (m, 7H, arom CH), 7.49-7.55 (m, 1H, arom CH), 7.65-7.69 (m, 1H, arom CH) 
ppm. 
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13C-NMR (75 MHz, CDCl3): 
δ = 13.93 (CH3), 22.12 (CH3CH2), 27.91 (CH3CH2CH2), 30.61 (CH2CHSO2), 32.00 (CH2CHN), 
51.45 (CHN), 65.23 (CHSO2), 66.95 (CH2OC=O), 121.52, 126.97, 128.05 128.25, 128.57 
128.69, 133.52 (arom CH), 136.14, 136.34, 139.40 ( arom C), 156.10 (C=O) ppm. 
 
IR (KBr):  
ῦ = 3402 (s), 2958 (m), 2928 (m), 1717 (vs), 1527 (vs), 1452 (m), 1298 (vs), 1238 (s), 1152 (s), 
1114 (m), 1014 (m), 756 (s), 699 (m), 586 (s), 552 (m). 
 
MS (EI, 70 eV):  
m/z (%) = 387 (8) [M+•], 286 (7), 176 (7), 130 (5), 108 (33),  91 (100), 65 (5). 
 
Elemental Analysis: 
Anal. Calcd for C21H25NO4S: C = 65.09  H = 6.50 N = 3.61 
Found:         C = 64.79  H = 6.15  N = 3.48 
3.18.3  (1S,2R)-[1-(1,1-Dioxo-2,3-dihydro-1H-1λ6-benzo[b]thiophen-2-yl)-2,2-dimethyl-
propyl]-carbamic acid benzyl ester (208e) 
 
HN
t-Bu
SO
O
O
O
 
 
 
a) To a well stirred solution of carbamate 207h (200 mg, 0.52 mmol) in 10 ml of MeOH at –
20°C, was added a catalytic amount of NiCl2 (13 mg, 20 %), followed by 4 equivalents of 
NaBH4 (79 mg, 2.08 mmol), according to GP17. After work-up, purification by flash column 
chromatography (Et2O: pentane 2:1) afforded two products, 208e (81 mg, 0.21 mmol) and 208g 
(60 mg, 0.15 mmol) as colorless solids. 
b) To a well stirred solution of carbamate 207h (200 mg, 0.52 mmol) in 10 ml of THF at –78°C, 
were added dropwise 1.04 ml of L-selectride® (1M solution in THF), according to GP17. After 
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work-up, purification by flash column chromatography (Et2O: pentane 2:1) afforded 208e (121 
mg, 0.31 mmol) as a colorless solid. 
Yield: colorless solid, 81 mg, 40%a, 121 mg, 60%b 
Mp: 56-57°C 
TLC: Rf = 0.25 (Et2O: pentane 2:1) 
Diastereomeric excess: de ≥ 96%a,b (1H-NMR) 
Enantiomeric excess: ee = 91%a,b (HPLC) 
Optical rotation: [α] 22 = –8.9 (c = 1.3, CHClD 3). 
1H-NMR (300 MHz, CDCl3): 
(signals of carbamate isomers are reported): 
δ = 0.98, 1.03 (s, 9H, CH3), 3.07-3.09 (d, 2H, J = 7.2 Hz, CH2CHSO2), 3.27 (ddd, 2H, J = 7.9, 
16.3, 37.1 Hz, CH2CHSO2), 3.48-3.58 (m, 1H, CHSO2) 3.61-3.67 (m, 1H, CHSO2), 4.37 (d, 1H, 
J = 10.1 Hz, CHN), 4.42 (dd, 1H, J = 3.2, 10.9 Hz, CHN), 4.94-5.13 (m, 3H, CH2OC=O, NH), 
6.49 (d, 1H, J = 11.1 Hz, NH), 7.05 (d, 1H, J = 7.1 Hz, arom CH), 7.24-7.55 (m, 9H, arom CH), 
7.66 (d, 1H, J = 7.4 Hz, arom CH) ppm. 
13C NMR (75 MHz, CDCl3): 
δ = 26.60 (CH3), 28.82, 29.54 (CH2CHSO2), 35.72 (CH3C), 55.79, 55.95 (CHN), 61.56 
(CHSO2), 66.87, 67.10 (CH2OC=O), 121.13, 121.64, 126.84, 127.19, 127.86, 128.06 128.30, 
128.43 128.59, 133.27 (arom CH), 136.25, 136.40, 136.78, 137.98, 138.56 (arom C), 155.89, 
156.97 (C=O) ppm. 
 
IR (KBr):  
ῦ = 3347 (s), 3046 (m), 3026 (s), 2963 (vs), 2876 (m), 1706 (vs), 1534 (vs), 1472 (m), 1454 (m), 
1298 (s), 1241 (s), 1152 (vs), 1122 (s), 1059 (s), 1012 (m), 756 (vs), 700 (s), 586 (s) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 387 (12) [M+•], 330 (27), 313 (8), 288 (5), 287 (11), 286 (67), 196 (10), 130 (5), 130 
(5), 92 (13), 91 (100), 65 (8). 
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Elemental Analysis: 
Anal. Calcd for C21H25NO4S: C = 65.09  H = 6.50 N = 3.61 
Found:         C = 64.80  H = 6.38  N = 3.50 
3.18.4  (1S,2S)-[1-(1,1-Dioxo-2,3-dihydro-1H-1λ6-benzo[b]thiophen-2-yl)-2,2-dimethyl-
propyl]-carbamic acid benzyl ester (208g) 
 
HN
t-Bu
SO
O
O
O
 
Yield: colorless solid, 60 mg, 30%a 
Mp: 59-60°C 
TLC: Rf = 0.35 (Et2O: pentane 2:1) 
Diastereomeric excess: de ≥ 96%a (1H-NMR) 
Enantiomeric excess: ee = 91%a (HPLC) 
Optical rotation: [α] 22 = –12.3 (c = 1.0, CHClD 3). 
 
 
1H-NMR (400 MHz, CDCl3): 
δ = 1.16 (s, 9H, CH3), 3.35 (d, 2H, J = 8.9 Hz, CH2CHSO2), 3.93 (dt, 1H, J = 2.7, 8.9 Hz, 
CHSO2) 4.10 (dd, 1H, J = 2.7, 10.7 Hz, CHN), 5.05 (d, 1H, JAB = 12.3 Hz, CHHOC=O), 5.15 (d, 
1H, JAB = 12.3 Hz, CHHOC=O), 6.25 (d, 1H, J = 10.7 Hz, NH), 7.27-7.34 (m, 9H, arom CH), 
7.44 (t, 1H, J = 7.4 Hz, arom CH), 7.56 (dt, 1H, J = 1.1, 7.4 Hz, arom CH) 7.68 (d, 1H, J = 8.0 
Hz, arom CH) ppm. 
13C-NMR (75 MHz, CDCl3): 
δ = 27.24 (CH3), 31.64 (CH2CHSO2), 35.89 (CH3C), 60.39 (CHN), 60.50 (CHSO2), 66.90 
(CH2OC=O), 121.35, 126.70, 127.68, 127.87, 128.27, 128.62, 133.29 (arom CH), 136.07, 
136.13, 139.01 (arom C), 156.97 (C=O) ppm. 
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IR (KBr):  
ῦ = 3421 (vs), 2963 (vs), 1722 (vs), 1513 (vs), 14724 (s), 1456 (m), 1337 (m), 1336 (m), 1301 
(m), 1253 (vs), 1149 (vs), 1120 (vs), 1061 (vs), 1019 (s), 803 (s), 753 (vs), 699 (s), 541 (s). 
 
MS (EI, 70 eV):  
m/z (%) = 387 (2) [M+•], 330 (12), 313 (6), 287 (5), 286 (33), 222 (5), 196 (5), 92 (8), 91 (100), 
57 (6). 
 
Elemental Analysis: 
Anal. Calcd for C21H25NO4S: C = 65.09  H = 6.50 N = 3.61 
Found:         C = 64.98  H = 6.41  N = 3.48 
3.18.5  (1S,2R)-[1-(1,1-Dioxo-2,3-dihydro-1H-1λ6-benzo[b]thiophen-2-yl)-2-methyl-
propyl]-carbamic acid benzyl ester (208f) 
 
HN
i-Pr
SO
O
O
O
 
 
 
Diastereomeric excess: de ≥ 96% (  
 
To a well stirred solution of carbamate 207d (185 mg, 0.5 mmol) in 10 ml of THF at –78°C, was 
added dropwise 1.0 ml of L-selectride® (1M solution in THF), according to GP17. After work-
up, purification by flash column chromatography (Et2O: pentane 2:1) afforded 208f (108 mg, 
0.29 mmol) as a colorless foam. 
Yield: colorless foam, 108 mg, 58% 
TLC: Rf = 0.25 (Et2O: pentane 2:1) 
1H-NMR)
Enantiomeric excess: ee = 99% (HPLC) 
Optical rotation: [α] 22 = –39.9 (c = 1.0 CHClD 3). 
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1H-NMR (300 MHz, CDCl3): 
(signals of carbamate isomers are reported): 
δ = 0.96 (d, 3H, J = 6.6 Hz, CH3), 1.01 (d, 3H, J = 6.6 Hz, CH3), 2.22-2.46 (m, 1H, CH3CH), 
3.24-3.30 (m, 2H, CH2CHSO2), 3.59 (q, 1H, J = 8.9 Hz, CHSO2), 3.71-4.00 (m, 1H, CHN, 
CHSO2), 4.33 (dt, J = 2.7, 10.2 Hz, 1H, CHN), 4.00-5.13 (m, 2H, CH2OC=O, NH), 5.18 (br, 1H, 
NH), 5.85 (d, 1H, J = 10.2 Hz, NH), 7.22-7.41 (m, 7H, arom CH), 7.47-7.54 (m, 1H, arom CH), 
7.63 (t, 1H, J = 7.9 Hz, arom CH) ppm. 
13C-NMR (75 MHz, CDCl3): 
δ = 15.29, 19.89, 20.25, 20.57 (CH3), 29.91 (CH3CH), 30.16, 30.97 (CH2CHSO2), 31.58 
(CH3CH), 55.18, 57.27 (CHN), 61.39, 63.03 (CHSO2), 66.95, 67.17 (CH2OC=O), 121.43, 
121.66, 127.04, 127.88, 128.13, 128.21, 128.35, 128.54, 128.66, 133.46, 133.64 (arom CH), 
136.18, 136.42, 136.50, 139.02, 139.64 ( arom C), 156.54, 157.02 (C=O) ppm. 
IR (CHCl3):  
ῦ = 3350 (m), 3023 (m), 2965 (m), 1711 (vs), 1523 (s), 1457 (m), 1296 (s), 1242 (s), 1151 (s), 
1121 (m), 757 (vs), 574 (m), 533 (m) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 373 (15) [M+•], 330 (10), 287 (5), 286 (47), 266 (7), 108 (10), 92 (12), 91 (100), 65 
(7). 
 
Elemental Analysis: 
Anal. Calcd for C20H23NO4S: C = 64.32  H = 6.21 N = 3.75 
Found:         C = 64.34  H = 6.11  N = 3.48 
3.18.6  (1S,2R)-[1-(1,1-Dioxo-2,3-dihydro-1H-1λ6-benzo[b]thiophen-2-yl)-3-phenyl-
propyl]-carbamic acid benzyl ester (208d) 
 
HN
SO
O
O
O
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a) To a well stirred solution of carbamate 207g (250 mg, 0.58 mmol) in 10 ml of MeOH at –
20°C, was added a catalytic amount of NiCl2 (15 mg, 20 %), followed by 4 equivalents of 
NaBH4 (90 mg, 2.38 mmol), according to GP17. After work-up, purification by flash column 
chromatography (Et2O:pentane 3:2)  afforded 208d (220 mg, 0.50 mmol) as a colorless solid. 
b) To a well stirred solution of carbamate 207g (250 mg, 0.58 mmol) in 10 ml of THF at –78°C, 
were added dropwise 1.16 ml of L-selectride® (1 M solution in THF), according to GP17. After 
work-up, purification by flash column chromatography (Et2O:pentane 3:2) afforded 208d (175 
mg, 0.40 mmol) as a colorless solid. 
Yield: colorless solid, 220 mg, 87%a, 175 mg, 70%b 
Mp: 123-125°C 
TLC: Rf = 0.32 (Et2O: pentane 3:2) 
Diastereomeric excess: de ≥ 96%a,b (1H-NMR) 
Enantiomeric excess: ee = 95%a,b (HPLC) 
Optical rotation: [α] 22 = –8.0 (c = 1.0, CHClD 3). 
1H-NMR (300 MHz, CDCl3): 
(signals of carbamate conformers are reported): 
δ = 2.04-2.51 (m, 2H, CH2CHNH), 2.66-2.89 (m, 2H, PhCH2), 3.13-3.32 (m, 2H, CH2CHSO2), 
3.72-3.80 (m, 1H, CHSO2) 4.18-4.35 (m, 1H, CHN), 5.06-5.18 (m, 2H, CH2OC=O), 5.36 (d, 1H, 
J = 9.1 Hz, NH), 5.90 (d, 1H, J = 9.9 Hz, NH), 7.16-7.72 (m, 14H, arom CH) ppm. 
13C-NMR (75 MHz, CDCl3): 
δ = 29.76, 30.59 (PhCH2), 32.24, 32.71 (CH2CHSO2), 33.50, 35.27 (CH2CHNH), 50.56, 51.45 
(CHN), 64.00, 64.98 (CHSO2), 67.05, 67.15 (CH2OC=O), 121.49, 121.64, 126.20, 126.26, 
127.04, 127.24, 127.99, 128.23, 128.40, 128.52, 128.55, 128.60, 128.64, 128.68, 128.84, 128.89, 
133.66, 133.71 (arom CH), 136.16, 136.34, 136.37, 138.91, 139.39, 140.76 (arom C), 156.06, 
156.71 (C=O) ppm. 
IR (CHCl3):  
ῦ = 3347 (m), 3030 (m), 1714 (vs), 1526 (vs), 1453 (s), 1296 (vs), 1244 (vs), 1151 (vs), 1123 (s), 
1054 (m), 911 (s), 734 (vs), 700 (s), 590 (m), 543 (m) cm−1. 
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MS (EI, 70 eV):  
m/z (%) = 435 (3) [M+•], 344 (15), 327 (10), 284 (10), 283 (47), 218 (6), 196 (40), 137 (12), 130 
(6), 129 (15), 117 (8), 116 (5), 115 (11), 108 (10), 107 (5), 105 (7), 104 (8), 92 (8), 91 (100), 79 
(12), 77 (13). 
 
Elemental Analysis: 
Anal. Calcd for C25H25NO4S: C = 68.94  H = 5.79 N = 3.22 
Found:         C = 69.09  H = 5.74  N = 3.16 
3.18.7  (1S,2R)-[1-(1,1-Dioxo-2,3-dihydro-1H-1λ6-benzo[b]thiophen-2-yl)-phenyl-methyl]-
carbamic acid benzyl ester (208c) 
 
HN
SO
O
O
O
 
 
 
 
a) To a well stirred solution of carbamate 207e (260 mg, 0.64 mmol) in 10 ml of MeOH at –
20°C, was added a catalytic amount of NiCl2 (16 mg, 20 %), followed by 4 equivalents of 
NaBH4 (98 mg, 2.56 mmol), according to GP17. After work-up, purification by flash column 
chromatography (Et2O:pentane 3:1) afforded 208c (155 mg, 0.38 mmol) as a colorless solid. 
b) To a well stirred solution of carbamate 207e (260 mg, 0.64 mmol) in 10 ml of THF at –78°C, 
were added dropwise 1.28 ml of L-selectride® (1 M solution in THF), according to GP17. After 
work-up, purification by flash column chromatography (Et2O:pentane 3:1) afforded 208c (210 
mg, 0.51 mmol) as a colorless solid. 
Yield: colorless solid, 155 mg, 60%a, 210 mg, 80%b 
Mp: 55-57°C 
TLC: Rf = 0.48 (Et2O: pentane 3:1) 
Diastereomeric excess: de ≥ 90%a (1H-NMR), de ≥ 96%b (1H-NMR) 
Enantiomeric excess: ee = 88%a,b (HPLC) 
Optical rotation: [α] 22 = –16.1 (c = 2.0, CHClD 3). 
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1H-NMR (300 MHz, CDCl3): 
(signals of carbamate isomers are reported): 
δ = 2.99-3.08 (m, 2H, CH2CHSO2), 3.23-3.40 (m, 2H, CH2CHSO2), 3.13-3.32 (m, 2H, 
CH2CHSO2), 3.95 (q, 1H, J = 7.9 Hz, CHSO2) 5.02-5.08 (m, 2H, CH2OC=O), 5.25-5.35 (m, 1H, 
CHN), 5.78 (d, 1H, J = 8.9 Hz, NH), 6.33 (d, 1H, J = 8.9, NH), 7.16-7.64 (m, 14H, arom CH) 
ppm. 
13C NMR (75 MHz, CDCl3): 
δ = 30.70, 31.00 (CH2CHSO2), 54.75, 54.96 (CHN), 64.93, 65.45 (CHSO2), 67.09, 67.25 
(CH2OC=O), 121.54, 127.03, 127.09, 127.66, 127.86, 128.00, 128.11, 128.22, 128.36, 128.44, 
128.55, 128.62, 128.78, 128.84, 129.00, 133.33, 133.48 (arom CH), 135.61, 135.87, 136.29, 
136.36, 138.13, 138.75, 139.52, 139.68 (arom C), 155.75 (C=O) ppm. 
IR (CHCl3):  
ῦ = 3347 (m), 1717 (vs), 1522 (s), 1454 (m), 1303 (vs), 1243 (s), 1149 (vs), 1126 (m), 757 (s), 
701 (s), 545 (m) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 407 (1) [M+•], 271 (9), 270 (54), 256 (12), 250 (10), 240 (16), 210 (5), 208 (6), 207 
(5), 206 (7), 205 (5), 204 (8), 196 (9), 180 (5), 179 (16), 178 (8), 165 (7), 137 (9), 108 (10), 107 
(8), 104 (5), 92 (7), 91 (100), 79 (6), 77 (8), 65 (6). 
 
Elemental Analysis: 
Anal. Calcd for C23H21NO4S: C = 67.79  H = 5.19 N = 3.44 
Found:         C = 67.32  H = 4.97  N = 3.42 
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3.19  β-sulfonamine 
3.19.1  (1S,2R)-1-(1,1-Dioxo-2,3-dihydro-1H-1λ6-benzo[b]thiophen-2-yl)-2,2-dimetyl-
propanamine (209) 
 
NH2
t-Bu
SO
O  
 
 
 
Carbamate 208e (190 mg, 0.49 mmol) was dissolved in dry EtOH (30 mL) and the mixture was 
hydrogenated using 10% Pd/C (60 mg) as catalyst at 4 atm. After 16 h, the solution was 
neutralized with solid Na2CO3 and the catalyst was filtered off. The solvent was evaporated in 
vacuo to give 209 (120 mg, 0.47 mmol) as a colorless solid. 
 
Yield: colorless solid, 120 mg, 96% 
Mp: 56-57°C 
Diastereomeric excess: de ≥ 96% (1H-NMR) 
Enantiomeric excess: ee = 91% (HPLC) 
Optical rotation: [α] 22 = –29.6 (c = 1.4, CHClD 3). 
1H-NMR (300 MHz, CDCl3): 
δ = 1.03 (s, 9H, CH3), 1.39-1.43 (br, 2H, NH2), 3.21 (dd, 1H, J = 8.2, 16.2 Hz, CHHCHSO2), 
3.50 (d, 1H, J = 0.9 Hz, CHNH), 3.71 (t, 1H, J = 8.2 Hz CHSO2), 3.79 (dd, 1H, J = 8.2, 16.2 Hz, 
CHHCHSO2), 7.32-7.47 (m, 2H, arom CH), 7.56 (dt, 1H, J = 1.2, 7.4 Hz, arom CH), 7.73 (d, 
1H, J = 7.4 Hz, arom CH) ppm. 
13C-NMR (75 MHz, CDCl3): 
δ = 26.64 (CH2), 27.08 (CH3), 34.97 (CH3C), 55.49 (CHN), 62.41 (CHSO2), 121.53, 127.38, 
128.54, 133.46 (arom CH), 137.58, 137.98 (arom C) ppm. 
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IR (KBr):  
ῦ = 3390 (m), 2959 (s), 2870 (m), 1601 (m), 1472 (m), 1454 (m), 1294 (vs), 1151 (vs), 1121 (s), 
756 (vs), 587 (s), 550 (s) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 198 (5), 197 (12), 196 (100). 
 
MS (CI, 100 eV, isobutane): 
m/z (%) = 255 (16) [M+•+2], 254 (100) [M+•+1], 237 (5), 197 (6), 196 (16). 
 
Elemental Analysis: 
Anal. Calcd for C13H19NO2S: C = 61.63  H = 7.56 N = 5.53 
Found:         C = 61.64  H = 7.62  N = 5.35 
 
3.20  N-protected aminoacids 
 
3.20.1 (S)-2-Benzoylamino-butyric acid 
 
N
COOH
H
Me
O
Ph
 
 
 
Benzamide 194f (150 mg, 0.65 mmol) was added to a stirred solution of RuCl3·H2O (2.9 mg, 2% 
mol) and NaIO4 (2.0 g, 9.75 mmol) in 20 ml of a CH2Cl2/MeCN/H2O (1.0:0.04:0.7) mixture 
according to GP16. After work-up and flash chromatography (CH2Cl2:MeOH 9:1) 201g was 
obtained as a colorless solid (117 mg, 0.56 mmol). 
 
Yield: colorless solid, 117 mg, 86% 
Mp: 140-142°C 
TLC: Rf = 0.44 (CH2Cl2:MeOH 9:1) 
Enantiomeric excess: ee ≥ 99 (HPLC) 
Optical rotation: [α] 22 = +20.5 (c = 1.1, CHClD 3). 
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1H-NMR (400 MHz, CDCl3): 
δ = 0.98 (t, 3H, J = 7.4 Hz, CH3CH2), 1.80-1.93 (m, 1H, CH3CHH), 2.00-2.09 (m, 1H, 
CH3CHH), 4.74-4.79 (m, 1H, CHNH), 6.99 (d, 1H, J = 7.7 Hz, NH), 7.39-7.43 (m, 2H, arom 
CH), 7.48-7.52 (m, 1H, arom CH), 7.78-7.80 (m, 2H, arom CH), 8.90-9.16 (br, 1H, OH) ppm. 
13C-NMR (100 MHz, CDCl3): 
δ = 9.92 (CH3CH2), 25.68 (CH3CH2), 54.22 (CHN), 127.38 128.85, 132.22 (arom CH), 133.68 
(arom C), 168.24 (NHC=O), 175.72 (COOH). 
IR (CHCl3):  
ῦ = 3340 (m), 2959 (s), 2931 (s), 2864 (m), 1726 (vs), 1643 (vs), 1536 (vs), 1489 (s), 758 (s), 
715 (m) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 207 (7) [M+•], 179 (8), 163 (5), 162 (19), 106 (8), 105 (100), 77 (32), 51 (14), 45 (10). 
HRMS: m/z calcd for C11H13NO3 (M+): 207.08954. Found: 207.08956 
 
3.20.2 (S)-2-Benzoylamino-4-phenyl-butyric acid (201b) 
 
N
COOH
H
O
Ph
Ph  
 
Benzamide 200b (200 mg, 0.65 mmol) was added to a stirred solution of RuCl3·H2O (2.9 mg, 
2% mol) and NaIO4 (2.0 g, 9.75 mmol) in 20 ml of a CH2Cl2/MeCN/H2O (1.0:0.04:0.7) mixture 
according to GP16. After work-up and crystallization (CH2Cl2), 201b was obtained as a colorless 
solid (167 mg, 0.59 mmol). 
 
Yield: colorless solid, 167 mg, 90% 
Mp: 160-111°C 
TLC: Rf = 0.6 (CH2Cl2:MeOH 9:1) 
Enantiomeric excess:  ee = 96% (HPLC) 
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Optical rotation: [α] 22 = +29.5(c = 1.8, CHClD 3). 
1H-NMR (400 MHz, CDCl3): 
δ = 2.04-2.33 (m, 2H, CH2CHN), 2.67 (t, 2H, J = 8.0 Hz, PhCH2), 4.75-4.82 (m, 1H, CHNH), 
6.78 (d, 1H, J = 7.7 Hz, NH), 7.09-7.43 (m, 8H, arom CH), 7.54-7.60 (m, 2H, arom CH), 9.90-
10.21 (br, 1H, OH) ppm. 
13C-NMR (100 MHz, CDCl3): 
δ = 32.00 (PhCH2CH2), 33.71 (CH2CH2), 53.08 (CHN), 126.53, 127.43, 128.72, 128.89, 133.82 
(arom CH), 133.55, 140.91 (arom C), 168.25 (C=O), 176.02 (COOH) ppm. 
 
IR (KBr):  
ῦ = 3395 (s), 1742 (s), 1634 (vs), 1577 (m), 1526 (vs), 1452 (m), 1397 (m), 1246 (m), 1206 (m), 
753 (m), 695 (m) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 283 (2) [M+•], 180 (8), 179 (78), 162 (6), 161 (59), 148 (5), 133 (8), 122 (6), 106 (9), 
105 (100), 91 (10), 77 (39), 57 (6), 51 (13). 
HRMS: m/z calcd for C17H17NO3 (M+): 283.12084. Found: 283.12084. 
 
3.20.3 (S)-2-benzoylamino-3,3-dimethyl-butyric acid (201c) 
 
N
COOH
H
Me
O
Ph
Me
Me
 
Benzamide 200c (150 mg, 0.58 mmol) was added to a stirred solution of RuCl3·H2O (2.6 mg, 2% 
mol) and NaIO4 (1.87 g, 8.75 mmol) in 20 ml of a CH2Cl2/MeCN/H2O (1.0:0.04:0.7) mixture, 
according to GP16. After work-up and crystallization (CH2Cl2), 201c was obtained as a colorless 
solid (105 mg, 0.45 mmol). 
 
Yield: colorless solid, 105 mg, 77% 
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Mp: 128-130°C 
Enantiomeric excess: ee = 98% (HPLC) 
Optical rotation: [α] 22 = +32.0 (c = 1.4 CHClD 3). 
1H-NMR (300 MHz, CDCl3): 
δ = 1.01 (s, 9H, CH3C), 4.64 (d, 1H, J = 9.3 Hz, CHN), 6.71 (d, 1H, J = 9.3 Hz, NH), 7.34-7.38 
(m, 2H, arom CH), 7.42-7.46 (m, 1H, arom CH), 7.70-7.73 (m, 2H, arom CH), 8.24-8.44(br, 1H, 
OH) ppm. 
13C-NMR (75 MHz, CDCl3): 
δ = 26.88 (CH3C), 35.28 (CH3C), 60.67 (CHN), 127.35, 128.93, 132.18 (arom CH), 134.11 
(arom C), 168.15 (C=O), 175.37 (COOH) ppm. 
 
IR (KBr):  
ῦ = 3425 (m), 3361 (s), 3065 (s), 2967 (vs), 1724 (vs), 1643 (vs), 1578 (m), 1527 (s), 1488 (s), 
1371 (m), 1337 (m), 1218 (vs), 1174 (m), 1088 (m), 757 (vs), 714 (s), 693 (s) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 220 (1) [M+•−CH3], 180 (9), 179 (89), 162 (10), 161 (100), 133 (10), 106 (9), 105 
(91), 77 (29), 57 (20), 51 (7). 
HRMS: m/z calcd for C12H14NO3 (M+−CH3): 220.09736. Found: 220.09733. 
 
3.20.4 (S)-2-benzoylamino-hexanoic acid (201d) 
 
N
COOH
H
O
Ph
Me
 
 
Benzamide 200a (150 mg, 0.58 mmol) was added to a stirred solution of RuCl3·H2O (2.6 mg, 
2% mol) and NaIO4 (1.87 g, 8.75 mmol) in 20 ml of a CH2Cl2/MeCN/H2O (1.0:0.04:0.7) 
mixture, according to GP16. After work-up and purification by flash chromatography 
(CH2Cl2:MeOH 9:1), 201d (96 mg, 0.41 mmol) was obtained as a colorless solid. 
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Yield: colorless solid, 96 mg, 70% 
Mp: 95-96°C 
TLC: Rf = 0.55 (CH2Cl2:MeOH 9:1) 
Enantiomeric excess: ee = 96% (HPLC) 
Optical rotation: [α] 22 = –26.3 (c = 1.4, CHClD 3). 
1H-NMR (300 MHz, CDCl3): 
δ = 0.88 (t, 3H, J = 7.1 Hz, CH3CH2), 1.30-1.43 (m, 4H, CH3CH2CH2), 1.76-1.86 (m, 1H, 
CHHCHN), 1.95-2.06 (m, 1H, CHHCHN), 4.79 (dt, 1H, J = 5.2, 7.4 Hz, CHN), 7.03 (d, 1H, J = 
7.4 Hz, NH), 7.38-7.47 (m, 2H, arom CH), 7.47-7.51 (m, 1H, arom CH), 7.77-7.80 (m, 2H, arom 
CH), 9.75-9.85 (br, 1H, OH) ppm. 
13C-NMR (75 MHz, CDCl3): 
δ = 14.23 (CH3CH2), 22.69 (CH3CH2), 27.71 (CH3CH2CH2), 32.21 (CH2CHN), 53.18 (CHN), 
127.41, 128.83, 132.20 (arom CH), 133.67 (arom C), 168.24 (C=O), 175.99 (COOH) ppm. 
 
IR (KBr):  
ῦ = 3427 (m), 3322 (m), 3065 (m), 2974 (s), 1727 (vs), 1647 (vs), 1577 (s), 1531 (s), 1489 (s), 
1345 (m), 1215 (s), 1161 (m), 1074 (m), 758 (vs), 714 (s), 692 (m), 667 (s). 
 
MS (EI, 70 eV):  
m/z (%) = 235 (2) [M+•], 190 (15), 179 (26), 161 (11), 148 (5), 106 (8), 105 (100), 77 (29), 51 
(10), 45 (6). 
HRMS: m/z calcd for C13H17NO3: 235.12084. Found: 235.12997 
 
3.20.5   (2S,3R)-2-Benzoylamino-3-methyl-hexanoic acid (201d) 
 
N
COOH
H
O
Ph
Me
Me  
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Benzamide 200d (180 mg, 0.66 mmol) was added to a stirred solution of RuCl3·H2O (3 mg, 2% 
mol) and NaIO4 (2.13 g, 9.96 mmol) in 20 ml of a CH2Cl2/MeCN/H2O (1.0:0.04:0.7) mixture, 
according to GP16. After work-up and crystallization (CH2Cl2), 201d (135 mg, 0.54 mmol) was 
obtained as a colorless solid. 
 
Yield: colorless solid, 135 mg, 82% 
Mp: 117-119°C 
TLC: Rf = 0.49 (CH2Cl2:MeOH 9:1) 
Diastereomeric excess: de ≥ 96% (1H-NMR) 
Enantiomeric excess: ee = 99% (HPLC) 
Optical rotation: [α] 22 = +39.5 (c = 1.3, CHClD 3). 
1H-NMR (300 MHz, CDCl3): 
δ = 0.82 (t, 3H, J = 7.1 Hz, CH3CH2), 0.90 (d, 2H, J = 6.9 Hz, CH3CH), 1.08-1.45 (m, 4H, 
CH3CH2CH2), 2.11-2.24 (m, 1H, CHCH3), 4.82 (dd, 1H, J = 3.9, 8.7 Hz, CHN), 6.63 (d, 1H, J = 
8.7 Hz, NH), 7.34-7.47 (m, 3H, arom CH), 7.70-7.74 (m, 2H, arom CH), 8.31-8.49 (br, 1H, OH) 
ppm. 
13C-NMR (75 MHz, CDCl3): 
δ = 14.30 (CH3CH2), 15.26 (CH3CH), 20.52 (CH3CH2), 35.78 (CH3CH2CH2), 35.96 (CHCH3), 
56.48 (CHN), 127.38, 128.89, 132.11 (arom CH), 134.26 (arom C), 168.19 (C=O), 176.35 
(COOH) ppm. 
 
IR (KBr):  
ῦ = 3314 (vs), 3228 (vs), 3065 (s), 2960 (vs), 2928 (vs), 2871 (s), 1729 (vs), 1642 (vs), 1603 (s), 
1543 (vs), 1352 (s), 1232 (vs), 1199 (s), 1075 (m), 862 (m), 836 (m), 737 (s), 722 (s), 691 (vs) 
cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 249 (3) [M+•], 204 (15), 179 (37), 162 (8), 161 (42), 133 (5), 122 (16), 106 (8), 105 
(100), 77 (35), 57 (7), 55 (5), 51 (15). 
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HRMS: m/z calcd for C14H19NO3: 249.13636. Found: 249.13649 
 
3.20.6 (2R,3S)-2-Benzoylamino-3-methyl-hexanoic acid (201e) 
 
N
COOH
H
O
Ph
Me
Me  
 
Benzamide 200e (150 mg, 0.55 mmol) was added to a stirred solution of RuCl3·H2O (2.5 mg, 2% 
mol) and NaIO4 (1.76 g, 8.30 mmol) in 20 ml of a CH2Cl2/MeCN/H2O (1.0:0.04:0.7) mixture, 
according to GP16. After work-up and crystallization (CH2Cl2), 201e (115 mg, 0.46 mmol) was 
obtained as a colorless solid. 
 
Yield: colorless solid, 115 mg, 84% 
Mp: 119-120°C 
TLC: Rf = 0.49 (CH2Cl2:MeOH 9:1) 
Diastereomeric excess: de ≥ 96% (1H-NMR) 
Enantiomeric excess: ee = 99% (HPLC) 
Optical rotation: [α] 22 = −40.4 (c = 1.3, CHClD 3). 
 
The other analytic data correspond to those reported for compound 201d. 
 
3.20.7 (S)-N-Benzoylalanine (201f) 
 
N
Me COOH
H
O
Ph
 
 
Benzamide 200f (140 mg, 0.65 mmol) was added to a stirred solution of RuCl3·H2O (2.9 mg, 
2%) and NaIO4 (2.09 g, 9.76 mmol) in 20 ml of CH2Cl2/MeCN/H2O (1.0:0.04:0.7) according to 
GP16. After work-up and crystallization (CH2Cl2), 201f (108 mg, 0.56 mmol) was obtained as a 
colorless solid. 
 
  234
Experimental Part 
 
 
 
 
MS (EI, 70 eV):  
 
 
Yield: colorless solid, 105 mg, 86% 
Mp: 148-149°C 
Enantiomeric excess: ee = 98% (HPLC) 
Optical rotation: [α] 22 = +29.1 (c = 1.0, CHClD 3). 
1H-NMR (300 MHz, CDCl3): 
δ = 1.54 (d, 3H, J = 7.1 Hz, CH3CH), 4.72-4.79 (m, 1H, CHN), 6.91 (d, 1H, J = 6.9 Hz, NH), 
7.38-7.53 (m, 3H, arom CH), 7.75-7.78 (m, 2H, arom CH), 8.42-8.50 (br, 1H, OH) ppm. 
13C-NMR (75 MHz, CDCl3): 
δ = 18.43 (CH3CH), 48.96 (CHN), 127.40, 128.92, 132.30 (arom CH), 133.62 (arom C), 168.04 
(C=O), 176.56 (COOH) ppm. 
 
IR (KBr):  
ῦ = 3409 (s), 1727 (vs), 1632 (vs), 1576 (m), 1550 (s), 1491 (s), 1460 (m), 1411 (s), 1338 (s), 
1218 (vs), 1171 (m), 1129 (m), 904 (m), 707 (s), 689 (m), 624 (m) cm−1. 
 
m/z (%) = 193 (8) [M+•], 149 (15), 148 (44), 106 (8), 105 (100), 77 (37), 51 (15), 45 (5). 
HRMS: m/z calcd for C10H11NO3: 193.07389. Found: 193.07387. 
 
3.20.8 (R)-N-Benzoylalanine (201h) 
N
Me CO2H
H
O
Ph
 
 
Benzamide 200h (160 mg, 0.74 mmol) was added to a stirred solution of RuCl3·H2O (3.3 mg, 
2% mol) and NaIO4 (2.39 g, 11.62 mmol) in 20 ml of a CH2Cl2/MeCN/H2O (1.0:0.04:0.7) 
mixture, according to GP16. After work-up and crystallization (CH2Cl2), 201h (108 mg, 0.56 
mmol) was obtained as a colorless solid. 
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Yield: colorless solid, 122 mg, 85% 
Mp: 149-150°C 
Enantiomeric excess: ee = 98% (HPLC) 
Optical rotation: [α] 22 = −30.0 (c = 0.15 CHClD 3). 
 
The other analytic data correspond to those reported for compound 201f. 
 
3.21  Oxidation of furfurylamines 
 
3.21.1 (S)-N-(1-Ethyl-2,5-dioxo-pent-3Z-enyl)-benzamide  
 
Me
HN
O O
O
Ph
H
 
 
 
, CDCl
 
To a well stirred solution of benzamide 193f (170 mg, 0.74 mmol) in 54 ml of 
H2O/Acetone/CH2Cl2 (1/0.8/0.9) were added 0.9 g of NaHCO3 followed by 1.5 g of oxone, 
according to GP17. After work-up, removal of the solvent in vacuo afforded 168 mg of a mixture 
of two products 204b and 205b (ratio = 8.5:1) as a yellow oil. 
 
Spetroscopic data of the major product 204b are reported: 
1H-NMR (300 MHz 3): 
δ = 0.98 (t, 3H, J = 7.3 Hz, CH3CH2), 1.66-1.87 (m, 1H, CH3CHH), 2.04-2.16 (m, 1H, 
CH3CHHCH), 4.91 (dt, 1H, J = 5.2, 7.2 Hz, CHN), 6.28 (dd, 1H, J = 6.9, 11.9 Hz, CHCHCHO), 
7.11 (d, 1H, J = 11.9 Hz, CHCH), 7.24-7.26 (br, 1H, NH), 7.35-7.51 (m, 3H, arom CH), 7.74-
7.85 (m, 2H, arom CH), 10.23 (d, 1H, J = 6.9 Hz, CHO) ppm. 
13C-NMR (75 MHz, CDCl3): 
δ = 9.59 (CH3CH2), 23.91 (CH3CH2), 58.92 (CHN), 127.18, 128.65, 131.99 (arom CH), 133.52 
(arom C), 137.65 (CH=CHCHO), 139.95 (CH=CHCHO), 168.63 (PhC=O), 192.42 (CHO), 
198.84 (CHC=O) ppm. 
  236
Experimental Part 
 
 
3.21.2 (S)-N-(1-Butyl-2,5-dioxo-pent-3Z-enyl)-benzamide (204f) 
 
HN
O O
O
Ph
HMe
 
 
 
 
 
To a well stirred solution of benzamide 200a (190 mg, 0.74 mmol) in 54 ml of a 
H2O/Acetone/CH2Cl2 (1/0.8/0.9) mixture,were added 0.9 g of NaHCO3 followed by 1.5 g of 
oxone, according to GP17. After work-up, removal of the solvent in vacuo afforded 204f (195 
mg, 0.71 mmol) as a yellow oil. 
 
Yield: yellow oil, 195 mg, 96% 
Enantiomeric excess: ee = 98% (HPLC) 
Optical rotation: [α] 22 = −21.0 (c = 1.0, CHClD 3). 
1H-NMR (300 MHz, CDCl3): 
δ = 0.88 (t, 3H, J = 7.0 Hz, CH3CH2), 1.23-1.41 (m, 4H, CH3CH2CH2), 1.64-1.80 (m, 1H, 
CHHCHNH), 1.94-2.03 (m, 1H, CHHCHNH), 4.87 (dt, 1H, J = 5.0, 7.7 Hz, CHN), 6.23 (dd, 
1H, J = 6.9, 11.9 Hz, CHCHCHO), 7.13 (d, 1H, J = 11.9 Hz, CHCH), 7.33-7.53 (m, 4H, arom 
CH, NH), 7.76-7.84 (m, 2H, arom CH), 10.21 (d, 1H, J = 6.9 Hz, CHO) ppm. 
13C-NMR (75 MHz, CDCl3): 
δ = 13.84 (CH3CH2), 22.41 (CH3CH2), 27.61 (CH3CH2CH2), 30.18 (CH2CHNH), 59.11 (CHN), 
127.28, 128.61, 131.98 (arom CH), 133.48 (arom C), 138.16 (CH=CHCHO), 139.64 
(CH=CHCHO), 167.83 (PhC=O), 192.63 (CHO), 199.15 (CHC=O) ppm. 
IR (CHCl3):  
ῦ = 3321 (vs), 3063 (m), 3013 (m), 2958 (vs), 2867 (s), 1643 (vs), 1531 (vs), 1488 (m), 1076 
(m), 1027 (s), 754 (vs), 712 (s) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 273 (1) [M+•], 191 (5), 190 (36), 105 (100), 77 (19), 51 (7). 
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3.21.3 (S)-N-(2,5-Dioxo-1-phenetyl-pent-3Z-enyl)-benzamide (204d) 
 
HN
O O
O
Ph
H
 
 
Optical rotation: [α = −11.9 (c = 0.10 CHCl
 
 
 
To a well stirred solution of benzamide 200b (200 mg, 0.65 mmol) in 54 ml of a 
H2O/Acetone/CH2Cl2 (1/0.8/0.9) mixture, were added 0.8 g of NaHCO3 followed by 1.32 g of 
oxone, according to GP17. After work-up, removal of the solvent in vacuo afforded 204d (198 
mg, 0.62 mmol) as a yellow oil. 
 
Yield: yellow oil, 198 mg, 94% 
Enantiomeric excess: ee = 98% (HPLC) 
] 22D 3). 
1H-NMR (400 MHz, CDCl3): 
δ = 2.05-2.16 (m, 1H, CH2CHH), 2.34-2.46 (m, 1H, CH2CHH), 2.68-2.80 (m, 2H, PhCH2), 4.99 
(dt, 1H, J = 4.7, 7.4 Hz, CHN), 6.24 (dd, 1H, J = 7.1, 11.8 Hz, CHCHCHO), 6.95-7.01 (m, 2H, 
NH, CHCH), 7.15-7.22 (m, 5H, arom CH), 7.40-7.54 (m, 3H, arom CH), 7.72-7.74 (m, 2H, arom 
CH), 10.20 (d, 1H, J = 7.1 Hz, CHO) ppm. 
13C-NMR (100 MHz, CDCl3): 
δ = 31.56 (CH2CH2), 32.25 (PhCH2CH2), 58.59 (CHN), 126.37, 126.91, 128.30, 128.47, 128.54, 
131.87 (arom CH), 133.15 (arom C), 136.73 (CH=CHCOH), 139.94 (CH=CHCHO), 140.03 
(arom C), 167.11 (PhC=O), 191.93 (CHO), 198.05 (CHC=O) ppm. 
IR (CHCl3):  
ῦ = 3333 (m), 3024 (m), 1685 (m), 1643 (s), 1529 (s), 1490 (m), 756 (vs), 701 (s) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) = 321 (1) [M+•], 238 (12), 217 (13), 122 (13), 117 (9), 106 (7), 105 (100), 91 (11), 77 
(27), 51 (5). 
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3.21.4 (S)-N-(1-Butyl-2,5-dioxo-pent-3Z-enyl)-benzamide (204e) 
 
HN
O O
O
Ph
H
OTBDMS  
 
Enantiomeric excess: ee = 98% (HPLC) 
 
 
 
To a well stirred solution of benzamide 200g (140 mg, 0.37 mmol) in 54 ml of a 
H2O/Acetone/CH2Cl2 (1/0.8/0.9) mixture, were added 0.45 g of NaHCO3 followed by 0.75 g of 
oxone, according to GP17. After work-up, removal of the solvent in vacuo afforded 204e (143 
mg, 0.368 mmol) as a yellow oil. 
 
Yield: yellow oil, 143 mg, 98% 
Optical rotation: [α] 22 = −15.7 (c = 1.4, CHClD 3). 
1H-NMR (300 MHz, CDCl3): 
δ = 0.7 (s, 3H, CH3Si), 0.8 (s, 3H, CH3Si), 0.91 (s, 9H, CH3CSi), 1.63-1.72 (m, 2H, CH2CH2O), 
1.85-1.93 (m, 1H, CHHCHNH), 2.13-2.18 (m, 1H, CHHCHNH), 3.70 (t, 2H, J = 5.7 Hz, 
CH2OSi), 4.96 (dt, 1H, J = 4.7, 7.6 Hz, CHN), 6.29 (dd, 1H, J = 7.2, 11.8 Hz, CHCHCHO), 7.16 
(d, 1H, J = 11.8 Hz, CHCH), 7.37-7.57 (m, 4H, arom CH, NH), 7.83-7.86 (m, 2H, arom CH), 
10.27 (d, 1H, J = 7.2 Hz, CHO) ppm 
13C NMR (75 MHz, CDCl3): 
δ = −5.33 (CH3Si), 18.23 (CSi), 25.91 (CH3CSi), 26.92 (CH2CH2OSi), 28.37 (CH2CHNH), 
58.70 (CHN), 61.99 (CH2OSi), 127.19, 128.60, 131.94 (arom CH), 133.51 (arom C), 137.74 
(CH=CHCHO), 139.78 (CH=CHCHO), 167.57 (PhC=O), 192.35 (CHO), 198.77 (CHC=O) 
ppm. 
IR (CHCl3):  
ῦ = 3314 (s), 2931 (vs), 2859 (vs), 1686 (s), 1642 (vs), 1531 (vs), 1488 (m), 1303 (m), 1255 (s), 
1102 (vs), 1006 (m), 837 (vs), 778 (s), 712 (m) cm−1. 
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Experimental Part 
 
 
MS (EI, 70 eV):  
 
Elemental Analysis: 
3.21.5 (S)-N-(1-tert-Butyl-2,5-dioxo-pent-3Z-enyl)-benzamide (204c) 
m/z (%) 332 (11), 314 (13), 268 (9), 211 (14), 178 (20), 174 (9), 137 (9), 136 (9), 105 (100), 77 
(24), 75 (16), 69 (9), 57 (10). 
MS (CI):  
m/z (%) = 390 (84) [M+•+1], 376 (16), 375 (10), 374 (39), 373 (29), 372 (100), 334 (16), 332 
(24), 316 (9), 314 (9), 306 (30), 269 (10), 268 (9), 260 (11), 240 (23), 137 (40), 136 (18), 122 
(30), 121 (46), 105 (36). 
 
Anal. Calcd for C21H31NO4Si:  C = 64.75  H = 8.02  N = 3.60 
Found:          C = 64.43  H = 8.22 N = 4.08 
 
 
Me
HN
O O
O
Ph
H
Me
Me  
 
 
 
To a well stirred solution of benzamide 200c (180 mg, 0.70 mmol) in 54 ml of a 
H2O/Acetone/CH2Cl2 (1/0.8/0.9) mixture, were added 0.9 g of NaHCO3 followed by 1.5 g of 
oxone, according to GP17. After work-up, removal of the solvent in vacuo afforded 204c (184 
mg, 0.368 mmol) as a yellow solid. 
Yield: yellow solid, 184 mg, 96% 
Mp: 45-47°C 
Enantiomeric excess: ee = 98% (HPLC) 
Optical rotation: [α] 22 = −23.2 (c = 1.2, CHClD 3). 
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Experimental Part 
 
 
 
 
1H-NMR (300 MHz, CDCl3): 
δ = 1.11 (s, 9H, (CH3)3C), 4.92 (d, 1H, J = 8.6 Hz, CHN), 6.24 (dd, 1H, J = 6.9, 11.9 Hz, 
CHCHCHO), 6.90 (d, 1H, J = 8.6 Hz, NH), 7.10 (d, 1H, J = 11.9 Hz, CHCH), 7.41-7.56 (m, 3H, 
arom CH), 7.78-7.81 (m, 2H, arom CH), 10.26 (d, 1H, J = 6.9 Hz, CHO) ppm. 
13C NMR (75 MHz, CDCl3): 
δ = 26.69 (CH3C), 35.73 (CH3C), 65.27 (CHN), 127.07, 128.71, 131.99 (arom CH), 133.72 
(arom C), 138.85 (CH=CHCHO), 139.39 (CH=CHCHO), 167.50 (PhC=O), 192.49 (CHO), 
199.93 (CHC=O) ppm. 
IR (CHCl3):  
ῦ = 3340 (s), 3061 (m), 2964 (vs), 2873 (s), 1796 (s), 1761 (vs), 1649 (vs), 1579 (m), 1519 (vs), 
1485 (vs), 1368 (m), 1332 (m), 1110 (m), 1076 (m), 1027 (m), 932 (m), 757 (vs), 713 (s) cm−1. 
 
MS (EI, 70 eV):  
m/z (%) 191 (5), 190 (44), 106 (6), 105 (100), 77 (18). 
 
MS (CI, 100 eV, isobutane):  
m/z (%) = 274 (59) [M+•+1], 258 (19), 257 (18), 256 (100), 200 (11), 190 (27), 137 (12), 105 
(27). 
 
Elemental Analysis: 
Anal. Calcd for C16H19NO3:   C = 70.31  H = 7.01  N = 5.12 
Found:          C = 69.94  H = 7.24 N = 4.78 
 
3.21.6 N-acetyl-benzamide (205) 
 
Me
O
N
H
O
 
 
To a well stirred solution of benzamide 200f (150 mg, 0.70 mmol) in 54 ml of a 
H2O/Acetone/CH2Cl2 (1/0.8/0.9) mixture, were added 0.9 g of NaHCO3 followed by 1.5 g of 
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Experimental Part 
 
 
 
 
 
ῦ = 3468 (m), 3275 (s), 1738 (vs), 1678 (s), 1513 (vs), 1485 (vs), 1282 (s), 1214 (vs), 706 (vs), 
553 (m) cm
Anal. Calcd for C 9NO   C = 66.25  H = 5.56  N = 8.58 
 
oxone, according to GP17. After work-up, purification by flash chromatography (Et2O:pentane = 
1:1) afforded 205 (57 mg, 0.35 mmol) as a colorless solid. 
 
Yield: colorless solid, 57 mg, 50% 
Mp: 73-75°C 
1H-NMR (300 MHz, CDCl3): 
δ = 2.61 (s, 3H, CH3C=O), 7.10 (d, 1H, J = 11.9 Hz, CHCH), 7.42-7.50 (m, 2H, arom CH), 7.58-
7.63 (m, 1H, arom CH), 7.87-7.90 (m, 2H, arom CH), 9.01-9.08 (br, 1H, NH) ppm. 
13C NMR (75 MHz, CDCl3): 
δ = 25.55 (CH3C=O) 127.56, 128.78 (arom CH), 132.49 (arom C), 133.04 (arom CH), 167.55 
(PhC=O), 173.39 (COCH3) ppm. 
IR (CHCl3):  
−1. 
 
MS (EI, 70 eV):  
m/z (%) = 163 (20) [M+•], 148 (5), 106 (8), 105 (100), 77 (47), 51 (23), 50 (8). 
 
Elemental Analysis: 
9H 2: 
Found:         C = 66.14  H = 5.41 N = 8.61 
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Acet.         Acetone 
CbzCl        Benzylchloroformate 
3   Abbreviations 
 
AcOEt        Ethyl acetate 
AcOH        Acetic acid 
Ar          Aryl 
Arom        Aromatic 
Boc2O        Di-tert-butyl-dicarbonate 
CAL-B        Candida antarctica B lipase 
CoA         Coenzyme A 
DDQ         2,3-Dichloro-5,6dicyano-1,4-benzoquinone 
DMAP        Dimethyl-amino-pyridine 
DMPU        1,3-Dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone 
EWG         Electron withdrawing 
LDA         Lithium-diisopropylamide 
m-CPBA       meta-Chloro-perbenzoic acid 
Me-DuPHOS      1,2-Bis(trans-2,5-dimethylpospholano)benzene 
Menth        Menthyl 
MOD-DIOP  4,5-Bis[bis(4'-methoxy-3',5'-dimtethylphenyl)phosphinomethyl]-
2,2-dimethyl-1,3-dioxolane 
4-MPPIM       1-(3-Phenylpropanoyl)-2-oxoimidazolidine-4-carboxylate 
NaHMDS       Sodium-bis(trimethylsylil)amide 
PAF         1-O-hexadecyl/octadecyl-2-acetyl-sn-glyceryl-3-posphorylcholine 
p-TsOH        para-Toluenesulfonic acid 
Ra-Ni        Nichel-Raney 
RAMP        (R)-(+)-amino-2-(-methoxymethyl)-pyrrolidine 
SAMP        (S)-(−)-amino-2-(-methoxymethyl)-pyrrolidine 
TFA         Trifluoroacetic acid 
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